0/0//2
‫התשס"ח‬/'‫ח‬
‫רשומות‬
ISRAEL STATE RECORDS
‫ח' בניסן התשס"ח‬
April 13, 2008
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Patents expired
Notices
Changes in particulars entered
in register
Corrigenda
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
Changes in particulars entered
in register
‫עמוד‬
Page
936
649
648
646
658
658
658
698
693
694
i
699
688
686
686
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫פטנטים שפג תוקפם‬
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫תיקוני טעויות‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.00::/ -‫ ו‬2::/ ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬0../ ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. /-0404.-0
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 69.
.₪ 69 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 85858.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
April 13, 2008– ‫ח' בניסן התשס"ח‬
.₪ 0,0.0 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,06 '‫מס‬
452
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
Applicant
Priority right: Convention country –
Number and date of
Foreign application
‫ לחוק הפטנטים‬09 ‫הודעה לפי סעיף‬
0697 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬:0 ‫בתקנה‬
:0692–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
453
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096/90661
174325
DNA VACCINE COMPOSITIONS AND
METHODS OF USE
UNIVERSITY OF KANSAS MEDICAL
CENTER
US
60/503197
16/09/2003
889648894
8598698884
US
PCT/US/2004/030512
WO/2005/027844
0096/90661
174536
THERAPEUTIC TREATMENT
ASTRAZENECA UK LIMITED
GB
0322552.1
26/09/2003
PCT/GB/2004/004120
WO/2005/030215
4/94490661
174741
COMBINATIONAL RADIOTHERAPY
AND CHEMOTHERAPY
COMPOSITIONS AND METHODS
NOVOGEN RESEARCH PTY LTD.
AU
2003906386 19/11/2003
PCT/AU/2004/001619
WO/2005/049008
6094690661
174763
TREATMENT OF DISEASES
INVOLVING ErbB2 KINASE
OVEREXPRESSION
MARS, INCORPORATED
US
60/510604
10/10/2003
PCT/US/2004/033355
WO/2005/034879
April 13, 2008– ‫ח' בניסן התשס"ח‬
A01N
‫תרכיבי חיסון דנ"א ושיטות לשימוש‬
A61K
‫טיפול רפואי‬
A61K
‫תכשירי קומבינציה רדיותראפיים‬
‫וכמותראפיים ושיטות‬
A61K
‫טיפול במחלה המעורבת בביטוי יתר של‬
ErbB2 ‫קינאז‬
454
6094690661
174765
METHOD OF TREATING AIRWAY
DISEASES WITH BETA-ADRENERGIC
INVERSE AGONISTS
INVERSEON, INC.
US
60/510250
989555868
US
PCT/US/2004/033157
WO/2005/034871
6094690661
174776
174800
BONE MORPHOGENETIC PROTEIN
(BMP) 2A AND USES THEREOF
QUARK PHARMACEUTICALS, INC.
US
60/509279
07/10/2003
PCT/IL/2004/000924
WO/2005/041857
455
‫שיטה לטיפול במחלות נתיבי אויר‬
–‫באמצעות אגוניסטיים נגדיים בתא‬
‫אדרנרגים‬
09/10/2003
8398398884
SYSTEMS AND METHODS FOR
IMMOBILIZATION USING CHARGE
DELIVERY
TASER INTERNATIONAL, INC.
US
60/509577
07/10/2003
989586468
8698898883
US
889884588
8398898883
US
889858384
3898898883
US
PCT/US/2004/033105
WO/2005/086618
6094690661
A61K
H05C
‫מערכות ושיטות למניעת תנועה בעזרת‬
‫מתן מטענים חשמליים‬
C07H
‫ ושימושיו‬BMP 2A ‫חלבון‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0094690661
174807
eNOS TRANSCRIPTION ENHANCERS
FOR USE IN THE CELL THERAPY OF
ISCHEMIC HEART DISEASES
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
03025512.9 06/11/2003
PCT/EP/2004/011944
WO/2005/044249
6094690661
4094690661
A61K
‫טבליות המכילות ונלאפקסין הידרוכלוריד‬
174864
A THERAPEUTIC COMBINATION OF
VX-497 AND RIBAVIRIN AND KITS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/510733
11/10/2003
PCT/US/2004/033739
WO/2005/037274
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ לשימוש בריפוי‬ENOS ‫מגבירי שעתוק‬
‫תאים במחלות לב איסכמיות‬
174830
PELLETS CONTAINING
VENLAFAXINE HYDROCHLORIDE
EGIS GYOGYSZERGYAR RT.
HU
P0303382
10/10/2003
PCT/HU/2004/000095
WO/2005/034930
A61K
A61K
‫ וריבאווירין‬VX–497 ‫שילוב תרופתי של‬
‫וערכות המכילות אותן‬
456
4094690661
174918
METHODS AND REAGENTS FOR THE
TREATMENT OF
IMMUNOINFLAMMATORY
DISORDERS
COMBINATORX, INC.
US
60/512415
15/10/2003
PCT/US/2004/033656
WO/2005/037203
4/94690661
‫שיטות וחומרי תגובה עבור טיפול‬
‫בהפרעה דלקתית כתגובה חיסונית‬
174927
174958
SUSTAINED RELEASE
PHARMACEUTICAL COMPOSITIONS
COMPRISING APLINDORE AND
DERIVATIVES THEREOF
WYETH
US
60/515315
29/10/2003
PCT/US/2004/036013
WO/2005/044262
0494690661
457
A61K
‫תכשירי רוקחות לשחרור מבוקר המכילים‬
‫אפילינדור ותולדותיו‬
174968
THE USE OF IFENPRODIL IN THE
TREATMENT OF PAIN
ARAKIS LTD.
GB
0324583.4
21/10/2003
848589844
8898898884
GB
PCT/GB/2004/004459
WO/2005/041964
0094690661
A61K
‫שימוש בתרכובות אורגניות‬
USE OF ORGANIC COMPOUNDS
NOVARTIS AG
US
60/512634
20/10/2003
PCT/EP/2004/011824
WO/2005/037278
0094690661
A61K
174986
A61K
‫השימוש של איפאנפרודיל בטיפול בכאב‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
IMMUNOGENIC COMPOSITION AND
METHOD OF DEVELOPING A
VACCINE BASED ON FUSION
PROTEIN
NMK RESEARCH, LLC
US
60/513827
23/10/2003
PCT/US/2004/035317
WO/2005/039501
0094690661
‫הרכב אימונוגני ושיטה לפיתוח תרכיב על‬
‫בסיס חלבון מחובר‬
175032
INHALABLE PHARMACEUTICAL
FORMULATIONS EMPLOYING
LACTOSE ANHYDRATE NAD
METHODS OF ADMINISTERING THE
SAME
GLAXO GROUP LIMITED
US
60/515077
28/10/2003
PCT/US/2004/035129
WO/2005/044187
0/94690661
175055
COMBINATIONS USEFUL FOR THE
TREATMENT OF NEURONAL
DISORDERS
PROBIODRUG AG
US
60/516717
03/11/2003
PCT/EP/2004/012301
WO/2005/049027
6094490661
April 13, 2008– ‫ח' בניסן התשס"ח‬
175064
A61K
‫תכשיר רוקחות לשאיפה המכיל לקטאז‬
‫אנהידראט ושיטות למתן התכשיר‬
A61K
‫צירופים המשמשים לטיפול באי סדרים‬
‫נוירונאלים‬
A61K
458
DESENSITIZATION OF
COMPLEMENT ACTIVATION USING
MONOCYTE/MACROPHAGE
INHIBITORY COMPOUNDS
BIOREST LTD.
US
60/518405
07/11/2003
PCT/IB/2004/003620
WO/2005/044175
0096190661
‫ביורסט בע"מ‬
175074
METHODS OF USING AND
COMPOSITIONS COMPRISING
SELECTIVE CYTOKINE INHIBITORY
DRUGS FOR TREATEMENT,
MODIFICATION AND MANAGEMENT
OF PAIN
CELGENE CORPORATION
US
10/693794
23/10/2003
PCT/US/2004/012722
WO/2005/043971
4094690661
‫ביטול רגישות של שיפעול משלים על ידי‬
‫תרכובות מעכבות מונוציטים‬
‫ומאקרופאגים‬
‫שיטות לשימוש והרכבים המכילים תרופות‬
,‫מעכבות ציטוקין באופן סלקטיבי לטיפול‬
‫תיקון וניהול של כאב‬
175080
MODERATING THE EFFECT OF
ENDOTOXINS
NESTEC S.A.
EP
03023015.5 13/10/2003
PCT/EP/2004/011470
WO/2005/039609
4/94690661
459
A01N
175085
A61P
‫מיתון ההשפעה של אנדוטוקסינים‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
–‫שימוש בתרכובות אנטגוניסטיות ל‬
‫ בטיפול‬CRTH2
USE OF CRTH2 ANTAGONIST
COMPOUNDS IN THERAPY
OXAGEN LIMITED
GB
0324763.2
23/10/2003
PCT/GB/2004/004417
WO/2005/044260
0094690661
175098
METHODS AND COMPOSITIONS
COMPRISING THALIDOMIDE FOR
TREATMENT OF FIBROMYALGIA
CELGENE CORPORATION
US
60/514548
24/10/2003
PCT/US/2004/035180
WO/2005/039497
0094690661
0094690661
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטות והרכבים המכילים תלידומיד‬
‫לטיפול בפיברומיאלגיה‬
175103
USE OF A PYRAZOLE DERIVATIVE
FOR PREPARING MEDICAMENTS
FOR THE PREVENTION AND THE
TREATMENT OF DYSLIPIDEMIA AND
ILLNESSES ASSOCIATED WITH
DYSLIPIDEMIA AND/OR OBESITY
SANOFI-AVENTIS
FR
0312553
24/10/2003
8384893
8598898883
FR
8488863
8598898884
FR
8483858
8998398884
FR
PCT/FR/2004/002715
WO/2005/046689
A61K
A61K
‫שימוש בתולדה של פיראזול להכנת‬
‫מוצרים רפואיים השימושיים במניעה‬
‫וטיפול של דיסליפידאמיאס ומחלות‬
‫או לשמינות‬/‫הקשורות לדיסליפידאמיאס ו‬
175128
A61K
460
‫ לטיפול בלימפומה של קרום‬CCI – 776
‫התא‬
CCI-779 FOR TREATING MANTLE
CELL LYMPHOMA
MAYO FOUNDATION FOR MEDICAL
EDUCATION AND RESEARCH
US
60/517329
04/11/2003
PCT/US/2004/035900
WO/2005/046681
0694690661
175147
PHARMACEUTICAL FORMULATIONS
CONTAINING FLAVOURING
SUBSTANCES WITH IMPROVED
PHARMACEUTICAL PROPERTIES
BAYER HEALTHCARE AG
DE
10351448.1 04/11/2003
PCT/EP/2004/012327
WO/2005/044271
0094690661
4094490661
461
‫פורמולציות רוקחיות המכילות חומרי טעם‬
‫בעלות תכונות רוקחיות משופרות‬
175193
ONCE-A-DAY, ORAL, CONTROLLEDRELEASE, OXYCODONE DOSAGE
FORMS
ALZA CORPORATION
US
60/515880
29/10/2003
PCT/US/2004/036132
WO/2005/041968
A61K
A61K
,‫צורות מינון של אוקסיקודון במתן–מבוקר‬
‫ פעם ביום‬,‫אוראלי‬
175228
G06F
April 13, 2008– ‫ח' בניסן התשס"ח‬
USE OF PUBLIC SWITCHED
TELEPHONE NETWORK FOR
CAPTURING ELECTRONIC
SIGNATURES IN ON-LINE
TRANSACTIONS
AUTHENTIFY, INC.
US
10/714314
14/11/2003
PCT/US/2004/038579
WO/2005/076782
0094690661
175235
USE OF BIOCOMPATIBLE POLYMERS
FOR THE PREPARATION OF A
COMPOSITION OR A MEDICAL
DEVICE
ORGANES TISSUS REGENERATION
REPARATION REMPLACEMENTOTR3
FR
0312605
28/10/2003
8483558
8598498884
FR
PCT/FR/2004/002780
WO/2005/041986
6094490661
‫שימוש ברשת טלפונית ממותגת ציבורית‬
‫לקבלת חתימות אלקטרוניות בעיסקות און‬
‫ליין‬
‫שימוש בפולימרים ביוקומפטביליים להכנה‬
‫של תכשיר או מכשיר רפואי‬
175247
MONOMETHYLVALINE
COMPOUNDS CAPABLE OF
CONJUGATION TO LIGANDS
SEATTLE GENETICS, INC.
US
60/518534
06/11/2003
989558889
8998398884
US
989566666
8498698884
US
989988455
8898898884
US
PCT/US/2004/038392
WO/2005/081711
0494690661
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
175257
A61K
‫תרכובות מונומתילואליניות המסוגלות‬
‫להתחבר לליגנדות‬
B29C
462
METHOD FOR PRODUCING
ABRASIVE NON-WOVEN CLOTH
N.R. SPUNTECH INDUSTRIES LTD.
IL
158781
06/11/2003
889685868
8998498884
US
PCT/IL/2004/000997
WO/2005/044177
0096190661
175311
CYTOKINE INHIBITORY DRUGS FOR
TREATMENT OF MACULAR
DEGENERATION
CELGENE CORPORATION
US
10/699110
30/10/2003
PCT/US/2004/013253
WO/2005/044269
0096190661
175312
COMPOSITION AND METHOD FOR
TREATING MACULAR
DEGENERATION
CELGENE CORPORATION
US
10/699154
30/10/2003
PCT/US/2004/013252
WO/2005/044259
0094690661
175334
USE OF A HYDROXIMIC ACID
HALIDE DERIVATIVE IN THE
TREATMENT OF
NEURODEGENERATIVE DISEASES
CYTRX CORPORATION
HU
P0303584
30/10/2003
PCT/HU/2004/000098
WO/2005/041965
6094490661
463
175340
‫שיטה לייצור בד שורט לא–ארוג‬
‫ ספונטק תעשיות בע"מ‬.‫ר‬.‫נ‬
A61K
‫תרופות מעכבות ציטוקין לטיפול בניוון‬
‫מקולרי‬
A61K
‫תרכובת ושיטה לטיפול בניוון מקולרי‬
A61K
‫שימוש של נגזרת הליד מחומצה‬
‫הידרוקסימית לטיפול במחלות ניוון עצבי‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הרכבים של סטרואידים רכים לשימוש‬
‫במשאפי אבקה יבשה‬
SOFT STEROID COMPOSITIONS FOR
USE IN DRY POWDER INHALERS
NORTON HEALTHCARE LTD.
US
60/517324
03/11/2003
PCT/US/2004/036477
WO/2005/041980
4094490661
175369
NOVEL COMPOUND,
CORRESPONDING COMPOSITIONS,
PREPARATION AND/OR TREATMENT
METHODS
SMITHKLINE BEECHAM
CORPORATION
US
60/519160
12/11/2003
989584584
8498898883
US
PCT/US/2004/037626
WO/2005/046608
0094490661
6094490661
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ הכנה‬,‫ תכשירים תואמים‬,‫תרכובת חדשה‬
‫או שיטות טיפול‬/‫ו‬
175380
OPHTHALMOLOGIC
PHARMACEUTICAL COMPOSITIONS
CONTAINING A HYDROXYLAMINE
COMPOUND
OTHERA PHARMACEUTICALS, INC.
US
60/523802
20/11/2003
PCT/US/2004/039719
WO/2005/051328
A61K
A61K
‫תכשירי רוקחות לעניים המכילים תרכובת‬
‫הידרוקסילאמין‬
175385
A61K
464
PHARMACEUTICALLY ACCEPTABLE
SALTS OF QUINOLINONE
COMPOUNDS HAVING IMPROVED
PHARMACEUTICAL PROPERTIES
NOVARTIS VACCINES AND
DIAGNOSTICS, INC.
US
60/517915
07/11/2003
989589485
8898898883
US
989589489
8898898883
US
989549888
8698898884
US
PCT/US/2004/036941
WO/2005/046589
0094690661
BI-LEVEL COUPLER
WERLATONE, INC.
US
10/731174
PCT/US/2004/035936
WO/2005/060436
6094490661
175401
465
H01P
‫מצמד בטכנולוגיית מידע עסקי‬
08/12/2003
175424
4-ANILINO-3QUINOLINECARBONITRILES FOR
THE TREATMENT OF CHRONIC
MYELOGENOUS LEUKEMIA (CML)
WYETH
US
60/517819
06/11/2003
PCT/US/2004/036722
WO/2005/046693
6194490661
‫מלחים של תרכובות קווינולינוניות‬
‫המקובלים מבחינה רוקחית בעלי תכונות‬
‫רוקחיות משופרות‬
A61K
‫–קוינולינקרבוניטרילים לטיפול‬:–‫–אנילינו‬4
)CML( ‫בלוקמיה מיאלוג'נוס כרונית‬
175426
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
METHODS OF USING AND
COMPOSITIONS COMPRISING PDE4
MODULATORS FOR THE
TREATMENT AND MANAGEMENT
OF ASBESTOS-RELATED DISEASES
AND DISORDERS
CELGENE CORPORATION
US
60/518603
06/11/2003
PCT/US/2004/037082
WO/2005/046592
6194490661
‫שיטות שימוש ותרכובות המכילות‬
‫ לטיפול וניהול‬PDE 4 ‫מודולטורים של‬
‫מחלות והפרעות הקשורות לאזבסט‬
175427
METHODS AND COMPOSITIONS
USING THALIDOMIDE FOR THE
TREATMENT AND MANAGEMENT
OF CANCERS AND OTHER DISEASES
CELGENE CORPORATION
US
60/517405
06/11/2003
PCT/US/2004/037083
WO/2005/046593
6194490661
4/96190661
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטות ותרכובות העושות שימוש‬
‫בתלידומיד לטיפול וניהול של מחלות‬
‫הסרטן ומחלות אחרות‬
175428
METHODS OF USING AND
COMPOSITIONS COMPRISING A JNK
INHIBITOR FOR THE TREATMENT
AND MANAGEMENT OF ASBESTOSRELATED DISEASES AND
DISORDERS
CELGENE CORPORATION
US
60/518601
06/11/2003
PCT/US/2004/037084
WO/2005/046594
A61K
A61K
‫שיטות לשימוש ותכשירים הכוללים מעכב‬
‫ לטיפול וניהול מחלות והפרעות‬JNK
‫הקשורות לאזבסט‬
175436
A61K
466
USE OF CATHEPSIN K INHIBITORS
FOR TREATING OF SEVERE BONE
LOSS DISEASES
NOVARTIS AG
EP
03026430.3 19/11/2003
PCT/EP/2004/004155
WO/2005/049028
4194090661
‫שימוש במעכבי קטפסין לטיפול במחלות‬
‫דלדול עצם חמור‬
175446
METHOD AND DEVICE FOR GRAB
TRANSFERRING AN INSTANT
MESSAGING AND PRESENCE (IMP)
SESSION
MOTOROLA, INC.
US
10/744894
23/12/2003
PCT/US/2004/041739
WO/2005/065163
0094490661
175498
PHARMACEUTICAL COMPOSITIONS
CONTAINING NHYDROXYPIPERIDINE DERIVATIVES
OTHERA PHARMACEUTICALS, INC.
US
60/523803
20/11/2003
PCT/US/2004/039716
WO/2005/055926
6/94490661
467
175556
G06F
‫שיטה והתקן להעברה מידית של מסר‬
‫ונוכחות אודות עבודה מכל מחשב‬
A61K
–N ‫תכשירי רוקחות המכילים תולדות‬
‫הידרוקסיפיפראדין‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
PHARMACEUTICAL COMPOSITION
FOR ORAL ADMINISTRATION OF A
PYRAZOL-3-CARBOXAMIDE
DERIVATIVE
SANOFI AVENTIS
FR
0313259
10/11/2003
PCT/FR/2004/002875
WO/2005/046690
4096/90661
175562
MULTILAYER DOSAGE FORM
COMPRISING A MATRIX THAT
INFLUENCES RELEASE OF A
MODULATORY SUBSTANCE
ROHM GMBH & CO. KG
DE
10353196.3 13/11/2003
PCT/EP/2004/010300
WO/2005/046561
4094490661
‫תכשיר תרופתי למתן פומי של נגזרת‬
‫–קרבוקסאמיד‬:–‫פירזול‬
‫צורת מתן רב שכבתית המכילה מטריצה‬
‫אשר משפיעה על שחרור חומר מאפנן‬
175578
INHIBITORS OF THE MUTANT FORM
OF KIT
NOVARTIS AG
US
60/520714
18/11/2003
PCT/EP/2004/013045
WO/2005/049032
4094490661
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
175599
A61K
‫מעכבים בעלי צורה מוטנטית של ערכה‬
A61F
468
SURFACTANT-BASED GEL AS AN
INJECTABLE, SUSTAINED DRUG
DELIVERY VEHICLE
ALZA CORPORATION
US
60/519989
14/11/2003
889665886
8898898884
US
PCT/US/2004/037782
WO/2005/048930
6/94490661
‫ג'ל על בסיס חומר פעיל שטח כאמצעי בר‬
‫הזרקה לשחרור מושהה של תרופה‬
175611
COMBINATIONS FOR THE
TREATMENT OF PROLIFERATIVE
DISEASES
COMBINATORX, INC.
US
60/519551
12/11/2003
889655838
8898598884
US
PCT/US/2004/037527
WO/2005/046607
4/94490661
175615
PHARMACEUTICAL COMPOSITIONS
AND KITS CONTAINING A
CHOLINESTERASE INHIBITOR AND
AN ANTIDEPRESSANT
THERACOS, INC
US
60/523610
19/11/2003
889663469
8698898884
US
PCT/US/2004/038981
WO/2005/051297
6094090661
469
175665
A61K
‫צירופים עבור טיפול במחלות המתרבות‬
‫במהירות‬
A61K
‫תכשירי רוקחות וערכות המכילים מעכב‬
‫כולינאסטרז ודוחה דיכאון‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
PHARMACEUTICAL COMPOSITIONS
AND KITS CONTAINING AN
ANTINEOPLASTIC THIOL-BINDING
MITOCHONDRIAL OXIDANT AND AN
ANTINEOPLASTIC NUCLEIC ACID
BINDING AGENT
THE ARIZONA BOARD OF REGENTS
ON BEHALF OF THE UNIVERSITY OF
ARIZONA
US
60/528181
08/12/2003
PCT/US/2004/041093
WO/2005/055952
4/94490661
‫תכשירי רוקחות וערכות המכילים מחמצן‬
–‫מיטוכונדריאלי אנטיניופלסטי המקשר‬
‫טיול וחומצת גרעין אנטיניופלסטית המהוה‬
‫חומר מקשר‬
175680
METHODOLOGY AND APPARATUS
FOR THE DETECTION OF
BIOLOGICAL SUBSTANCES
BIOWARN, LLC.
US
60/523303
20/11/2003
889666886
8998898884
US
PCT/US/2004/037184
WO/2005/081707
4094490661
6094490661
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטה ומכשיר לאיתור חומר ביולוגי‬
175684
METHOD AND APPARATUS FOR
DATA STORAGE USING STRIPING
SPINNAKER NETWORKS, INC.
US
10/727169
02/12/2003
PCT/US/2004/038423
WO/2005/060477
G01N
G06F
‫שיטה ומכשיר לאחסון מידע על ידי שימוש‬
‫בפסים‬
175746
A61K
470
ORAL FORMULATIONS OF
DESOXYPEGANINE AND USES
THEREOF
HF ARZNEIMITTELFORSCHUNG
GMBH
DE
10354894.7 24/11/2003
PCT/EP/2004/012606
WO/2005/053698
0194490661
‫תכשירים פומיים של דסוקסיפגנין‬
‫ושימושים שלהם‬
175749
CHAPERONE - BASED THERAPY FOR
NIEMANN-PICK DISEASE
MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK
UNIVERSITY
US
60/525497
25/11/2003
PCT/US/2004/041345
WO/2005/051331
0094090661
471
‫טיפול מבוסס צ'פרון במחלת ניימן–פיק‬
175762
USE OF SUBSTITUTED 2AMINOTETRALINES FOR THE
PREVENTATIVE TREATMENT OF
PARKINSON'S DISEASE
SCHWARZ PHARMA AG
DE
10361258.0 24/12/2003
PCT/EP/2004/014656
WO/2005/063238
6094090661
A61K
A61K
‫–אמינו טטראלינים מותמרים‬0–‫שימוש ב‬
‫לטיפול מונע של מחלת פרקינסון‬
175764
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
PHARMACEUTICAL PREPARATION
CONTAINING GABAPENTIN
ZAMBON GROUP S.P.A.
IT
MI2003A002399 09/12/2003
PCT/EP/2004/053233
WO/2005/055993
6094490661
175772
USE OF DEOXYPEGANINE FOR
TREATING SCHIZOPHRENIC
PSYCHOSES
HF ARZNEIMITTELFORSCHUNG
GMBH
DE
10354893.9 24/11/2003
PCT/EP/2004/012605
WO/2005/053673
4094090661
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
‫שימוש בדאוקסיפגנין לטיפול בפסיכוזה‬
‫סכיזופרנית‬
175774
USE OF SIRAMESINE IN THE
TREATMENT OF CANCER
H. LUNDBECK A/S
DK
PA200301889 19/12/2003
PCT/DK/2004/000885
WO/2005/058324
4094490661
‫תכשיר רוקחות המכיל גאבאפנטין‬
175780
A61K
‫שימוש בסירמסין בטיפול בסרטן‬
A61K
472
METHODS AND COMPOSITIONS FOR
THE TREATMENT OF
HELICOBACTER PYLORIASSOCIATED DISEASES USING
ENDOPEROXIDE BRIDGECONTAINING COMPOUNDS
VECTA LTD.
US
60/523114
19/11/2003
PCT/IB/2004/003759
WO/2005/048912
4094490661
‫שיטות ותכשירים לטיפול במחלות‬
‫הקשורות בהליקובקטר פילורי באמצעות‬
‫תרכובות המכילות אנדופראוקסיד‬
175781
METHODS AND REAGENTS FOR THE
TREATMENT OF INFLAMMATORY
DISORDERS
COMBINATORX, INC.
US
60/524117
21/11/2003
PCT/US/2004/038512
WO/2005/051293
0094490661
175792
TUBULAR PROTEINURIA AS
INDICATOR FOR ELEVATED
CARDIOVASCULAR RISK
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
03027312.2 26/11/2003
PCT/EP/2004/013511
WO/2005/051379
6094090661
473
175812
‫פלד‬-‫וקטה בע"מ אצל דר' אסנת בר‬
A61K
‫שיטות וחומרי תגובה עבור טיפול‬
‫בהפרעה דלקתית‬
A61K
‫חלבון צינורי בשתן כאינדיקטור לעליה‬
‫בסיכון קרדיו–וסקולרי‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
PYRROLO [2,3-D] PYRIMIDINE
COMPOUNDS FOR TREATING
TRANSPLANT REJECTION
PFIZER PRODUCTS, INC.
US
60/531180
17/12/2003
PCT/IB/2004/004034
WO/2005/060972
6094090661
176068
METHOD AND APPARATUS FOR
ACQUIRING MULTIDIMENSIONAL
SPECTRA AND IMPROVED
UNIDIMENSIONAL SPECTRA WITHIN
A SINGLE SCAN
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
10/728069
04/12/2003
PCT/US/2004/040449
WO/2005/062753
4094090661
‫] פירימידין לטיפול‬D–:,0[ ‫תרכובות פירולו‬
‫בדחיית שתל‬
‫שיטה והתקן לקבלת ספקטרום רב מימדי‬
‫וספקטרא חד–מימדית משופרת בסריקה‬
‫אחת‬
176335
OPERATOR CONTROL UNIT WITH
TRACKING
ANTHROTRONIX, INC.
US
10/739603
18/12/2003
PCT/US/2004/042353
WO/2005/060666
0694090661
April 13, 2008– ‫ח' בניסן התשס"ח‬
G01V
176382
‫ידע חברה למחקר ופיתוח בע"מ‬
H04N
‫יחידת בקרה למפעיל עם מעקב‬
C07K
474
METHOD AND COMPOSITIONS FOR
DETECTING BOTULINUM
NEUROTOXIN
WISCONSIN ALUMNI RESEARCH
FOUNDATION
US
60/530645
19/12/2003
989586854
8598998884
US
PCT/US/2004/042366
WO/2005/076785
6094090661
176393
PATTERNED LASER TREATMENT OF
THE RETINA
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY
US
10/745954
24/12/2003
PCT/US/2004/040562
WO/2005/065116
6096490660
176436
TRANSPORT FORMAT
COMBINATION SELECTION IN A
WIRELESS TRANSMIT/RECEIVE
UNIT
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/535426
09/01/2004
889886466
8898898884
US
PCT/US/2005/000571
WO/2005/067659
4696490660
475
176565
‫שיטה ותרכובות לגילוי רעלן עצבי מסוג‬
‫בוטולינום‬
A61B
‫טיפול תבניתי בלייזר של הרישתית‬
H04B
‫תצריפים ובחירת פורמאט להעברה‬
‫קליטה אלחוטית‬/‫ביחידת שידור‬
C07K
April 13, 2008– ‫ח' בניסן התשס"ח‬
O-LINKED GLYCOSYLATION OF
PEPTIDES
NEOSE TECHNOLOGIES, INC.
US
60/535284
08/01/2004
989544488
8898898884
US
989549938
8898898884
US
989555683
8398398884
US
989588668
8898598884
US
PCT/US/2005/000799
WO/2005/070138
6094090661
176579
USE OF A LYOPHILISATE OF
DEDIFFERENTIATED PLANT CELLS
FOR SKIN DEPIGMENTATION
AND/OR LIGHTENING
BIOTECHMARINE
FR
0315521
29/12/2003
PCT/FR/2004/003109
WO/2005/072697
0094090661
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
–‫שימוש בליאופיליסאט של תאי צמח דה‬
‫או‬/‫מובחנים לדפיגמנטציה של העור ו‬
‫הבהרה‬
176580
PAYMENT SYSTEMS AND METHODS
FOR EARNING INCENTIVES USING
AT LEAST TWO FINANCIAL
INSTRUMENTS
BCD REWARDS, LLC
US
10/748710
30/12/2003
PCT/US/2004/043667
WO/2005/065314
0096490660
‫ של חלבונים‬O–‫גליקולזילציה לקשר‬
G06Q
‫מערכת תשלום ושיטות להרוויח תמריצים‬
‫המשתמשות בלפחות שני כלים פיננסיים‬
176594
C07H
476
MODIFIED HUMAN FOUR HELICAL
BUNDLE POLYPEPTIDES AND THEIR
USES
AMBRX, INC.
US
60/541528
02/02/2004
989568384
8698998884
US
989568885
8698998884
US
989568665
8698998884
US
989936989
8898898884
US
PCT/US/2005/003537
WO/2005/074650
0096490660
‫ שונים ושימושיהם‬HB4 ‫פוליפפטידים‬
176595
MODIFIED HUMAN GROWTH
HORMONE POLYPEPTIDES AND
THEIR USES
AMBRX, INC.
US
60/541528
02/02/2004
989568384
8698998884
US
989568885
8698998884
US
989568665
8698998884
US
989936989
8898898884
US
PCT/US/2005/002724
WO/2005/074546
0096490660
0496490660
477
‫פוליפפטידים שונים של הורמון גדילה‬
‫אנושי ושימושיהם‬
176596
MODIFIED HUMAN INTERFERON
POLYPEPTIDES AND THEIR USES
AMBRX, INC.
US
60/541528
02/02/2004
989568384
8698998884
US
989568885
8698998884
US
989568665
8698998884
US
989936989
8898898884
US
PCT/US/2005/002599
WO/2005/074524
C12P
C07K
‫פוליפפטידים שונים של אינטרפרון אנושי‬
‫ושימושיהם‬
177012
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
QUINOLINE DERIVATIVES AND USE
THEREOF AS MYCOBACTERIAL
INHIBITORS
JANSSEN PHARMACEUTICA N.V.
US
60/538907
23/01/2004
PCT/EP/2005/050271
WO/2005/070430
4096490660
177155
THERAPEUTIC COMBINATIONS
PFIZER INC
US
60/540749
30/01/2004
989985888
8898898884
US
PCT/IB/2005/000101
WO/2005/082362
6096090660
177271
HEPARANASE INHIBITORS AND
USES THEREOF
INSIGHT BIOPHARMACEUTICALS
LTD.
US
60/541904
06/02/2004
PCT/IL/2005/000149
WO/2005/074375
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
177330
‫תולדות קווינוליניות ושימושן כמעכבות‬
‫מיקובקטריות‬
A61K
‫צירופים רפואיים‬
C07C
‫מעכבי הפאראנז ושימושים שלהם‬
‫אינסייט ביופרמצבטיקה בע"מ‬
G01N
478
‫קבצי שטף מולקולרי דרך מסלולים‬
‫קריטיים הנמדדים באמצעות סימון‬
‫ כסמנים ביולוגיים‬,‫באיזוטופים בגוף החי‬
‫של פעילות של תרופות ופעילות של‬
‫מחלה‬
MOLECULAR FLUX RATES
THROUGH CRITICAL PATHWAYS
MEASURED BY STABLE ISOTOPE
LABELING IN VIVO, AS BIOMAKERS
OF DRUG ACTION AND DISEASE
ACTIVITY
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/546580
20/02/2004
989568886
8898998884
US
PCT/US/2005/005660
WO/2005/081943
0096090660
177644
INHIBITORS OF
DIPEPTIDYLPEPTIDASE IV FOR
REGULATING GLUCOSE
METABOLISM
TRUSTEES OF TUFTS COLLEGE
US
60/547227
23/02/2004
989566339
8998698884
US
PCT/US/2005/006128
WO/2005/082348
0096090660
‫ עבור ויסות‬IV ‫מעכבי דיפפטידילפפטידאז‬
‫חילוף חומרים של גלוקוז‬
178215
ENHANCEMENT OF
ANTITUBERCULAR ACTIVITY OF
EXTRACTS OF SALICORNIA
BRACHIATA
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH
IN
0969DEL2004 27/05/2004
PCT/IN/2005/000168
WO/2005/115424
0/96190661
479
A61K
A61K
‫הגברה של הפעילות האנטישחפתית של‬
SALICORNIA BRACHIATA‫מיצויי‬
178399
C07H
April 13, 2008– ‫ח' בניסן התשס"ח‬
USE OF SPINOSYNS FOR WOUND
HEALING
ELI LILLY AND COMPANY
‫שימוש בספינוסינס לריפוי פצעים‬
PCT/US/2004/011268
WO/2005/112950
0/96190660
178458
MANAGEMENT OF BREAKTHROUGH
BLEEDING IN EXTENDED
HORMONAL CONTRACEPTIVE
REGIMENS
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
US
60/566443
30/04/2004
989585884
8698598884
US
989588866
8898998884
US
989936368
8898898884
US
989998896
8898398885
US
PCT/EP/2005/004777
WO/2005/105103
0096190660
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫טיפול בדימום במשטרים ממושכים‬
‫הורמונליים למניעת הריון‬
178895
SMART CARD FOR PASSPORT,
ELECTRONIC PASSPORT, AND
METHOD, SYSTEM, AND
APPARATUS FOR AUTHENTICATING
PERSON HOLDING SMART CARD OR
ELECTRONIC PASSPORT
E-SMART TECHNOLOGIES, INC.
US
10/823781
26/04/2004
PCT/US/2005/013896
WO/2005/104704
A61K
G06K
‫ פספורט‬,‫כרטיס חכם עבור פספורט‬
‫ מערכת ומתקן לאימות‬,‫אלקטרוני ושיטה‬
‫זהות של אדם המחזיק בכרטיס חכם או‬
‫פספורט אלקטרוני‬
179248
A61K
480
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN ICE/CASPASE-1
INHIBITOR
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/571314
15/05/2004
PCT/US/2005/017177
WO/2005/115362
6096090660
179641
METHOD FOR TRANSFERRING
PLATES
TRACIT TECHNOLOGIES
FR
0451085
02/06/2004
PCT/FR/2005/050411
WO/2005/124826
0096090660
180159
ALPHA, BETA-UNSATURATED
SULFONES, SULFOXIDES,
SULFONIMIDES, SULFINIMIDES,
ACYLSULFINAMIDES AND
THERAPEUTIC USES THEREOF
TEMPLE UNIVERSITY OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION
US
60/583009
24/06/2004
PCT/US/2005/022394
WO/2006/025924
0696090660
481
180196
/ ICE ‫תכשירי רוקחות המכילים מעכב‬
0–‫קספז‬
H01L
‫שיטה להעברת שבבים‬
C07C
,‫ סולפוקסידים סולפונימידים‬,‫סולפונים‬
‫ אצילסולפונאמידים‬,‫סולפינימידים‬
‫ואצ'לסולפינאמידים אלפא–ביטא בלתי‬
‫ והשימוש הרפואי שלהם‬,‫רוויים‬
C12N
April 13, 2008– ‫ח' בניסן התשס"ח‬
TRANSGENIC PLANTS CONTAINING
A DEHYDRIN GENE
CARMEL-HAIFA UNIVERSITY
ECONOMIC CORP. LTD.
US
60/580726
21/06/2004
PCT/IL/2005/000656
WO/2005/122697
0696090660
‫צמחים טרנסגניים הכוללים את הגן‬
‫דהידרין‬
‫החברה הכלכלית של אוניברסיטת‬-‫כרמל‬
‫חיפה בע"מ‬
180384
‫מוצרים המכילים קרח‬
ICE-CONTAINING PRODUCTS
UNILEVER PLC
EP
04254315.7 19/07/2004
PCT/EP/2005/006700
WO/2006/007924
0696090660
180386
180574
METHODS OF DETECTING A
PHENOTYPE OF A POLYMORPHIC
PROTEIN
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/586733
12/07/2004
PCT/IB/2005/004185
WO/2006/092669
6096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A23G
‫מוצרים המכילים קרח‬
ICE-CONTAINING PRODUCTS
UNILEVER PLC
EP
04254314.0 19/07/2004
8485438548
8698898884
EP
PCT/EP/2005/006698
WO/2006/007922
4496090660
A23G
C07K
‫שיטות לזיהוי פנוטיפ של חלבון פולימורפי‬
180575
‫המכון למחקר במדעי הרפואה ע"ש‬
‫משפחת רפפורט‬
C07H
482
THE USE OF MEMANTINE FOR THE
PREPARATION OF A MEDICAMENT
FOR THE ADJUNCTIVE TREATMENT
TO ATYPICAL ANTIPSYCHOTICS IN
SCHIZOPHRENIA PATIENTS
FOREST LABORATORIES, INC.
US
60/586553
09/07/2004
PCT/US/2005/024285
WO/2006/017188
6096090660
‫שימוש בממנטין להכנת תרופה לטיפול‬
‫משלים לתכשירים אנטיפסיכוטיים לא‬
‫טיפוסיים לחולי סכיזופרניה‬
180622
‫מערכת זרז דו–מרכבית לאיזומריזציה של‬
‫קסילן‬
XYLENE ISOMERIZATION TWOCOMPONENT CATALYST SYSTEM
EXXONMOBIL CHEMICAL PATENTS
INC.
US
10/902322
29/07/2004
PCT/US/2005/020413
WO/2006/022991
4/96090660
180631
A PHARMACEUTICAL COMPOSITION
COMPRISING GABAPENTIN
ZAMBON GROUP S.P.A.
IT
MI2004A001447 20/07/2004
PCT/EP/2005/053473
WO/2006/008295
4096090660
180634
METHOD FOR PRODUCING FUEL
FROM CAPTURED CARBON DIOXIDE
ENGINEUITY RESEARCH &
DEVELOPMENT LTD
US
60/586869
12/07/2004
PCT/IL/2005/000739
WO/2006/006164
4196090660
483
C07C
180645
C07C
‫תכשיר רוקחות המכיל גאבאפנטין‬
C07C
‫שיטה לייצור דלק מדותחמוצת הפחמן‬
‫לכוד‬
‫ חברה‬,‫אנג'יניואיטי מחקר ופיתוח בע"מ‬
‫ישראלית מאזור התעשיה הדרומי‬
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
METHODS FOR TREATING
HEPATITIS C
PTC THERAPEUTICS, INC
US
60/587487
14/07/2004
989934686
8398898884
US
989945569
8498898885
US
989995346
8698398885
US
989985448
8698498885
US
PCT/US/2005/024881
WO/2006/019831
0496090660
180651
COMPOSITIONS COMPRISING 5ALPHA REDUCTASE INHIBITORS,
AND SERMS AND METHODS OF USE
THEREOF
GTX, INC.
US
10/895401
21/07/2004
PCT/US/2005/025840
WO/2006/010162
4096090660
180677
COMPOUNDS, COMPOSITIONS AND
METHODS FOR TREATMENT OF
HYPERPROLIFERATIVE DISEASES,
SUCH AS CANCER
IDUN PHARMACEUTICALS, INC.
US
60/587471
12/07/2004
989963685
8398598885
US
PCT/US/2005/024700
WO/2006/017295
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
180839
C ‫שיטה לטיפול בצהבת מטיפוס‬
A61K
–‫–אלפא‬. ‫תכשירים המכילים מעכבי‬
‫רדוקטאז ומאפננים סלקטיבים לקולטן‬
‫ ושיטות לשימושם‬,‫האסטרוגן‬
C07D
‫ תכשירים ושיטות לטיפול‬,‫תרכובות‬
,‫ כגון‬,‫במחלות המתפשטות במהירות‬
‫סרטן‬
C07K
484
VACCINE COMPRISING
RECOMBINANT CT OR LT TOXIN
GAVISH-GALILEE BIO
APPLICATIONS LTD
IL
163249
28/07/2004
PCT/IL/2005/000808
WO/2006/011151
0096090660
180879
METHODS AND COMPOSITIONS FOR
INHIBITING, DESTROYING, AND/OR
INACTIVATING VIRUSES
SINOFRESH HEALTHCARE, INC.
US
60/590781
23/07/2004
889868585
8898898885
US
PCT/US/2005/026138
WO/2007/001323
0496090660
181072
METHODS, MATERIALS AND
APPARATUS FOR TREATING BONE
AND OTHER TISSUE
DISC-O-TECH MEDICAL
TECHNOLOGIES, LTD
US
60/592149
30/07/2004
899888
8698898884
IL
989948864
3898898885
US
989954465
8898898885
US
PCT/IL/2005/000812
WO/2006/011152
6/96090660
485
181179
LT ‫ או‬CT ‫תרכיב המכיל טוקסין‬
‫ריקומביננטי‬
‫גליל ביו יישומים בע"מ‬-‫גביש‬
A61K
‫או‬/‫ להשמיד ו‬,‫שיטות ותכשירים לעצר‬
‫להבטיל וירוסים‬
A61B
‫חומרים ומכשיר לטיפול ברקמת עצם‬
‫וברקמות אחרות‬
‫דיסקוטק טכנולוגיות רפואיות בע"מ‬
H04Q
April 13, 2008– ‫ח' בניסן התשס"ח‬
PERIODIC RANGING IN A WIRELESS
ACCESS SYSTEM FOR MOBILE
STATION IN SLEEP MODE
LG ELECTRONICS INC.
10-2004KR
09/08/2004
0062623
PCT/KR/2005/002582
WO/2006/016765
6094690660
181228
VLP-ANTIGEN CONJUGATES AND
THEIR USES AS VACCINES
CYTOS BIOTECHNOLOGY AG
US
60/615637
05/10/2004
8588588648
8498998885
EP
PCT/EP/2005/055009
WO/2006/037787
4696090660
181233
BINDING DOMAIN FUSION
PROTEINS
TRUBION PHARMACEUTICALS, INC.
US
60/600755
11/08/2004
PCT/US/2005/028496
WO/2007/011363
4496090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
181261
‫טיווח תקופתי במערכת גישה אלחוטית‬
‫עבור תחנה ניידת במצב רדום‬
A61K
‫ ושימוש בהם‬VLP–‫תצמידי אנטיגן‬
‫כחיסונים‬
C07K
‫חלבוני איחוי הנקשרים לאתרים‬
A61B
486
LOCALIZATION OF A RADIOACTIVE
SOURCE WITHIN A BODY OF A
SUBJECT
NAVOTEK MEDICAL LTD
US
60/600725
12/08/2004
989986868
8698898884
US
989986668
8698898884
US
PCT/IL/2005/000871
WO/2006/016368
0096090660
181300
PHOTOSENSITIZER FORMULATIONS
AND USES THEREOF
CERAMOPTEC INDUSTRIES, INC.
US
60/602264
16/08/2004
889853883
8598998885
US
PCT/US/2005/026051
WO/2006/023194
6096090660
181394
ATMOSPHERIC PRESSURE
CHEMICAL VAPOR DEPOSITION
SOLAR FIELDS, LLC
US
60/602405
18/08/2004
PCT/US/2005/027368
WO/2006/023262
4096090660
181405
REMOVABLE SURFACE COVERING
AZULINDUS Y MARTI, S.A
ES
P200402065 20/08/2004
ES
P200500247 8698898885
ES
P200501392 8898998885
PCT/ES/2005/000458
WO/2006/042883
6096/90660
487
181438
‫קביעת מיקומו של מקור קרינה גרעינית‬
‫בתוך הגוף‬
‫נבוטק מדיקל בע"מ‬
C07D
‫פורמולציות של חומרים מפעיל–רגישות‬
‫לאור ושימושיהן‬
C23C
‫שיקוע אדים כימיים בלחץ אטמוספירי‬
B66B
‫כיסוי למשטח הניתן להורדה‬
C12N
April 13, 2008– ‫ח' בניסן התשס"ח‬
CULTURING HUMAN EMBRYONIC
STEM CELLS
WISCONSIN ALUMNI RESEARCH
FOUNDATION
US
60/608040
08/09/2004
989965888
8698998885
US
PCT/US/2005/031839
WO/2006/029198
6496/90660
181487
SALT RESISTANT TRANSGENIC
PLANTS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/606415
02/09/2004
PCT/IL/2005/000932
WO/2006/025059
6496/90660
181488
SALT RESPONSIVE GENES USEFUL
FOR GENERATING SALT RESISTANT
TRANSGENIC PLANTS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/606414
02/09/2004
PCT/IL/2005/000933
WO/2006/025060
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
181740
‫גידול תאי עובר אדם בתרבית‬
C12N
‫צמחים טרנסגניים עמידים למלח‬
‫) בע"מ‬0662( ‫תרביות רה"ן‬
C12N
‫גנים שמגיבים למלח ויעילים ליצירת‬
‫צמחים טרנסגניים עמידים למלח‬
‫) בע"מ‬0662( ‫תרביות רה"ן‬
A61K
488
THERAPEUTIC AGENTS TARGETING
THE NCca-atp CHANNEL AND
METHODS OF USE THEREOF
UNIVERSITY OF MARYLAND
US
60/610758
18/09/2004
PCT/US/2005/026455
WO/2006/036278
4/96/90660
NCca– ‫גורמים רפואיים המכוונים לתעלה‬
‫ ושיטות לשימוש בהם‬atp
181748
COMPOSITIONS AND THEIR USES
FOR LYSOSOMAL ENZYME
DEFICIENCIES
UNIVERSITY OF MASSACHUSETTS
US
60/610872
17/09/2004
PCT/US/2005/033300
WO/2006/032039
4096/90660
181810
COMPOSITIONS CONTAINING
URIDINE, AND METHODS UTILIZING
SAME
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
10/941025
15/09/2004
889644896
8898698884
US
889688888
8998898884
US
PCT/US/2005/032312
WO/2006/031683
4096/90660
489
181826
A61K
‫הרכבים ושימושם בחוסרים של אנזימי‬
‫ליזוזום‬
C07H
‫ ושיטות‬,‫תכשירים המכילים אורידין‬
‫לשימושם‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
THERAPEUTIC AGENTS TARGETING
THE NCCA-ATP CHANNEL AND
METHODS OF USE THEREOF
UNIVERSITY OF MARYLAND
US
60/610758
18/09/2004
989966888
8898898885
US
PCT/US/2005/033194
WO/2006/034048
0096/90660
ATP ‫גורמים רפואיים הפועלים על תעלת‬
‫ – ושיטות לשימוש בהם‬NCCA
181922
METHOD FOR TREATING
VASCULITIS
GENENTECH, INC.
US
60/616104
05/10/2004
PCT/US/2005/034647
WO/2006/041680
6096190660
181936
A SYSTEM FOR SALE OF ENTRANCE
TICKETS
SAZKA, A.S.
PUV2004CZ
01/10/2004
15868
PCT/CZ/2005/000033
WO/2006/037281
4/96/90660
FRAUD RISK ADVISOR
DIGITAL ENVOY INC.
US
10/943454
889886665
US
PCT/US/2005/033502
WO/2006/034205
4196090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
181966
A61K
‫שיטה לטיפול בדלקת בכלי הדם‬
G06Q
‫מערכת למכירת כרטיסי כניסה‬
G06Q
‫יועץ לסיכון הונאה‬
17/09/2004
8398698885
182051
A61F
490
METHOD AND APPARATUS FOR
NON-INVASIVELY REMOVING HEAT
FROM SUBCUTANEOUS LIPID-RICH
CELLS INCLUDING A COOLANT
HAVING A PHASE TRANSITION
TEMPERATURE
ZELTIQ AESTHETICS, INC.
US
11/435502
17/05/2006
PCT/US/2007/064016
WO/2007/133839
0096/90660
‫שיטה והתקן הכוללים חומר קירור בעל‬
‫טמפרטורת מצב מעבר להסרה לא‬
‫פולשנית של חום מתאים תת עוריים‬
‫עשירים בליפידים‬
182063
METHODS AND COMPOSITIONS FOR
EVALUATING BREAST CANCER
PROGNOSIS
TRIPATH IMAGING, INC.
US
60/611965
22/09/2004
989988883
8898698884
US
PCT/US/2005/034152
WO/2006/036788
0096/90660
0496/90660
491
‫שיטות ותכשירים להערכת פרוגנוזה של‬
‫סרטן השד‬
182086
COMPOSITIONS FOR USE AGAINST
ONE OR MORE PATHOGENS
BIONEXT
EP
04447209.0 24/09/2004
PCT/EP/2005/010342
WO/2006/032530
G01N
A01N
‫תרכובות לשימוש כנגד פתוגן אחד או יותר‬
182101
A61L
April 13, 2008– ‫ח' בניסן התשס"ח‬
COMPOSITIONS AND METHODS FOR
STEM CELL EXPANSION AND
DIFFERENTIATION
NVR LABS LTD. NEURAL &
VASCULAR RECONSTRUCTION
US
60/611566
21/09/2004
989889884
8698698885
US
PCT/IL/2005/001007
WO/2006/033103
4094690660
182116
NANOBODIES TM AGAINST
AMYLOID-BETA AND
POLYPEPTIDES COMPRISING THE
SAME FOR THE TREATMENT OF
DEGENERATIVE NEURAL DISEASES
SUCH AS ALZHEIMER'S DISEASE
ABLYNX N.V.
US
60/618148
13/10/2004
989886988
8898698885
US
PCT/EP/2005/011018
WO/2006/040153
0096/90660
182160
MANAGING ON-LINE ADVERTISING
USING METRICS SUCH AS RETURN
ON INVESTMENT AND/OR PROFIT
GOOGLE, INC.
US
10/953861
PCT/US/2005/034237
WO/2006/039210
4096/90660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫תכשירים ושיטות לריבוי והתמיינות של‬
‫תאי גזע‬
‫אר שחזור עצבי בע"מ‬.‫וי‬.‫מעבדות אן‬
C07K
‫ נגד אמילואיד–בטא‬TM NANOBODIES
‫ופוליפפטידים המכילים אותם לטיפול‬
‫במחלות עצביות ניווניות כגון מחלת‬
‫אלצהיימר‬
G06Q
‫ניהול פרסום מקוון על ידי שימוש‬
‫או‬/‫במטריצות כגון חזרה על השקעה ו‬
‫רווח‬
29/09/2004
182198
A61K
492
OSTEOGENIC OLIGONUCLEOTIDES
AND USES THEREOF
IMMUNOTECH S.A.
EP
04077653.6 27/09/2004
PCT/EP/2005/054521
WO/2006/034956
0/96/90660
182209
MEDIUM-CHAIN LENGTH FATTY
ALCOHOLS AS STIMULATORS OF
HEMATOPOIESIS
PROMETIC BIOSCIENCES INC
US
60/614478
01/10/2004
PCT/CA/2005/001490
WO/2006/086871
0096/90660
182215
LOW FAT FROZEN CONFECTIONERY
PRODUCT
UNILEVER PLC
EP
04256393.2 18/10/2004
PCT/EP/2005/010579
WO/2006/042632
4/94690660
182265
SYSTEM AND METHOD FOR
RESOLVING TRANSACTIONS
APOLLO ENTERPRISE SOLUTIONS,
LLC
US
60/620131
19/10/2004
PCT/US/2005/037949
WO/2006/045060
6094690660
493
182287
‫אוליגונוקליאוטיידים אוסטיוגניים‬
‫ושימושיהם‬
A61K
‫כוהלים שומניים בעלי אורך שרשרת‬
‫ממוצע כמעוררי היווצרות תאי דם‬
A23G
‫תוצר קונפיטורה קפוא דל שומן‬
G06Q
‫מערכת ושיטה לבצוע עסקאות‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטה למניעת הריון המשתמשת בטיפול‬
‫הורמוני‬
A METHOD OF CONTRACEPTION
UTILIZING HORMONAL TREATMENT
DURAMED PHARMACEUTICALS, INC
US
60/616424
07/10/2004
989964596
8998598885
US
PCT/US/2005/035997
WO/2006/042021
0096/90660
182297
THE USE OF WINTER SAVORY
(SATUREJA MONTANA) OR THE
EXTRACTS THEREOF FOR THE
PREPARATION OF MEDICAMENTS FOR
THE TREATMENT OF THE PREMATURE
EJACULATION
INDENA S.P.A.
IT
MI2004A001871 01/10/2004
PCT/EP/2005/010481
WO/2006/037535
0096/90660
182323
RECOMBINANT HUMAN T2 RNASE
AND USES THEREOF
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/613702
29/09/2004
PCT/IL/2005/001041
WO/2006/035439
6094690660
April 13, 2008– ‫ח' בניסן התשס"ח‬
182353
A61K
SATUREJA ( "‫שימוש ב"חורף ריחני‬
‫) או במיצויים שלו לצורך‬MONTANA
‫הכנת תרופות לטיפול בשפיכה‬
‫מוקדמת‬
C12N
T2 ‫ריבונוקליאז הומני מהונדס מסוג‬
‫ושימושיו‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
A61K
494
METHODS USING
GLYCOSAMINOGLYCANS FOR THE
TREATMENT OF KIDNEY DISEASE
‫שיטות המשתמשות בגליקוזאמינוגליקנים‬
‫לטיפול במחלות כליה‬
KERYX BIOPHARMACEUTICALS,
INC.
US
60/615472
01/10/2004
989988338
8998898884
US
PCT/US/2005/035790
WO/2006/039709
0694090660
182462
TREATMENT OF GRAFT-VERSUSHOST DISEASE AND LEUKEMIA
WITH BECLOMETHASONE
DIPROPIONATE AND PREDNISONE
DOR BIOPHARMA, INC.
US
60/640178
30/12/2004
PCT/US/2005/047666
WO/2006/072093
4094690660
)"‫ ("שתל נגד אורח‬GVHD ‫טיפול במחלת‬
‫ולוקמיה עם בקלומתאזון דיפרופיונאט‬
‫ופרדניזון‬
182464
COMPOUNDS FOR NONSENSE
SUPPRESSION, AND METHODS FOR
THEIR USE
PTC THERAPEUTICS, INC
US
60/617633
13/10/2004
989988934
8398898884
US
989988953
8398898884
US
989988955
8398898884
US
989988988
8398898884
US
989984888
8398898884
US
PCT/US/2005/036761
WO/2006/044502
6494490660
495
A61K
182574
A61K
‫תרכובות לדיכוי רצפי פסק ושיטות‬
‫לשימוש בהן‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
GPR41 AND MODULATORS THEREOF
FOR THE TREATMENT OF INSULINRELATED DISORDERS
ARENA PHARMACEUTICALS, INC.
US
60/624867
03/11/2004
PCT/US/2005/039551
WO/2006/052566
4094690660
‫ ומווסטים שלו לטיפול בהפרעות‬GPR40
‫הקשורות לאינסולין‬
182584
COMBINED TREATMENT WITH
BORTEZOMIB AND AN EPIDERMAL
GROWTH FACTOR RECEPTOR
KINASE INHIBITOR
PIPERDI, BILAL
US
60/619844
18/10/2004
PCT/US/2005/037324
WO/2006/110175
6094490660
0494690660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫טיפול משולב עם בורטזומיב ומעכב קינז‬
‫של קולטן של גורם גדילה אפידרמי‬
182791
SYSTEM AND METHOD FOR
PREDICTIVE ANALYSIS AND
PREDICTIVE ANALYSIS MARKUP
LANGUAGE
VIZIANT CORPORATION
US
60/623868
02/11/2004
PCT/US/2005/039223
WO/2006/050245
A61K
G06Q
‫מערכת ושיטה לאיבחון חיזוי ושפת איבחון‬
‫חיזוי תוספת מחיר‬
182805
A61K
496
METHODS AND COMPOSITIONS FOR
REDUCING NEURODEGENERATION
IN AMYOTROPHIC LATERAL
SCLEROSIS
YOO, SEO HONG
US
60/624100
01/11/2004
989986488
8998898884
US
PCT/US/2005/039089
WO/2006/050165
4696190660
‫שיטות ותכשירים להפחתת ההתנוונות‬
‫העצבית הנגרמת כתוצאה מטרשת צד‬
‫חוט השדרה‬
182832
‫פוליאוריאה מוסגל סיליקון‬
SILICONE MODIFIED POLYUREA
REACTAMINE TECHNOLOGY, LLC
US
11/400956
10/04/2006
PCT/US/2007/009017
WO/2007/120759
6094090660
182837
METHODS, ASSAYS AND
COMPOSITIONS FOR TREATING
RETINOL-RELATED DISEASES
SIRION THERAPEUTICS, INC.
US
60/634449
08/12/2004
989998684
8898398885
US
989998684
8898398885
US
989988485
8698498885
US
989966588
8898898885
US
PCT/US/2005/044416
WO/2006/063128
0194690660
CYCLIZATION OF A PEPTIDE
497
C08G
A61K
‫שיטות בדיקות ותרכובות לטיפול במחלות‬
‫הקשורות ברטינול‬
182884
C07K
‫ציקליזציה של פפטיד‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
LONZA AG
EP
04025866.7
8588636848
EP
PCT/EP/2005/011383
WO/2006/048144
0096190660
01/11/2004
8698498885
182989
CRYOPROTECTANT FOR USE WITH
A TREATMENT DEVICE FOR
IMPROVED COOLING OF
SUBCUTANEOUS LIPID-RICH CELLS
ZELTIQ AESTHETICS, INC.
US
60/795799
28/04/2006
889848888
8898498888
US
PCT/US/2007/067638
WO/2007/127924
4094490660
183093
METHODS AND COMPOSITIONS FOR
TREATING PAIN
LIMERICK NEUROSCIENCES, INC.
US
60/628646
16/11/2004
PCT/US/2005/041608
WO/2006/055672
4494490660
183109
ANTIINFECTIVE LIPOPEPTIDES
CUBIST PHARMACEUTICALS, INC.
US
60/627056
12/11/2004
989888885
8398698885
US
PCT/US/2005/040919
WO/2006/110185
6094490660
April 13, 2008– ‫ח' בניסן התשס"ח‬
183115
A61F
‫מגן קור לשימוש בהתקן טיפול לקירור‬
‫משופר של תאים תת עוריים עשירים‬
‫בליפידים‬
A61K
‫שיטות והרכבים לטיפול בכאב‬
C07K
‫ליפופפטידים נוגדי זיהום‬
A61K
498
METHODS AND COMPOSITIONS
USING IMMUNOMODULATORY
COMPOUNDS FOR TREATMENT AND
MANAGEMENT OF PARASITIC
DISEASES
CELGENE CORPORATION
US
60/626975
12/11/2004
PCT/US/2005/040823
WO/2006/053160
4194490660
‫שיטות והרכבים המשתמשים בתרכובות‬
‫אימונומודולטוריות לטיפול וניהול של‬
‫מחלות טפיליות‬
183129
LIPASE INHIBITORS
TRUSTEES OF TUFTS COLLEGE
US
60/627476
12/11/2004
PCT/US/2005/041022
WO/2006/053250
0094490660
183134
DOSAGE REGIMEN OF AN S1P
RECEPTOR AGONIST
NOVARTIS AG
US
60/631483
29/11/2004
PCT/US/2005/043044
WO/2006/058316
0094490660
183138
COMBINATIONS COMPRISING
EPOTHILONES AND PROTEIN
TYROSINE KINASE INHIBITORS AND
PHARMACEUTICAL USES THEREOF
NOVARTIS AG
US
60/631837
30/11/2004
PCT/US/2005/042975
WO/2006/060331
4694490660
499
183152
A61K
‫מעכבי ליפאז‬
A61K
S1P ‫תכנית מינון לאגוניסט של קולטן‬
A61K
‫שילובים הכוללים איפוטילונים ומעכבי‬
‫ ושימושיהם הרפואיים‬,‫טירוזין קינאזות‬
A61P
April 13, 2008– ‫ח' בניסן התשס"ח‬
INHIBITORS OF HIV-1 CAPSID
FORMATION: SUBSTITUTED ARYL
AMINOMETHYL THIAZOLE UREAS
AND ANALOGUES THEREOF
UNIVERSITY OF MARYLAND,
BALTIMORE COUNTY
US
60/626902
11/11/2004
PCT/US/2005/041358
WO/2006/053323
6494090660
183155
GRAPHICAL USER INTERFACE FOR
3-D IN-VIVO IMAGING
XENOGEN CORPORATION
US
11/006294
06/12/2004
PCT/US/2005/043978
WO/2006/062914
4194490660
183158
FC VARIANTS WITH ALTERED
BINDING TO FCRN
XENCOR, INC
US
60/627763
12/11/2004
989948669
8898898885
US
989946586
8898898885
US
989998496
8598398885
US
989996388
8998498885
US
989968988
8998598885
US
989968888
8398998885
US
989969986
8598898885
US
989883886
8898898885
US
989889453
8898898885
US
PCT/US/2005/041220
WO/2006/053301
4094490660
PHARMACEUTICAL PRODUCT
April 13, 2008– ‫ח' בניסן התשס"ח‬
183178
‫ אריל‬:‫ קפסידים‬HIV–1 ‫מעכבי הווצרות‬
‫אמינומתיל תיאזול אוריאות מותמרות‬
‫ואנלוגים שלהן‬
G06F
‫ממשק גראפי עבור הדמיה תלת–ממדית‬
IN–VIVO
C07K
‫ בעלי יכולת קישור‬FC ‫וריאנטים של‬
FCRN ‫שעברה שינוי ל‬
A61J
‫תוצר רוקחות‬
500
SMITHKLINE BEECHAM
CORPORATION
US
60/629838
989998558
US
PCT/US/2005/042216
WO/2006/055928
19/11/2004
8498398885
4094490660
183192
A METHOD OF MODULATING B
CELL FUNCTIONING
ANGIOGEN PHARMACEUTICALS
PTY. LTD.
US
60/628935
17/11/2004
PCT/AU/2005/001754
WO/2006/053390
4094490660
4/94090660
FROZEN AERATED CONFECTIONS
UNILEVER PLC
501
B ‫שיטה לוויסות תפקוד של תאי‬
183212
FUSED CYCLIC AND HETEROCYCLIC
COMPOUNDS WHICH BIND TO
TUBULIN AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
THRESHOLD PHARMACEUTICALS,
INC.
US
60/630422
22/11/2004
989889686
8498898885
US
PCT/US/2005/042095
WO/2006/057946
A61K
A61K
‫תרכובות ציקליות והטרוציקליות מותכות‬
‫המתקשרות לטובולין ותכשירי רוקחות‬
‫המכילים אותן‬
183257
A23G
‫מרקחות קפואות מאווררות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
EP
04258092.8
PCT/EP/2005/014241
WO/2006/066979
4094490660
23/12/2004
183299
METHODS AND SYSTEMS FOR USE
IN BIOMETRIC AUTHENTICATION
AND/OR IDENTIFICATION
TRIAD BIOMETRICS, LLC
US
60/629295
19/11/2004
PCT/US/2005/041687
WO/2006/055714
0094490660
0094490660
A61K
‫הגברת הטיפול בסרטן והפרעות מתווכות‬
: ‫ ע"י אנטגוניסטים לרצפטור אדנוזין‬HIF–0
A
183310
ENHANCING TREATMENT OF HIF-1
MEDIATED DISORDERS WITH
ADENOSINE A3 RECEPTOR
AGONISTS
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫או זיהוי ביומטרי‬/‫מערכות ושיטות לאימות ו‬
183307
ENHANCING TREATMENT OF
CANCER AND HIF-1 MEDIATED
DISORDERS WITH ADENOSINE A3
RECEPTOR ANTAGONISTS
KING PHARMACEUTICALS
RESEARCH & DEVELOPMENT, INC.
US
60/630557
22/11/2004
PCT/US/2005/042551
WO/2007/040565
G06F
A61K
HIF–0 ‫הגברת הטיפול בהפרעות מתווכות‬
A: ‫ע"י אגוניסטים של רצפטור אדנוזין‬
502
KING PHARMACEUTICALS
RESEARCH & DEVELOPMENT, INC.
US
60/630555
22/11/2004
PCT/US/2005/042552
WO/2006/055970
0094490660
183314
TRUST-LINKED DEBIT CARD
TECHNOLOGY
ALAIN L. DE LA MOTTE
US
60/630234
22/11/2004
989938833
8898898884
US
PCT/US/2005/042566
WO/2006/055972
0094490660
183321
CHROMANYLUREA COMPOUNDS
THAT INHIBIT VANILLOID
RECEPTOR SUBTYPE 1 (VR1)
RECEPTOR AND USES THEREOF
ABBOTT LABORATORIES
US
60/630636
24/11/2004
PCT/US/2005/042545
WO/2006/065484
4094490660
183329
JNK INHIBITORS FOR TREATMENT
OF CNS INJURY
CELGENE CORPORATION
US
60/630598
23/11/2004
PCT/US/2005/042330
503
G06Q
‫טכנולוגית כרטיס חיוב הקשור לחשבון‬
‫נאנמות‬
C07D
‫תרכובות כרומנילאוראה המעכבות‬
0 ‫רצפטור הוונילואיד רצפטור תת–סוג‬
‫ ) ושימושיהן‬VR1(
A61K
‫ לטיפול בפגיעה במערכת‬JNK ‫מעכבי‬
‫העצבים המרכזית‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
WO/2006/058007
6094090660
183349
USE OF OMEGA-3 FATTY ACID(S)
FOR TREATING
HYPERCHOLESTEROLEMIA CAUSED
BY ANTI-RETROVIRAL TREATMENT
OF HIV-INFECTED PATIENTS
PIERRE FABRE MEDICAMENT
FR
0412862
03/12/2004
PCT/EP/2005/056431
WO/2006/058920
0094090660
0194490660
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07K
‫ שימושים כמעכבים של‬,‫פפטידים חדשים‬
‫ ושימושים הביולוגיים‬CASPASE–0/–9
183412
METHODS AND SYSTEMS FOR
SYNCHRONOUS EXECUTION OF
COMMANDS ACROSS A
COMMUNICATION LINK
QUALCOMM INCORPORATED
US
60/630853
24/11/2004
C07K
‫ ושימוש בהם‬BR: ‫פוליפפטידים הקושרים‬
183400
NEW PEPTIDES USEFUL AS DUAL
CASPASE-2/-6 INHIBITORS AND
THEIR BIOLOGICAL APPLICATIONS
THERAPTOSIS S.A.
US
60/630249
24/11/2004
PCT/EP/2005/013976
WO/2006/056487
0094490660
‫ לטיפול‬:–‫שימוש בחומצות שומן אומגה‬
‫ביתר כולסטרול בדם הנגרמת עקב טיפול‬
‫נוגד רטרו–וירוסים של חולים אשר נדבקו‬
HIV–‫ב‬
183353
POLYPEPTIDES THAT BIND BR3 AND
USES THEREOF
GENENTECH, INC.
US
60/640323
31/12/2004
PCT/US/2005/047072
WO/2006/073941
A61K
H04J
‫שיטות והתקנים לביצוע מסונכרן של‬
‫פקודות לאורך חיבור תקשורת‬
504
PCT/US/2005/042415
WO/2006/058053
4094490660
183424
AN IMPLANT FOR INTRAOCULAR
DRUG DELIVERY
THERAKINE CORPORATION
US
60/630751
24/11/2004
PCT/US/2005/041330
WO/2006/057859
0494490660
183426
MEDIA CONTENT PROTECTION
HADAS ARNON
US
60/630565
26/11/2004
PCT/IL/2005/001227
WO/2006/056973
0094490660
183519
A METHOD AND SYSTEM FOR
PROTECTING A SOFTWARE
APPLICATION FROM PIRACY
ALADDIN KNOWLEDGE SYSTEMS
LTD.
US
60/631150
29/11/2004
889869654
8898898885
US
PCT/IL/2005/001264
WO/2006/056993
0694490660
183540
SHRAPNEL AND PROJECTILE
CONTAINMENT SYSTEMS AND
EQUIPMENT AND METHODS FOR
PRODUCING SAME
LIFE SHIELD ENGINEERED
SYSTEMS, LLC,
US
60/632074
01/12/2004
989948668
8898898885
US
505
A61K
‫שתל עבור מתן תרופה תוך–עינית‬
G06F
‫הגנת תוכן מדיה‬
‫ארנון הדס‬
G06Q
‫שיטה ומערכת להגנת יישומי תוכנה‬
‫מפירטיות‬
‫אלדין מערכות מידע בע"מ‬
E04B
‫מערכות הכלה לרסיסים וקליעים וציוד‬
‫ושיטות לייצורן‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
PCT/US/2005/042983
WO/2007/073363
6094090660
183585
APOPTOSIS-SPECIFIC EIF-5A AND
POLYNUCLEOTIDES ENCODING
SAME
SENESCO TECHNOLOGIES, INC.
US
60/632514
03/12/2004
989999989
3898398885
US
989985664
8698498885
US
989888368
8998698885
US
PCT/US/2005/044266
WO/2006/060823
6094090660
‫ ייחודיים לאפופטוזיס‬EIF–5A
‫ופולינוקלאוטידים המקודדים להם‬
183587
METHODS OF USING [3.2.0]
HETEROCYCLIC COMPOUNDS AND
ANALOGS THEREOF
NEREUS PHARMACEUTICALS, INC.
US
60/633379
03/12/2004
989943688
8398898885
US
989956664
8498398885
US
989989533
8698498885
US
PCT/US/2005/044091
WO/2006/060809
0696490660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
]/.0.:[ ‫שיטות לשימוש בתרכובות‬
‫הטרוציקליות ותולדותיהן‬
183610
PROCESS FOR PRODUCING
POLYPEPTIDE MIXTURES USING
HYDROGENOLYSIS
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/649442
02/02/2005
PCT/US/2006/002351
WO/2006/083608
C07K
A61K
–‫תהליך לייצור תערובות פוליפפטידים על‬
‫ידי הידרוגנוליזה‬
‫טבע תעשיות פרמצבטיות בע"מ‬
506
0494090660
183710
C07K
‫תוצר מצומד‬
CONJUGATION PRODUCT
MOLMED SPA
US
60/638158
23/12/2004
PCT/IB/2005/004058
WO/2006/067633
4/94090660
183723
BINDING MOLECULES CAPABLE OF
NEUTRALIZING WEST NILE VIRUS AND
USES THEREOF
CRUCELL HOLLAND B.V.
EP
PCT/EP2004/053609
EP
PCT/EP2005/052160
EP
PCT/EP2005/052648
EP
PCT/EP2005/052946
EP
PCT/EP2005/054002
PCT/EP/2005/056926
WO/2006/067122
6094090660
‫מולקולות בעלות יכולת קישור‬
,‫היכולות לנטרל נגיף נילוס מערבי‬
‫ושימושים בהן‬
20/12/2004
8898598885
8698998885
8398998885
8598698885
183744
MEDICAMENT FOR HYGIENIC
APPLICATION INSIDE THE EAR
BAYER HEALTHCARE AG
DE
102004059220.9 09/12/2004
88888585536548
8898898885
DE
PCT/EP/2005/012978
WO/2006/061156
507
G01N
A61K
‫תרופה למתן באופן הגייני בתוך האוזן‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096490660
183762
DIRECT COMPRESSION
FORMULATION AND PROCESS
NOVARTIS AG
US
60/644645
18/01/2005
989968464
8498998885
US
PCT/US/2006/001473
WO/2006/078593
6094090660
4096090660
A61L
‫חומרים ושיטות למתן של תרכובות זרימות‬
‫ בחודרניות מינימלית‬,‫המכילות תאים‬
185374
SECURE UNIVERSAL
CONFIGURATION SOFTWARE FOR
CLUSTER TOOLS
LAM RESEARCH CORPORATION
US
60/656862
25/02/2005
889868636
3898398885
US
PCT/US/2006/005636
WO/2006/093691
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫תכשירים של דחיסה ישירה ותהליך‬
183784
MATERIALS AND METHODS FOR
MINIMALLY-INVASIVE
ADMINISTRATION OF A CELLCONTAINING FLOWABLE
COMPOSITION
PERVASIS THERAPEUTICS, INC.
US
60/634155
08/12/2004
989993656
8898398885
US
989968854
8698598885
US
PCT/US/2005/043967
WO/2006/062909
A61K
G06F
‫תוכנת תצורה אוניברסאלית בטוחה עבור‬
‫כלי מצרר‬
508
6096190660
186416
METHOD AND SYSTEM FOR
CALCULATING AN INTRADAY
INDICATIVE VALUE OF LEVERAGED
BULLISH AND BEARISH EXCHANGE
TRADED FUNDS
PROFOUND ADVISORS, LLC
US
60/668601
06/04/2005
989886665
8998698885
US
889368688
8598498889
US
PCT/US/2006/012717
WO/2006/108062
0496090664
6496090660
509
G06F
‫מערכת גלובלית ליצירת מסמכים הכוללת‬
‫מחשב שרת מנהלי‬
186488
METHOD FOR MEASURING
SENSITIVITY OF DATA PACKET
SIGNAL RECEIVER
LITEPOINT CORPORATION
US
10/908946
01/06/2005
PCT/US/2006/021190
WO/2006/130732
0096090660
‫שיטה ומערכת לחישוב ערך תוך–יומי‬
‫אינדיקטיבי של קרנות סחירות ממונפות‬
‫בעלות נטייה לעליית וירידת מחירים‬
186477
GLOBAL DOCUMENT CREATION
SYSTEM INCLUDING
ADMINISTRATIVE SERVER
COMPUTER
DICTAPHONE CORPORATION
US
09/515902
29/02/2000
PCT/US/2001/005402
WO/2001/065333
G06Q
H04L
‫שיטה למדידת רגישות של קולט סיגנל של‬
‫חבילת מידע‬
186570
G06F
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מערכת המערבלת צפנים‬
NATIVE SCRAMBLING SYSTEM
NDS LIMITED
IL
168337
02/05/2005
896469
8698598885
IL
888668
8898698885
IL
PCT/IL/2006/000367
WO/2006/117775
0096190660
186757
IMAGE COMPARISON BY METRIC
EMBEDDINGS
MICROSOFT CORPORATION
US
11/141362
31/05/2005
PCT/US/2006/016609
WO/2006/130292
4496090660
‫השוואת דמויות באמצעות קיבוע מטרי‬
187025
HARD CARAMEL CONTAINING
ISOLMALTULOSE AND PROCESS FOR
THE MANUFACTURE THEREOF
SUDZUCKER AKTIENGESELLSCHAFT
MANNHEIM/OCHSENFURT
DE
102005022601.9 11/05/2005
PCT/EP/2006/004418
WO/2006/119991
6094490660
A23G
‫קרמל קשית המכיל איזומלטולוז ושיטה‬
‫ליצורו‬
187290
HYDRAULIC MOTORS FOR
ACTUATING AND CONTROLLING AN
ANTI-SWING SYSTEM IN
CONTAINER-HANDLING CRANES
MAERSK ESPANA S.A.
ES
P200501200 10/05/2005
PCT/ES/2005/000607
WO/2006/136620
April 13, 2008– ‫ח' בניסן התשס"ח‬
G06K
B66C
‫מנועים הידראולים להנעה ובקרה של‬
‫מערכת נוגדת תנודות במנופים המטפלים‬
‫במיכלים‬
510
4496090660
187292
B01F
‫שיטה לייצור תערובות גז ראשוניות‬
‫סטנדרטיות‬
SYSTEM FOR PRODUCING PRIMARY
STANDARD GAS MIXTURES
PRAXAIR TECHNOLOGY, INC.
US
11/127144
12/05/2005
PCT/US/2006/018264
WO/2006/124519
4696090660
187293
RECOMBINANT N-GLYCOSYLATED
PROTEINS FROM PROCARYOTIC
CELLS
EIDGENOSSISCHE TECHNISCHE
HOCHSCHULE ZURICH
EP
05010276.3 11/05/2005
PCT/EP/2006/004397
WO/2006/119987
6096090660
‫חלבונים רקומביננטיים שעברו‬
‫ מתאים פרוקריוטים‬N ‫גליקוזילציה באתר‬
187295
ELECTRONIC COMPONENT AND
METHOD FOR FIXING THE SAME
WURTH ELEKTRONIK IBE GMBH
DE
102005022927.1 13/05/2005
PCT/EP/2006/004206
WO/2006/122660
4096090660
187296
SUB-SCALE SONIC BOOM
MODELING
GULFSTREAM AEROSPACE
CORPORATION
US
60/679980
12/05/2005
989968888
8898598885
US
PCT/US/2006/018485
WO/2007/086917
511
C12P
H01F
‫רכיב אלקטרוני ושיטה להתקנתו‬
B64C
‫בחינת תופעת בום על קולי על ידי מודל‬
‫מוקטן‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096090660
187297
SYSTEM AND METHOD FOR
UNLIMITED LICENSING TO A FIXED
NUMBER OF DEVICES
NAPSTER LLC
US
11/137347
24/05/2005
PCT/US/2006/019103
WO/2006/127359
6096090660
0096190660
‫שיטה ומערכת לרישוי לא מוגבל למספר‬
‫קבוע של מכשירים‬
187299
ADAPTABLE NOZZLE ATTACHMENT
FOR POOL CLEANER
WATER TECH LLC
US
11/139093
26/05/2005
PCT/US/2006/017790
WO/2006/127259
187301
187302
HETEROCYCLES AS NICOTINIC ACID
RECEPTOR AGONISTS FOR THE
TREATMENT OF DYSLIPIDEMIA
SCHERING CORPORATION
US
60/681848
17/05/2005
989885595
8698698885
US
989838836
8698898885
US
PCT/US/2006/018186
WO/2006/124490
April 13, 2008– ‫ח' בניסן התשס"ח‬
E04H
‫חיבור מותאם של פי צינור למנקה בריכה‬
METHODS OF SYNTHESIZING 6 ALKYLAMINOQUINOLINE
DERIVATIVES
WYETH
US
60/685040
25/05/2005
PCT/US/2006/015931
WO/2006/127203
4496090660
H04L
C07D
– 9 ‫שיטות לסינתזה של נגזרות של‬
‫אלקילאמינוקווינולין‬
C07D
‫הטרוציקלים כאגוניסטים לרצפטור של‬
‫חומצה ניקוטינית לטיפול בדיסליפידמיה‬
512
0096190660
187303
METHODS OF PREPERING 3 - CYANO
- QUINOLINES AND INTERMEDIATES
MADE THEREBY
WYETH
US
60/684683
25/05/2005
PCT/US/2006/016019
WO/2006/127205
4496090660
187304
PYRROLOPYRIDINE - BASED
INHIBITORS OF DIPEPTIDYL
PEPTIDASE IV AND METHODS
BRISTOL-MYERS SQUIBB COMPANY
US
60/682968
20/05/2005
889438958
8698598889
US
PCT/US/2006/018185
WO/2006/127287
4096090660
187307
CLOSURE SYSTEM AND METHOD OF
FILLING A VIAL
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0510057.3
17/05/2005
PCT/EP/2006/004629
WO/2006/122757
6096090660
513
187308
C07C
‫ – ציאנו – קווינולינים‬: ‫שיטות להכנת‬
‫ותוצרי ביניים הנוצרים ע"י שיטות אלו‬
C07D
IV ‫מעכבים של דיפפטידיל פפטידאז‬
‫המבוססים על פירולופירידין ושיטות‬
B65D
‫מערכת סגירה ושיטה למילוי בקבוקון‬
C07K
April 13, 2008– ‫ח' בניסן התשס"ח‬
METHOD OF PRODUCING
ANTIBODIES WITH MODIFIED
FUCOSYLATION LEVEL
GENENTECH, INC.
US
60/687625
03/06/2005
989839668
8498898885
US
PCT/US/2006/021854
WO/2006/133148
0096090660
187309
SOLID COMPOSITIONS AND
METHODS FOR TREATING MIDDLEOF-THE NIGHT INSOMNIA
TRANSCEPT PHARMACEUTICALS,
INC.
US
60/684842
25/05/2005
989848983
8898898885
US
989866348
3898398889
US
989866846
3898398889
US
PCT/US/2006/020502
WO/2006/128022
0096090660
‫שיטה ליצור נוגדנים בעלי רמות פוקוזיל‬
‫מותאמות‬
‫תכשירים מוצקים ושיטות לטיפול בנידודי‬
‫שינה באמצע הלילה‬
187310
BICYCLIC DERIVATIVES AS P38
KINASE INHIBITORS
PALAU PHARMA S.A.
EP
05380140.3 29/06/2005
PCT/EP/2006/006255
WO/2007/000339
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
187311
C07D
P38 ‫תולדות ביציקליות כמעכבות קינאז‬
C07D
514
N,N-SUBSTITUTED 3AMINOPYRROLIDINE COMPOUNDS
USEFUL AS MONOAMINES
REUPTAKE INHIBITORS
OTSUKA PHARMACEUTICAL CO,
LTD
2005JP
13/05/2005
141230
PCT/JP/2006/309988
WO/2006/121218
4096090660
‫–מותמרות‬N,N ‫–אמינופירולידין‬: ‫תרכובות‬
‫המשמשות כמעכבי ספיגה מחדש של‬
‫מונואמינים‬
187312
INPUT DEVICE INCLUDING A
SCROLL WHEEL ASSEMBLY
MICROSOFT CORPORATION
US
11/167286
28/06/2005
PCT/US/2006/018751
WO/2007/001667
0096090660
‫התקן קלט הכולל הרכב גלגל גלילה‬
187313
SYSTEM AND METHOD FOR
PASSIVE WIRE DETECTION
THE BOEING COMPANY
US
11/184472
19/07/2005
PCT/US/2006/019542
WO/2007/011450
4696090660
515
G06T
‫מערכת ושיטה לגילוי פאסיבי של חוטים‬
187314
METHOD FOR PRODUCING
WEATHER-RESISTANT IAMINATES
FOR ENCAPSULATING SOLAR CELL
SYSTEMS
ISOVOLTA AG
AT
A1230/2005 21/07/2005
PCT/AT/2006/000295
WO/2007/009140
G09G
B32B
‫שיטה ליצור חומרים מצופי ניילון העמידים‬
‫לשחיקה עבור תרמול תאים של מערכת‬
‫סולרית‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4194090660
187315
FLUID RECOVERY
ATLAS COPCO MAI GMBH
AT
A87/2006
19/01/2006
PCT/AT/2006/000516
WO/2007/082319
0496090660
187316
ANTI-INTERLEUKIN 2 ANTIBODIES
MICROMET AG
EP
05011845.4 01/06/2005
PCT/EP/2006/005194
WO/2006/128690
4096090660
187317
A POLYPEPTIDE COMPLEX AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
UNIVERSITY OF CONNECTICUT
HEALTH CENTER
US
60/681663
17/05/2005
889435468
8898598889
US
PCT/US/2006/019403
WO/2007/001677
6496090660
187318
PHARMACEUTICAL COMPOSITIONS
CONTAINING A NEUTRALIZYING
ANTI-HUMAN HEPATOCYTE
GROWTH FACTOR ANTIBODY FOR
TREATING BRAIN TUMORS
THE JOHNS HOPKINS UNIVERSITY
US
60/687118
02/06/2005
989858868
8598898885
US
PCT/US/2006/021293
WO/2006/130773
April 13, 2008– ‫ח' בניסן התשס"ח‬
E21D
‫קבלת נוזל בחזרה‬
C07K
0 ‫נוגדנים נגד אינטרלוקין‬
C07K
‫תצמיד פוליפפטידי ותכשירי רוקחות‬
‫המכילים אותו‬
A61K
‫תכשירי רוקחות המכילים נוגדון מנטרל‬
‫נגד גורם גדילת הפטוציט אנושי לטיפול‬
‫בגדולים ממאירים במוח‬
516
0496090660
187319
DERIVATIVES OF 4 OR 5-AMINOSALICYLIC ACID AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE SAME
ANTIBE THERAPEUTICS INC.
CA
PCT/CA2005/000819 27/05/2005
PCT/CA/2006/000484
WO/2006/125295
4496090660
187321
HOST CELL SPECIFIC BINDING
MOLECULES CAPABLE OF NEUTRALIZING
VIRUSES AND USES THEREOF
CRUCELL HOLLAND B.V.
EP
PCT/EP2005/052160
EP
PCT/EP2005/052648
EP
PCT/EP2005/052946
EP
PCT/EP2005/054002
PCT/EP/2006/062250
WO/2006/120230
4096090660
517
‫–סליצילית‬. ‫ או‬4 ‫תולדות חומצה‬
‫ותכשירי רוקחות המכילים אותן‬
C07K
‫מולקולות ספציפיות לתאי מארח‬
‫בעלות יכולת קישור היכולות‬
‫לנטרל נגיפים ושימושים בהן‬
12/05/2005
8698998885
8398998885
8598698885
187322
OBJECT DETECTION METHOD AND
APPARATUS
THE MACALEESE COMPANIES, INC.
DBA SAFE ZONE SYSTEMS
US
60/680627
12/05/2005
PCT/US/2006/018452
WO/2007/086916
4096090660
C07F
187323
G01S
‫שיטה והתקן לאיתור עצמים‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
TREATMENT OF INFLAMMATORY
BOWEL DISEASE (IBD) WITH
ANTIANGIOGENIC COMPOUNDS
ATTENUON. LLC
US
60/679977
12/05/2005
PCT/US/2006/018463
WO/2006/124611
4/96190660
187324
GLASS SHEET BENDING STATION
AND METHOD AND RESULTING
BENT GLASS SHEET
GLASSTECH, INC.
US
11/128450
13/05/2005
PCT/US/2006/014725
WO/2006/124185
4096090660
‫חומרים אנטי–אנגיוגניים לטיפול במחלות‬
‫מעיים דלקתיות‬
‫שיטה ותחנת כפוף ליריעת זכוכית ויריעת‬
‫זכוכית מכופפת בהתאם‬
187325
187326
CRYSTALLINE FORM OF
BENZAZEPINIUM MALEATE
DERIVATIVE
GLAXO GROUP LIMITED
GB
0510599.4
24/05/2005
PCT/EP/2006/004954
WO/2006/125622
4696090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A01N
‫ייצור דגים משופר‬
IMPROVED FISH PRODUCTION
ELI LILLY AND COMPANY
US
60/684886
26/05/2005
PCT/US/2006/018797
WO/2006/127322
0096090660
C03B
C07D
‫צורה גבישית של נגזרת של בנזאזפיניום‬
‫מאלאט‬
187327
A01N
518
METHODS FOR TREATING DRUG
RESISTANT CANCER
NOVARTIS AG
US
60/680722
13/05/2005
PCT/US/2006/017922
WO/2006/124413
0/96090660
‫שיטות לטיפול בסרטן עמיד לתרופות‬
187328
‫תרכובות של דיארילהידנתוין‬
DIARYLHYDANTOIN COMPOUNDS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/680835
13/05/2005
989858358
8598898885
US
989859558
8998898889
US
PCT/US/2006/011417
WO/2006/124118
4096090660
187329
PRODUCTION PROCESS OF
NUCLEUS-HALOGENATED
METHYLBENZYL ALCOHOL
SHOWA DENKO K.K.
2005JP
22/06/2005
182323
PCT/JP/2006/312193
WO/2006/137348
0196090660
4096090660
519
C07C
‫תוצר תהליך של מתילבנזיל–אלכוהול‬
‫שעבר הלוגנציה גרעינית‬
187330
A METHOD OF MARKING
COMPOSITION FOR ORAL
ADMINISTRATION
EISAI R & D MANAGEMENT CO. LTD.
2005JP
26/05/2005
154745
PCT/JP/2006/310301
WO/2006/126561
C07D
F25D
‫שיטה לסימון הרכב לשימוש בניהול שבעל‬
‫פה‬
187331
A61L
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫עיקור סופי של מוצרי קולגן הניתנים‬
‫להזרקה‬
TERMINAL STERILIZATION OF
INJECTABLE COLLAGEN PRODUCTS
ALBIOREX, LLC
US
60/682507
19/05/2005
PCT/US/2006/019064
WO/2006/124988
4496090660
187332
ENDOSCOPIC MEASUREMENT
TECHNIQUES
G.I. VIEW, LTD.
US
60/680599
13/05/2005
PCT/IL/2006/000563
WO/2006/120690
4696190660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫טכניקות מדידה אנדוסקופיות‬
‫וויו בע"מ‬.‫איי‬.‫גי‬
187334
CONTAINER FOR TRANSPORTING
TEMPERATURE CONTROLLED
ITEMS
AMERICAN THERMAL WIZARDS
INTERNATIONAL, INC.
US
60/681769
17/05/2005
989968884
8898598885
US
989968888
8898598885
US
989968386
8698598885
US
889868546
8898898885
US
889333864
8898898889
US
889886589
3898498889
US
PCT/US/2006/013247
WO/2006/124149
G06K
F25D
‫מיכל להובלת פריטים מבורקי טמפרטורה‬
520
4096090660
187335
CAPSULE IMAGING DEVICES,
SYSTEMS AND METHODS FOR IN
VIVO IMAGING APPLICATIONS
THE UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL
US
60/680580
13/05/2005
989848866
8898898885
US
PCT/US/2006/018513
WO/2006/124648
4096090660
‫ מערכות ושיטות קופסית הדמייה‬,‫התקנים‬
‫עבור יישומי הדמייה בגוף חי‬
187336
DYNAMIC SPINE STABILIZER
YALE UNIVERSITY
US
11/132538
19/05/2005
PCT/US/2006/019412
WO/2006/125142
0496090660
NIOBIUM SUBOXIDES
H. C. STARCK GMBH
GB
0511321.2
898833843
GB
PCT/EP/2006/005184
WO/2006/128687
6496090660
CAPACITOR
H. C. STARCK GMBH
GB
0511321.2
521
A61B
187337
A61B
‫מייצב עמוד שידרה דינמי‬
C01G
‫ניוביום סאבאוקסידים‬
03/06/2005
8998898889
187338
H01G
‫קבל‬
03/06/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
898833843
GB
PCT/EP/2006/005220
WO/2006/128698
0196090660
8998898889
187341
SCALABLE FERMENTATION
PROCESS
CYTOS BIOTECHNOLOGY AG
EP
05011416.4 26/05/2005
8588988649
8898898885
EP
PCT/EP/2006/062628
WO/2006/125821
4/96090660
187342
A REMOTE SENSING AND
COMMUNICATION SYSTEM
HADRONEX, LLC.
US
11/134691
20/05/2005
PCT/US/2006/019497
WO/2006/127479
4196090660
187343
COMPOSITIONS AND METHODS FOR
THE DIAGNOSIS AND TREATMENT
OF TUMOR
GENENTECH, INC.
US
60/692092
20/06/2005
989863658
8898498889
US
PCT/US/2006/023099
WO/2007/001851
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
187344
C12N
‫תהליך תסיסה שניתן לאמידה בסקלה‬
G08B
‫מערכת חישה ותקשורת מרוחקת‬
C07K
‫תכשירים ושיטות לאבחון וטיפול בגידול‬
C07D
522
COMPOUNDS MODULATING C-KIT
AND C-FMS ACTIVITY AND USES
THEREFOR
PLEXXIKON, INC.
US
60/682063
17/05/2005
989968858
8898598885
US
989968848
8898598885
US
989968858
8898998885
US
989968698
8898998885
US
PCT/US/2006/018726
WO/2007/013896
6096090660
187345
ELECTRICAL CONTACT PROBE
WITH COMPLIANT INTERNAL
INTERCONNECT
DELAWARE CAPITAL FORMATION,
INC.
US
60/689755
10/06/2005
PCT/US/2006/022311
WO/2006/135680
4096090660
187346
AEROSOLIZED
FLUOROQUINOLONES AND USES
THEREOF
MPEX PHARMACEUTICALS, INC.
US
60/682530
18/05/2005
989969898
8898898885
US
989883388
8398898889
US
PCT/US/2006/019351
WO/2006/125132
0196090660
523
187347
–‫ ו‬C– KIT ‫תרכובות מאפננות פעילות‬
‫ ושימושים שלהן‬FMS–C
G01R
‫אמצעי לבדיקת מגע חשמלי עם חיבור‬
‫פנימי תואם‬
C07J
‫פלואורוקווינולונים כתרסיס ושימושים‬
‫שלהם‬
C07K
April 13, 2008– ‫ח' בניסן התשס"ח‬
IGG–‫איחוי של אנטרפרון ו‬
INTERFERON-IGG FUSION
SCHERING CORPORATION
US
60/685018
26/05/2005
PCT/US/2006/020000
WO/2006/127757
4196090660
187348
C12N
PIGGYBAC AS A TOOL FOR GENETIC
MANIPULATION AND ANALYSIS IN
VERTEBRATES
FUDAN UNIVERSITY
‫ ככלי עבודה למניפולציה‬PIGGYBAC
‫גנטית ואנליזה בחולייתנים‬
PCT/CN/2005/000674
WO/2006/122442
6096190660
187349
A61M
‫מערכת העברת תרופה לחלל האף‬
‫המופעלת באמצעות נשימה‬
BREATH ACTUATED NASAL DRUG
DELIVERY SYSTEM
KOS LIFE SCIENCES, INC.
US
11/160493
27/06/2005
PCT/US/2006/012949
WO/2007/001585
6096090660
187351
ELECTROMAGNETIC RADIATION
EMITTING TOOTHBRUSH AND
DENTIFRICE SYSTEM
A61C
‫מברשת שיניים הפולטת קרינה‬
‫אלקטרומגנטית ומערכת תכשיר לניקוי‬
‫שיניים‬
BIOLASE TECHNOLOGY, INC.
US
60/682752
18/05/2005
989966886
8998998885
US
989836384
8398898885
US
PCT/US/2006/019630
WO/2006/125204
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
187352
C12N
524
ESTABLISHMENT OF A HUMAN
EMBRYONIC STEM CELL LINE USING
MAMMALIAN CELLS
RELIANCE LIFE SCIENCES PVT. LTD.
IN
595/MUM/2005 17/05/2005
889439863
8898598889
US
PCT/IN/2006/000169
WO/2007/020655
4096090660
187353
HETEROCYCLIC INHIBITORS OF
MEK AND METHODS OF USE
THEREOF
ASTRAZENECA AB
US
60/682335
18/05/2005
PCT/US/2006/019108
WO/2007/044084
6096090660
‫ייסוד של קו תאי גזע עובריים אנושיים‬
‫על ידי שימוש בתאי יונק‬
‫ ושיטות‬MEK ‫מעכבים הטרוסיקליקים של‬
‫שימוש בהם‬
187354
ERYTHROPOIETIN RECEPTOR
PEPTIDE FORMULATIONS AND USES
AFFYMAX, INC.
US
60/687655
03/06/2005
PCT/US/2006/021845
WO/2006/133144
0096090660
187356
IMPROVED REEL AND REEL
HOUSING
GREAT STUFF, INC.
US
60/686236
31/05/2005
525
C07D
A61K
‫פורמולציות של פפטיד הרצפטור‬
‫ ושימושיהם‬,‫לאריתרופואטין‬
B65H
‫סליל משופר ובית לסליל‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
889868868
US
PCT/US/2006/020868
WO/2006/130583
4694690660
8898898885
187357
LOW WEAR PISTON SLEEVE
RAYTHEON COMPANY
US
11/255432
20/10/2005
PCT/US/2006/039447
WO/2007/047220
0096090660
187358
TIGECYCLINE AND METHODS OF
PREPARING 9-AMINOMINOCYCLINE
WYETH
US
60/685146
27/05/2005
PCT/US/2006/020536
WO/2006/130500
0096090660
187359
CRYSTALLINE SOLID FORMS OF
TIGECYCLINE AND METHODS OF
PREPARING SAME
WYETH
US
60/684955
27/05/2005
PCT/US/2006/020871
WO/2006/128150
0096090660
187360
TIGECYCLINE AND METHODS OF
PREPARATION
WYETH
US
60/685285
27/05/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
F16J
‫מעטפת בוכנה בעלת שחיקה נמוכה‬
C07C
–6 ‫טיגציקלין ושיטות להכנת‬
‫אמינומינוציקלין‬
C07C
‫צורות גבישיות מוצקות של טיגציקלין‬
‫ושיטות להכנתן‬
C07C
‫טיגציקלין ושיטות להכנתו‬
526
PCT/US/2006/020229
WO/2006/130418
0096090660
187361
METHODS OF PURIFYING
TIGECYCLINE
WYETH
US
60/685626
27/05/2005
PCT/US/2006/020270
WO/2006/130431
0696090660
‫שיטות לטיהור טיגציקלין‬
187362
DERIVATIVES OF A 1PHENYLTRIAZOLE AS
ANTIPARASITIC AGENTS
BASF AKTIENGESELLSCHAFT
US
60/687027
03/06/2005
PCT/EP/2006/062719
WO/2006/128867
4096090660
187363
187364
RECIPROCATING MECHANISM FOR
A REEL ASSEMBLY
GREAT STUFF, INC.
US
60/685637
27/05/2005
989888455
8898898889
US
527
A01N
‫–פנילטריאזול כגורמים אנטי‬0 ‫תולדות של‬
‫פרזיטיים‬
MULTIPLE COMPONENT MOULDED
BODY COMPRISING POLYESTER
LAYERS
BASF AKTIENGESELLSCHAFT
DE
102005027549.4 14/06/2005
PCT/EP/2006/063167
WO/2006/134115
0096090660
C07C
B32B
‫גוף מעוצב מרובה מרכיבים המכיל‬
‫שכבות פוליאסטר‬
B65H
‫מנגנון השבה עבור מכלול גלגול‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
PCT/US/2006/019726
WO/2006/130377
0096090660
187585
TWEAK BINDING ANTIBODIES
Biogen Idec MA Inc.
US
60/685149
27/05/2005
PCT/US/2006/019706
WO/2006/130374
0696090660
187744
METHODS FOR MODULATING
OSTEOCHONDRAL DEVELOPMENT
USING PULSED ELECTROMAGNETIC
FIELD THERAPY
HEALTHONICS, INC.
US
60/687430
03/06/2005
989963468
8398998885
US
989868886
8898498889
US
PCT/US/2006/020819
WO/2006/132855
0696090660
187745
INTERFACINGS BETWEEN BLOCK
TYPE AND ROD AND CONNECTOR
TYPE CONSTRUCTION TOY SETS
K'NEX LIMITED PARTNERSHIP
GROUP
US
11/146971
07/06/2005
PCT/US/2006/011550
WO/2006/132693
0696090660
187746
PROCESS FOR THE PRODUCTION OF
BENZOIMIDAZOLE DERIVATIVES AS
INTERMEDIATES FOR THE
PREPARATION OF TRICYCLIC
BENZIMIDAZOLE COMPOUNDS
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
‫נוגדנים הנקשרים באופן צובט‬
A61N
‫שיטות לאיפנון פיתוח אוסטאוחונדרל‬
‫בשימוש בריפוי שדה אלקטרומגנטי בעל‬
‫דופק‬
A63H
‫מימשק בין סוג בלוק ומוט וסוג מחבר‬
‫במערכות משחק בניה‬
C07D
‫תהליך להכנת תולדות בנזואימידאזול‬
‫כחומרי ביניים להכנת תרכובות‬
‫בנזאמידאזול‬
528
NYCOMED GMBH
EP
05105566.3
8988896644
EP
PCT/EP/2006/063350
WO/2006/136552
6096090660
22/06/2005
8598898889
187748
PHARMACEUTICAL COMPOSITIONS
CONTAINING MISOPROSTAL
DURAMED PHARMACEUTICALS,
INC.
US
60/686973
03/06/2005
PCT/US/2006/021659
WO/2006/133048
0096090660
‫תכשירי רוקחות המכילים מיסופרוסטול‬
187749
PROCESS FOR THE PREPARATION AND
ISOLATION OF PHOSPHATIDES
FIDIA FARMACEUTICI S.P.A.
IT
PD2005A000164 30/05/2005
989883688
8898698885
US
PCT/EP/2006/005030
WO/2006/128639
0096090660
187750
IMAGING 18F OR 11C-LABELLED
ALKYLTHIOPHENYL GUANIDINES
HAMMERSMITH IMANET LIMITED
GB
0512770.9
23/06/2005
PCT/GB/2006/002315
WO/2006/136846
529
A61K
A23J
‫תהליך להכנה ובידוד של פוספאטידים‬
C07C
‫הדמיית גוואנידינים אלקילתיאופניל‬
F18 ‫ או‬C11 ‫מסווגים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
187751
‫משלוח מסרים בתצורת דף‬
PAGE-MODE MESSAGING
NOKIA CORPORATION
FI
20055288
06/06/2005
PCT/FI/2006/050234
WO/2006/131597
4096090660
WOUND HEALING
GENENTECH, INC.
US
60/691909
989864886
US
PCT/US/2006/023318
WO/2006/138468
0696090660
187753
17/06/2005
8898498889
187754
H02G
‫מסלול הנעה גמיש‬
187761
PROCESS FOR HEAT TREATING
METAL POWDER AND PRODUCTS
MADE FROM THE SAME
CABOT CORPORATION
US
11/141685
31/05/2005
PCT/US/2006/019353
WO/2006/130355
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61K
‫החשת החלמת פצעים‬
FLEXIBLE POWER RACEWAY
CONNECTEURS ELECTRIQUES
DEUTSCH
EP
05013505.2 22/06/2005
989968684
8898998885
US
PCT/EP/2006/005914
WO/2006/136376
4/96090660
H04L
B22F
‫תהליך לטיפול בחום של אבקה מתכתית‬
‫ומוצרים העשויים ממנה‬
530
6096090660
187763
SOLAR COLLECTOR HAVING AN
INTEGRATED HEAT STORAGE
ECONCERN B.V.
NL
1029168
02/06/2005
PCT/NL/2006/000276
WO/2006/130006
6096090660
4096090660
‫קולט שמש עם אחסון חום אינטגראלי‬
187830
FORMULATION OF A
THIENOPYRIDINE PLATELET
AGGREGATION INHIBITOR
ELI LILLY AND COMPANY
US
60/689183
10/06/2005
PCT/US/2006/021860
WO/2006/135605
188101
188104
COMPOUNDS USEFUL FOR
TREATING BIPOLAR DISORDERS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
11/153894
16/06/2005
PCT/IL/2006/000697
WO/2006/134600
531
C07D
‫תכשיר של טיאנופירידין מעכב הצטברות‬
‫טסיות‬
USE OF HIF 1-ALPHA MODULATORS
FOR TREATMENT OF CANCER
FIBROGEN, INC.
US
60/691006
15/06/2005
PCT/US/2006/023399
WO/2006/138511
4096090660
F24J
A61K
‫–אלפא לטיפול‬HIF 1 ‫שימוש במאפנני‬
‫בסרטן‬
C07C
‫תרכובות לטיפול במחלות ביפולריות‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0/96090660
188234
MAGNETORHEOLOGICAL LIQUID
BASF AKTIENGESELLSCHAFT
DE
102005030613.6 30/06/2005
PCT/EP/2006/063702
WO/2007/003580
0696090660
188235
N-THIO-ANTHRANILAMID
COMPOUNDS AND THEIR USE AS
PESTICIDES
BASF AKTIENGESELLSCHAFT
US
60/697166
07/07/2005
PCT/EP/2006/063761
WO/2007/006670
0096090660
188238
IMPROVED PROCESS FOR
PREPARING INSECTICIDAL
(DISUBSTITUTEDPROPENYL)
PHENYLALKYL SUBSTITUTED
HETEROCYCLES
BAYER CROPSCIENCE AG
US
60/695295
30/06/2005
PCT/US/2006/025143
WO/2007/005454
0096090660
188239
IMIDAZOLE BASED LXR
MODULATORS
EXELIXIS, INC.
US
60/694372
27/06/2005
989839888
8898898885
US
PCT/US/2006/024757
April 13, 2008– ‫ח' בניסן התשס"ח‬
H01F
‫נוזל מגנטוריאולוגי‬
C07D
‫–תיו–אנטראנילאמידיות‬N ‫תרכובות‬
‫ושימושיהן כחומרי הדברה‬
C07D
‫תהליך משופר להכנת קוטלי חרקים‬
‫(פרופניל די–מותמר) פניל אלקיל‬
‫הטרוציקלים מותמרים‬
C07D
‫ המבוססים על אימידזול‬LXR ‫מאפנני‬
532
WO/2007/002563
4/96090660
188240
A01N
CRYSTALLINE MODIFICATIONS TO
PYRACLOSTROBIN
BASF AKTIENGESELLSCHAFT
DE
102005028493.0 20/06/2005
PCT/EP/2006/005869
WO/2006/136357
4096090660
188241
CRIPOWELLINS AND SYNTHETIC
DERIVATIVES THEREOF USED AS
MEDICAMENTS
BAYER CROPSCIENCE AG
DE
102005029126.0 23/06/2005
PCT/EP/2006/005650
WO/2006/136309
4496090660
‫שינויים גבישיים לפיראכלוסטרובין‬
188242
METHOD FOR DETERMINING
TRAFFIC INFORMATION, AND A
DEVICE ARRANGED TO PERFORM
THE METHOD
TOM TOM INTERNATIONAL B.V
C07D
‫קריפווולינים ונגזרות סינטתיות שלהם‬
‫המשמשים כתרופות‬
G08G
‫שיטה לקביעת מידע תעבורתי והתקן‬
‫המאורגן לביצוע השיטה‬
PCT/NL/2005/000496
WO/2007/008055
4096090660
188243
NAVIGATION DEVICE AND METHOD
OF SCROLLING MAP DATA
DISPLAYED ON A NAVIGATION
DEVICE
TOM TOM INTERNATIONAL B.V
G01C
‫מכשיר ניווט ושיטה לגולל נתוני מפה‬
‫המוצגים על גבי מכשיר הניווט‬
PCT/NL/2005/000595
WO/2007/021169
533
April 13, 2008– ‫ח' בניסן התשס"ח‬
4196090660
188244
C07D
‫משפעלי אוריאה גלוקוקינאז‬
UREA GLUCOKINASE ACTIVATORS
NOVO NORDISK A/S
EP
05106449.1 14/07/2005
PCT/EP/2006/064289
WO/2007/006814
0696090660
188245
B01D
‫מסנן אוויר מיקרוביצידאלי‬
MICROBICIDAL AIR FILTER
BOLDUC LEROUX INC
US
11/169636
30/06/2005
PCT/CA/2006/001092
WO/2007/003047
6096090660
188246
‫מברשת שיניים המכילה זיפים משופעים‬
‫ומחודדים‬
TOOTHBRUSH COMPRISING
INCLINED AND POINTED BRISTLES
GABA INTERNATIONAL AG
CH
1307/05
08/08/2005
PCT/CH/2006/000405
WO/2007/016802
4096090660
188247
PROCESS AND APPARATUS FOR
TREATING EXHAUSTED ABRASIVE
SLURRIES FOR THE RECOVERY OF
THEIR REUSABLE COMPONENTS
SIC PROCESSING AG
IT
RM2005A000329
PCT/IT/2006/000461
WO/2006/137098
April 13, 2008– ‫ח' בניסן התשס"ח‬
A46B
B24B
‫תהליך ומערכת לטיפול בתערובות‬
‫של חומרי שחיקה שנשחקו לקבלה‬
‫בחזרה של רכיביהן הניתנים לשימוש‬
‫חוזר‬
24/06/2005
534
0496090660
188248
PYRROLO[2,3-B] PYRIDINE
DERIVATIVES AS PROTEIN KINASE
INHIBITORS
PLEXXIKON, INC.
US
60/692960
22/06/2005
989838586
8698898885
US
PCT/US/2006/024361
WO/2007/002325
0696090660
C07D
‫] פירידין כמעכבות‬B –: ,0[ ‫תולדות פירולו‬
‫פרוטאין קינאז‬
188251
A61F
PROPHYLACTIC BACTERICIDAL
IMPLANT
WAYNE J. SEBASTIANELLI OF
US
11/172138
30/06/2005
989886388
8598698885
US
PCT/US/2006/026000
WO/2007/005842
0096090660
‫שתל קוטל חיידקים המונע מחלות‬
188252
METHOD FOR THE POTENTIATION OF
OPIOID ANALGESICS EFFECTS ON PAIN
LAY LINE GENOMICS S.P.A.
IT
RM2005A000332 24/06/2005
PCT/IT/2006/000488
WO/2006/137106
535
C07K
‫שיטה להגברת ההשפעה של אופיאויד‬
‫כמשכך כאבים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0/96090660
188253
PHARMACUTICAL FORMULATION
OF NITROOXYDERIVATIVES OF
NSAIDS
NICOX SA
EP
05106854.2 26/07/2005
PCT/EP/2006/063672
WO/2007/012539
0096090660
0496090660
C12Q
ABCG2 ‫) של גן‬MISSENSE( ‫מוטציות סלף‬
‫של שור ושימושים בהן‬
‫ משרד החקלאות ופיתוח‬- ‫מדינת ישראל‬
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
‫וולקני‬
188265
EFFICIENT PERIODIC LOCATION
REPORTING IN A RADIO ACCESS
NETWORK
QUALCOMM INCORPORATED
US
60/693003
21/06/2005
989888688
8598698885
US
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הרכב רוקחות של תולדות ניטרואוקסי של‬
NSAIDS
188257
BOVINE ABCG2 GENE MISSENSE
MUTATIONS AND USES THEREOF
THE STATE OF ISRAEL- MINISTRY
OF AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION
VOLCANI CENTER
US
60/694430
28/06/2005
989969864
8898898885
US
PCT/US/2006/025117
WO/2007/002735
A61K
H04Q
‫דיווח מיקום עיתי יעיל ברשת בעלת‬
‫נגישות לרדיו‬
536
989886888
US
989888868
US
989888888
US
989888889
US
PCT/US/2006/024328
WO/2007/002303
4096090660
8998698885
8998898889
8898898889
8698898889
188268
TRANSDERMAL SYSTEM FOR
VARENICLINE
PFIZER PRODUCTS INC.
US
60/702961
26/07/2005
PCT/IB/2006/002081
WO/2007/012963
0096090660
188269
NAVIGATIONAL AID FOR DIVER
ALBERT R. BASILICO
US
11/158678
22/06/2005
PCT/US/2006/024234
WO/2007/002246
0096090660
188270
SYSTEM AND METHOD OF
CONTROLLING POWER IN A MULTITHREADED PROCESSOR
QUALCOMM INCORPORATED
US
11/167973
27/06/2005
PCT/US/2006/025299
WO/2007/002801
0096090660
537
188271
A61K
‫מערכת טרנסדרמלית לוארניקלין‬
G05D
‫עזרה בניווט לצוללן‬
G06F
‫מערכת ושיטה לשליטת כוח במעבד רב‬
‫יישומים‬
G06F
April 13, 2008– ‫ח' בניסן התשס"ח‬
PREVENTING MULTIPLE
TRANSLATION LOOKASIDE BUFFER
ACCESSES FOR A SAME PAGE IN
MEMORY
QUALCOMM INCORPORATED
US
11/174097
29/06/2005
PCT/US/2006/025301
WO/2007/002803
0496090660
188272
SnAr PROCESS FOR PREPARING
BENZIMIDAZOLE COMPOUNDS
ASTRAZENECA AB
US
60/693374
23/06/2005
PCT/US/2006/023986
WO/2007/002092
0496090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
BENZIMIDAZOLE ‫תהליך יצור תרכובות‬
188276
EXPOSURE METHOD AND
EXPOSURE APPARATUS, AND
DEVICE MANUFACTURING METHOD
NIKON CORPORATION
2005JP
28/06/2005
188837
PCT/JP/2006/312763
WO/2007/000984
C07D
BENZIMIDAZOLE ‫תהליך יצור תרכובות‬
SnAr ‫בעזרת‬
188273
PROCESS FOR PREPARING
BENZIMIDAZOLE COMPOUNDS
ASTRAZENECA AB
US
60/693270
23/06/2005
PCT/US/2006/024084
WO/2007/002157
0096090660
‫מניעת גישות מרובות של מטמון יחידת‬
‫עיבוד מרכזית לאותו עמוד בזיכרון‬
H01L
‫שיטת ומתקן חשיפה ומתקן ליצורו‬
538
0096090660
188277
AMORPHOUS SALT OF 4-(3-CHLORO4(CYCLOPROPYLAMINOCARBONYL)
AMINOPHENOXY)-7-METHOXY-6QUINOLINECARBOXAMIDE AND
PROCESS FOR PRODUCING THE
SAME
EISAI R&D MANAGEMENT CO. LTD.
US
60/693044
23/06/2005
PCT/JP/2006/312487
WO/2006/137474
4/96090660
4096090660
A61K
‫תערובות מרדימות ממיסות במים ושיטות‬
‫לייצורן‬
188279
APPARATUS FOR MEASURING A SET
OF ELECTRICAL CHARACTERISTICS
IN A PLASMA
LAM RESEARCH CORPORATION
US
11/172014
29/06/2005
PCT/US/2006/023027
WO/2007/005210
539
–4–‫–כלורו‬:(–4 ‫מלח אמורפי של‬
–)‫(ציקלופרופילאמינוקרבוניל)אמינופנוקסי‬
‫–קוינולינקרבוקסאמיד‬9–‫–מתוקסי‬7
‫ותהליך לייצורו‬
188278
WATER SOLUBLE ANALGESIC
FORMULATIONS AND METHODS
FOR PRODUCTION
SOLUPRIN PHARMACEUTICALS,
INC.
US
60/693591
24/06/2005
PCT/US/2006/023737
WO/2007/001957
C07D
C02F
‫התקן למדידת קבוצה של תכונות‬
‫חשמליות בפלאזמה‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4/94090660
188280
‫משטח צף‬
FLOATING PLATFORM
ISRAEL AEROSPACE INDUSTRIES
LTD.
IL
173254
19/01/2006
PCT/IL/2006/001457
WO/2007/083292
0096090660
6096090660
‫התעשייה האוירית לישראל בע"מ‬
188281
MACROCYCLIC INHIBITORS OF
HEPATITIS C VIRUS
TIBOTEC PHARMACEUTICALS LTD.
EP
05107066.2 29/07/2005
8988888648
8398898889
EP
PCT/EP/2006/064812
WO/2007/014918
188282
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07K
‫אימונוגלובולינים‬
188283
MACROCYLIC INHIBITORS OF
HEPATITIS C VIRUS
TIBOTEC PHARMACEUTICALS LTD.
EP
05107067.0 29/07/2005
8588848349
8898698885
EP
PCT/EP/2006/064813
WO/2007/014919
C07K
C ‫מעכבים מקרוציקליים של וירוס צהבת‬
IMMUNOGLOBULINES
GLAXO GROUP LIMITED
GB
0513766.6
05/07/2005
858544648
8498898885
GB
PCT/EP/2006/006535
WO/2007/003421
0096090660
B63B
C07D
C ‫מעכבים מקרוציקליים של וירוס צהבת‬
540
4096/90660
188284
METHOD AND APPARATUS TO
TRANSMIT AND RECEIVE DATA IN A
WIRELESS COMMUNICATION
SYSTEM HAVING SMART
ANTENNAS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/717673
16/09/2005
PCT/US/2006/035424
WO/2007/035320
0696090660
‫שיטה ומערכת לשידור וקליטת נתונים‬
‫במערכת תקשורת אלחוטית בעלת‬
‫אנטנות חכמות‬
188285
188288
POLYPEPTIDE HAVING AN
ACTIVITY OF SUPPRESSING FOOD
INTAKE AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
TEIJIN PHARMA LIMITED
JP
05/184441
24/06/2005
899894986
8698398889
JP
PCT/JP/2006/313041
WO/2006/137597
6496090660
INTERCEPTION OF MULTIMEDIA
SERVICES
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
C07D
‫תולדות תיאופניות חדשות‬
NOVEL THIOPHENE DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
EP
PCT/EP05/006840 24/06/2005
PCT/IB/2006/051990
WO/2006/137019
0096090660
H04Q
C12N
‫פוליפפטיד עם פעילות לדיכוי אכילת מזון‬
‫ותכשירי רוקחות המכילים אותו‬
188289
H04L
‫ירוט שרותי מולטימדיה‬
PCT/SE/2005/001102
WO/2007/004938
541
April 13, 2008– ‫ח' בניסן התשס"ח‬
0096090660
188290
A HAND PIECE FOR THE DELIVERY
OF LIGHT AND SYSTEM EMPLOYING
THE HAND PIECE
ONDINE INTERNATIONAL LTD.
US
60/694952
29/06/2005
889485546
8898998889
US
PCT/US/2006/024272
WO/2007/005313
0/96090660
188291
IMAGE CORRECTION ACROSS
MULTIPLE SPECTRAL REGIMES
FLIR SYSTEMS, INC.
US
60/696299
01/07/2005
889888539
8698698885
US
PCT/US/2006/025504
WO/2007/005567
0/96090660
188292
IMAGE STABILIZATION SYSTEM
FLIR SYSTEMS, INC.
US
60/696306
01/07/2005
889363446
8698398889
US
PCT/US/2006/025789
WO/2007/005721
6196090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188293
A61C
‫מכשיר ידני להעברת אור ומערכת‬
‫המשתמשת במכשיר היד‬
G06K
‫תיקון בבואה דרך מכפל מישטרי קרינה‬
G02B
‫מערכת יצוב בבואה‬
C07D
542
‫אנלוגים חדשים של פירידין‬
NEW PYRIDINE ANALOGUES
ASTRAZENECA AB
SE
0501663-9
13/07/2005
8588354-4
8498898885
SE
PCT/SE/2006/000832
WO/2007/008140
4096090660
188294
A METHOD FOR TRANSPORTING A
PARTICULATE MATERIAL AND A
TRANSPORTATION DEVICE FOR A
PARTICULATE MATERIAL
ASTRAZENECA AB
SE
0501687-8
15/07/2005
PCT/SE/2006/000877
WO/2007/011283
6096090660
B65G
‫שיטה להעברת חלקיקי חומר והתקן‬
‫להעברת חלקיקי חומר‬
188296
H02K
‫מנוע חשמלי‬
ELECTRIC MOTOR
ELCKON LIMITED
PCT/GB/2005/002673
WO/2007/003868
0/96090660
188297
EXPOSURE APPARATUS,
SUBSTRATE PROCESSING METHOD
AND DEVICE PRODUCING METHOD
NIKON CORPORATION
2005JP
29/06/2005
190254
8889-883486 8898498889
JP
PCT/JP/2006/312973
WO/2007/001045
543
H01L
‫ תהליך לעיבוד מצע ותהליך‬,‫מתקן חשיפה‬
‫ליצירת מתקן‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0496090660
188298
A METHOD AND A SYSTEM TO
COMMUNICATE AND MANAGE
WORK-ORDER INFORMATION ON
THE MANUFACTURING FLOOR
NAOMI NISHRI
US
60/693081
23/06/2005
889848648
8498898885
US
PCT/IL/2006/000724
WO/2006/137065
0096090660
‫שיטה ומערכת לתקשר ולנהל מידע‬
‫הנוגע להזמנות עבודה במשטח הייצור‬
‫נעמי נשריי‬
188299
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/692662
22/06/2005
989868338
8398398889
US
PCT/IL/2006/000733
WO/2006/137069
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
188301
PROTEIN KINASE C INHIBITORS FOR
PREVENTION OF INSULIN
RESISTANCE AND TYPE 2 DIABETES
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
US
60/694691
29/06/2005
PCT/IL/2006/000755
WO/2007/000770
A01N
‫ספונינים המופקים מזקום מצרי‬
)AEGYPTIACA BALANITES(
‫ושימושיהם‬
BALANITES AEGYPTIACA SAPONINS
AND USES THEREOF
0096090660
G06F
C07K
‫מעכבי פרוטאין קינאז סי למניעה של‬
0 ‫התנגדות אינסולין וסוכרת מסוג‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
544
0496090660
188304
REINFORCING FIBROUS STRUCTURE
FOR A COMPOSITE MATERIAL AND
A PART CONTAINING SAID
STRUCTURE
SNECMA PROPULSION SOLIDE
FR
0506441
24/06/2005
PCT/FR/2006/050617
WO/2006/136755
0/96090660
‫מבנה סיבי מחזק לחומר מרוכב וחלק‬
‫הכולל מבנה זה‬
188305
CELL-FREE GRAFT
TRANSTISSUE TECHNOLOGIES GMBH
DE
102005030614.4 30/06/2005
PCT/EP/2006/006281
WO/2007/003324
0496090660
188306
CRYSTALS OF PHENYLALANINE
DERIVES,, PRODUCTION METHOD
THEREOF AND USE THEREOF
AJINOMOTO CO., INC.
2005JP
21/06/2005
181219
PCT/JP/2006/312432
WO/2006/137450
0496090660
545
B29C
188307
A61F
‫הרכבה ללא תאים‬
C07D
‫ שיטה‬,‫גבישים של נגזרי פנילאלאנין‬
‫לייצורם והשימוש בהם‬
A61B
April 13, 2008– ‫ח' בניסן התשס"ח‬
TECHNIQUES FOR PREDICTION AND
MONITORING OF CLINICAL
EPISODES
EARLYSENSE LTD
US
60/692105
21/06/2005
889868869
8398698885
US
PCT/IL/2006/000727
WO/2006/137067
0096090660
188308
SOY PROTEIN PRODUCTS HAVING
REDUCED OFF-FLAVOR AND
PROCESSES FOR MAKING THE SAME
SOLAE, LLC
US
11/159547
23/06/2005
PCT/US/2006/024557
WO/2007/002450
0096090660
188310
THROMBOSPONDIN-1 DERIVED
PEPTIDES AND TREATMENT
METHODS
RAMTIN AGAH
US
60/693574
24/06/2005
PCT/US/2006/024692
WO/2007/002534
0096090660
188312
ANTI-IL-23 ANTIBODIES
ELI LILLY AND COMPANY
US
60/711336
25/08/2005
989888355
8898898889
US
PCT/US/2006/032752
WO/2007/024846
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188313
‫שיטות לחיזוי ומעקב אחר אפיזודות‬
‫קליניות‬
‫ארליסנס בע"מ‬
A23J
,‫מוצרי חלבון סויה מופחתי טעם רע‬
‫ושיטות להכנתם‬
A61K
, 0–‫פפטידים שמוצאם מתרומבוספונדין‬
‫ושיטות לטיפול‬
C07K
IL– 0: ‫נוגדנים כנגד‬
A61K
546
HIGHLY BIOAVAILABLE ORAL
DELAYED RELEASE DOSAGE FORMS
OF O-DESMETHYLVENLAFAXINE
SUCCINATE
WYETH
US
60/699623
15/07/2005
PCT/US/2006/027106
WO/2007/011619
0096090660
188314
CYANOPYRROLE-SULFONAMIDE
PROGESTERONE RECEPTOR
MODULATORS AND USES THEREOF
WYETH
US
60/704009
29/07/2005
PCT/US/2006/029125
WO/2007/016212
0096090660
–O ‫צורות מינון אוראליות של‬
‫דסמתילוונלאפאקסיין סוקצינט בעלות‬
‫זמינות ביולוגית גבוהה ושחרור מבוקר‬
– ‫מודולטורים של רצפטור של ציאנופירול‬
‫סולפונאמיד פרוגסטרון ושימושיהם‬
188315
LIQUID COMPOSITIONS FOR
TREATING PLANT PROPAGATION
MATERIALS
SYNGENTA PARTICIPATIONS AG
US
60/695143
29/06/2005
PCT/US/2006/025187
WO/2007/005470
6196090660
188316
KININ ANTAGONISTS FOR
TREATING BLADDER DYSFUNCTION
JERINI AG
EP
05014581.2 05/07/2005
PCT/EP/2006/006504
WO/2007/003411
6096090660
547
C07D
188317
A01N
‫תכשירים נוזליים לטיפול בחומרי רבייה‬
‫צמחיים‬
A61K
‫אנטגוניסטים לקינין לטיפול בהפרעות‬
‫בשלפוחית השתן‬
G01N
April 13, 2008– ‫ח' בניסן התשס"ח‬
DETECTION OF A TARGET ANTIGEN
IRRESPECTIVE OF THE PRESENCE
OR ABSENCE OF A CORRESPONDING
THERAPEUTIC ANTIBODY
F. HOFFMANN-LA ROCHE AG
EP
05014618.2 06/07/2005
8988444849
8998398889
EP
PCT/EP/2006/006524
WO/2007/003420
0096090660
188318
USE OF ANTI-MADCAM ANTIBODIES
FOR THE TREATMENT OF COELIAC
DISEASE AND TROPICAL SPRUE
PFIZER LIMITED
US
60/697454
08/07/2005
PCT/IB/2006/001837
WO/2007/007145
0096090660
‫זיהוי של אנטיגן מטרה מבלי להתחשב‬
‫בנוכחות או העדר של נוגדן טיפולי מקביל‬
‫ לטיפול‬MADCAM ‫שימוש בנוגדנים כנגד‬
‫במחלת צליאק ובכרסת טרופית‬
188319
188320
MACROCYCLIC INHIBITORS OF
HEPATITIS C VIRUS
TIBOTEC PHARMACEUTICALS LTD.
EP
05107057.1 29/07/2005
8988386848
8598498889
EP
PCT/EP/2006/064822
WO/2007/014927
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12P
– 0 ,0 ,0 ‫הפחתה אסימטרית של‬
‫טריפלואורואצטון‬
ASYMMETRIC REDUCTION OF 1,1,1TRIFLUOROACETONE
F. HOFFMANN-LA ROCHE AG
EP
05106261.0 08/07/2005
PCT/EP/2006/063621
WO/2007/006650
0096090660
A61K
C07D
‫מעכבים מקרוציקליים של וירוס הפטיטיס‬
C
188321
A61B
548
SURGICAL ACCESS INSTRUMENTS
FOR USE WITH SPINAL OR
ORTHOPEDIC SURGERY
VYCOR MEDICAL, INC.
US
60/692959
22/06/2005
PCT/US/2006/024243
WO/2007/002251
0096090660
188322
NANOPARTICULATE MEGESTROL
FORMULATIONS
ELAN PHARMA INTERNATIONAL
LTD.
US
60/693127
22/06/2005
PCT/US/2006/024349
WO/2007/002315
0096090660
188323
SUBSTITUTED GLYCINAMIDES
HAVING AN ANTITHROMBOTIC AND
FACTOR XA -INHIBITING EFFECT
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05014270.2 30/06/2005
PCT/EP/2006/063611
WO/2007/003536
4096090660
188324
DOSAGE DELIVERY DEVICE
SARDRETTE (GUERNSEY) LIMITED
GB
0512893.9
24/06/2005
898448848
8998398889
GB
PCT/GB/2006/001743
WO/2006/136769
4096090660
549
188325
‫כלי גישה כירורגיים לשימוש בניתוח של‬
‫עמוד השדרה או אורתופדי‬
A61K
‫פורמולציות ננוחלקיקיות של מגסטרול‬
C07D
‫גליצינאמידים מותמרים בעלי השפעה‬
XA ‫נוגדת פקקת ומעכבת גורם‬
A61M
‫מתקן למשלוח מינון‬
A62B
April 13, 2008– ‫ח' בניסן התשס"ח‬
IMPROVED DISPENSING DEVICE
AND METHOD
VENTAIRA PHARMACEUTICALS ,
INC.
US
60/699932
15/07/2005
889465868
8398898889
US
PCT/US/2006/027669
WO/2007/011866
0096090660
188326
ELECTROMAGNETIC FORCE FOR
ENHANCING TISSUE REPAIR
REGENETECH, INC.
US
11/169614
29/06/2005
PCT/US/2006/024814
WO/2007/005373
6096090660
188327
INHIBITORS OF FIBROBLAST
ACTIVATION PROTEIN ALPHA
TRUSTEES OF TUFTS COLLEGE
US
60/696772
05/07/2005
PCT/US/2006/026258
WO/2007/005991
0096090660
188328
ARTIFICIAL NIPPLE WITH
REINFORCEMENT
MEDELA HOLDING AG
US
11/173860
30/06/2005
PCT/US/2006/025010
WO/2007/005427
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188329
‫מכשיר ושיטת חלוקה משופרים‬
A61N
‫כח אלקטרומגנטי לחיזוק תיקון רקמה‬
C07C
‫מעכבי מפעילי פיברובלסט חלבון אלפא‬
A61J
‫פיטמה מלאכותית עם חיזוק‬
C07C
550
NIACIN RECEPTOR AGONISTS,
COMPOSITIONS CONTAINING SUCH
COMPOUNDS AND METHODS OF
TREATMENT
MERCK & CO., INC.
US
60/694711
28/06/2005
PCT/US/2006/024740
WO/2007/002557
0/96090660
188330
PROCESSES FOR THE PREPARATION
OF
4-AMINO-2-(2,6-DIOXOPIPERIDIN-3YL)
ISOINDOLINE-1,3-DIONE
COMPOUNDS
CELGENE CORPORATION
US
60/696224
30/06/2005
PCT/US/2006/026210
WO/2007/005972
0696090660
C07D
–0–‫–אמינו‬4 ‫תהליכים להכנת תרכובות של‬
–‫–יל)איזואינדולין‬:–‫–דיאוקסופיפרידין‬9,0(
‫–דיון‬0,:
188332
DIMMER HAVING A
MICROPROCESSOR-CONTROLLED
POWER SUPPLY
LUTRON ELECTRONICS CO. INC.
US
60/695784
30/06/2005
PCT/US/2006/025662
WO/2007/005651
551
‫ הרכבים‬,‫אגוניסטים של רצפטור ניאצין‬
‫המכילים תרכובות כאלה ושיטות לטיפול‬
H05B
–‫מעמעם בעל ספק כח מבוקר במיקרו‬
‫פרוססור‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
188333
METHOD FOR CONTROLLING
ACCESS TO ENCRYPTED DATA
NAGRAVISION S.A.
EP
05106186.9 07/07/2005
PCT/EP/2006/063989
WO/2007/006736
6096090660
188334
METHOD AND DEVICE FOR
CONTROLLING ACCESS TO
ENCRYPTED DATA
NAGRACARD S.A.
EP
05106185.1 07/07/2005
PCT/EP/2006/063988
WO/2007/006735
0096090660
188335
CONTACTLESS BATTERY
CHARGING APPAREL
CYNETIC DESIGNS LTD
US
60/694248
28/06/2005
PCT/CA/2006/001078
WO/2007/000055
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188339
H04N
‫שיטה לבקרת גישה לנתונים מוצפנים‬
H04N
‫שיטה והתקן לבקרת גישה לנתונים‬
‫מוצפנים‬
H02J
‫לבוש נטול מגעים לטעינת סוללה‬
A61K
552
COMPOSITIONS AND METHODS FOR
ENHANCEMENT OF SEXUAL
FUNCTION
SIVAN GOREN
US
60/693798
27/06/2005
989886894
8898698885
US
PCT/IL/2006/000747
WO/2007/000764
4196090660
‫תכשירים ושיטות להגברת התפקוד המיני‬
‫סיון גורן‬
188340
BROMINATED STYRENIC
POLYMERS AND THEIR
PREPARATION
ALBEMARLE CORPORATION
US
60/696468
30/06/2005
989868438
8998498889
US
PCT/US/2006/023396
WO/2007/005233
0096090660
‫פולימרים סטירניים שעברו ברומינציה‬
‫והכנתם‬
188341
NON-DRAM INDICATOR AND
METHOD OF ACCESSING DATA NOT
STORED IN DRAM ARRAY
C08F
G06F
‫מצבעי ללא גישה לזיכרון דינאמי רנדומלי‬
‫ושיטה לגישה לנתונים שאינם מאוחסנים‬
‫במערך נתונים של גישה לזיכרון דינאמי‬
‫רנדומלי‬
QUALCOMM INCORPORATED
US
11/165950
23/06/2005
PCT/US/2006/024498
WO/2007/002413
4696090660
METHODS FOR MONITORING
NEUROINFLAMMATORY
DESTRUCTION OF NEURONS AND
FOR TREATING DISEASES HAVING
AN INFLAMMATORY COMPONENT
RELATED TO PHOSPHOLIPASE A2
553
188342
G01N
‫שיטות לניטור הרס נוירואינפלמטורי של‬
‫נוירונים ולטיפול במחלות בעלות מרכיב‬
A 0 ‫דלקתי הקשור עם פוספוליפאז‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
PHILADELPHIA HEALTH AND
EDUCATION CORPORATION
CORPORATION D/B/A DREXEL
UNIVERSITY COLLEGE OF
MEDICINE
US
60/697598
08/07/2005
PCT/US/2006/026568
WO/2007/008690
0/96090660
188343
SYSTEM AND METHOD FOR
RESOLVING CONFLICTS IN
MULTIPLE SIMULTANEOUS
COMMUNICATIONS IN A WIRELESS
SYSTEM
QUALCOMM INCORPORATED
US
11/173659
30/06/2005
PCT/US/2006/026208
WO/2007/005971
0/96090660
0096090660
G06F
‫שיטה והתקנים לדיאגנוזה ושיטה לחריגה‬
‫עבור רשת שלמה לזיהוי ולסיווג חרידות‬
‫רשת תוך שימוש במאפייני חלוקת תנועה‬
188345
B-CELL REDUCTION USING CD37SPECIFIC AND CD20-SPECIFIC
BINDING MOLECULES
TRUBION PHARMACEUTICALS, INC.
US
60/702499
25/07/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מערכת ושיטה לפתרון קונפליקטים‬
‫בתקשורות בו זמניות מרובות במערכת‬
‫אלחוטית‬
188344
METHOD AND APPARATUS FOR
WHOLE-NETWORK ANOMALY
DIAGNOSIS AND METHOD TO
DETECT AND CLASSIFY NETWORK
ANOMALIES USING TRAFFIC
FEATURE DISTRIBUTIONS
TRUSTEES OF BOSTON UNIVERSITY
US
60/694853
29/06/2005
989964648
8698998885
US
PCT/US/2006/025398
WO/2007/002838
H04L
A61K
‫ באמצעות מולקולות‬B ‫הפחתה של תאי‬
‫ באופן ספציפי‬CD 0/–‫ ו‬CD :7 ‫הקושרות‬
554
989688565
US
PCT/US/2006/029038
WO/2007/014278
0096090660
8998598889
188346
METHOD AND APPARATUS FOR
REPOSITIONING FLOW ELEMENTS
IN A TAPERED FLOW STRUCTURE
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/692963
23/06/2005
PCT/IL/2006/000728
WO/2006/137068
0696090660
0696090660
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
G08B
‫מערכת מעקב ושיטה לזיהוי תנועה אסורה‬
‫לאורך נתיב הנקבע מראש‬
188350
IL-28 AND IL 29 TRUNCATED
CYSTEINE MUTANTS AND
ANTIVITAL METHODS OF USING
SAME
ZYMOGENETICS INC.
US
60/700905
20/07/2005
PCT/US/2006/028215
WO/2007/012033
555
‫שיטה ומתקן למיקום מחדש של מתקני‬
‫הזרמה במבנה הזרמה מדורג‬
188349
SURVEILLANCE SYSTEM AND
METHOD FOR DETECTING
FORBIDDEN MOVEMENT ALONG A
PREDETERMINED PATH
PLANUM VISION LTD.
IL
169487
30/06/2005
888884
8498698885
IL
PCT/IL/2006/000764
WO/2007/004217
B01D
‫פלנום ויז'ן בע"מ‬
A61K
06–‫ ו‬IL 02 ‫מוטנטים ציסטאינים קטועים‬
‫ ושיטות אנטי–ויראליות לשימוש בהם‬IL
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096090660
188351
PROMOTION OF EPITHELIAL
REGENERATION
RENOVO LTD
GB
0514262.5
12/07/2005
PCT/GB/2006/002577
WO/2007/007098
4096090660
‫קידום התחדשות אפיתל‬
188352
188353
INTERLEUKIN-1 AND TUMOR
NECROSIS FACTOR-A
MODULATORS: SYNTHESES OF
SUCH MODULATORS AND METHODS
OF USING SUCH MODULATORS
NEREUS PHARMACEUTICALS, INC.
US
60/701932
21/07/2005
989834568
8898898885
US
989834986
8898898885
US
989846548
8898898885
US
989865883
8898398889
US
PCT/US/2006/027385
WO/2007/015757
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07C
,‫ נמק שאת‬A –‫ וגורם‬0–‫מאפנני אינטגלןקין‬
‫סינטזה של מאפננים אלו ושיטות לשימוש‬
‫במאפננים אלו‬
188354
HAND HELD OBJECT AND
HANDLING LABELS
SARDRETTE (GUERNSEY) LIMITED
GB
0514667.5
18/07/2005
A61K
‫תכשירים רוקחיים‬
PHARMACEUTICAL COMPOSITIONS
RENOVO LTD
GB
0514259.1
12/07/2005
858489846
8898898885
GB
PCT/GB/2006/002574
WO/2007/007095
4196090660
A61K
A47G
‫פריט המוחזק ביד ותוויות לטיפול‬
556
898839848
GB
PCT/GB/2006/002648
WO/2007/010230
8498898889
4096090660
188356
‫שיטה למצוי חומצה לקטית‬
‫מסוספנסיות מיימיות‬
METHOD FOR EXTRACTING LACTIC
ACID FROM AQUEOUS SUSPENSIONS
BASF AKTIENGESELLSCHAFT
DE
102005033432.6 18/07/2005
PCT/EP/2006/064324
WO/2007/009970
0696090660
188357
USE OF TRUNCATED CYSTEINE IL28
AND IL29 MUTANTS TO TREAT
CANCERS AND AUTOIMMUNE
DISORDERS
ZYMOGENETICS INC.
US
60/700951
20/07/2005
989888898
8698898889
US
PCT/US/2006/028106
WO/2007/013944
0096090660
557
A61K
–‫ ו‬IL 02 ‫שימוש במוטנטים קצוצי ציסטאין‬
‫ לטיפול בסרטן ובאי סדרים‬IL 06
‫אוטואימוניים‬
188358
SYSTEM, APPARATUS AND
METHODS FOR AUTOMATICALLY
CALCULATING DISCOUNTS FOR
PURCHASES
VISA U.S.A. INC.
US
11/166473
24/06/2005
PCT/US/2006/024317
WO/2007/002296
C07C
G06K
‫ מכשיר ושיטות לחישוב אוטומטי‬,‫מערכת‬
‫של הנחות עבור קניות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0096090660
188359
COMPOSITIONS CONTAINING
FLUORINE SUBSTITUTED OLEFINS
HONEYWELL INTERNATIONAL INC.
US
60/693853
24/06/2005
PCT/US/2006/024886
WO/2007/002625
4196090660
188360
SECURE HARDWARE DESKTOP
BUFFER COMPOSITION
MICROSOFT CORPORATION
US
11/187303
22/07/2005
PCT/US/2006/027235
WO/2007/018957
4496090660
188361
SECURE KEY MANAGEMENT FOR
SCALABLE CODESTREAMS
MICROSOFT CORPORATION
US
11/178943
11/07/2005
PCT/US/2006/027391
WO/2007/009066
0096090660
188363
METHOD FOR MANUFACTURE AND
COATING OF NANOSTRUCTURED
COMPONENTS
WASHINGTON STATE UNIVERSITY
RESEARCH FOUNDATION
US
60/693683
24/06/2005
989844833
8898498889
US
PCT/US/2006/024435
WO/2007/002369
April 13, 2008– ‫ח' בניסן התשס"ח‬
C09K
‫תכשירים המכילים אולפינים המותמרים‬
‫בפלואור‬
G09G
‫הרכב בפר לשולחן העבודה לאבטחת‬
‫החמרה‬
H04L
‫ניהול מפתח אבטחה עבור רצפי קודים‬
‫הניתנים לדירוג‬
B01J
‫שיטה ליצור וציפוי מרכיבים זעירים‬
558
0696090660
188366
F16J
‫משאבה חזרתית‬
RECIPROCATING PUMP
SEAPOWER PACIFIC PTY LTD.
AU
2005903457 30/06/2005
PCT/AU/2006/000928
WO/2007/002997
0696090660
188367
H01R
HIGH SPEED, HIGH DENSITY
ELECTRICAL CONNECTOR
AMPHENOL CORPORATION
US
60/695705
30/06/2005
889863594
8698898885
US
PCT/US/2006/025564
WO/2007/005599
0696090660
‫מחבר חשמלי ובעל צפיפות גדולה‬
188368
CONNECTOR WITH IMPROVED
SHIELDING IN MATING CONTACT
REGION
AMPHENOL CORPORATION
US
60/695264
30/06/2005
889489856
8698998889
US
PCT/US/2006/025562
WO/2007/005597
0496090660
‫מחבר חשמלי ובעל יכולת הגנה גבוהה‬
188370
DRIVE DEVICE ON THE BASIS OF A
GEL-TYPE PROPELLANT AND METHOD
FOR CONVEYING PROPELLANT
DEUTSCHES ZENTRUM FUR LUFT-UND
RAUMFAHRT E.V.
DE
102005030437.0 30/06/2005
PCT/EP/2006/005925
WO/2007/003270
559
H01R
F02K
‫מכשיר הנעה על בסיס חומר מניע‬
‫מסוג ג'ל ושיטה להעביר חומר מניע‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4/96090660
188371
‫תולדות חדשות של פיפרידין‬
NOVEL PIPERIDINE DERIVATIVES
ASTRAZENECA AB
SE
0501719-9
21/07/2005
8988636-8
8398498889
SE
PCT/SE/2006/000893
WO/2007/011293
4096090660
188372
PYRROLO[2,3-D]PYRIMIDINE
DERIVATIVES; THEIR
INTERMEDIATES AND SYNTHESIS
PFIZER PRODUCTS INC.
US
60/704011
29/07/2005
PCT/IB/2006/002048
WO/2007/012953
0/96090660
188373
0/96090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
B32B
‫פריט עמיד בליסטית‬
188375
RECOMBINANT INTERFERON ?2
(IFN?2) MUTANTS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/694810
29/06/2005
PCT/IL/2006/000754
WO/2007/000769
C07D
‫ חומרי‬,‫]פירימידין‬D –3 , 2 [ ‫תולדות פירולו‬
‫ביניים שלהן וסינתזה‬
BALLISTIC-RESISTANT ARTICLE
DSM IP ASSETS B.V.
EP
05076502.3 30/06/2005
PCT/EP/2006/006301
WO/2007/003334
0096090660
C07D
C07K
?0 ‫מוטנטים רקומביננטיים של אינטרפרון‬
) IFN ?0(
188376
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K
560
POLYNUCLEOTIDES ENCODING
ISOPRENOID MODIFYING ENZYMES
AND METHODS OF USE THEREOF
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/697067
05/07/2005
PCT/US/2006/025572
WO/2007/005604
4096090660
188378
USE OF ADIPOSE TISSUE DERIVED
STROMAL STEM CELLS IN
TREATING FISTULA
UNIVERSIDAD AUTONOMA DE
MADRID
US
11/167061
24/06/2005
PCT/EP/2006/004605
WO/2006/136244
4096090660
‫פולינוקליאוטידים המקודדים אנזימים‬
‫ ושיטות‬,‫העושים מודיפיקציה לאיזופרנואיד‬
‫לשימוש בהם‬
‫שימוש ברקמות שומן הגורמים לתאי גזע‬
‫סטרומה לטיפול בפיסטולה‬
188380
188381
PYRAZOLOPYRIDINE DERIVATIVES
AS INHIBITORS OF BETAADRENERGIC RECEPTOR KINASE 1
SANOFI AVENTIS
EP
05013774.4 27/06/2005
PCT/EP/2006/005649
WO/2007/000241
561
C07D
‫נגזרות איזוקווינולינים‬
ISOQUINOLINE DERIVATIVES
SANOFI AVENTIS
EP
05013868.4 28/06/2005
PCT/EP/2006/005648
WO/2007/000240
4096090660
C12N
C07D
0 ‫נגזרות פיראזולופירידינים כמעכבי קינאז‬
‫של קולטן ביתא אדרנרגי‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4196090660
188382
HETEROARYL-SUBSTITUTED
AMIDES COMPRISING A
SATURATED LINKER GROUP, AND
THEIR USE AS PHARMACEUTICALS
SANOFI AVENTIS
EP
05013870.0 28/06/2005
PCT/EP/2006/005706
WO/2007/000246
4196090660
188383
HETEROARYL-SUBSTITUTED
AMIDES COMPRISING AN
UNSATURATED OR CYCLIC LINKER
GROUP, AND THEIR USE AS
PHARMACEUTICALS
SANOFI AVENTIS
EP
05013869.2 28/06/2005
PCT/EP/2006/005716
WO/2007/000248
0096090660
188385
HIGH PERFORMANCE RESIN FOR
ABRASIVE PRODUCTS
SAINT GOBAIN ABRASIVES, INC.
US
60/695233
29/06/2005
PCT/US/2006/025133
WO/2007/005452
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
‫אמידים מותמרי הטרוארילים המכילים‬
‫ והשימוש בהם‬,‫קבוצה מקשרת רוויה‬
‫כתכשירים רוקחיים‬
C07D
‫אמידים מותמרי הטרוארילים המכילים‬
,‫קבוצה מקשרת בילתי רוויה או ציקלית‬
‫והשימוש בהם כתכשירים רוקחיים‬
C08L
‫רזין בעל ביצועים גבוהים עבור מוצרי‬
‫השחזה‬
562
0/96090660
188386
‫מוצרים העוברים עיקור עצמי‬
SELF-STERILIZING PRODUCTS
L. MOLTENI & C. DEI FRATELLI ALITTISOCIETA DI ESERCIZIO S.P.A.
US
60/695752
29/06/2005
IT
FI2006A000089 8498498889
PCT/EP/2006/063695
WO/2007/000472
4096090660
188388
PYRAZOLE DERIVATIVES AS CB1
MODULATORS
ASTRAZENECA AB
GB
0514738.4
19/07/2005
PCT/GB/2006/002631
WO/2007/010217
4096090660
188389
563
C07D
–.–‫– מתוקסי‬N–(3 ‫מלח אתנולאמין של‬
–YL2)–2–(4–[4,3,1–‫מתילפיריאזין‬
–:–‫]פניל)פירידין‬YL–0–‫אוקסאדיאזול‬
‫סולפונאמיד‬
188390
IMIDAZOLYL-PYRIMIDINE
COMPOUNDS FOR USE IN THE
TREATMENT OF PROLIFERATIVE
DISORDERS
ASTRAZENECA AB
GB
0515743.3
30/07/2005
858886848
8998898885
GB
858988543
8898898885
GB
898638848
8698498889
GB
PCT/GB/2006/002801
C07D
CB 0 ‫נגזרות פיראזול כמודולטורים של‬
ETHANOLAMINE SALT OF N-(3METHOXY-5-METHYLPYRZIN-2YL)2-(4-[1,3,4-OXADIAZOLE-2YL]PHENYL)
PYRIDINE-3-SULPHONAMIDE
ASTRAZENECA AB
GB
0514743.4
19/07/2005
PCT/GB/2006/002654
WO/2007/010235
0096090660
A61K
C07D
‫תרכובות אימידאזוליל–פירימידין לשימוש‬
‫בטיפול בהפרעות התרבות תאים מהירה‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
WO/2007/015064
0196090660
188442
A61K
COMPOSITIONS FOR AFFECTING
WEIGHT LOSS
OREXIGEN THERAPEUTICS, INC.
US
60/702877
27/07/2005
PCT/US/2006/028875
WO/2007/016108
0096090660
‫תכשירים להפעלת איבוד משקל‬
188443
TIME VARYING ELECTROMAGNETIC
FORCE SLEEVE FOR THE
EXPANSION OF CELLS AND
METHOD OF USING THE SAME
REGENETECH, INC.
US
11/169386
29/06/2005
889896983
8698998885
US
PCT/US/2006/024241
WO/2007/005306
0096090660
‫שרוול כח אלקטרומגנטי המשתנה בזמן‬
‫להרחבת תאים ושיטות לשימוש בו‬
188444
CASE FOR ACCOMMODATING A
MEDICAMENT PACK, AND USE
THEREOF
BAYER SCHERING PHARMA AG
DE
102005032015.5 01/07/2005
PCT/EP/2006/006533
WO/2007/025593
0/96090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12M
188446
A61J
‫מארז לאחסון חבילת תרופות ושימוש‬
‫בו‬
H04L
564
SIGNAL MESSAGE COMPRESSOR
NOKIA CORPORATION
GB
0513433.3
30/06/2005
PCT/IB/2006/001850
WO/2007/004042
4696090660
188448
FORMULATIONS FOR ENHANCED
MUCOSAL DELIVERY OF PYY
NASTECH PHARMACEUTICAL
COMPANY INC.
US
60/698052
11/07/2005
989966864
8398898885
US
PCT/US/2006/026707
WO/2007/008778
0096090660
188449
COMPOSITIONS TO IMPROVE THE
BIOAVAILABILITY OF
POLYMETHOXYFLAVONES AND
TOCOTRIENOLS FOR THE
TREATMENT OF CARDIOVASCULAR
DISEASE
KGK SYNERGIZE INC.
US
60/694720
28/06/2005
PCT/US/2006/025588
WO/2007/002897
0696090660
188450
METHODS OF DETERMINING
PHARMACOKINETICS OF TARGETED
THERAPIES
WYETH
US
60/695419
01/07/2005
PCT/US/2006/025736
WO/2007/005690
565
‫מדחס להודעות סיגנל‬
A61K
‫פורמולציות להעברה רירית מוגברת של‬
YY ‫פפטיד‬
A61K
‫תכשירים לשיפור מידת הספיגה של‬
‫פולימתוקסיפלבונים וטוקוטריאנולים‬
‫לטיפול המחלה של הלב וכלי הדם‬
G01N
‫שיטות לקביעת פארמאקינטיקות של‬
‫תרופות ממוקדות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0/96090660
188451
POLYMER INTERLAYERS
COMPRISING POLY
(CYCLOHEXANEDIMETHYLENE
TEREPHTHALATE-CO-ETHYLENE
TEREPHTHALATE)COPOLYESTER
SOLUTIA INC.
US
11/170643
30/06/2005
889888445
3898998885
US
PCT/US/2006/025771
WO/2007/005711
0696090660
0096090660
‫שכבות ביניים פולימריות המכילות‬
–‫פולי(ציקלוהקסאנדימתילן טרפהלאט–קו‬
‫אתילן טרפהלאט) קופוליאסטר‬
188452
2,4-DIAMINO-PYRIMIDINES USED AS
AURORA INHIBITORS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05106007.7 01/07/2005
PCT/EP/2006/063736
WO/2007/003596
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
‫–דיאמינו–פירימידינים לשימוש כמעכבי‬4,0
‫אורורה‬
188454
KITCHEN ASPIRATOR AND AIR
CLEANER WITH WET FILTER
SYSTEM
YASAR BOZKURT ASICI
TR
2005/02480 27/06/2005
PCT/TR/2006/000025
WO/2007/001242
0696090660
B32B
188456
F24C
‫קולט אדים למטבח ומנקה אוויר עם‬
‫מערכת סינון רטובה‬
A61K
566
COMPOSITIONS AND METHODS FOR
TREATING GRAM POSITIVE
BACTERIAL INFECTION IN A
MAMMALIAN SUBJECT
THE SCRIPPS RESEARCH INSTITUTE
US
60/701216
20/07/2005
889468458
8698898889
US
PCT/US/2006/028385
WO/2007/120170
0696090660
‫תכשירים ושיטות לטיפול בזיהום‬
‫ ביוניק‬GRAM ‫בקטריאלי חיובי‬
188459
ELECTRICAL CONNECTOR FOR
INTERCNNECTION ASSEMBLY
AMPHENOL CORPORATION
US
60/695308
30/06/2005
889489638
8698998889
US
PCT/US/2006/025563
WO/2007/005598
6096090660
567
‫מחבר חשמלי למכלול חיבורים‬
188460
DIAGNOSTIC METHODS AND
COMPOSITIONS FOR DIAGNOSING
AND TREATING INFLUENZA
ARBOR VITA CORPORATION
US
60/696221
01/07/2005
989889388
8398898885
US
989895868
8898898889
US
989868884
8498498889
US
PCT/US/2006/026155
WO/2007/018843
H01R
G01N
‫שיטות איבחון ותכשירים לאיבחון ולטפול‬
‫בשפעת‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096090660
188469
CARTRIDGE FOR STERILE MIXING OF A
TWO-PHASE COMPOUND,
PARTICULARLY FOR TWOCOMPONENT ACRYLIC RESINS
TECRES S.P.A.
IT
VI2005A000187 28/06/2005
PCT/IB/2006/001275
WO/2007/000631
4696090660
188470
MULTIPLE MASK PROCESS WITH
ETCH MASK STACK
LAM RESEARCH CORPORATION
US
11/170273
28/06/2005
PCT/US/2006/018144
WO/2007/001647
0496090660
NEW SALT I
ASTRAZENECA AB
SE
0501768-6
PCT/SE/2006/000920
WO/2007/015666
4496090660
188474
‫מחסנית לערבוב סטרילי של תרכובת‬
‫ במיוחד לשרפים אקריליים‬,‫דו–פאזית‬
‫בעלי שני מרכיבים‬
H01L
‫תהליך רב מיסוך באמצעות ערימה של‬
‫מסיכות צריבה‬
C07D
I ‫מלח חדש‬
02/08/2005
188475
PYRIDO [2,3-D]PYRIMIDINE-2,4DIAMINE COMPOUNDS AS PTPIB
INHIBITORS
F. HOFFMANN-LA ROCHE AG
US
60/701467
21/07/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61F
C07D
–0,4–‫]פירימידינ‬D–2,3[ ‫תרכובות פירידו‬
PTPIB ‫דיאמין כמעכבי‬
568
PCT/EP/2006/064091
WO/2007/009911
4496090660
188476
PYRIDAZINONE DERIVATIVES AS
THYROID HORMONE RECEPTOR
AGONISTS
F. HOFFMANN-LA ROCHE AG
US
60/701215
21/07/2005
PCT/EP/2006/064093
WO/2007/009913
6196090660
4096090660
‫תולדות פירידאזינון כאגוניסטים לרצפטור‬
‫להורמון טיירואיד‬
188478
INDOL-3-CARBONYL-SPIROPIPERIDINE DERIVATIVES AS V1A
RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
05106443.4 14/07/2005
8588639446
8898898885
EP
PCT/EP/2006/063846
WO/2007/006688
GLYCOSYLATED IL-7,
PREPARATION AND USES
CYTHERIS
569
C07D
‫–קרבוניל–ספירו–פיפרידין‬:–‫תולדות אינדול‬
A1V ‫כאנטגוניסטים של רצפטור‬
188479
C07D
]‫גאמא‬/‫ [אלפא‬PPAR ‫אגוניסטים של‬
‫ותהליכים להכנתם‬
PPAR [ALPHA/GAMMA]AGONISTS
AND PROCESSES OF PREPARING
NOVARTIS AG
US
60/698801
13/07/2005
PCT/US/2006/027441
WO/2007/009080
4/96090660
C07D
188480
C12N
‫ הכנה ושימושים‬,‫ שעבר גליקוזידציה‬IL–7
April 13, 2008– ‫ח' בניסן התשס"ח‬
EP
05291556.8
PCT/IB/2006/002663
WO/2007/010401
0496090660
NEW SALT II
ASTRAZENECA AB
SE
0501770-2
PCT/SE/2006/000921
WO/2007/015667
20/07/2005
188481
II ‫מלח חדש‬
02/08/2005
0096090660
188482
METHOD AND PLANT FOR
MANUFACTURING ARTICLES IN THE
FORM OF SHEETS OR BLOCKS OF
CONGLOMERATE STONE OR STONELIKE MATERIAL
TONCELLI, LUCA
IT
TV2005A000106 18/07/2005
PCT/EP/2006/063632
WO/2007/009860
0096090660
B29C
‫שיטה ומפעל לייצור חפצים בצורת‬
‫יריעות או בלוקים של אבן מלוכדת או‬
‫של חומר דמוי אבן‬
188483
CRYSTALLINE FORMS OF 4-[(2,4DICHLORO-5METHOXYPHENYL)AMINO]-6METHOXY-7-[3-(4-METHYL-1PIPERAZINYL)PROPOXY]-3QUINOLINECARB-ONITRILE AND
METHODS OF PREPARING THE
SAME
WYETH
US
60/696381
01/07/2005
PCT/US/2006/025160
WO/2007/005462
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
C07D
–.–‫–דיכלורו‬0,4([–4 ‫קריסטלים של‬
]‫מתוקסיפניל)אמינו‬
–0–‫–מתיל‬4(–:[–7–‫–מתוקסי‬9–
–:–]‫פיפרזיניל)פרופוקסי‬
‫קווינוליינקרב–אוניטריל ושיטות להכנתם‬
570
0496090660
NEW SALT III
ASTRAZENECA AB
SE
0501769-4
PCT/SE/2006/000922
WO/2007/015668
6096090660
188484
III ‫מלח חדש‬
02/08/2005
188486
BENZIMIDAZOLE DERIVATIVES AS
5-HT6,5-HT24
F. HOFFMANN-LA ROCHE AG
US
60/699435
13/07/2005
PCT/EP/2006/063788
WO/2007/006677
0096090660
DRINKING STRAW
UNILEVER PLC
EP
05076887.8
PCT/EP/2006/007631
WO/2007/019958
6096490660
188488
C07D
HT–5 ,6 HT–504–‫תולדות בנזימידאזול כ‬
A47G
‫קשית‬
15/08/2005
188489
AIR-STABLE METAL OXIDE
NANOPARTICLES
NANOSCALE MATERIALS, INC.
US
10/164901
07/06/2002
PCT/US/2003/000548
WO/2003/103804
571
C07D
B01J
‫חלקיקי ננו מתל אוקסיד היציבים באויר‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4696090660
188490
F16K
‫התקן בקרת ניגרים‬
FLUID CONTROL DEVICE
FUJIKIN INCORPORATED
PCT/JP/2005/014653
WO/2007/017937
0196090660
188491
DEVICE FOR LONGITUDINALLY
CUTTING A WEB OF
CONTINUOUSLY MOVING
MATERIAL TO FORM A STRIP WITH
VARIABLE LONGITUDINAL PROFILE
MEGASPIREA PRODUCTION S.A.S.
FR
0507878
25/07/2005
PCT/FR/2006/001798
WO/2007/012739
0196090660
‫התקן לחיתוך אורכי של יריעה של חומר‬
‫הנעה בתמידות ליצירת פס בעל פרופיל‬
‫המשתנה לאורכו‬
188492
METHOD FOR MAKING MAILING
COVERS AND MACHINE
IMPLEMENTING SAID METHOD
MEGASPIREA PRODUCTION S.A.S.
FR
0507877
25/07/2005
PCT/FR/2006/001799
WO/2007/012740
6096090660
B43M
‫שיטה ליצירת מעטפות דואר ומכונה‬
‫ליישום השיטה‬
188494
NOVEL 2,4-DIANLINOPYRIMIDINE
DERIVATIVES, THE PREPARATION
THEREOF, THEIR USE AS
MEDICAMENTS, PHARMACEUTICAL
COMPOSITIONS AND, IN
PARTICULAR, AS IKK INHIBITORS
April 13, 2008– ‫ח' בניסן התשס"ח‬
B26D
C07D
,‫–דיאנילינופירימידין‬4,0 ‫תולדות חדשות של‬
‫הכנתן שימושן כתרופות וכהרכבים‬
IKK ‫רקחיים ובייחוד כמעכבי‬
572
SANOFI-AVENTIS
FR
0507370
8588658
FR
PCT/FR/2006/001619
WO/2007/006926
11/07/2005
8598898885
0696090660
188498
ANTIBACTERIAL AGENT COMPOSED
OF SILVER-CONTAINING
ALUMINUM SULFATE HYDROXIDE
PARTICLES AND USE THEREOF
KYOWA CHEMICAL INDUSTRY CO.,
LTD.
2005JP
30/06/2005
192471
8885-864888 8898898885
JP
PCT/JP/2006/313527
WO/2007/004713
6096090660
188500
COMPOSITIONS AND METHODS
COMPRISING STINGING
CAPSULES/CELLS FOR DELIVERING
A BIOLOGICALLY ACTIVE AGENT
INTO A PLANT CELL
CBD TECHNOLOGIES LTD.
US
60/696799
07/07/2005
PCT/IL/2006/000779
WO/2007/007316
6096090660
NUCLEIC ACID AGENTS FOR
DOWNREGULATING H19, AND
METHOD OF USING SAME
573
188501
A01N
‫גורם אנטיבקטריאלי המורכב מחלקיקי‬
‫אלומיניום סולפאט הידרוקסיד המכילים‬
‫כסף‬
C12N
‫מנגנוני‬/‫תכשירים ושיטות המכילים תאי‬
‫צריבה להחדרת חומר ביולוגי לתוך תא‬
‫צמח‬
‫די טכנולוגיות בע"מ‬.‫בי‬.‫סי‬
C12N
H 06 ‫חומצות גרעין לעיכוב הביטוי של‬
‫ושיטות לשימוש בהם‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/696795
07/07/2005
PCT/IL/2006/000785
WO/2007/007317
0696090660
188506
USE OF AN IMMUNOGEN FOR
PREPARATION OF PHARMACEUTICAL
COMPOSITION FOR TREATING
ALZHEIMER'S DISEASE
PHARMEXA A/S
DK
PA200101231 20/08/2001
989338543
8898898888
US
DK
PA200200558 8998498888
989383888
8998498888
US
PCT/DK/2002/000547
WO/2003/015812
6096090660
188508
METHOD AND SYSTEM FOR DATA
RECORDING AND READING IN
MULTI-PHOTON EXCITABLE MEDIA
MEMPILE INC.
US
60/696810
07/07/2005
PCT/IL/2006/000788
WO/2007/007319
6096090660
188512
PROCESS FOR PREPARING
MALATHION FOR
PHARMACEUTICAL USE
TARO PHARMACEUTICALS U.S.A.
INC.
US
60/697010
06/07/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
A61K
‫שימוש באימונוגן להכנת תכשיר רוקחי‬
‫לטיפול במחלת אלזהיימר‬
G11B
‫שיטה ומערכת להקלטת וקריאת מידע‬
‫בתווך של פוטונים רבים מעוררים‬
A01N
‫תהליך להכנת מאלאתיון לשימושים‬
‫רוקחיים‬
574
989848398
US
989843848
US
PCT/US/2006/026251
WO/2007/005988
6494490660
8898898885
8498398889
188514
LOCATING A ROVING POSITION
RECEIVER WITHIN A LOCATION
NETWORK
QX CORPORATION PTY LTD.
AU
PR8634
02/11/2001
PCT/AU/2002/001495
WO/2003/038469
6494490660
188515
FREQUENCY COHERENCE WITHIN A
LOCATION NETWORK
QX CORPORATION PTY LTD.
AU
PR8634
02/11/2001
PCT/AU/2002/001495
WO/2003/038469
6494490660
188516
A METHOD AND DEVICE FOR
CHRONOLOGICALLY
SYNCHRONIZING ALOCATION
NETWORK
QX CORPORATION PTY LTD.
AU
PR8634
02/11/2001
PCT/AU/2002/001495
WO/2003/038469
575
G01S
‫מיקום מקלט עמדה ניידת בתוך רשת‬
‫מיקום‬
G01S
‫קוהרנטיות תדר בתוך רשת מיקום‬
G01S
‫שיטה ומכשיר לסינכרוניזציה כרונולוגית‬
‫של רשת–מיקום‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
0696090660
188518
PHAGE DISPLAY USING
COTRANSLATIONAL
TRANSLOCATION OF FUSION
POLYPEPTIDES
UNIVERSITY OF ZURICH
EP
05106236.2 08/07/2005
PCT/EP/2006/063729
WO/2007/006665
0496090666
4/96090660
‫תצוגת פאז'ים תוך שימוש בשינוי מיקום‬
‫תוך כדי תרגום של פוליפפטידים מאוחים‬
188519
UNIT DOSE CAPSULES AND DRY
POWDER INHALER
MANNKIND CORPORATION
US
60/145464
23/07/1999
989889883
8898598888
US
PCT/US/2000/040454
WO/2001/007107
188520
188521
COMPOSITIONS AND METHODS FOR
PROTEIN DEAGGREGATION
TRUBION PHARMACEUTICALS, INC.
US
60/702545
25/07/2005
PCT/US/2006/028706
WO/2007/014170
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61M
‫קופסיות יחידת מינון ומשאף אבקה יבשה‬
N-(ARYLALKYL)-1HPYRROLOPYRIDINE-2CARBOXAMIDE DERIVATIVES
PREPARATION AND USE THEREOF
SANOFI-AVENTIS
FR
0507804
22/07/2005
PCT/FR/2006/001767
WO/2007/010138
0196090660
C12N
C07D
–H0–)‫–(ארילאלקיל‬N ‫תולדות‬
‫ הכנתן‬,‫ קרבוקסאמיד‬0–‫פירולופירידין‬
‫ושימושים רפואיים בהן‬
C07K
‫הרכבים ושיטות לדהאגרגציה של חלבון‬
576
4096094//0
188522
C12N
‫ חומצות גרעין‬,‫מווסתים של משקל הגוף‬
‫ ושימושים שלהם‬,‫וחלבונים מתאימים‬
‫ברפואה ובאבחנה‬
MODULATORS OF BODY WEIGHT,
CORRESPONDING NUCLEIC ACIDS
AND PROTEINS AND DIAGNOSTIC
AND THERAPEUTIC USES THEREOF
THE ROCKEFELLER UNIVERSITY
US
292345
17/08/1994
348593
3898898664
US
436438
8898598665
US
463888
8898998665
US
6496090660
188525
PROJECTION OF SUBSURFACE
STRUCTURE ONTO AN OBJECT'S
SURFACE
LUMINETX TECHNOLOGIES
CORPORATION
A61B
‫היטל של מבנה תת–שטח לשטח מטרה‬
PCT/US/2005/023522
WO/2007/005018
0496090660
188526
METHODS AND SYSTEMS FOR
UTILIZATION OF RESOURCES OF
CONTENTION UNDER ANY LOAD TO
FACILITATE DESIRED BANDWIDTH
ACROSS SINGLE OR MULTIPLE
CLASSES OF DEVICES
LUCENT TECHNOLOGIES INC.
577
H04L
‫שיטות ומערכות להפקת תועלת‬
‫ממשאבים תחרותיים תחת הספק‬
‫כלשהוא על מנת להקל על מעבר רוחב‬
‫פס רצוי בין התקנים מסוג אחד או ממספר‬
‫סוגים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
US
11/193522
PCT/US/2006/028632
WO/2007/016023
0096090660
29/07/2005
188527
‫התקן לריכוך אדמה‬
SOIL CONDITIONING DEVICE
TERRACON TECHNOLOGIES LLC.
US
11/176569
07/07/2005
PCT/US/2006/024803
WO/2007/008393
4696090660
188528
METHODS AND COMPOSITIONS FOR
TREATING OPHTHALMIC
CONDITIONS VIA SERUM RETINOL
SERUM RETINOL BINDING PROTEIN
(RBP), AND/OR SERUM RETINOL-RBP
MODULATION
SIRION THERAPEUTICS, INC.
US
60/698512
11/07/2005
PCT/US/2006/026770
WO/2007/008821
0696090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A01N
‫שיטות ותכשירים לטיפול בתנאים עיניים‬
‫ חלבון קושר סרום‬,‫באמצעות סרום רטינול‬
RBP ‫או אפנון סרום רטינול‬/‫) ו‬RBP( ‫רטינול‬
188532
SYSTEM OF PROVIDING MESSAGE
CONTENT IN A COMMUNICATION
SYSTEM RING-BACK SPACE
ARAUZ, NICK
US
60/696447
01/07/2005
889866348
8998698885
US
889485463
8898998889
US
PCT/US/2006/026109
WO/2007/005917
A01B
G06F
‫מערכת העברת תוכן הודעות במערכת‬
‫תקשורת בזמן צליל החיוג‬
578
0094490660
188534
C07C
CRYSTAL FORMS OF CINACALCET
HCI AND PROCESSES FOR THEIR
PREPARATION
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/739215
22/11/2005
989848989
8598898885
US
PCT/US/2006/045252
WO/2007/062147
4/94690660
‫פורמים קריסטליניים של סינאקלסט‬
‫הידרוכלוריד ותהליכים להכנתם‬
‫טבע תעשיות פרמצבטיות בע"מ‬
188535
PROCESS FOR THE PREPARATION OF HIGHLY
PURE 1-[2-DIMETHYLAMINO-(4METHOXYPHENYL)ETHYL]CYCLOHEXANOL
HYDROCHLORIDE
TEVA PHARMACEUTICAL INDUSTRIES LTD.
US
60/728632
19/10/2005
989866869
8398498889
US
989866688
8698598889
US
PCT/US/2006/041119
WO/2007/047972
0096090660
188542
MULTI-LAYER, LIGHT MARKABLE
MEDIA AND METHOD AND
APPARATUS FOR USING SAME
SINCLAIR SYSTEM
INTERNATIONAL, LLC
US
60/712640
29/08/2005
989866585
8498498889
US
PCT/US/2006/033586
WO/2007/032900
579
C07C
–0[–0 ‫תהליך להכנת‬
–4(–‫דימתילאמינו‬
]‫מתוקסיפניל)אתיל‬
‫ציקלוהקסנול הידרוכלוריד‬
‫בניקיון גבוה‬
‫טבע תעשיות פרמצבטיות בע"מ‬
B65C
‫מדיה רב–שכבתית ניתנת לסימון‬
‫ ושיטה והתקן לשימוש‬,‫באמצעות אור‬
‫בנ"ל‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6196090660
188543
METHOD AND DEVICE FOR SUPPLY
TO A MAGNETIC COUPLER
UNIVETRSITE MONTPELLIER II
FR
0501736
05/07/2005
PCT/FR/2006/001579
WO/2007/006902
4696090660
188544
LIGANDS OF MELANOCORTIN
RECEPTORS
SOCIETE DE CONSEILS DE
RECHERCHES ET D'APPLICATIONS
SCIENTIFIQUES S.A.S.
US
60/697594
08/07/2005
PCT/US/2006/026554
WO/2007/008684
4696090660
188545
MELANOCORTIN RECEPTOR
LIGANDS
SOCIETE DE CONSEILS DE
RECHERCHES ET D'APPLICATIONS
SCIENTIFIQUES S.A.S.
US
60/697779
08/07/2005
989846658
8698898885
US
PCT/US/2006/026586
WO/2007/008704
0/96090660
188546
CLEANROOM WIPER
KIMBERLY-CLARK WORLDWIDE,
INC.
US
60/698116
11/07/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
H02M
‫שיטה ומתקן לאספקת מצמד מגנטי‬
A61K
‫ליגנדים של קולטני מלאנוקורטין‬
A61K
‫ליגנדים של קולטן מלאנוקורטין‬
D04B
‫מגב לחדר נקי‬
580
889868958
US
PCT/US/2006/025453
WO/2007/008444
0/96090660
8898898885
188547
CLEANROOM WIPER
KIMBERLY-CLARK WORLDWIDE,
INC.
US
60/698116
11/07/2005
889863446
8898898885
US
PCT/US/2006/025452
WO/2007/008443
0/96090660
188548
APPLIANCE FOR DELIVERING A
COMPOSITION
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/190597
26/07/2005
PCT/US/2006/025451
WO/2007/018822
6196090660
188550
HETEROCYCLIC COMPOUNDS AS
AGONISTS FOR THE THYROID
RECEPTOR
KARO BIO AB
GB
0513692.4
04/07/2005
PCT/EP/2006/006522
WO/2007/003419
4096090660
188551
IMPROVED CRYSTALLINE FORM OF
THE COMPOUND A-348441
KARO BIO AB
GB
0514302.9
12/07/2005
PCT/EP/2006/006811
WO/2007/006561
581
D04B
‫מטלית לניקוי‬
A47K
‫כלי להעברת תכשיר‬
C07D
‫תרכובות הטרוציקליות כאגוניסטים‬
‫לרצפטור התירואיד‬
C07J
‫צורה גבישית משופרת של התרכובת‬
A–:42440
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
188554
NOVEL PHAGE DISPLAY
TECHNOLOGIES
RIBOVAX BIOTECHNOLOGIES S.A.
EP
PCT/EP05/007325 07/07/2005
PCT/IB/2006/001878
WO/2007/007154
0096090660
188555
CYANOPYRIDINE PESTICIDES
BASF AKTIENGESELLSCHAFT
US
60/703753
29/07/2005
PCT/EP/2006/064788
WO/2007/014913
4/96090660
188556
STABLE AQUEOUS DISPERSIONS OF
COLOUR DEVELOPER
CIBA SPECIALTY CHEMICALS
HOLDING INC.
EP
05106950.8 28/07/2005
PCT/EP/2006/064387
WO/2007/014847
6096090660
188557
IMPROVED CONTROL SYSTEM FOR
SUPPLYING FLUID MEDIUM TO
ENDOSOCPE
STRYKER GI LTD.
US
60/703200
28/07/2005
PCT/IL/2006/000776
WO/2007/013055
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12N
‫טכנולוגיות חדשות ליצוג פאג'ים‬
C07D
‫קוטלי חרקים ציאנופירידיניים‬
C07C
‫דיספרסיות מיימיות יציבות של מפתח‬
‫צבעים‬
A61B
‫מערכת בקרה לבספקת נוזלים‬
‫לאנדוסקוף‬
‫ בע"מ‬.‫ אי‬.‫סטריקר ג'י‬
582
6196090660
188558
SERUM-FREE CULTURE MEDIUM
FOR THE PRODUCTION OF
RECOMBINANT GONADOTROPINS
ARES TRADING S.A.
EP
05106060.6 05/07/2005
989968888
8998898885
US
PCT/EP/2006/063862
WO/2007/003640
0696090660
188560
ADENO-ASSOCIATED VIRUS
VECTORS ENCODING SUPEROXIDE
DISMUTASE AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
GENZYME CORPORATION
US
60/697450
07/07/2005
PCT/US/2006/025980
WO/2007/008486
0696090660
188561
PHARMACEUTICAL COMPOSITION
CONTAINING AN ADENOASSOCIATED VIRUS ENCODING AN
IMMUNOMODULATORY
TRANSGENE
GENZYME CORPORATION
US
60/697459
07/07/2005
PCT/US/2006/025979
WO/2007/008485
583
C12N
‫מדיום ללא סרום לייצור של‬
‫גונאדוטרופינים רקומביננטים‬
A01N
‫וקטורי נגיף הקשורים לאדנו המקודדים‬
‫חמצתית–על דיסמוטז ותכשירי רוקחות‬
‫המכילים אותם‬
A01N
‫תכשירי רוקחות המכילים נגיף הקשור‬
‫לאדנו המקודד טרנסגן המגווין חסינית‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
188562
AROMATIC POLYAMIDE
FILAMRNTS AND METHODS FOR
THE PRODUCTION THEREOF
KOLON INDUSTRIES, INC.
10-2005KR
05/07/2005
0060308
PCT/KR/2006/002625
WO/2007/004849
6096090660
188563
AROMATIC POLYAMIDE FILAMENTS
AND METHODS FOR THE
PRODUCTION THEREOF
KOLON INDUSTRIES, INC.
10-2005KR
06/07/2005
0060501
PCT/KR/2006/002627
WO/2007/004851
6096090660
188564
AROMATIC POLYAMIDE FILAMENTS
AND METHODS FOR THE
PRODUCTION THEREOF
KOLON INDUSTRIES, INC.
10-2005KR
06/07/2005
0060502
PCT/KR/2006/002624
WO/2007/004848
April 13, 2008– ‫ח' בניסן התשס"ח‬
D01F
‫סיבים מפוליאמיד ארומטית ותהליכים‬
‫להכנתם‬
D01F
‫סיבים מפוליאמיד ארומטית ותהליכים‬
‫להכנתם‬
D01F
‫סיבים מפוליאמיד ארומטית ותהליכים‬
‫להכנתם‬
584
6096090660
188566
METHOD TO IMPROVE DIELECTRIC
AND/OR DISSIPATION FACTORS OF
FLAME RETARDANT COMPOSITIONS
ALBEMARLE CORPORATION
US
60/697705
05/07/2005
PCT/US/2006/026656
WO/2007/006054
6096090660
BALLOON CATHETER
ANGIOSLIDE LTD
US
60/695868
989889898
US
PCT/IL/2006/000770
WO/2007/004221
188567
B02C
‫או‬/‫שיטה לשיפור גורמים די אלקטריים ו‬
‫גורמי פיזור של הרכבים מעכבי בערה‬
A61M
‫צנתר בלון‬
‫אנג'יוסלייד בע"מ‬
05/07/2005
8498898885
0696090660
188568
HAIR CLIPPER WITH MOTORISED
CUTTING GUIDE
FACO S.A.
EP
05447164.4 07/07/2005
PCT/BE/2006/000069
WO/2007/006106
6096090660
COUPLING BETWEEN TWO TUBES
WIDEE B.V.
188570
B26B
‫קוצץ שיער עם מוביל חיתוך ממונע‬
F16L
‫חבור בין שני צנורות‬
PCT/NL/2005/000471
WO/2007/004860
585
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
188571
COUPLING BETWEEN TWO BODIES
COMPRISING AN ELASTICALLY
DEFORMABLE CUTTING RING WITH
A SCREW THREAD FORMING
CUTTING LIPS
WIDEE B.V.
F16L
‫חבור בין שני גופים המכילים טבעת חיתוך‬
‫המעוותת בצורת אלסטית עם שפתי‬
‫תתיכה היוצרים הברגה‬
PCT/NL/2005/000472
WO/2007/004861
6096090660
188572
F16L
‫חבור בין שני צנורות עם מחברי כינון‬
‫נפרדים‬
COUPLING BETWEEN TWO TUBES
WITH SEPARATE SET-UP CLAMPS
WIDEE B.V.
PCT/NL/2005/000473
WO/2007/004862
6096090660
188573
‫חבור בין שני גופים‬
COUPLING BETWEEN TWO BODIES
WIDEE B.V.
NL
1029412
03/07/2005
PCT/NL/2006/050161
WO/2007/004880
6096090660
188575
DEVICE AND METHOD FOR THE
TREATMENT OF BIOMASSES WITH
PERMANENT MAGNETS
MEIER, TONIO
DE
102005031873.8 07/07/2005
PCT/DE/2006/001160
WO/2007/006269
April 13, 2008– ‫ח' בניסן התשס"ח‬
F16L
C02F
‫מכשיר ושיטה לטיפול בביומסה‬
‫באמצעות מגנטים קבועים‬
586
6494094///
188576
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
6494094///
188577
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
587
C12N
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
C12N
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6494094///
188578
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
6494094///
188579
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12N
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
C12N
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
588
6494094///
188580
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
6494094///
188581
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
GENENTECH, INC.
US
60/112851
16/12/1998
989883845
8998898666
US
989883588
8898898666
US
989885595
8898898666
US
989885556
8898898666
US
989885833
8898898666
US
989886348
8698898666
US
989886538
8898898666
US
989886695
8898898666
US
US
PCT/US99/12252 8898998666
PCT/US/1999/028634
WO/2000/036102
589
C12N
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
C12N
‫פולפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
6096090660
188582
SURGICAL FASTENERS AND
DEVICES FOR SURGICAL
FASTENING
ENDOGUN MEDICAL SYSTEMS LTD.
US
60/696516
06/07/2005
PCT/IL/2006/000783
WO/2007/004228
6196090660
188586
PACKAGING BOX FOR PACKAGING,
PRESERVING, MICROWAVE STEAM
COOKING AND CONSUMPTION OF
FOODS
SEBBAN CLAUDE
FR
0507122
05/07/2005
8988848
8898898889
FR
PCT/FR/2006/050675
WO/2007/003864
0696090660
188588
ANTI-CTLA -4 ANTIBODY AND CPGMOTIF-CONTAINING SYNTHETIC
OLIGODEOXYNUCLEOTIDE
COMBINATION THERAPY FOR
CANCER TREATMENT
PFIZER INC.
US
60/697082
07/07/2005
PCT/US/2006/025711
WO/2007/008463
6096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188589
A61B
‫מהדקים ניתוחיים והתקני הידוק‬
‫אנדוגן מערכות רפואיות בע"מ‬
B65D
‫ בישול‬,‫ שימור‬,‫קופסת אריזה לאריזה‬
‫באדים במיקרוגל וצריכת מזון‬
C07K
CTLA–4 ‫טיפול משולב של נוגדן כנגד‬
‫ואוליגונוקליאוטיד סינטתי המכיל מוטיף‬
‫ לטיפול בסרטן‬CPG
G09F
590
SYSTEM AND METHOD FOR
SECURING ACCESSORIES TO
CLOTHING
JIBBITZ LLC
US
60/697326
07/07/2005
989884945
8898698885
US
989838885
8998898885
US
PCT/US/2006/026508
WO/2007/008655
4196490666
188590
SCHIZOCHYTRIUM PKS GENES
MARTEK BIOSCIENCES
CORPORATION
US
/09231899
14/01/1999
PCT/US/2000/000956
WO/2000/042195
4496090660
188591
METHODS OF TREATING
AUTOIMMUNE DISEASE USING
HUMANIZED ANTI-CD16A
ANTIBODIES
MACROGENICS, INC.
US
60/698623
11/07/2005
PCT/US/2006/027387
WO/2007/009065
4496090660
591
188592
‫שיטה ומערכת להצמדת אביזרים לביגוד‬
C07K
PKS ‫גנים–סכיזוקטריום‬
A61K
‫שיטות לטיפול במחלה אוטואימונית ע"י‬
‫שימוש בגרסה אנושית של נוגדנים מסוג‬
A16CD – ‫אנטי‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטות לטיפול בהפרעות אוטואימוניות‬
‫באמצעות שימוש בנוגדים מונוקלונלים‬
‫בעלי רעילות מופחתת המדכאים את‬
‫הפעילות החיסונית‬
METHODS FOR THE TREATMENT OF
AUTOIMMUNE DISORDERS USING
IMMUNOSUPPRESSIVE
MONOCLONAL ANTIBODIES WITH
REDUCED TOXICITY
MACROGENICS, INC.
US
60/698517
11/07/2005
PCT/US/2006/027386
WO/2007/009064
6496090660
188593
ADAPTOR FOR AN AIR
COMPRESSOR AND AN AIR
COMPRESSOR
BGM INNOVATIONS LIMITED
AU
2005903616 07/07/2005
PCT/AU/2006/000748
WO/2007/006074
6096090660
‫מתאם למדחס אויר ומדחס אויר‬
188594
ANTI-CCR7 RECEPTOR ANTIBODIES FOR
THE TREATMENT OF CANCER
UNIVERSIDAD AUTONOMA DE MADRID
EP
PCT/EP2005/007371 06/07/2005
PCT/EP/2006/006556
WO/2007/003426
0696090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
F15B
188595
A61K
‫ לטיפול בסרטן‬CCR7 ‫נוגדנים אנטי‬
H04Q
592
APPARATUS AND METHOD FOR
RESOLVING REQUEST COLLISION IN
A HIGH BANDWIDTH WIRELESS
NETWORK
QUALCOMM INCORPORATED
US
11/173832
30/06/2005
PCT/US/2006/026083
WO/2007/005897
4196090660
188596
ADIPOSE TISSUE DERIVED CELLS
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
COGNATE THERAPEUTICS, INC.
US
60/699553
15/07/2005
PCT/US/2006/027515
WO/2007/011797
4096090660
‫מתקנים ושיטה לפתרון בקשת התנגשות‬
‫ברשת אלחוטית בטווח תדרים גבוה‬
‫תאים המופקים מרקמה אדיפוזית ותכשירי‬
‫רוקחות המכילים אותם‬
188597
BENZOIMIDAZOLE DERIVATES AND
PHARMACEUTICAL COMPOUNDS
CONTAINING THE SAME
TAIHO PHARMACEUTICAL CO., LTD.
2005JP
13/07/2005
204957
8885-885686 8898698885
JP
PCT/JP/2006/313827
WO/2007/007778
0096090660
593
C12N
188598
C07D
‫תולדות בנזואימידאזול ותכשירי רוקחות‬
‫המכילים אותן‬
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
A SOLVATE OF CABERGOLINE AND
METHODS OF PREPARING
CABERGOLINE FORM 1 UTILIZING
THE SAME
RESOLUTION CHEMICALS LIMITED
GB
0515430.7
27/07/2005
PCT/GB/2006/002784
WO/2007/012846
4096090660
0 ‫מימס של קברגולין ושיטות להבנת צורה‬
‫של קברגולין המשתמשות בו‬
188599
METHODS AND SUBSTANCES FOR
ISOLATING MICRORNA
BIOVENTURES INC.
US
60/709861
19/08/2005
PCT/US/2006/032264
WO/2007/024653
4496090660
188600
METHOD FOR PREPARING
ESOMEPRAZOLE
HANMI PHARM. CO., LTD.
10-2005KR
28/07/2005
0068761
PCT/KR/2006/002719
WO/2007/013743
6096090660
188603
PREPARATION OF INSULIN
CONJUGATES
BIOCON LIMITED
C12Q
RNA ‫שיטות וחומרים לבדידת מיקרו‬
C07D
‫תהליך להכנת אסאומאפראזול‬
C07K
‫הכנה של תצמידי אינסולין‬
PCT/IN/2005/000234
WO/2007/007345
6096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188604
F16L
594
‫חיבור לצינורות‬
PIPE CONNECTION
UPONOR INNOVATION AB
EP
05106243.8 08/07/2005
PCT/FI/2006/050322
WO/2007/006863
0/96090660
188605
A METHOD AND A SYSTEM FOR
PROCESSING PRINTED PRODUCTS
ePAC TECHNOLOGIES
US
11/175676
06/07/2005
PCT/US/2006/025279
WO/2007/008434
4096090660
‫שיטה ומערכת לעיבוד מוצרים מודפסים‬
188606
NOVEL 1,4-BENZOTHIAZEPINE-1,1DIOXIDE, DERIVATIVE HAVING
IMPROVED PROPERTIES, METHOD FOR
THE PRODUCTION THEREOF,
MEDICAMENTS CONTAINING SAID
COMPOUND, AND USE THEREOF
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102005033100.9 15/07/2005
PCT/EP/2006/006849
WO/2007/009656
6096090660
H04N
‫ דיאוקסיד‬0,0 ‫ בנזותיאזפינים‬0,4 ‫נגזרות‬
,‫ שיטות ליצירתן‬,‫בעלי תכונות משופרות‬
‫תכשירים המכילים אותם ושימוש בהם‬
188607
HIGH TRYPTOPHAN SOYBEAN
MEAL
RENESSEN LLC
US
60/697452
08/07/2005
PCT/US/2006/026269
WO/2007/008546
4096090660
595
C07D
C12N
‫מזון סויה עשיר בטריפטופן‬
188608
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
1,4-BENZOTHIAZEPINE 1,1-DIOXIDE
DERIVATIVE, PROCESS FOR ITS
PREPARATION, MEDICAMENTS
COMPRISING THIS COMPOUND, AND
USE THEREOF AS A HYPOLIPIDAEMIC
SANOFI-AVENTIS DEUTSCHLAND
GMBH
DE
102005033099.1 15/07/2005
PCT/EP/2006/006848
WO/2007/009655
4496090660
,‫–דיאוקסיד‬0,0 ‫–בנזותיאזפינין‬0,4 ‫נגזרות‬
‫ ותרופות המכילות אותו‬,‫תהליך ליצירתו‬
188609
‫התקן להוצאת טיפונת‬
DROPLET DEPOSITION APPARATUS
XAAR TECHNOLOGY LIMITED
GB
0514202.1
11/07/2005
PCT/GB/2006/002551
WO/2007/007079
4196090666
188610
6096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
188611
SP1 POLYPEPTIDES, MODIFIED SP1
POLYPEPTIDES AND USES THEREOF
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/696779
07/07/2005
PCT/IL/2006/000795
WO/2007/007325
A61K
‫תכשירים אנטי–אלרגיים חדשניים‬
NOVEL ANTI-ALLERGIC AGENTS
RAMOT AT TEL AVIV UNIVERSITY
LTD.
IL
130526
17/06/1999
PCT/IL/2000/000346
WO/2000/078346
6/96090660
B41J
C07K
‫ והשימוש‬,‫ ודומיהם‬SP0 ‫פוליפפטידים מסוג‬
‫בהם‬
188612
‫ בע"מ‬.‫פ‬.‫פולכרום ס‬
H04L
596
METHODS AND DEVICES FOR
LOCATION DETERMINATION AND
LOCATION-BASED SERVICES IN
WIRELESS WIDE AREA NETWORKS,
WIRELESS LOCAL AREA NETWORKS
AND WIRELESS PERSONAL AREA
NETWORKS
QUALCOMM INCORPORATED
US
60/697504
07/07/2005
989888388
8698698885
US
889848383
3898698885
US
PCT/US/2006/026309
WO/2007/008574
6096090660
188613
METHODS AND DEVICES FOR
INTERWORKING OF WIRELESS WIDE
AREA NETWORKS AND WIRELESS
LOCAL AREA NETWORKS OR
WIRELESS PERSONAL AREA
NETWORKS
QUALCOMM INCORPORATED
US
60/697504
07/07/2005
989888388
8698698885
US
889848845
3898698885
US
PCT/US/2006/026308
WO/2007/008573
4096090660
‫שיטות ומכשירים להגדרת מיקום‬
‫ושירותים מבוססי מיקום ברשתות‬
‫ לרשתות אלחוטיות‬,‫אלחוטיות לאזור רחב‬
‫מקומיות ולרשתות אלחוטיות אישיות‬
‫איזוריות‬
‫שיטות ומכשירים לעבודה יחד לביצוע‬
‫משימה של רשתות אלחוטיות לאיזור רחב‬
‫ולרשתות אלחוטיות מקומיות או לרשתות‬
‫אלחוטיות אישיות אזוריות‬
188614
HIGHLY SELECTIVE SEROTONIN
AND NOREPINEPHRINE DUAL
REUPTAKE INHIBITOR AND USE
THEREOF
WYETH
US
60/699665
15/07/2005
PCT/US/2006/026991
WO/2007/011594
4096090660
597
H04L
188615
C07C
‫מעכב קליטה– מחדש דואלי בעל‬
‫סלקטיביות גבוהה של נורפינפירין‬
‫וסרוטונין ושימוש שלו‬
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
HIV REVERSE TRANSCRIPTASE
INHIBITORS
MERCK & CO. INC.
US
60/701797
22/07/2005
989888689
8698898885
US
989868885
8898498889
US
PCT/US/2006/027700
WO/2007/015812
6196090660
188616
ACTIVATOR OF PEROXISOME
PROLIFERATOR ACTIVATED
RECEPTOR ?
NIPPON CHEMIPHAR CO., LTD.
2005JP
06/07/2005
197484
PCT/JP/2006/313636
WO/2007/004733
4496090660
188617
GLUTAMATE AGGRECANASE
INHIBITORS
WYETH
US
60/697590
11/07/2005
PCT/US/2006/027066
WO/2007/008994
4196090660
188618
HCV NS3 PROTEASE INHIBITORS
MERCK & CO. INC.
US
60/700764
20/07/2005
989884599
8898898885
US
PCT/US/2006/027573
WO/2007/015787
0696090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188619
TRANSCRIPTASE ‫מעכבים של‬
REVERSE HIV
C07D
‫אקטיבטור לפרוקסיסום פרוליפרטור‬
‫המפעיל רצפטור דלתא‬
C07C
‫מעכבים לגלוטמט אגרקנאז‬
C07K
‫ מעכבי פרוטאז‬NS HCV:
C07J
598
PROCESS FOR THE PRODUCTION OF
3-OXO-PREGN-4-ENE-21,17CARBOLACTONES BY THE METALFREE OXIDATION OF 17-(3HYDROXYPROPYL)-3,17
DIHYDROXYANDROSTANES
BAYER SCHERING PHARMA AG
EP
05090214.7 21/07/2005
889865664
8898898885
US
PCT/EP/2006/007287
WO/2007/009821
6096090660
,00–‫–אן‬4–‫–אוקסו–פרגן‬: ‫תהליך להכנת‬
‫–קרבולקטונים באמצעות חמצון ללא‬07
–07,:–)‫–הידרוקסיפרופיל‬:(–07 ‫מתכת של‬
‫דיהידרוקסיאנדרוסטאנים‬
188621
‫סכין חיתוך לסרט דביק בעל ידית‬
‫אסימטרית‬
TAPING KNIFE WITH OFFSET
HANDLE
UNITED STATES GYPSUM COMPANY
US
11/187569
22/07/2005
PCT/US/2006/021792
WO/2007/018704
0/96090660
188623
PORTABLE HANDHELD SECURITY
DEVICE
CATCHER, INC.
US
PCT/US2005/24506 08/07/2005
PCT/US/2005/026812
WO/2007/008217
6496090660
599
B05C
188624
G08B
‫התקן אבטחה נייד שמוחזק ביד‬
B26B
April 13, 2008– ‫ח' בניסן התשס"ח‬
TAPING KNIFE HANDLE WITH
IDENTIFICATION INSERT
UNITED STATES GYPSUM COMPANY
US
11/187582
22/07/2005
889386538
8898898889
US
PCT/US/2006/021191
WO/2007/018690
6096090660
‫ידית לסכין חיתוך סרטים עם זיהוי מוחדר‬
188625
PORTABLE HANDHELD SECURITY
DEVICE
CATCHER, INC.
G08B
‫התקן אבטחה נייד המוחזק ביד‬
PCT/US/2005/024506
WO/2007/008204
0096090660
188626
FOOD ARTICLE COMPRSING A
MICROCAPSULE
OCEAN NUTRITION CANADA LTD
US
60/697092
07/07/2005
889435985
8898598889
US
989688583
8898998889
US
989688638
8698998889
US
PCT/US/2006/024735
WO/2007/008384
4696090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188629
A23L
‫פריט אוכל המכיל כמוסת–מיקרו‬
G01N
600
‫שיטות לחיפוש מודולטורים של‬
‫ מודוטורים של‬,)IL–:0( :0 ‫אינטרלאוקין‬
‫ המזוהים על ידי שיטות כאלה‬IL–:0
‫והשימוש בהם‬
METHODS OF SCREENING FOR
MODULATORS OF INTERLEUKIN-32
(IL-32), MODULATORS OF IL-32
IDENTIFIED BY SAID METHODS AND
THEIR USE
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
IL
169622
11/07/2005
PCT/IL/2006/000798
WO/2007/007327
6096090660
‫ידע חברה למחקר ופיתוח בע"מ‬
188631
MASS STORAGE DEVICE WITH
AUTOMATED CREDENTIALS
LOADING
SANDISK CORPORATION
US
60/697906
08/07/2005
889386856
8898898885
US
889386635
8898898885
US
PCT/US/2006/026241
WO/2007/008540
4096090660
6096090660
601
‫ציוד אחסון המצויד במערכת הרשאות‬
‫אוטומטית‬
188632
TRANSGENIC MICE CARRYING HP-2
GENE AND USES AS MODELS FOR
VASCULAR DISEASES
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/698012
12/07/2005
PCT/US/2006/026842
WO/2007/008870
H04L
C12P
–0 ‫עכברים טרנסגניים הנושאים את הגן‬
‫ והשימושים כמודלים למחלות כלי דם‬HP
188634
‫המכון למחקר במדעי הרפואה ע"ש‬
‫משפחת רפפורט‬
H04R
April 13, 2008– ‫ח' בניסן התשס"ח‬
LISTENING DEVICE FOR CLEAR
PERCEPTION OF SOUND SIGNALS IN
A NOISY ENVIRONMENT
AMPLIFON A.G.
CH
01138/05
08/07/2005
PCT/IB/2006/052311
WO/2007/007265
4696090660
188635
6096090660
09/07/2005
188639
FENTANYL FORMULATION
CONTAINING AN ESSENTIAL OIL
SOSEI R&D LTD
GB
0514043.9
08/07/2005
PCT/GB/2006/002526
WO/2007/007059
6096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
B24B
‫סידור אפקטור קצה משופר לזרוע עבור‬
‫התאמה על ידי רפידה לפלנריזציה כימית‬
)CMP( ‫מכנית‬
ENHANCED END EFFECTOR ARM
ARRANGEMENT FOR CMP PAD
CONDITIONING
TBW INDUSTRIES, INC.
US
60/697893
PCT/US/2006/026771
WO/2007/008822
‫מכשיר להאזנה המשמש לתפיסה ברורה‬
‫של אותות קול בסביבה רועשת‬
188640
A61K
‫תערובת פנטאניל שהוכנה באמצעות‬
‫נוסחא המכילה שמן חיוני‬
H04L
602
METHODS AND DEVICES FOR
INTERWORKING OF WIRELESS WIDE
AREA NETWORKS AND WIRELESS
LOCAL AREA NETWORKS OR
WIRELESS PERSONAL AREA
NETWORKS
QUALCOMM INCORPORATED
US
60/697504
07/07/2005
989888388
8698698885
US
889848885
3898698885
US
PCT/US/2006/026307
WO/2007/008572
0096090660
188641
FITTING SYSTEMS ADAPTED
ESPECIALLY FOR FIXING SEAT
POSITIONS
WEBER AIRCRAFT LP
US
60/702133
25/07/2005
PCT/US/2006/028753
WO/2007/014184
4096090660
‫שיטות ומכשירים לעבודה יחד לביצוע‬
‫משימה של רשתות אלחוטיות לאיזור רחב‬
‫ולרשתות אלחוטיות מקומיות או לרשתות‬
‫אלחוטיות אישיות איזוריות‬
‫מערכות התאמה מותאמות במיוחד לשם‬
‫תיקון תנוחות כיסא‬
188642
HUMAN ANTI-B7RP1 NEUTRALIZING
ANTIBODIES
MEDAREX, INC.
US
60/700265
18/07/2005
PCT/US/2006/027862
WO/2007/011941
0696090660
603
B64D
188643
C07K
‫ ממקור אנוש‬RP7B0–‫נוגדני ניטרול אנטי‬
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
N-(HETEROARYL)-1HETEROARYLALKYL-1H-INDOLE-2CARBOXAMIDE DERIVATIVES,
PREPARATION AND USE THEREOF
SANOFI-AVENTIS
FR
0507803
22/07/2005
PCT/FR/2006/001782
WO/2007/010144
6/96090660
–0–)‫ (הטרואריל‬N–‫תולדות‬
–0–‫–אינדול‬H0–‫הטרוארילאלקיל‬
‫הכנתן ושימושיהן‬,‫קרבוקסאמיד‬
188644
TRANSPARENT TRANSPORT OF
FIBRE CHANNEL TRAFFIC OVER
PACKET-SWITCHED NETWORKS
CORRIGENT SYSTEMS LTD.
US
60/698538
11/07/2005
889486565
8698998889
US
PCT/IL/2006/000794
WO/2007/007324
6496090660
‫תחבורה שקופה של תנועת ערוץ סיב‬
‫ברשתות החלפת חבילת מידע‬
‫קוריגנט מערכות בע"מ‬
188654
MAGNETIC AND ELECTROSTATIC
CONFINEMENT OF PLASMA IN A
FIELD REVERSED CONFIGURATION
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/266074
01/02/2001
989868869
8698998888
US
889899484
3898898888
US
PCT/US/2002/002854
WO/2002/062112
4696090664
April 13, 2008– ‫ח' בניסן התשס"ח‬
H04L
H05H
‫הגבלת פלסמה בעזרת שדה מגנטי‬
‫ואלקטרוסטטי בתצורת שדה הפוכה‬
188667
C12N
604
HOST CELL INFECTED BY A
MODIFIED VACCINIA VIRUS ANKARA
(MVA)
BAVARIAN NORDIC A/S
DK
PA200000410 14/03/2000
PCT/EP/2001/002703
WO/2001/068820
4096490660
188676
MINIMALLY INVASIVE GLAUCOMA
SURGICAL INSTRUMENT AND
METHOD
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/263617
18/01/2001
PCT/US/2002/001665
WO/2002/056805
4096090666
VACCINE
SMITHKLINE BEECHAM
BIOLOGICALS S.A.
GB
9919468.0
668833946
GB
PCT/EP/2000/007965
WO/2001/012797
4096490660
188686
605
A61B
‫מכשיר ושיטה לניתוח גלאוקומה חודרני‬
‫מזערית‬
A61K
‫תכשיר חיסון חדש‬
17/08/1999
8698898666
188710
NUCLEIC ACID AND PROTEIN
ENCODED THEREBY
DSM FINE CHEMICALS AUSTRIA
NFG GMBH & CO. KG
AT
A60/2001
16/01/2001
8398498888
AT
A523/2001
6094690660
‫תא פונדקאי מודבק ע"י נגיף וציניה‬
)MVA( ‫אנקארה ששונה‬
188774
C12N
‫חומצת גרעין וחלבון המקודד על–ידה‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
COMPOSITIONS FOR DELIVERY OF
DRUG COMBINATIONS
CELATOR PHARMACEUTICALS, INC.
US
60/326671
03/10/2001
989348586
8898898888
US
989359856
8598898888
US
8363586
8398498888
CA
989488664
8898698888
US
989486833
8998698888
US
PCT/CA/2002/001500
WO/2003/028696
6496090660
‫תכשירים לנתינה של תערובות תרופות‬
188790
H01L
‫שיטות להכנת קרומים בעלי דיאלקטריות‬
‫נמוכה‬
PROCESSES FOR PREPARING LOW
DIELECTRIC FILMS
AIR PRODUCTS AND CHEMICALS,
INC.
US
60/384321
30/05/2002
889936648
8898598883
US
0496094//0
188791
HYPOXIA-REGULATING GENES
QUARK PHARMACEUTICALS, INC.
US
60/056453
21/08/1997
PCT/US/1998/017296
WO/1999/009049
0096090660
188828
MESSAGING SYSTEM AND METHOD
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12N
‫גנים המסדירים מצב של חוסר חמצן‬
G06F
‫מערכת ושיטה למשלוח הודעות‬
606
TRIPLAY COMMUNICATIONS LTD
US
60/709830
22/08/2005
989846985
8398898885
US
989846989
8398898885
US
PCT/IL/2006/000976
WO/2007/023494
6096090660
188829
SYSTEM AND METHOD OF SLURRY
TREATMENT
SIEMENS WATER TECHNOLOGIES
CORP.
US
11/195108
02/08/2005
PCT/US/2006/026336
WO/2007/018854
0696090660
188832
SYSTEMS AND METHODS FOR
STABILIZATION OF BONE
STRUCTURES
VERTIFLEX, INC.
US
60/701660
22/07/2005
889398399
8398898889
US
PCT/US/2006/028586
WO/2007/014119
0096090666
607
188833
‫טריפליי תקשורת בע"מ‬
C02F
‫מערכת ושיטה לטיפול במים עכורים‬
A61B
‫מערכות ושיטות לייצוב מבני עצם‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
STABLE PHARMACEUTICAL
SOLUTION FORMULATIONS FOR
PRESSURISED METERED DOSE
INHALERS
CHIESI FARMACEUTICI S.P.A.
‫תמיסות של הרכבי רוקחות יציבים עבור‬
‫משאפים הנותנים מנה קצובה בלחץ‬
PCT/EP/2000/004635
WO/2001/089480
0/96090660
188834
C12N
‫תכשיר חיסון חדש‬
NOVEL VACCINE COMPOSITION
SAECHISCHES SERUNWERK
DRESDEN BRANCH OF SMITHKLINE
BEECHAM PHARMA GMBH & CO. KG
GB
0113083.0
30/05/2001
888488946
8898898888
GB
PCT/EP/2002/005883
WO/2002/097072
0496090660
188835
F22B
‫מחלק אדים נייד‬
PORTABLE VAPORIZING DISPENSER
TEMPRA TECHNOLOGY, INC.
US
60/704573
01/08/2005
PCT/US/2006/030572
WO/2007/016705
0696090660
188836
METHOD AND APPARATUS FOR
MULTI-LANGUAGE USER
SELECTION FOR SYSTEM USER
INTERFACE
GOLDMINE WORLD, INC.
US
11/185030
20/07/2005
PCT/US/2006/028034
WO/2007/013921
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
G07F
‫שיטה והתקן לבחירה רב שפות על ידי‬
‫משתמש עבור מערכת בעלת ממשק‬
‫משתמש‬
188837
C22C
608
MAGNESIUM ALLOY
GKSS-FORSCHUNGSZENTRUM
GEESTHACHT GMBH
DE
102005033835.6 20/07/2005
PCT/DE/2006/001212
WO/2007/009435
6496090660
188838
FUSED HETEROCYCLIC
COMPOUNDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
PHARMA MAR, S.A.
GB
0515673.2
01/08/2005
PCT/GB/2006/050229
WO/2007/015112
4096090660
188839
SUBSTITUTED PROPANAMIDE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
DAIICHI SANKYO COMPANY,
LIMITED
2005JP
19/07/2005
208036
PCT/JP/2006/314144
WO/2007/010885
4/96090660
609
188840
‫סגסוגת מגנזיום‬
C07D
‫תרבובות הטרוצקליות מותכות ותכשירי‬
‫רוקחות המכילים אותן‬
A61K
‫תולדות פרופאנאמיד מותמרות ותכשירי‬
‫רוקחות המכילים אותן‬
A61K
April 13, 2008– ‫ח' בניסן התשס"ח‬
TWO-STAGE GAS REGULATING
ASSEMBLY
FATS INC.
US
60/700595
19/07/2005
PCT/US/2006/028074
WO/2007/012018
0496090660
‫מערכת דו שלבית לויסות גז‬
188841
MULTIPLE GENE EXPRESSION
INCLUDING SORF CONSTRUCTS
AND METHODS WITH
POLYPROTEINS, PRO-PROTEINS,
AND PROTEOLYSIS
ABBOTT LABORATORIES
US
60/701855
21/07/2005
PCT/US/2006/028691
WO/2007/014162
0096490660
SORF ‫ביטוי גנים מרובה הכולל מבני‬
,‫ושיטות המשתמשות בפוליפרוטאינים‬
‫פרו–פרוטאינים ופרוטאוליזה‬
188844
FLUORO SUBSTITUTED
CYCLOALKANOINDOLES AND
THEIR USE AS PROSTAGLANDIN D2
RECEPTOR ANTAGONISTS
MERCK FROSST CANADA LTD
US
60/351384
24/01/2002
PCT/CA/2003/000084
WO/2003/062200
0094690660
C07D
‫ציקלואלקנואינדולים מותמרי פלואור‬
‫ושימושם כאנטגוניסטים של רצפטור‬
D2 ‫פרוסטאגלנדין‬
188846
DIETARY FIBER FORMULATION
AND METHOD OF ADMINISTRATION
April 13, 2008– ‫ח' בניסן התשס"ח‬
C12P
A23L
‫פורמולציה של סיב תזונתי ושיטת אספקה‬
610
NOVARTIS AG
US
60/729767
989848884
US
PCT/US/2006/041568
WO/2007/050656
24/10/2005
8898898885
0096090660
188847
NUTRITION FOR OBESE PATIENTS
NESTEC S.A.
EP
05018626.1 26/08/2005
8588855948
8698898885
EP
PCT/EP/2006/065562
WO/2007/042341
0196090660
188848
NOVEL HETEROCYCLIDENE
ACETAMIDE DERIVATIVE
MOCHIDA PHARMACEUTICAL CO.,
LTD.
2005JP
22/07/2005
213534
PCT/IB/2006/002016
WO/2007/010383
4096090660
188850
CATHEPSIN K INHIBITORS
F. HOFFMANN-LA ROCHE AG
US
60/702937
27/07/2005
PCT/EP/2006/064306
WO/2007/014839
0096090660
SALTS AND POLYMORPHS OF A
VEGF-R INHIBITOR
PFIZER INC.
611
188851
A23L
‫תזונה עבור חולים בהשמנת יתר‬
C07D
‫נגזרת חדשה של הטרוציקלידין אצטמיד‬
C07D
K ‫מעכבי קתפסין‬
C07D
R–VEGF ‫מלחים ופולימורפים של מעכב‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
US
60/706332
989858866
US
PCT/IB/2006/002171
WO/2007/017740
0496090660
08/08/2005
8498898885
188852
F16D
ANTI-OXIDATION PROTECTION OF
PIECES MADE FROM A COMPOSITE
MATERIAL CONTAINING CARBON
MESSIER-BUGATTI
FR
0508196
01/08/2005
PCT/FR/2006/050765
WO/2007/015026
4494090664
‫הגנה נגד חימצון של חלקים העשויים‬
‫מחומר מורכב המכיל פחמן‬
188853
HETEROCYCLIC SULFONAMIDE
INHIBITORS OF BETA AMYLOID
PRODUCTION
WYETH
US
60/255105
13/12/2000
PCT/US/2001/048375
WO/2002/057252
0196090660
–‫מעקבים הטרוציקליים של יצירת ביטא‬
‫אמילואיד המבוססים על סולפונאמיד‬
188854
188855
PROCESS FOR THE RECYCLING OF
EXPANDED POLYSTYRENE
POLIMERI EUROPA S.P.A.
IT
MI2005A001409 22/07/2005
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
‫תולדות בנזילפיפרזין ושימושים רפואיים‬
‫שלהן‬
BENZYLPIPERAZINE DERIVATES
AND THEIR MEDICAL USE
GLAXO GROUP LIMITED
GB
0515381.2
26/07/2005
898849646
8698998889
GB
PCT/EP/2006/007390
WO/2007/012479
0096090660
C07D
C08J
‫תהליך למיחזור פוליסטירן מורחב‬
612
PCT/EP/2006/006247
WO/2007/009559
0496090660
188856
NOVEL PIPERIDINE DERIVATIVES
AS CHEMOKINE RECEPTOR
MODULATORS USEFUL FOR THE
TREATMENT OF RESPIRATORY
DISEASES
ASTRAZENECA AB
SE
0501757-9
01/08/2005
PCT/SE/2006/000918
WO/2007/015664
6096090660
‫נגזרות פיפרידין חדשות כמווסתות רצפטור‬
‫של כימוקין השימושיות לטיפול במחלות‬
‫נשימתיות‬
188857
NOVEL BENZOTHIAZOLONE
DERIVATIVES
ASTRAZENECA AB
SE
0501793-4
09/08/2005
8588684-9
3898698885
SE
8988585-8
8698398889
SE
PCT/SE/2006/000927
WO/2007/018461
4196090660
188858
MEDICAL DEVICES COATED WITH A
FAST DISSOLVING BIOCOMPATIBLE
COATING
FMC BIOPOLYMER AS
US
60/706396
21/07/2005
PCT/US/2006/027425
613
C07D
C07D
‫נגזרות בנזותיאזולון חדשות‬
A61F
‫מכשירים רפואיים המצופים עם ציפוי‬
‫מתאים ביולוגית המתמוסס מהר‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
WO/2007/015761
6096090660
188859
C07D
COMBINATIONS COMPRISING
EPOTHILONE DERIVATIVES AND
ALKYLATING AGENTS
UNIVERSITY OF NEWCASTLE UPON
TYNE
US
60/362738
08/03/2002
PCT/EP/2003/002364
WO/2003/075899
6094494//0
‫שילובים המכילים נגזרות של אפותילון‬
‫וחומרים העושים אלקילציה‬
188860
BIODEGRADABLE HETEROPHASE
POLYMERIC COMPOSITIONS
COMPRISING A THERMOPLASTIC
STARCH, A THERMOPLASTIC
POLYMER INCOMPATIBLE WITH
STARCH AND AN INTERFACIAL
AGENT, PROCESS FOR THEIR
PREPARATION AND THEIR USE IN
ORGANIC AND INORGANIC
PRODUCTS
NOVAMONT S.P.A.
IT
TO96A000890 05/11/1996
IT
TO96A000996 8698898669
PCT/EP/1997/006103
WO/1998/020073
4096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הרכבים של פולימרים הטרופאזיים ברי‬
‫פירוק ביולוגי המכילים עמילן‬
‫ פולימר תרמופלסטי שאינו‬,‫תרמופלסטי‬
‫מסיס בעמילן ויסוד המהווה שכבת‬
‫ תהליך להכנתם ושימוש בהם‬,‫ביניים‬
‫במוצרים אורגניים ואי–אורגניים‬
188861
1,4-DIHYDROPYRIDINE-FUSED
HETEROCYCLES, PROCESS FOR
PREPARING THE SAME, USE AND
COMPOSITIONS CONTAINING THEM
Aventis Pharma S.A
EP
05291558.4 20/07/2005
PCT/IB/2006/002734
C08L
C07D
,‫–דיהידרופירידין–מאוחים‬4,0 ‫הטרוציקלים‬
‫ שימושים והרכבים‬,‫שיטה להכנתם‬
‫המכילים אותם‬
614
WO/2007/012972
4096090660
EAR CLEANING DEVICE
RAFI KOREN
US
60/700543
PCT/IL/2006/000827
WO/2007/010529
0096090660
188862
A61F
‫התקן לניקוי אוזניים‬
‫רפי קורן‬
18/07/2005
188863
DIGITAL CERTIFICATE ON
CONNECTORS AND OTHER
PRODUCTS USING RFID TAGS
AND/OR LABELS AS WELL AS RFID
READER/INTERROGATOR
H04Q
‫זיהוי אלקטרוני על מחברים ומוצרים‬
‫אחרים המשתמשים בטכנולוגיה של תגים‬
‫של תיוג אלקטרוני באמצעות גלי רדיו‬
‫חוקרי‬/‫או תוויות כמו גם קוראי‬/‫) ו‬RFID(
‫תיוג אלקטרוני באמצעות גלי רדיו‬
STRATOS INTERNATIONAL, INC.
US
11/183525
18/07/2005
PCT/US/2006/024422
WO/2007/011493
0096090660
188864
GROWTH-STIMULATING
POLYPEPTIDES FOR USE IN FISH
AND CRUSTACEANS
CENTRO DE INGENIERIA GENETICA
Y BIOTECNOLOGIA
CU
2005-0135
21/07/2005
PCT/CU/2006/000006
WO/2007/009403
615
C07K
‫פוליפפטידים ממריצי צמיחה לשימוש‬
‫בדגים וסרטנים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096090660
188865
REDUCTION IN MYOCARDIAL
INFARCTION SIZE
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
11/183251
18/07/2005
PCT/US/2006/027476
WO/2007/011773
4/96090660
4096090660
ARMORED VEHICLE
MOWAG GMBH
EP
05405483.8
PCT/IB/2006/002276
WO/2007/020531
4096090660
‫הקטנת גודל אוטם שריר הלב‬
‫המכון למחקר במדעי הרפואה ע"ש‬
‫משפחת רפפורט‬
188866
SYSTEM FOR LIVE TELEVISION
BROADCASTING FROM A MOBILE
TELEPHONE
CREATECNA XXI S.L.
ES
P200501769 20/07/2005
ES
P200601898 8898898889
PCT/ES/2006/000421
WO/2007/010070
A61K
H04N
‫מערכת לשידור טלויזיוני חי ממכשיר טלפון‬
‫נייד‬
188868
F41H
‫כלי רכב משוריין‬
18/08/2005
188869
APOPTOSIS SENSITIVITY TO
AP02L/TRAIL BY TESTING FOR
GALNAC-T14 EXPRESSION IN
CELLS/TISSUES
GENENTECH, INC.
US
60/708677
16/08/2005
989686889
8498598889
US
PCT/US/2006/031785
April 13, 2008– ‫ח' בניסן התשס"ח‬
G01N
TRAIL/L20AP/‫רגישות אפופטוזיס ל‬
T–GALNAC04 ‫באמצעות בחינה של ביטוי‬
‫רקמות‬/‫בתאים‬
616
WO/2007/022157
6096090660
188870
PULL TAB ACTIVATED SEALED
PACKET
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/217110
31/08/2005
PCT/US/2006/021356
WO/2007/027255
0696090660
‫אריזה חתומה המופעלת במשיכת תווית‬
188871
188872
METHOD FOR STIMULATING THE
ORGANISM BIOCHEMICAL
REACTIONS FOR TREATING
ORGANS AND TISSUES, A BOARD
FOR CARRYING OUT SAID METHOD
AND A BOARD EMITTER
NIKOLAY VENIAMINOVICH
CHADAYEV OF
RU
2005123065 20/07/2005
8885834688
8898898885
RU
8889888353
8998998889
RU
617
A61F
‫אריזה לקונדומים‬
PACKAGING FOR CONDOMS
MAPA GMBH GUMMI-UND
PLASTIKWERKE,
DE
102005033875.5 20/07/2005
PCT/EP/2006/006364
WO/2007/009570
4/96090660
B65D
A61H
‫שיטה להמרצת תגובות ביוכימיות של‬
‫ התקן‬,‫אורגניזם לטיפול באיברים וברקמות‬
‫לביצוע השיטה ומכשיר הפולט את ההתקן‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
8889888365
RU
8889885888
RU
PCT/RU/2006/000385
WO/2007/011266
8398998889
8698898889
4/96090660
SMOKE-FREE CIGARETTE
NICCULTO AG
DE
102005034169.1
PCT/EP/2006/007125
WO/2007/009785
4096090660
188873
‫סיגריה ללא עשן‬
21/07/2005
188874
APOPTOSIS SENSIVITY TO
AP02L/TRAIL BY TESTING FOR
GalNac -T14 EXPRESSION IN
CELLS/TISSUES
GENENTECH, INC.
US
60/708677
16/08/2005
989686889
8498598889
US
PCT/US/2006/031894
WO/2007/022214
6096094///
188875
TUMOR-ASSOCIATED ANTIGEN
DERIVATIVES FROM THE MAGE
FAMILY, AND NUCLEIC ACID
SEQUENCES ENCODING THEM,
USED FOR THE PREPARATION OF
FUSION PROTEINS AND OF
COMPOSITIONS FOR VACCINATION
SMITHKLINE BEECHAM
BIOLOGICALS S.A.
GB
9802543.0
05/02/1998
668895843
8998898666
GB
PCT/EP/1999/000660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A24F
G01N
TRAIL/L02AP–‫רגישות אופופטוזיס ל‬
GalNac 14T–‫באמצעות בחינה של ביטוי‬
‫רקמות‬/‫בתאים‬
C12N
MAGE ‫נגזרות אנטיגן ממשפחת‬
‫הקשורות לגידול ורצפי חומצות גרעין‬
‫המקודדים להם המשמשים להכנת‬
‫חלבונים מותכים ותכשירים לחיסון‬
618
WO/1999/040188
4/96090660
188876
A61N
ORGAN ASSIST SYSTEM AND
METHOD
ZVI BEN SHALOM
US
60/700311
19/07/2005
PCT/IL/2006/000838
WO/2007/010535
0196090660
‫מערכת סיוע לאבר ותהליך‬
‫צבי בן שלום‬
188877
IMPROVEMENTS TO ANALOGOUS
COMPOUNDS OF 6-THIOGUANOSINE
TRIPHOSPHATE, THEIR USE IN
MEDICAL FIELDS AND PROCESSES FOR
THEIR PREPARATION
GIULIANI INTERNATIONAL LIMITED
IT
RM2005A000391 22/07/2005
888998446
8498998889
IE
PCT/IE/2006/000077
WO/2007/010515
0196090660
4096090660
619
–9 ‫שיפורים לתרכובות אנלוגיות של‬
‫ שימושן‬,‫תיוגואנוסין תלת–פוספט‬
‫בתחומים רפואיים ותהליכים לייצורן‬
188878
COMPOUNDS AND THEIR SALTS
SPECIFIC TO THE PPAR RECEPTORS
AND THE EGF RECEPTORS AND THEIR
USE IN THE MEDICAL FIELD
GIULIANI INTERNATIONAL LIMITED
IT
RM2005A000389 22/07/2005
PCT/IE/2006/000078
WO/2007/010516
188879
C07H
C07C
–‫תרכובות ומלחיהן המיוחדות לקולטי‬
‫ ושימושן בתחום‬EGF–‫ ולקולטי‬PPAR
‫הרפואי‬
A47K
April 13, 2008– ‫ח' בניסן התשס"ח‬
DRYING APPARATUS
Dyson Technology Limited
GB
0515749.0
898868648
GB
PCT/GB/2006/002199
WO/2007/015045
4096090660
DRYER
Dyson Technology Limited
GB
0515752.4
PCT/GB/2006/002139
WO/2007/015043
4096090660
‫התקן יבוש‬
30/07/2005
8898898889
188880
‫מייבש‬
30/07/2005
188881
VIBRATIONAL THERAPY ASSEMBLY
FOR TREATING AND PREVENTING
THE ONSET OF DEEP VENOUS
THROMBOSIS
JUVENT, INC.
US
60/700092
18/07/2005
989888685
8898898885
US
989888835
8898898885
US
989638869
8898898889
US
889466888
8698898889
US
PCT/US/2006/027723
WO/2007/011885
April 13, 2008– ‫ח' בניסן התשס"ח‬
A47K
A61H
‫מכשור טיפל ברטט לטיפול ולמניעת‬
‫התחלה של תרומבוזה ורידית עמוקה‬
620
0696090660
188882
A61B
‫קתטר איוד‬
ABLATION CATHETER
ABLATION FRONTIERS, INC.
US
60/692416
20/06/2005
PCT/US/2006/023808
WO/2007/001981
0496090660
188886
C09B
METHOD OF PREPARING PIGMENT
COMPOSITIONS
CABOT CORPORATION
US
60/702079
22/07/2005
PCT/US/2006/028319
WO/2007/014007
0696090660
‫שיטה להכנת הרכבי פיגמנטים‬
188888
LIQUID FLOW VALVE WITH A
BISTABLE ELECTROMAGNETIC
CONTROL ASSEMBLY
R.P.E. S.R.L.
IT
MI2005A001404 21/07/2005
PCT/EP/2006/064477
WO/2007/010026
6096090660
188889
SECRETION OF ANTIBODIES
WITHOUT SIGNAL PEPTIDES FROM
BACTERIA
621
F16K
‫שסתום זרימת נוזל עם שליטה קיבוצית‬
‫אלקטרומגנטית ביסטאבילית‬
C07K
‫הפרשה של נוגדנים ללא פפטידים‬
‫מסומנים מבקטריות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
KALOBIOS PHARMACEUTICALS ,
INC.
US
60/701902
22/07/2005
889883689
8498898885
US
PCT/US/2006/026334
WO/2007/018853
4/96090660
188890
COMBINATION OF A DESALINATION
PLANT AND A SALINITY GRADIENT
POWER REVERSE
ELECTRODIALYSIS PLANT AND USE
THEREOF
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
EP
05447175.0 20/07/2005
PCT/BE/2006/000078
WO/2007/009196
0496090660
188891
APPARATUS AND METHOD FOR
SCULPTING THE SURFACE OF A
JOINT
ALEXANDRIA RESEARCH
TECHNOLOGIES LLC
US
60/701270
21/07/2005
889456648
8898898889
US
PCT/US/2006/028143
WO/2007/013959
0496090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188892
H01M
‫שילוב בין מתקן התפלה לבין מתקן כח‬
‫מליחות הדרגתית אלקטרודיאליסטית‬
‫חוזרת‬
A61B
‫מכשיר ושיטה לגילוף פני השטח של‬
‫מפרק‬
G06F
622
METHOD AND SYSTEN FOR
GENERATING INDIVIDUAL
ELECTRONIC MEDICAL RECORD
DR. MALIK M. HASAN
US
60/704309
01/08/2005
PCT/US/2006/029694
WO/2007/016468
4/96/90660
‫שיטה ומערכת ליצירת רשומה רפואית‬
‫אלקטרונית אישית‬
188894
‫תרכובות לטיפול במחלות מושפעות‬
‫ליפאז‬
COMPOUNDS FOR TREATMENT OF
LIPASE-MEDIATED DISEASES
RELIANCE LIFE SCIENCES PVT. LTD.
IN
864/MUM/2005 21/07/2005
PCT/IN/2005/000318
WO/2007/010546
0196090660
188896
DIAZEPINOQUINOLINES, SYNTHESIS
THEREOF, AND INTERMEDIATES
THERETO
WYETH
US
60/702509
26/07/2005
PCT/US/2006/028655
WO/2007/016029
0696090660
623
C07D
‫ ותוצרי‬,‫ סינתזה שלהם‬,‫דיאזפינוקווינולינים‬
‫הביניים שלהם‬
188897
3-(2(DIMETHYLAMINO)METHYL(CYCLOHEX
-1-YL)PHENOL MALEATE AND ITS
CRYSTALLINE FORMS
GRUNENTHAL GMBH
DE
102005034974.9
22/07/2007
PCT/EP/2006/007160
WO/2007/009792
0696090660
C07C
188898
C07C
–0(–:
–0–‫(דימתילאמינו)מתיל(ציקלוהקס‬
‫איל)פנול מלאט וצורות גבישיות שלו‬
C07H
April 13, 2008– ‫ח' בניסן התשס"ח‬
PROCESSES FOR PREPARING
PYRAZOL-O-GLYCOSIDE
DERIVATIVES AND NOVEL
INTERMEDIATES OF SAID
PROCESSES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05015935.9 22/07/2005
PCT/EP/2006/064435
WO/2007/010015
0696090660
–O–‫תהליכים להכנת תולדות של פיראזול‬
‫גליקוציד ותוצרי ביניים חדשים של‬
‫תהליכים אלו‬
188900
THIOCOLCHICOSIDE ANALOGUES
WITH MYORELAXANT AND ANTIINFLAMMATORY ACTIVITY
INDENA S.P.A.
IT
MI2005A001418 22/07/2005
PCT/EP/2006/007108
WO/2007/009772
4096090660
0496090660
N-OXIDES AS PRODRUGS OF
PIPERAZINE & PIPERIDINE
DERIVATIVES
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫אנלוגים של תיאוקולקיקוסיד עם‬
‫פעילות מיאורלקסנטית ואנטי דלקתית‬
188902
RANKING FUNCTIONS USING A
BIASED CLICK DISTANCE OF A
DOCUMENT ON A NETWORK
MICROSOFT CORPORATION
US
11/206286
15/08/2005
PCT/US/2006/031965
WO/2007/022252
C07H
G06F
‫פונקציות דרוג המשתמשות במרחק קליק‬
‫מוטה של מסמך ברשת‬
188903
C07D
‫–אוקסידים של תולדות פיפראזין‬N
‫ופיפרידין כמטרימי תרופות‬
624
SOLVAY PHARMACEUTICALS B.V.
EP
05107671.9 22/08/2005
989886688
8898698885
US
PCT/EP/2006/065477
WO/2007/023141
0096/90660
188904
GLP-1 (GLUCAGON-LIKE PEPTIDE-1)
FUSION POLYPEPTIDES WITH
INCREASED PEPTIDASE
RESISTANCE
BIOCOMPATIBLES UK LTD
EP
05020718.2 22/09/2005
PCT/EP/2006/009226
WO/2007/039140
0096090660
–‫ (פפטיד דמוי גלוקגון‬GLP–0 ‫פוליפפטידים‬
‫)מאוחים בעלי עמידות מוגברת לפפטידאז‬0
188905
CONTAINER CLOSURE ASSEMBLY
OBRIST CLOSURES SWITZERLAND
GMBH
EP
05255021.7 12/08/2005
PCT/EP/2006/064724
WO/2007/020169
4696090660
C07K
188906
B65D
‫מכלול סגירה למיכל‬
G05F
‫מכשיר לויסות מתח‬
A VOLTAGE REGULATION DEVICE
ENERGETIX VOLTAGE CONTROL
LIMITED
PCT/GB/2005/003121
WO/2007/017618
4096090660
625
188907
C12N
April 13, 2008– ‫ח' בניסן התשס"ח‬
PROTEIN EXTRACTED FROM
PLANTS OF THE GENUS LUPINUS OR
PRODUCED IN RECOMBINANT
FORM, NUCLEOTIDE SEQUENCE
ENCODING IT AND ITS USE IN
ANIMAL NUTRITION, AS A PLANT
GROWTH PROMOTER AND IN THE
FIGHT AGAINST PATHOGENIC
FUNGI
VIRGILIO BORGES LOUREIRO OF
PT
103322
21/07/2005
883588
8698998889
PT
PCT/IB/2006/052403
WO/2007/010459
4096090660
‫ או‬LUPINUS ‫תמצית חלבון מצמחים מסוג‬
‫ רצף‬,‫המיוצרת בצורה רקומביננטית‬
‫נוקליאוטידי המקודד אותה ושימושה‬
‫ כמקדם גידול צמח ובמלחמה‬,‫בהזנת חיות‬
‫נגד פטריות פתוגניות‬
188908
METHODS AND COMPOSITIONS FOR
IDENTIFYING A PEPTIDE HAVING
AN INTERMOLECULAR
INTERACTION WITH A TARGET OF
INTEREST
AEBI LTD.
US
60/701092
21/07/2005
PCT/IL/2006/000815
WO/2007/010525
0096090660
188910
A RADIOACTIVE SURFACE SOURCE
AND A METHOD FOR PRODUCING
THE SAME
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
60/702288
26/07/2005
PCT/IL/2006/000850
WO/2007/013060
April 13, 2008– ‫ח' בניסן התשס"ח‬
G01N
‫שיטות ותכשירים לזיהוי פפטיד בעל‬
‫אינטראקציה בין–מולקולרית עם מטרה‬
‫בעלת עניין‬
A61K
‫מקור רדיואקטיבי משטחי ושיטה לייצורו‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
626
4096090660
188911
LOBSTER EYE X-RAY IMAGING
SYSTEM AND METHOD OF
FABRICATION THEREOF
PHYSICAL OPTICS CORPORATION
US
11/191095
27/07/2005
PCT/US/2006/027569
WO/2007/015784
0096090660
‫מערכת לדימות רנטגן במבנה עין–לובסטר‬
‫ושיטה להכנתה‬
188913
NITROCATECHOL DERIVATIVES AS
COMT INHIBITORS
PORTELA & CA. S.A.
GB
0515327.5
26/07/2005
8988688346
8898498889
EP
8988888348
3898598889
EP
PCT/PT/2006/000020
WO/2007/013830
6096090660
188915
627
A61K
‫תכשירים נוזליים‬
188916
PROCESS FOR PRODUCING 1BENZYL-4-[(5,6-DIMETHOXY-1INDANONE)-2YLIDENE]METHYLPIPERIDINE
EISAI R&D MANAGEMENT CO, LTD.
2005JP
25/07/2005
213820
PCT/JP/2006/314568
WO/2007/013395
C07D
COMT ‫תולדות ניטרוקטכול כמעכבי‬
LIQUID FORMULATIONS
NOVARTIS AG
US
60/706820
09/08/2005
PCT/US/2006/030836
WO/2007/021666
0196090660
G01N
C07D
–‫–דימתוקסי‬.,9([–4–‫–בנזיל‬0 ‫תהליך לייצור‬
]‫–ילאידן‬0–)‫–אינדאנונ‬0
‫מתילפיפרידין‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
4096090660
188917
2-HYDROXY-PROPIONIC ACID
DERIVATIVES AND 3-HYDROXYBENZOFURAN-2-ONE DERIVATIVES
WITH AFFINITY FOR THE GABA-BRECEPTOR
F. HOFFMANN-LA ROCHE AG
EP
05106979.7 28/07/2005
PCT/EP/2006/064347
WO/2007/014843
6096090660
AMIDE DERIVATIVES
ASTRAZENECA AB
GB
0516570.9
PCT/GB/2006/003023
WO/2007/020411
‫–הידרוקסי–פרופיונית‬0 ‫תולדות חומצה‬
‫–און עם‬0–‫–הידרוקסי–בנזופוראנ‬: ‫ותולדות‬
B–‫אפיניות לרצפטור גאבא‬
188918
12/08/2005
188930
MEDICAMENT DISPENSER
GLAXO GROUP LIMITED
GB
0515584.1
28/07/2005
PCT/GB/2006/002831
WO/2007/012871
4496090660
188931
A WIRELESS COMMUNICATION
DEVICE USING ADAPTIVE
BEAMFORMING
April 13, 2008– ‫ח' בניסן התשס"ח‬
C07D
‫תולדות אמיד‬
0096090660
SIBEAM
US
11/202995
PCT/US/2006/031306
WO/2007/021891
C07D
A61M
‫מחלק תרופות‬
H04B
‫מכשיר תקשורת אלחוטי המשתמש‬
‫בטכניקת עיבוד אותות‬
‫) הניתנת להתאמה‬BEAMFORMING(
12/08/2005
628
6096090660
188932
SPHINGOSINE KINASE INHIBITORS
AND METHODS OF THEIR USE
APOGEE BIOTECHNOLOGY
CORPORATION
US
60/705608
04/08/2005
PCT/US/2006/030327
WO/2007/019251
4496090660
188933
FLUORINATION PROCESS OF
ANILIDE DERIVATIVES AND
BENZOTHIAZOLE FLUORINATE
DERIVATIVES AS IN VIVO IMAGING
AGENTS
GE HEALTHCARE LIMITED
GB
0516564.2
12/08/2005
PCT/GB/2006/003009
WO/2007/020400
6096090660
188934
EMULSIFIABLE CONCENTRATE
BASF AKTIENGESELLSCHAFT
US
60/707312
11/08/2005
PCT/EP/2006/065134
WO/2007/017501
6096090660
188935
PESTICIDAL MIXTURES
BASF AKTIENGESELLSCHAFT
US
60/707312
11/08/2005
989633456
8998898889
US
PCT/EP/2006/065135
WO/2007/017502
0496090660
629
188936
C07D
‫מעכבי ספינגוזין קינאז ושיטות לשימוש‬
‫בהם‬
C07C
‫תהליך פלורינציה של תולדות אניליד‬
‫ותולדות בנזותיאזול פלורינאט כגורמים‬
‫להדמיה תוך גופית‬
A01N
‫תרכיז שיכול לשמש ליצירת תחליב‬
A01N
‫תערובות קוטלות מזיקים‬
G01N
April 13, 2008– ‫ח' בניסן התשס"ח‬
HEPARIN COMPOSTIONS AND
SELECTIN INHIBITION
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/701893
22/07/2005
PCT/US/2006/028404
WO/2007/014049
4496090660
188937
HYBRID POLYPEPTIDES WITH
SELECTABLE PROPERTIES
AMYLIN PHARMACEUTICALS, INC.
US
11/201664
11/08/2005
889889683
8898698885
US
889388844
8898898885
US
PCT/US/2006/031724
WO/2007/022123
0096090660
C07K
‫פוליפפטידים מוכלאים עם תכונות נבחרות‬
188938
CELL/LIGAND MARKING SYSTEM,
WHEREIN THE MARKER IS OF EPH
TYPE, CELL MATERIAL COMPRISING
SAID SYSTEM, METHOD FOR
PREPARING SAME AND
PROANGIOGENETIC USE
UNIVERSITE PARIS 7-DENIS
DIDEROT
FR
0508029
27/07/2005
PCT/FR/2006/001837
WO/2007/012764
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫תכשירי הפארין ומעכבי סלקטין‬
C12N
‫ליגנד כאשר הסמן הינו‬/‫מערכת סימון תא‬
,‫ חומר תאי המכיל מערכת זו‬,EPH ‫מטיפוס‬
‫שיטה להכנתה ושימוש בה ליצור כלי דם‬
630
6096090660
188939
Cu ‫תמיסות חריטה מיוצבות לשכבות‬
Cu/Ni–‫ו‬
STABILIZED ETCHING SOLUTIONS FOR
Cu AND Cu/Ni LAYERS
BASF AKTIENGESELLSCHAFT
DE
102005038414.5 12/08/2005
PCT/EP/2006/065104
WO/2007/020206
0096090660
C23F
188940
A01N
‫תכשירי לבקרת מזיקים‬
PEST CONTROL COMPOSITION
MITSUI CHEMICALS INC.
PCT/JP/2005/013728
WO/2007/013150
0096190660
188941
PYRAZINOL YGUANIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
PARION SCIENCES INC.
US
11/195758
03/08/2005
PCT/US/2006/015957
WO/2007/018640
0496090660
631
C07D
‫תולדות פיראזינוילגואנידין ותכשירי רוקחות‬
‫המכילים אותן‬
188942
C07D
April 13, 2008– ‫ח' בניסן התשס"ח‬
BENZIMIDAZOLE DERIVATIVES
AND PHARMACEUTICAL
COMPSITIONS CONTAINING THE
SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/702399
26/07/2005
PCT/US/2006/028149
WO/2007/015923
4096090660
‫תולדות בנזאימידאזול ותכשירי רוקחות‬
‫המכילים אותן‬
188946
TRITYLATION REACTIONS BASED ON
METALLIC CATALYSIS
UNIVERSITA DEGLI STUDI DI ROMA "LA
SAPIENZA"
IT
RM2005A000386 21/07/2005
PCT/EP/2006/064242
WO/2007/009944
0096090660
188947
C07C
‫תגובות טריטילציה מבוססות קטליזה‬
‫מתכתית‬
A61C
‫עיצוב קונטור חריצים עם גובה משתנה‬
‫ועם חלקים מורמים משתנים עבור פצירות‬
‫אנדודונטיות‬
VARIABLE-LAND, MULTIPLE
HEIGHT FLUTE CONTOUR DESIGN
FOR ENDODONTIC FILES
STEPHEN L. BUCHANAN
US
60/703766
28/07/2005
889463498
8598898889
US
PCT/US/2006/029262
WO/2007/016278
0096090660
April 13, 2008– ‫ח' בניסן התשס"ח‬
188948
A01N
632
AGRICULTURAL COMPOSITIONS
COMPRISING AN OIL-IN-WATER
EMULSION BASED ON OILY
GLOBULES COATED WITH A
LAMELLAR LIQUID CRYSTAL
COATING
DOW AGROSCIENCES LLC
US
60/703525
28/07/2005
989838586
8998898885
US
PCT/US/2006/029743
WO/2007/014386
0696090660
‫תכשירים חקלאיים המכילים אמולסיה של‬
‫שמן במים המבוססת על כדוריות‬
‫שמנוניות המכוסות בכיסוי שטוח נוזלי‬
‫גבישיי‬
188949
CYCLOHEXYLAMIN ISOQUINOLONE
DERIVATIVES AS RHO-KINASE
INHIBITORS
SANOFI AVENTIS
EP
05016153.8 26/07/2005
PCT/EP/2006/007140
WO/2007/012422
4096090660
188950
RARE EARTH OXYSULFIDE
SCINTILLATOR AND METHODS FOR
PRODUCING SAME
SAINT-GOBAIN CERAMICS &
PLASTICS, INC.
US
60/702330
25/07/2005
PCT/US/2006/027850
WO/2007/015862
0096090660
633
188951
C07D
‫נגזרות איזוקווינולון ציקלוהקסילאמין‬
‫ קינאזות‬RHO ‫כמעכבי‬
C04B
‫ זוהר ושיטות‬,‫אוקסי–סולפיד אדמה נדיר‬
‫להפקתו‬
G21G
April 13, 2008– ‫ח' בניסן התשס"ח‬
ALIGNMENT ADAPTER FOR USE
WITH A RADIOISOTOPE
GENERATOR AND METHODS OF
USING THE SAME
MALLINCKRODT INC.
US
60/703036
27/07/2005
PCT/US/2006/029057
WO/2007/016172
0096090660
188952
SYSTEM AND METHOD OF
IDENTIFYING ELUANT AMOUNTS
SUPPLIED TO A RADIOISOTOPE
GENERATOR
MALLINCKRODT INC.
US
60/702927
27/07/2005
PCT/US/2006/029055
WO/2007/016170
0096090660
‫מתאם יישור לשימוש עם מחולל‬
‫רדיואיזוטופי ושיטות לשימוש בו‬
‫מערכת ושיטה לזיהוי כמויות של נוזל מיצוי‬
‫מסופקות למחולל רדיואיזוטופי‬
188953
RADIATION -SHIELDING
ASSEMBLIES AND METHODS
MALLINCKRODT INC.
US
60/703035
27/07/2005
PCT/US/2006/029059
WO/2007/016174
4496190660
April 13, 2008– ‫ח' בניסן התשס"ח‬
A61N
188954
G21F
‫מכלולים להגנה מפני קרינה ושיטות‬
C07D
634
USE OF DERIVATIVES OF
BENZOPYRAN IN THE
MANUFACTURE OF MEDICAMENTS
FOR MODULATING OR INHIBITING
KSP KINESIN ACTIVITY AND
DISEASES RELATED THERETO
SMITHKLINE BEECHAM
CORPORATION
US
60/373454
17/04/2002
989488968
8398698888
US
PCT/US/2003/011432
WO/2003/088903
4496190660
188954
USE OF DERIVATIVES OF
BENZOPYRAN IN THE
MANUFACTURE OF MEDICAMENTS
FOR MODULATING OR INHIBITING
KSP KINESIN ACTIVITY AND
DISEASES RELATED THERETO
SMITHKLINE BEECHAM
CORPORATION
US
60/373454
17/04/2002
989488968
8398698888
US
PCT/US/2003/011432
WO/2003/088903
6096090660
DRYING APPARATUS
Dyson Technology Limited
GB
0515750.8
898868849
GB
PCT/GB/2006/002093
WO/2007/015040
0096090660
635
‫שימוש של נגזרות בנזופירן לייצור תרופות‬
KSP ‫לשם התאמת או עצירת פעילות‬
‫ ומחלות המיוחסות לזאת‬,‫קיניסין‬
C07D
‫שימוש של נגזרות בנזופירן לייצור תרופות‬
KSP ‫לשם התאמת או עצירת פעילות‬
‫ ומחלות המיוחסות לזאת‬,‫קיניסין‬
188955
A47K
‫התקן יבוש‬
30/07/2005
8898898889
188956
A47K
April 13, 2008– ‫ח' בניסן התשס"ח‬
DRYING APPARATUS
Dyson Technology Limited
GB
0515749.0
898868648
GB
PCT/GB/2006/002347
WO/2007/015046
‫התקן יבוש‬
30/07/2005
8898898889
6096090660
188957
H05B
‫אנדוסקופייה מונחית–בלון‬
‫סמארט מדיקל מערכות בע"מ‬
BALLOON GUIDED ENDOSCOPY
SMART MEDICAL SYSTEMS LTD.
PCT/IL/2005/000849
WO/2007/017854
6496090660
FUEL ADDITIVES
INNOSPEC LIMITED
GB
0515998.3
PCT/GB/2006/002861
WO/2007/015080
April 13, 2008– ‫ח' בניסן התשס"ח‬
188958
C07C
‫תוספות דלק‬
03/08/2005
636
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
637
- ‫ לחוק הפטנטים תשכ"ז‬09 ‫הודעה לפי סעיף‬
0679
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬07 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬:/ ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬.7 ‫הפטנטים בדרך הקבועה בתקנה‬
.0692 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬0//9
‫המהדורה השמינית של הסיווג הבינלאומי‬
)2006 ‫של פטנטים (משנה‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
709421
‫שיטה להגנה על גידולי צמחים מפני‬
‫מזיקים מסוג חרקים‬
]01[
METHOD OF PROTECTING
CROP PLANTS AGAINST INSECT
PESTS
]00[
]04[
]04[
]04[
23.12.1996
96007869
]00[ 15.01.1996
]00[ GB
Int. Cl.8 A01H 005/00, 005/10, A01N 063/00, C07K 014/32, 014/325, C12N 015/32
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/1997/026339
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] Method for protecting plants
including the progeny thereof against
damage caused by Sesamia species,
comprising direct or indirect application of
a toxin protein of a Bacillus species to the
plant or the plant seed or to the growing
area of the plant, wherein the toxin protein
is a Vegetative Insecticidal Protein (VIP)type protein, and wherein said direct or
indirect application comprises application
of any of the following:
(i) a VIP-type protein,
(ii) a microorganism of Bacillus species
expressing said VIP-type protein,
(iii) a transgenic plant expressing said
VIP-type protein, or
(iv) a composition comprising at least (i)
or (ii) together with an agronomically
acceptable carrier.
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
638
]44[]04[
703220
‫אנלוגים פפטידים אינסולינוטרופיים דמויי‬
‫ תכשירים המכילים אותם‬,‫גלוקגון‬
‫ושימושים בהם‬
]01[
GLUCAGON-LIKE
INSULINOTROPIC PEPTIDE
ANALOGS, COMPOSITIONS
COMPRISING THEM AND USES
THEREOF
]00[
]04[
22.08.1997
0931/96
]00[ 30.08.1996
]00[ DK
400/9/0
6014414//0
DK
41069/0
0614014//0
DK
Int. Cl.8 A61K 038/26, 047/48, A61P 003/04, 003/10, C07K 014/435, 014/605
NOVO NORDISK A/S, DENMARK
WO/1998/008871
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] A derivative of GLP-1 (7-37) or an
analogue of GLP-1 (7-37) which derivative
is an agonist of the human GLP-1 receptor,
characterized in that the derivative has
only one lipophilic substituent which is
attached to an amino acid residue which is
The applications for division
from this application have
not yet been published
not the N-terminal or C-terminal amino
acid residue.
5866839
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
639
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
BIODEGRADABLE
HETEROPHASE POLYMERIC
COMPOSITIONS COMPRISING A
THERMOPLASTIC STARCH, A
THERMOPLASTIC POLYMER
INCOMPATIBLE WITH STARCH
AND AN INTERFACIAL AGENT,
PROCESS FOR THEIR
PREPARATION AND THEIR USE
IN ORGANIC AND INORGANIC
PRODUCTS
]00[
]04[
05.11.1997
TO96A000890 ]00[ 05.11.1996
TO96A000996
6/14014//0
Int. Cl.8 C08L 003/00
NOVAMONT S.P.A., ITALY
WO/1998/020073
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]04[
]00[
]01[
[57] Biodegradable heterophase
polymeric compositions having improved
resistance to ageing and to low humidity
conditions, comprising:
(1) a thermoplastic starch,
(2) a thermoplastic polymer incompatible
with starch,
in which compositions, starch constitutes
the dispersed phase and the thermoplastic
polymer constitutes the continuous phase,
and
(3) an interfacial agent selected from the
following (a) – (e) classes of compounds;
(4) esters of polyols with mono-or
polycarboxylic acids with values of the
dissociation constant pK lower than 4.5
(the value relates to the pK of the first
carboxyl group in the case of
polycarboxylic acids), characterized by
hydrophilic/lipophilic balance index values
(HLB) greater than 8;
April 13, 2008– ‫ח' בניסן התשס"ח‬
704191
‫הרכבים פולימרים הטרופאזיים ברי פירוק‬
,‫ביולוגי המכילים עמילן תרמופלסטי‬
‫פולימר תרמופלסטי שאינו מסיס בעמילן‬
‫ תהליך‬,‫ויסוד המווה שכבת ביניים‬
‫להכנתם ושימוש בהם במצורים אורגניים‬
‫ואי–אורגניים‬
]00[
IT
IT
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(b) esters of pplyols with mono-or
polycarboxylic acids with less than 12
carbon atoms and with pK values greater
than 4.5 and having HLB indices between
5.5 and 8;
(c) esters of polyols with C12-C22 fatty
acids having HLB indices lower than 5.5,
the esters being used in quantities of from
10 to 40% by weight of the starch;
(d) non-ionic, water-soluble surfactants
which, when added to the
strarch/thermoplastic polymer
compositions indicated above, migrate in
water by no more than 30% wt of their
concentration after the material containing
them has been immersed in water for 100
hours at ambient temperature,
(e) reaction products of an aliphatic or
aromatic diisocyanate with a polymer
containing terminal groups reactive with
the diisocyanates.
640
5866698
The applications for division
from this application have not
yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
___________
]44[]04[
‫פורמולציה לחיסון דרך העור‬
]01[
FORMULATION FOR
TRANSCUTANEOUS
IMMUNIZATION
]00[
]04[
14.11.1997
08/749164
]00[ 14.11.1996
6090/0600
4016014//0
Int. Cl.8 A61K 039/00, 039/39
THE GOVERNMENT OF THE
UNITED STATES OF AMERICA,
U.S.A.
WO/1998/020734
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]04[
]04[
]00[
]01[
704474
[57] Use of an antigen and an adjuvant,
in the manufacture of a formulation for
transcutaneous immunization of a subject
wherein said formulation induces an
immune response specific for the antigen
]00[
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
following application of the formulation to
the subject's skin, and further wherein the
formulation does not include a penetration
enhancer.
__________
]44[]04[
641
704449
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ – כלורוקוינוזולינים מותמרים‬4
‫באלקוקסי‬
]01[
ALKOXY-SUBSTITUTED 4CHLOROQUINAZOLINES
]00[
]04[
21.03.1996
413300
]00[ 30.03.1995
]00[ US
PCT/IB95/00436
6016014//0
WO
Int. Cl.8 A61K 031/517, 031/5375, A61P 013/08, 017/06, 035/00, C07D 239/00,
239/86, 401/04, 401/14, 403/04, 403/12, 403/14, 413/04, 413/14, 491/04
DIVISION FROM 117598
PFIZER PRODUCTS, INC., U.S.A.
OSI PHARMACEUTICALS, INC.,
U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]00[
]04[
]01[
[57] 4-Chloro-6,7-bis-(2-methoxyethoxy)-quinazoline.
The applications for division
from this application have not
yet been published
5866838
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
722222
642
‫תכשירים לטיפול בטפילים פנימיים‬
,‫וחיצוניים המכילים תולדה של אברמקטין‬
‫דיהידרואברמקטין או מילבמיצין‬
‫אנטגוניסט לקולטן האצטילכולין‬/‫ואגוניסט‬
‫הניקוטינארגי בחרק‬
]01[
ENDO-/ECTOPARASITICIDAL
COMPOSITIONS COMPRISING
AN AVERMECTIN,
DIHYDROAVERMECTIN OR
MILBEMYCIN DERIVATIVE AND
AN INSECT NICOTINERGIC
ACETYLCHOLINE RECEPTOR
AGONIST/ANTAGONIST
]00[
]04[
]04[
]04[
11.12.1997
19654079.8
]00[ 23.12.1996
]00[ DE
Int. Cl.8 A01N 043/90, 047/44, C07H 017/08, C12P 019/62
BAYER AKTIENGESELLSCHAFT,
GERMANY
WO/1998/027817
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] An endo-/ectoparasiticidal
composition comprising at least one
B1 ‫מ‬avermectin, 22, 23-dihydroavermectin
(ivermectins) or milbemycin with agonists
or antagonists of the nicotinergic
acetylcholine receptors of insects selected
from the compounds of the formula
in which
R represents hydrogen, or represents
optionally substituted radicals from the
group consisting of acyl, alkyl, aryl,
aralkyl, heteroaryl and heteroarylalkyl;
A represents a monofunctional group from
the group consisting of hydrogen, acyl,
alkyl and aryl or represents a bifunctional
group linked to the radical Z;
E represents an electron-withdrawing
radical;
X represents the radicals –CH= or =Nwherein in the radical –CH= the H-atom
may be replaced by a link to the radical Z;
Z represents a munofunctional group
selected from the group consisting of alkyl,
- O-R, -S-R and –NR2 or represents a
bifunctional group linked to the radical A
or the radical X;
optionally in association with a diluent
and/or excipient, provided that the at least
one avermectin does not include
abamectin.
___________
]44[]04[
643
720772
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫וקטוריים וירליים בעלי חלבוני מעטפת‬
IgG ‫כימריים המכילים את אתר הקישור‬
A ‫של חלבון‬
]01[
VIRAL VECTORS HAVING
CHIMERIC ENVELOPE
PROTEINS CONTAINING THE
IGG-BINDING DOMAIN OF
PROTEIN A
]00[
]04[
]04[
]04[
]00[
]01[
30.03.1998
08/829558
]00[ 28.03.1997
]00[ US
Int. Cl.8 C07K 019/00, C12N 007/00, 015/63, 015/86
NEW YORK UNIVERSITY, U.S.A.
WO/1998/044132
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] A Sindbis viral vector for
transducing a target cell with high
efficiency which comprises a gene
encoding a chimeric envelope protein
containing an IgG-binding domain of
protein A sufficient to bind an Fc domain
of an antibody with strong affinity wherein
the envelope protein is a Sindbis virus
envelope protein; wherein the envelope
protein is operatble to direct the assembly
of the protein into a viral particle; and
wherein said chimeric envelope protein
alters natural viral tropism.
__________
]44[]04[
]01[
METHOD FOR CALIBRATING
AND VERIFYING THE
ATTITUDE OF A COMPASS
]00[
]04[
]04[
]01[
03.10.1999
Int. Cl.8 G01C 021/00
AZIMUTH TECHNOLOGIES, LTD.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A method for verifying the attitude
of a compass, the compass comprising an
attitude determining device, a tilt sensor
and an inertial sensor, the method
comprising the steps of: determining the
attitude of said compass with reference to
the earth's axis from said attitude
determining device; and determining the
tilt of said compass from said sensor;
April 13, 2008– ‫ח' בניסן התשס"ח‬
720747
‫שיטה לאיפוס ואישור כיוון מצפן‬
‫אזימוט טכנולוגיות בע"מ‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
determining the angular velocity of said
compass from said inertial sensor;
determining a predicted azimuth value
from said angular velocity and said
compass attitude; and comparing the
azimuth of said compass, obtained from
said step of determining the attitude of
compass with reference to the earth's axis,
with the predicted azimuth value, and
644
‫‪from said step of determining the tilt,‬‬
‫‪thereby verifying the attitude of said‬‬
‫‪compass.‬‬
‫בקשות חלוקה מבקשה זו‬
‫שטרם פורסמו‪4‬‬
‫‪comparing the elevation of said compass,‬‬
‫‪obtained from said step of determining the‬‬
‫‪attitude of said compass with reference to‬‬
‫‪the earth's axis with the elevation obtained‬‬
‫‪5869844‬‬
‫‪The applications for‬‬
‫‪division from this‬‬
‫‪application have not yet‬‬
‫‪been published‬‬
‫_________‬
‫‪720244‬‬
‫אביזר לאיבטוח חוטים‬
‫יראל יאירוב‪ ,‬ירושלים‬
‫יראל יאירוב‪,‬‬
‫רח' שבתאי הנגבי ‪ ,7./06‬ירושלים‬
‫[‪ ]00‬מערכת לאבטוח חוטים זה לזה הכוללת‪:‬‬
‫(א) אלמנט מאורך ראשון "זכר" (‪ )1‬המכיל באחד‬
‫מקצותיו הברגה חיצונית ומגרעת להכלה של לפחות‬
‫חוט אחד; והמכיל בקצהו השני מאפיין התאמה בולט‬
‫(‪ )46‬ומשני צידיו לשוניות (‪ )44‬אבטחה‪ ,‬כך‬
‫שביצירת המחבר זכר‪-‬נקבה‪ ,‬לשוניות אלו נמצאות‬
‫משני צידי המחבר‪,‬‬
‫(ב) אלמנט מאורך שני "נקבה" (‪ )0‬המכיל באחד‬
‫מקצותיו הברגה חיצונית ומגרעת להכלה של לפחות‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
‫[‪]44[]04‬‬
‫‪ACCESSORY FOR FASTENING‬‬
‫‪WIRES‬‬
‫[‪]01‬‬
‫‪02.11.1999‬‬
‫‪Int. Cl.8 H01R 004/30‬‬
‫‪YAREL YAIROV‬‬
‫‪YAREL YAIROV,‬‬
‫‪75/19 SHABTAY HANEGBI‬‬
‫‪ST.,JERUSALEM‬‬
‫[‪]00‬‬
‫[‪]04‬‬
‫[‪]04‬‬
‫[‪]01‬‬
‫חוט אחד; וכולל בקצהו השני מאפיין התאמה חלול‬
‫(‪ ;)41‬כך שמאפיין ההתאמה הבולט של הזכר‪,‬‬
‫ומאפיין ההתאמה החלול של הנקבה יוצרים‬
‫בהתחברם מחבר זכר‪-‬נקבה‪,‬‬
‫(ג) מכסה מתברג לאלמנט הראשון (זכר) לסגירה על‬
‫ההברגה החיצונית ולאחיזה של חוט‪,‬‬
‫(ד) מכסה מתברג לאלמנט השני (נקבה) לסגירה על‬
‫ההברגה החיצונית ולאחיזה של החוט‪1‬‬
‫‪645‬‬
‫____________‬
‫‪729271‬‬
‫מצלמה לצילום בתוך מעיים‬
‫גולד פטנטים וייעוץ כלכלי (‪ )0660‬בע"מ‪,‬‬
‫רובינשטיין‪ ,4:‬חיפה‬
‫]‪ [57‬מערכת לסריקה אופטית של מערכת העיכול‬
‫של נבדק הכוללת‪:‬‬
‫מארז מוארך (‪ )46‬בעל שני קטבים בצורת גלולה‬
‫הניתנת לבליעה‪ ,‬הכולל שני מערכים אופטיים (‪)41‬‬
‫במארז הגלולה‪ ,‬הממוקמים בקטבים של הגלולה‬
‫והצופים לעבר גזרות נגדיות ביחס לגלולה‪ ,‬הכוללים‬
‫אמצעים למיקוד‪ ,‬חיישן אופטי (‪ )40‬שעליו ממוקד‬
‫‪646‬‬
‫[‪]44[]04‬‬
‫‪CAMERA FOR VIEWING INSIDE‬‬
‫‪INTESTINES‬‬
‫[‪]01‬‬
‫‪13.01.2000‬‬
‫‪Int. Cl.8 A61B 001/04‬‬
‫‪CAPSULE VIEW INC., U.S.A.‬‬
‫‪GOLD PATENTS LTD.,‬‬
‫‪43 RUBINSTEIN ST.,‬‬
‫‪HAIFA 34987‬‬
‫[‪]00‬‬
‫[‪]04‬‬
‫[‪]04‬‬
‫[‪]01‬‬
‫מידע אופטי הנפצה ע"י המערך האופטי‪ ,‬מקור‬
‫תאורה (‪ )40‬המאיר לעבר הגזרות השונות‪ ,‬יחידת‬
‫בקרה (‪ )06‬ועיבוד המעבדת את המידע הנקלט‬
‫בחיישן האופטי למידע דיגיטלי‪ ,‬יחידת תקשורת‬
‫המשדרת את המידע הדיגיטלי למקלט חיצוני לצורך‬
‫הצגתו או שמירתו‪1‬‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
___________
]44[]04[
]01[
METHOD FOR PRODUCING A
SELF-DEFOLIATING COTTON
PLANT AND PLANT PRODUCED
THEREBY
]00[
]04[
]04[
]04[
20.07.1998
PO8174
]00[ 22.07.1997
Int. Cl.8 A01H 001/00, 005/00
VIRGIN COTTON COMPANY PTY
LTD., AUSTRALIA
WO/1999/004620
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method for producing a selfdefoliating cotton plant, comprising: (A)
selfing a first cotton plant or crossing it
with a second cotton plant, such that
progeny seeds are produced, wherein said
first cotton plant is of variety "Rainbow
39", represented by a deposit under AGAL
729779
‫שיטה לייצור צמח כותנה בעל נשירה עצית‬
‫וצמח המיוצר בשיטה זו‬
]00[
AU
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
Accession No. NM 98/06259; (B)
harvesting and growing said progeny seeds
under conditions for plant growth,
whereby progeny plants are produced; and
(C) selecting among said progeny plants to
obtain at least one progeny plant with a
self-defoliating phenotype.
___________
647
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
DUAL VIAL CONNECTING
SYSTEM FOR LYOPHILIZED
PRODUCTS
]00[
]04[
]04[
27.08.1997
Int. Cl.8 A61J 001/00
PENTAPHARM AG,
SWITZERLAND
FRANCK MOISIO, FRANZ A.
KLUG
WO/1999/009931
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]00[
]00[
]01[
[57] A dual vial connecting system for
temporary connection of two containers,
usually a glass or plastic vial (1) and
plastic solvent bottle (3), the purpose being
to reconstitute a dry product, such as a
lyophilisate or powder contained in the
glass or plastic vial with a corresponding
solvent product contained in the plastic
solvent bottle, the connecting system
having a cylindrical closing and
connecting plastic sleeve (4) with a lower
portion (5) having inwardly directed
securing means (24) for secure connection
with the neck of the glass or plastic vial, an
upper portion (6) having an internal thread
(15) for screwing connection with the
plastic solvent bottle and an integrated
plastic membrane (7) being perforated by
the orifice reducer (22) of the plastic
solvent bottle when screwed into the upper
inner threaded portion of the closing and
connecting plastic sleeve, the perforable
membrane separating the upper inner
threaded portion from the lower portion of
the closing and connecting plastic sleeve,
April 13, 2008– ‫ח' בניסן התשס"ח‬
729212
‫מערכת חיבור דו צלוחית עבור מוצרים‬
‫המיובשים בהקפאה‬
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
and an inner cylindrical plastic skirt (12)
located in the inner lower portion of the
closing and connecting plastic sleeve and
extending downwardly from the lower
surface of the perforable membrane (7),
said skirt having an outer diameter coming
in contact with the wall of the inner neck
of the glass or plastic vial, characterized by
an elastomer sealing ring (13) fixed at the
uppermost position around the outer
surface of the said skirt, an elastomer
sealing plug (18) with a pre-cut section
(21) and a cavity (19) in its centre, the said
sealing plug being placed around a
cylindrical collar (17) located in the upper
inner portion of the closing and connecting
plastic sleeve and extending upwardly
from the upper surface of the perforable
membrane and held in place by an annular
rib (16), whereby the perforable
membrane, the cylindrical skirt, the collar
and the annular rib are integrally moulded
parts of the said closing and connecting
plastic sleeve.
648
__________
]44[]04[
729421
‫הרכבים סינרגיסטיים ושיטות לטיפול‬
‫בגידולים ממאירים או סרטניים ולשיקום‬
‫והאצת ייצור תאי שורש הדם‬
]01[
SYNERGISTIC COMPOSITION
AND METHODS FOR TREATING
NEOPLASTIC OR CANCEROUS
GROWTHS AND FOR
RESTORING OR BOOSTING
HEMATOPOIESIS
]00[
]04[
]04[
]04[
]00[
]01[
17.09.1998
08/933359
]00[ 18.09.1997
]00[ US
Int. Cl.8 A61K 039/12, 039/385, 039/395, 045/00, 045/06
BIOGEN IDEC INC., U.S.A.
WO/1999/013912
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] Use of:
(a) an admixture comprising a cancer or
tumor antigen expressed by cells of a
cancer to be treated and a microfluidized
antigen formulation comprising:
(i) a stabilizing detergent,
(ii) a micelle-forming agent, and
(iii) a biodegradable and biocompatible oil,
said antigen formulation being formulated
as a stable oil-in-water emulsion; said
admixture being capable to induce a
cytotoxic T-lymphocyte response in a
patient which is specific for the cancer or
tumor antigen contained in said admixture,
and
(b) a therapeutically effective amount of at
least one agent which is capable of
neutralizing, blocking, antagonizing, or
down regulating the activity or preventing
activation of transforming growth factor β
(TGFβ) specifically, which agent is
selected from the group consisting of an
anti-TGFβ antibody, a TGFβR-fusion
protein, a TGFβ analog, a TGFβ binding
protein, and a TGFβR blocking antibody;
for the preparation of a combined
medicament suitable for simultaneously,
separate or sequential administration for
treating cancer.
__________
649
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
721971
BAB ‫ או‬ABA ‫פולימרים של טריבלוק‬
‫הניתנים לפירוק ביולוגי‬
]01[
BIODEGRADABLE ABA-OR BABTYPE TRI-BLOCK POLYMER
]00[
]04[
02.10.1998
08/943167
]00[ 03.10.1997
]00[ US
6/9401000
6414614//0
US
Int. Cl.8 A61K 009/00, 047/34, C08G 063/664, 063/91, 065/32, C08L 071/02
MACROMED, INC., U.S.A.
RAMESH C. RATHI, GAYLEN M.
ZENTNER, BYEONGMOON JEONG
WO/1999/018142
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]04[
]04[
]00[
]00[
]01[
[57] A biodegradable ABA- or BAB-type
triblock polymer, said ABA triblock of the
formula:
PL(G)z-1 A-PEG-PL(G)z-1 A
and said BAB triblock of the formula:
PEG-PL(G)z-1 acid-PEG
wherein z is an integer of 1 or 2, wherein
the A-block is represented by GL(G)z-1 A
such that when z is 2 the A-block is a
poly(lactide-co-glycolide) or PLGA
copolymer, and when z is 1 the A-block is
a poly (lactide) or PLA polymer and
wherein the B-block is represented by PEG
which is a hydrophilic polyethylene glycol
polymer, said block copolymer having a
weight average molecular weight of
between about 2000 to 4990 and
possessing reverse thermal gelation
properties, and wherein said PL(G)z-1 A Ablock comprises about 51 to 83% by
weight of said polymer and the PEG Bblock comprises about 17 to 49% by
weight of said polymer.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
650
]44[]04[
]01[
PROCESS FOR PRODUCING
TETRABROMOBISPHENOL – A
]00[
]04[
]04[
]04[
06.04.2000
09/288195
]00[ 08.04.1999
Int. Cl.8 C07C 037/62, 039/367
ALBEMARLE CORPORATION,
U.S.A.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]01[
[57] A process for the preparation of
tetrabromobisphenol-A, which process
comprises:
(a) brominating bisphenol-A in a liquid
phase reaction medium in which
tetrabromobisphenol-A is relatively
insoluble, using a stoichiometric
deficiency of bromine to thereby form in
the reaction mass a precipitate consisting
721109
A– ‫תהליך לייצור טטראברומוביספנול‬
]00[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
essentially of about 50 to about 95 wt% of
tetrabromobisphenol-A and about 50 to
about 5 wt% of underbrominated
bisphenol-A;
(b) recovering precipitate from the reaction
mass; and
(c) recovering tetrabromobisphenol-A
from the precipitate.
____________
]44[]04[
]01[
METHOD OF DIAGNOSING
NEOPLASTIC CELL GROWTH BY
DETECTION OF THE WNT-1
INDUCED SECRETED
POLYPEPTIDE WISP-1
]00[
]04[
29.10.1998
60/063704
]00[ 29.10.1997
069600040
6016014//0
0696040/0
4116114//0
Int. Cl.8 C12Q 001/68, G01N 033/53
GENENTECH, INC., U.S.A.
WO/1999/021998
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
651
721129
‫שיטה לדיאגנוזה של גידול סרטני של‬
‫תאים על ידי זהוי הפוליפפטיד המופרש‬
WNT–1 ‫ המושפע על ידי‬WISP–1
]00[
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] A method of diagnosing neoplastic
cell growth or proliferation in a human
comprising detecting the level of
expression of a gene encoding a WISP-1
(Wnt-1-Induced) polypeptide having at
least 85% amino acid sequence identity
with human mature WISP-1 polypeptide
having amino acid residues 23 to 367 of
the amino acid sequence shown in Figures
3A and 3B (SEQ ID NO:3), or human full
length WISP-1 polypeptide having amino
acid residues 1 to 367 of the amino acid
sequence shown in Figures 3A and 3B
(SEQ ID NO:4), (a) in a test sample of
tissue cells obtained from the human, and
(b) in a control sample of known normal
tissue cells of the same cell type, wherein a
higher expression level in the test sample,
relative to said control sample indicates the
presence of a tumor in the human from
which the test tissue cells were obtained.
__________
]44[]04[
721990
MAGE ‫נגזרות אנטיגן ממשפחת‬
‫הקשורות לגידול ורצפי חומצות גרעין‬
‫המקודדים להם המשמשים להכנת‬
‫חלבונים מותכים ותכשירים לחיסון‬
]01[
TUMOR-ASSOCIATED ANTIGEN
DERIVATIVES FROM THE MAGE
FAMILY AND NUCLEIC ACID
SEQUENCES ENCODING THEM,
USED FOR THE PREPARATION
OF FUSION PROTEINS AND OF
COMPOSITIONS FOR
VACCINATION
]00[
]04[
02.02.1999
9802543.0
]00[ 05.02.1998
]00[ GB
/06000610
6016014//0
GB
Int. Cl.8 A61K 039/39, 048/00, C07K 001/00, 014/47, 019/00, C12N 001/21, 015/12,
015/62, 015/70
SMITHKLINE BEECHAM
BIOLOGICALS S.A., BELGIUM
WO/1999/040188
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] A tumor-associated antigen
derivative from the MAGE family wherein
The applications for division
from this application have
not yet been published
the derivative comprises derivatised thiol
residues.
58666855886888
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
652
]44[]04[
721313
‫ שיטה‬,‫פקטור ניורוטרופי סיליארי משתנה‬
‫להכנתו ושיטות לשימוש בו‬
]01[
MODIFIED CILIARY
NEUROTROPHIC FACTOR,
METHOD OF MAKING IT AND
METHODS OF USE THEREOF
]00[
]04[
]04[
26.02.1999
09/031693
]00[ 27.02.1998
]00[ US
Int. Cl.8 A61K 038/18, 047/48, A61P 003/04, 003/10, 025/00, 025/14, 043/00, C07K
014/47, 014/475, C12N 001/21, 005/10, 015/12, 015/18
REGENERON
PHARMACEUTICALS, INC., U.S.A.
WO/1999/043813
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]00[
]01[
[57] Modified human ciliary neurotrophic
factor having the modification Cys 17-Ala,
Gln63-Arg, and a deletion of the terminal
15 amino acid residues.
___________
]44[]04[
]01[
HYDRATED POLYMERIC
COMPOSITION AND
AGRICULTURAL APPLICATION
THEREOF
]00[
]04[
]04[
19.09.2000
Int. Cl.8 C08L 089/00, C09K 015/34
EXOTECH BIO SOLUTION LTD.
MIRCEA DAN BUCEVSCHI
MONICA COLT
]01[
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[57] A hydrated polymeric composition
for application to soil comprising: a
mixture of a modified collagen
biopolymer, component A, and a synthetic
ternary copolymer, component B, in the
ratios of A:B = 10:90 to 75:20, wherein:
component A comprises a collagen
653
723121
‫הרכב פולימרי ממויים ויישום חקלאי שלו‬
‫ קרית –גת‬,‫אקסוטק ביו סולושין בע"מ‬
‫מירצ'ה דן בוצ'בסקי‬
‫מוניקה קולט‬
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
biopolymer having an average molecular
weight between 5000 and 80,000 and
wherein 0 to 30% of the free carboxyl
groups of the collagen material are
esterified with a C1 to C6 alcohol,
preferably ethanol, and 20 to 30% of the
free amino groups are blocked with
April 13, 2008– ‫ח' בניסן התשס"ח‬
ionizable hydrophilic groups, preferably
phthalic or succinic anhydride, and
component B comprises a ternary
copolymer having an average molecular
weight between 20,000 and 200,000 Da, a
glass temperature Tg = 5-110oC, formed by
copolymerization of monomers C, D and
E, wherein: C-represents a vinyl or acrylic
monomer of the formula:
CH2=CR1R2
wherein: R1=-H, or –CH3; R2 = -H, -C6H5,
-CH2C6H5, -CH=CH2,
-COOR3 or CN, and
R3 = -(CH2)k-H with k = 2-8;
D-is a polar monomer having the formula:
CHR4=CHR5
wherein: R4= -H or-COOH; R5= -COOH, CN,-O-CO-CH3, -OH, -NH2, -O-(CH2)2OH, -O-NH2 or –NH-(CH2)2-NH2;
and
E-is a reactive monomer selected from
acryloyl chloride, acrolein, maleic
anhydride, itaconic anhydride,
glycidymethacrylate, vinyl oxazole and
reactive acrylic ester, having the following
formula:
CH2=CH(COOR6)
wherein R6=phenyl, benzyl,
pentachlorophenyl or p-nitrophenyl.
__________
]44[]04[
]01[
METHOD AND APPARATUS FOR
CASCADING DATA THROUGH
REDUNDANT DATA STORAGE
UNITS
]00[
]04[
]04[
]04[
]00[
]01[
12.10.1999
09/251812
]00[ 17.02.1999
Int. Cl.8 G06F 011/14
EMC CORPORATION, U.S.A.
WO/2000/049500
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A method for transferring data
between a facility for altering data and
facility for receiving data including the
steps of establishing a first data store for
receiving the altered data, a second data
store, and a first table for recording the
identification of changes in the first data
store produced by the facility for altering
data and a first (ESTABLISH or REESTABLISH) of a plurality of operating
modes during which the second data store
receives data from the first data store
April 13, 2008– ‫ח' בניסן התשס"ח‬
724224
‫שיטה והתקן להעברה מדורגת של נתונים‬
‫דרך יחידות איחסון מידע יתרות‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
according to the identified changes in the
first table, said method being characterized
by:
(a) establishing a second table for
recording the identification of changes in
the first data store produced by the facility
for altering data, and
(b) shifting operations to a second
(CASCADE DIFFERENTIAL SPLIT) of a
plurality of operating modes for copying
data from the second data store to the
receiving facility according to the changes
654
in the second table identified at the time
the second operating mode is established,
which changes correspond to changes in
the first data store since a prior shift to the
second operating mode.
__________
]44[]04[
]01[
MEDICAL VALVE WITH
POSITIVE FLOW
CHARACTERISTICS
]00[
]04[
]04[
]04[
]00[
]01[
14.05.1999
09/078941
]00[ 14.05.1998
Int. Cl.8 A61M 039/26
ICU MEDICAL, INC., U.S.A.
WO/1999/058186
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A medical valve (20) for controlling
the flow of fluid between a first medical
implement and second medical implement,
said valve comprising a housing (28)
having a passage and a piston (42)
comprising a rigid material and positioned
within said passage, the valve adapted for
connection to said second medical
implement and having an opening adapted
to receive said first medical implement, the
piston having a first position in which said
655
724171
‫שסתום רפואי בעל תכונות זרימה‬
‫חיוביות‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
piston prevents fluid flow through said
valve and a second position in which fluid
flow is permitted through said valve, said
passage including a fluid space which
automatically and reversibly increases in
size when said first medical implement is
connected to said valve and which
contracts in size when said first medical
implement is disconnected to generate a
positive flow of fluid in the direction of
said second medical implement, wherein
April 13, 2008– ‫ח' בניסן התשס"ח‬
said housing further comprises at least one
screw thread on an outside surface of said
housing, said valve further comprising at
least one o-ring attached to said piston.
___________
]44[]04[
]01[
INJECTABLE AQUEOUS
DISPERSIONS OF PROPOFOL
]00[
]04[
]04[
]04[
]00[
18.08.1999
60/097071
]00[ 19.08.1998
Int. Cl.8 A61K 009/00, 009/107
RTP PHARMA INC., U.S.A.
GARY W. PACE, AWADHESH K.
MISHRA, MICHAEL G. VACHON
WO/2000/010531
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]00[
]01[
[57] A stable, sterile, and injectable
aqueous dispersion of a water-insoluble
microdroplet matrix of mean diameter
from about 50 nm to about 1000 nm
consisting essentially of
(a) between about 1% to about 15% of
propofol;
(b) between about 1% to about 8% of a
propofol-soluble diluent;
(c) between about 0.5% to about 5% of a
surface stabilizing amphiphilic agent;
April 13, 2008– ‫ח' בניסן התשס"ח‬
797241
‫פיזורים מימיים של פרופופול בעלי‬
‫הזקרה‬
]00[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
(d) a pharmaceutically acceptable watersoluble polyhydroxy additive that acts as a
tonicity modifier; and
(e) water;
(f) provided the ratio of propofol to diluent
is about 1:4 to about 1:0.1 and the ratio of
propofol to amphiphilic agent is about
1:0.8 to about 1:2.5, and the composition
has a viscosity of from about 0.8 to about
15 centipoise, wherein the dispersion
prevents microbial growth, defined as no
656
more than 0.5 log increase from the initial
inoculum, of each of Staphylococcus
aureus (ATCC 6538), Escherichia coli
(ATCC 8739 and ATCC 8454),
Pseudomonas aeruginosa (ATCC 9027),
Candida albicans (ATTCC 10231), and
Aspergillus niger (ATCC 16403) for at
least 7 days as measured by a test wherein
a washed suspension of each said organism
is added to a separate aliquot of a
dispersion at approximately 1000 colony
forming units (cfu) per mL, at a
temperature in the range 20-25oC,
whereafter said aliquots are incubated at
20-25oC and are tested for viability of the
microorganisms in the inoculated
dispersion as determined by counting the
colonies of said organism after 24, 48
hours and 7 days or other suitable length of
time; and results in little or no irritation at
the site of injection as evidenced by a test
wherein said dispersion is administered as
a single daily bolus injection of 12.5
mg/kg, given on the basis of body weight,
for 2 to 3 successive days over a period of
approximately 30 seconds, in the caudal
vein of a rat such that no visual increase in
the diameter of the rat tail is noted after 48
hours post injection.
_________
]44[]04[
797217
‫ שיטה‬,DNA ‫ רצף‬,DNA ‫שיטה לגילוי רצף‬
‫ והשמוש בהם‬DNA ‫להכנת מבנה‬
]01[
METHOD OF DETECTING A DNA
SEQUENCE, A DNA SEQUENCE,
A METHOD OF MAKING A DNA
CONSTRUCT AND THE USE
THEREOF
]00[
]04[
16.08.1999
1009862
]00[ 14.08.1998
]00[ NL
4646006
0014414//0
NL
Int. Cl.8 C12N 015/09, 015/11, 015/12, 015/63, C12Q 001/68
CHROMAGENICS B.V., THE
NETHERLANDS
ARIE PIETER OTTE
WO/2000/009749
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]04[
]04[
]00[
]00[
]01[
[57] Method of detecting, and optionally
selecting, a DNA sequence, wherein the
DNA sequence to be detected possesses a
stable expression-enhancing quality, which
method comprises the steps of:
(1) cloning DNA fragments having a size
of <5000 base pairs into a vector at a
location between (i) a DNA sequence
recognized by a repressor protein complex,
which repressor protein complex is
657
involved in the induction of genetranscription repressing chromatin, and (ii)
a reporter gene comprising a promoter,
resulting in a variety of fragmentcomprising vectors, wherein the distance
between the DNA sequence recognized by
a repressor protein complex and the
reporter gene is fewer than 5000 base
pairs;
April 13, 2008– ‫ח' בניסן התשס"ח‬
(2) introducing the vectors into host cells,
and wherein the repressor protein complex
is expressed in the host cells, and in which
host cells the promoter may be active but
induction of gene-transcription repressing
chromatin in the vectors results in the
repression of the reporter gene; and
(3) subjecting the host cells to a selection
step in order to identify a host cell
exhibiting reporter gene activity.
___________
]44[]04[
797923
‫תכשירים לטיפול בפיברוסיס בלב המכילים‬
‫נגזרות של הלופוגינון‬
]01[
COMPOSITIONS FOR TREATING
CARDIAC FIBROSIS
COMPRISING HALFUGINONE
DERIVATIVES
]00[
]04[
13.08.1999
125790
]00[ 13.08.1998
]00[ IL
069400410
6416014///
US
Int. Cl.8 A61K 031/505, 048/00, A61P 009/00, C07D 401/06
STATE OF ISRAEL, MINISTRY OF
‫ מרכז‬,‫ משרד החקלאות‬,‫מדינת ישראל‬
AGRICULTURE , VOLCANI
‫ בית דגן‬,‫וולקני‬
CENTER
,‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
HADASIT MEDICAL RESEARCH
‫ירושלים‬
SERVICES & DEVELOPMENT LTD.
]04[
]04[
]00[
]01[
WO/2000/009070
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
,'‫ד"ר וב ושות‬
‫ רחובות‬,0026 .‫ד‬.‫ ת‬, 0 ‫רח' פקריס‬
[57] Composition for treating cardiac
fibrosis, comprising a pharmaceutically
effective amount of a compound in
combination with a pharmaceutically
acceptable carrier, said compound being a
member of a group of the formula:
wherein: n=1-2;
R1 is a member of the group consisting of
hydrogen, halogen, nitro, benzo, lower
alkyl, phenyl and lower alkoxy;
R2 is a member of the group consisting of
hydroxy, acetoxy and lower alkoxy; and
R3 is a member of the group consisting of
hydrogen and lower alkenoxy-carbonyl,
and pharmaceutically acceptable salts
thereof.
___________
April 13, 2008– ‫ח' בניסן התשס"ח‬
658
]44[]04[
]01[
ORDER OF TITLES IN A REALTIME DVD VIDEO RECORDING
]00[
]04[
]04[
]04[
21.06.2000
99202056.0
]00[ 25.06.1999
Int. Cl.8 G11B 027/034
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2001/001415
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method of recording an encoded
bit stream, said encoded bit stream
representing a plurality of video objects
comprising a sequence of cells together
constituting a part of an MPEG2 Program
Stream, on a disc like record carrier, such
as an optical disc, said method comprising:
recording a collection of contiguously
arranged video objects in a video object
storage area of said disc, said collection
being partitioned into adjacent recordings
that represent playable titles; recording
797202
‫סדר הופעות הכותרות בהקלטת וידאו‬
‫ בזמן אמת‬DVD
]00[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
management information in a management
information area of said disc for storing
information about recorded video objects;
defining a playable title as a playback
sequence of all completer cells or a subset
of complete cells of a recording in the
order of allocation within the video object
storage area on the disc; and generating a
title list of titles sorted in the order of
arrangement within the video object
storage area on the disc.
____________
659
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
DEVICE AND METHOD FOR IN
VITRO DETECTION OF BLOOD
]00[
]04[
]04[
]04[
14.03.2001
09/525016
]00[ 14.03.2000
Int. Cl.8 G01N 021/77
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
GIVEN IMAGING LTD.
GAVRIEL MERON, ITAMAR
WILLNER
PEARL COHEN ZEDEK LATZER,
5 SHENKAR STREET,
P.O.B. 12704
HERZLIYA 46733
]00[
]01[
[57] A device for in vitro detection of
blood comprising a support (22) having
immobilized thereon at least one
polyelectrolyte reactant (24) configured to
790202
IN VITRO ‫מתקן ושיטה לזיהוי דם‬
]00[
US
‫יישום חברה לפיתוח המחקר של‬
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
‫ איתמר וילנר‬,‫גבריאל מירון‬
,‫פרל כהן צדק לצר‬
,007/4 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
come into unfiltered contact with a sample,
and capable of reacting with blood, said
reaction directly resulting in an optical
change viewable by the naked human eye.
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
660
]44[]04[
]01[
METHOD OF CONTROLLING
CUTWORM PESTS USING A
CRY1F TOXIN
]00[
]04[
]04[
]04[
]00[
]01[
23.08.2000
60/150319
]00[ 23.08.1999
Int. Cl.8 A01N 063/00, 063/02
MYCOGEN CORPORATION, U.S.A.
WO/2001/013731
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
790717
‫שיטה לשליטה בזחלי מזיקים על ידי‬
Cry1F ‫שימוש ברעלן‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
[57] A method for controlling a cutworm
pest wherein said method comprises
contacting said pest with a Cry1F toxin.
__________
]44[]04[
]01[
SWABBABLE NEEDLELESS LOW
REFLUX INJECTION PORT
SYSTEM
]00[
]04[
]04[
]04[
01.10.1999
09/166559
]00[ 05.10.1998
Int. Cl.8 A61M 039/00
RYMED TECHNOLOGIES INC.,
U.S.A.
DANA W. RYAN
WO/2000/020070
EDWARD LANGER, C/O SHIBOLET,
YISRAELI, ROBERTS, ZISMAN &
CO.,
4 BERKOWITZ ST.,
TEL AVIV 64238
]00[
]00[
]01[
[57] An injection port assembly for
coupling to and uncoupling from a first
fluid pathway of a first connector and for
receiving and passing a fluid into the first
fluid pathway from a device provided with
a second connector (102), said injection
port assembly comprising:
(a) a body having a first end provided with
661
790927
‫מערכת הזרקה דרך שער ללא מחט‬
‫ברפלוקס נמוך הניתן לניקוי‬
]00[
US
,‫אדוארד לנגר‬
‫ תל אביב‬,4 ‫רח' ברקוביץ‬
a first mating structure adapted to mate
with the first connecter, and a second end
(196);
(b) a hollow spike (104) defining a shaft
having a first end coupled to said body and
a second end provided with a penetrating
April 13, 2008– ‫ח' בניסן התשס"ח‬
tip, said first mating structure and said
hollow spike being in fluid communication
with each other;
(c) a resilient first barrier extending over
said spike and having a tip portion about
said tip of said spike;
(d) a resilient second barrier provided over
and contacting said tip portion of said first
barrier; and
(e) a hollow component having a first end
and a second end, said first end being
coupled to said body, said hollow
component extending around at least
portions of said spike, said first barrier and
said second barrier, and said second end
being provided with a second mating
structure adapted to removably couple to
the second connector, wherein when the
second connector is coupled to said second
mating structure, said second connector
forces said second resilient barrier and said
tip portion of said first resilient barrier
over said spike such that said second
connector and said first connector are in
fluid communication with each other
through said hollow spike and said first
mating structure.
___________
April 13, 2008– ‫ח' בניסן התשס"ח‬
662
]44[]04[
792921
‫תרכובות קינולין וקינוקסלין‬
]01[
QUINOLINE AND QUINOXALINE
COMPOUNDS
]00[
]04[
]04[
]04[
23.11.1999
09/198716
]00[ 24.11.1998
]00[ US
Int. Cl.8 A61K 031/47, 031/498, A61P 035/00, C07D 215/16, 241/44, 405/12
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2000/031050
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A stent device characterized by a
polymeric coating into which is
incorporated a restenosis inhibiting
effective amount of a compound of the
formula
wherein
R1a is one to three carbon alkoxy;
R1b is one to three carbon alkoxy;
R2 is
R3 is hydrogen or meta-halo;
Za is N or CH; and
Zb is N or CH; and
Zb is NH or O, or
an N-oxide thereof, hydrate thereof,
solvate thereof, or salt thereof.
__________
663
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
792103
‫גורמים תרופתיים המכילים טוקסין‬
‫בוטולינום להפחתת רעש נחירות‬
]01[
THERAPEUTIC AGENTS
CONTAINING BOTULINUM
TOXIN FOR THE SUPPRESSION
OF SNORING NOISES
]00[
]04[
]04[
10.12.1999
19856897.5
]00[ 10.12.1998
]00[ DE
Int. Cl.8 A61K 009/08, 009/127, 009/19, 009/48, 035/66, 035/74, 038/16, 038/48,
A61P 011/00, 011/02, 011/04, C07K 014/33, C12N 009/48
BIOTECON GESELLSCHAFT FUR
BIOTECHNOLOGISCHE
ENTWICKLUNG UND
CONSULTING MBH, GERMANY
WO/2000/033863
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]04[
]00[
]01[
[57] Use of high-purity Clostridium toxin
BoNT/A for manufacturing a therapeutic
agent, to be administered intramuscularly,
for suppressing snoring noises.
__________
]44[]04[
]01[
PHARMACEUTICAL
COMPOSITION COMPRISING A
BIOCOMPATIBLE SUSPENSION
OF A PROTEIN IN A POLYOL/OIL
]00[
]04[
20.12.1999
09/221181
]00[ 23.12.1998
6/9110060
0014414///
Int. Cl.8 A61K 009/00
AMGEN, INC., U.S.A.
WO/2000/038652
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]04[
]04[
]00[
]01[
[57] A pharmaceutical composition
comprising an effective amount of a
biologically active agent (BAA)
incorporated into a biocompatible
792122
‫תכשיר רוקחות המכיל תרחיף‬
‫שמן‬/‫ביוקומפטבילי של חלבון בפולי–אול‬
]00[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
polyol/oil suspension, wherein said
suspension contains a thickener, and
wherein said biologically active agent is a
protein.
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
664
]44[]04[
]01[
PHARMACEUTICAL
PREPARATIONS FOR
INCREASING BRAIN GLUCOSE
UTILIZATION
]00[
]04[
17.12.1999
60/112669
]00[ 17.12.1998
069400000
0116014///
Int. Cl.8 A61K 031/42, 031/425, 031/44
MINDSET BIOPHARMACEUTICALS
(USA), INC., U.S.A.
WO/2000/035437
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Use of an agent that improves insulin
sensitivity in the brain for the preparation
of a pharmaceutical composition for
improving mental performance in patients
792123
‫תכשירים תרופתיים להגברת ניצולת‬
‫גלוקוזה במוח‬
]00[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
having symptoms of reduced mental
performance and are neither in a state of
non-insulin dependent diabetes nor a state
of general impaired glucose tolerance.
___________
]44[]04[
792314
– . – )‫)– – אימידזולילבנזיל‬α 7 ‫תולדות‬
‫ תכשירים‬,‫ – קוינולין מחושלות‬0,0 – ‫פניל‬
‫ תרכובות ביניים‬,‫רוקחיים המכילים אותן‬
‫של קינולין מותמר והכנתם‬
]01[
7-(Α-IMIDAZOLYL BENZYL)-5PHENYL-1,2-ANNELATED
QUINOLINE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM, THE CORRESPONDING
SUBSTITUTED QUINOLINE
INTERMEDIATES THEREOF AND
THEIR PREPARATION
]00[
]04[
]04[
]04[
17.12.1999
98204444.8
]00[ 23.12.1998
]00[ EP
Int. Cl.8 A61K 031/4709, A61P 035/00, C07D 403/06, 405/14, 471/04
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2000/039082
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
665
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] A compound of the formula
or a pharmaceutically acceptable acid
addition salt of a stereochemically
isomeric form thereof, wherein =x1 x2- x3is a trivalent radical of the formula
=N-CR6=CR7=N-N=CR6=N-NH-C(=O)=N-N=N-
=CR6-CR7=CR8=CR6-N=CR7=CR6-NH-C(=O)or =CR6-N=N6
=N-CR =N-
wherein each R6, R7 and R8 are
independently hydrogen, C1-4 alkyl,
hydroxy, C1-4 alkyloxy, aryloxy, C1-4
alkyloxycarbonyl, hydroxy C1-4 alkyl, C1-4
>CH-CHR9>CH=N>CH-NR9or >C=CR9wherein R9 is hydrogen, halo,
halocarbonyl, aminocarbonyl, hydroxy C1-4
alkyl, cyano, carboxyl, C1-4 alkyl, C1-4
alkyloxy, C1-4 alkyloxy C1-4 alkyl, C1-4
alkyl, aryl;
alkyloxy C1-4 alkyl, mono- or di(C1-4 alkyl)
amino C1-4 alkyl, cyano, amino, mercapto,
C1-4 alkylthio, arylthio or aryl; >Y1-Y2-is a
trivalent radical of the formula
r and s are each independently 0,1,2,3,4, or
5;
t is 0,1,2 or 3;
-O-CH2-O-O-CH2-CH2-O-O-CH=CH-O-CH2-CH2or –CH=CH-CH=CHApril 13, 2008– ‫ח' בניסן התשס"ח‬
each R1 and R2 are independently hydroby,
halo, cyano, C1-6 alkyl, trihalomethyl,
trihalomethoxy, C2-6 alkenyl, C1-6
alkyloxy, hydroxy C1-6 alkyloxy, C1-6
alkylthio, C1-6 alkyloxy C1-6 alkyloxy, C1-6
alkyloxycarbonyl, amino C1-6 alkyloxy,
mono- or di(C1-6 alkyl) amino, mono- or
di(C1-6 alkyl) amino C1-6 alkyloxy, aryl,
aryl C1-6 alkyl, aryloxy or aryl C1-6
isomeric form thereof, wherein=x1-x2-x3-is
a trivalent radical of formula
alkyloxy, hydroxycarbonyl, C1-6
alkyloxycarbonyl, aminocarbonyl, amino
C1-6 alkyl, mono- or di (C1-6 alkyl)
aminocarbonyl, mono-or di (C1-6 alkyl)
amino C1-6 alkyl; or
two R1 or R2 substituents adjacent to one
another on the phenyl ring may
independently form together a bivalent
radical of the formula
-O-CH2-CH2-CH2R3 is hydrogen, halo, C1-6 alkyl, cyano,
halo C1-6 alkyl, hydroxyl C1-6 alkyl, cyano,
C1-6 alkyl, amino C1-6 alkyl, C1-6 alkyl, C1-6
alkyl, C1-6 alkyloxy C1-6 alkyl, C1-6
666
alkylthio C1-6 alkyl, aminocarbonyl C1-6
alkyl, hydroxycarbonyl, hydroxycarbonyl
C1-6 alkyl, C1-6 alkyloxycarbonyl C1-6 alkyl,
C1-6 alkylcarbonyl C1-6 alkyl, C1-6
alkyloxycarbonyl, aryl, aryl C1-6 alkyloxy
C1-6 alkyl, mono- or di (C1-6 alkyl) amino
C1-6 alkyl; or a radical of the formula
-O-R10
-S-R10
-NR11R12
wherein
R10 is hydrogen, C1-6 alkyl, C1-6
alkylcarbonyl, aryl, aryl C1-6 alkyl, C1-6
alkyloxcarbonyl C1-6 alkyl, or a radical of
formula –Alk-OR13 or – Alk-NR14R15;
R11 is hydrogen, C1-6 alkyl, aryl or aryl C1-6
alkyl; R12 is hydrogen, C1-6 alkyl, aryl,
hydroxy, amino, C1-6 alkyloxy, C1-6
alkylcarbonyl C1-6 alkyl, aryl, C1-6 alkyl,
C1-6 alkylcarbonylamino, mono-or di(C1-6
alkyl) amino, C1-6 alkylcarbonyl,
aminocarbonyl, arylcarbonyl, halo, C1-6
alkylcarbonyl, aryl C1-6 alkylcarbonyl, C1-6
alkyloxycarbonyl, C1-6 alkyloxy C1-6
alkylcarbonyl, mono- di (C1-6 alkyl),
aminocarbonyl wherein the alkyl moiety
may optionally be substituted by one or
more substitutents independently selected
from aryl or C1-3 alkyloxycarbonyl,
aminocarbonylcarbonyl, mono -or di (C1-6
alkyl) amino C1-6 alkylcarbonyl, or a
radical of formula –Alk-OR13 or –AlkNR14R15; wherein Alk is C1-6 alkanediyl;
R13 is hydrogen, C1-6 alkyl, C1-6
alkylcarbonyl, hydroxy C1-6 alkyl, aryl or
aryl C1-6 alkyl; R14 is hydrogen, C1-6 alkyl,
aryl or aryl C1-6 alkyl; R15 is hydrogen, C1-6
alkyl, C1-6 alkylcarbonyl, aryl or aryl C1-6
alkyl; R4 is a radical of formula
wherein R16 is hydrogen, halo, aryl, C1-6
alkyl, hydroxy C1-6 alkyl, C1-6 alkyloxy C16 alkyl, C1-6 alkyloxy, C1-6 alkylthio,
amino, mono- or di (C1-4 alkyl) amino,
hydroxycarbonyl, C1-6 alkyloxycarbonyl,
C1-6 alkylthio C1-6 alkyl, C1-6 alkyl S(O)C117
6 alkyl or C1-6 alkyl S(O)2 C1-6 alkyl; R is
hydrogen, C1-6 alkyl, C1-6 alkyloxy C1-6
alkyloxy C1-6 alkyl, aryl C1-6 alkyl,
trifluoromethyl or di (C1-4 alkyl)
aminosulfonyl;
R5 is C1-6 alkyl, C1-6 alkyloxy or halo;
aryl is phenyl, naphthalenyl or phenyl
substituted with 1 or more substituents
each independently selected from halo, C16 alkyl, C1-6 alkyloxy or trifluoromethyl.
___________
667
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
799232
‫ ויישומים‬,‫ שורות תאי סבוציט‬,‫סבוציטים‬
‫שלהם‬
]01[
SEBOCYTES, SEBOCYTE CELL
LINES AND APPLICATIONS
THEREOF
]00[
]04[
]04[
15.12.1999
19903920.8
]00[ 01.02.1999
]00[ DE
Int. Cl.8 A61K 000/800000 035/36, A61P 017/00, A61Q 001/900000 C12N 005/06,
005/10
CHRISTOS ZOUBOULIS,
GERMANY
WO/2000/046353
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]00[
]01[
[57] Sebocytes which are immortalized
and of human origin, obtainable by
transfection of sebocytes with a DNA
comprising DNA sequences coding for the
large T protein of SV-40, characterized in
that they possess features of normal, nontransfected and differentiating sebocytes.
__________
]44[]04[
791912
‫מודולטורים של רצפטור גלוקוקורטיקואיד‬
]01[
GLUCOCORTICOID RECEPTOR
MODULATORS
]00[
]04[
]04[
27.03.2000
60/132130
]00[ 30.04.1999
]00[ US
Int. Cl.8 C07C 035/42, 049/647, 069/76, 255/49, 271/44, C07D 213/24, 233/20,
239/26, 241/14, 249/08, 251/12, 263/30, 271/00, 277/22, 285/02
PFIZER PRODUCTS, INC., U.S.A.
WO/2000/066522
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]00[
]01[
[57] A compound of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
668
an isomer thereof, or a pharmaceutically
acceptable salt of said compound, or
isomer; wherein m is 1 or 2; D is CR7, or
CR7R16; E is C, or CR6; F is CR4, or
CR4R5;
R1 is aryl' wherein aryl' is substituted
independently with 0,1 or 2 of the
following:-Z-OH, -Z-NR12R13, -Z-NR12het, -C(O)-(C1-C6) alkyl, -NR12-C(O)-(C2C6) alkenyl, -NR12-C(O)-(C2-C6) alkynyl, NR12-C(O)-Z-het, -CN, -Z-het, -O-(C1-C3)
alkyl –C(O)O(C1-C6) alkyl, -NR12-ZC(O)O(C1-C6) alkyl, -N(Z-C(O)O(C1-C6)
alkyl)2, -NR12-Z-C(O)-NR12R13, -Z-NR12SO2-R13, -NR12-SO2-het, -C(O)H, -Z-NR12Z-O(C1-C6) alkyl, -Z-NR12-Z-NR12R13, -ZNR12-(C3-C6) cycloalkyl, -Z-N(Z-O(C1-C6)
alkyl)2, -SO2R12, -SOR12, -SR12, SO2NR12R13, -O-C(O)-(C1-C4) alkyl, -OSO2-(C1-C4) alkyl, -halo or –CF3; -SOR12,
-SR12, -SO2NR12R13, -O-C(O)-(C1-C4)
alkyl, -O-SO2-(C1-C4) alkyl, -halo, or –
CF3; Z for each occurrence is
independently (a) –(C0-C6) alkyl, (b) –(C2C6) alkenyl or (c) –(C2-C6) alkynyl; R2 is
(a) –H, (b) –halo, (c) –OH, (d) –(C1-C6)
alkyl substituted with 0 or 1 – OH, (e) –
NR12R13, (f) –Z-C(O)(C1-C6) alkyl, (g) –ZC(O)NR12R13, (h) –O-(C1-C6) alkyl, (i) –ZO-C(O)-(C1-C6) alkyl, (j) –Z-O-(C1-C3)
alkyl-C(O)-NR12R13, (k) –Z-O-(C1-C3)
alkyl-C(O)-O(C1-C6) alkyl, (l) –O-(C2-C6)
alkenyl, (m) –O-(C2-C6) alkynyl, (n) –O-Zhet, (o) –COOH, (p) –C(OH)R12R13 or (q)
–Z-CN;
R3 is (a) –H,(b)-(C1-C10) alkyl wherein 1 or
2 carbon atoms, other than the connecting
carbon atom, may optionally be replaced
with 1 or 2 heteroatoms independently
669
selected from S, O and N and wherein each
carbon atom is substituted with 0, 1 or 2
Ry, (c) –(C2-C10) alkenyl substituted with 0,
1 or 2 Ry, (d) –(C2-C10) alkynyl wherein 1
carbon atom, other than the connecting
carbon atom, may optionally be replaced
with 1 oxygen atom and wherein each
carbon atom is substituted with 0, 1 or 2
Ry, (e)-CH=C=CH2, (f) –CN, (g) –(C3-C6)
cycloalkyl, (h) –Z-aryl (i) –Z-het (j) –
C(O)O(C1-C6) alkyl, (k) –O(C1-C6) alkyl,
(l)-Z-S-R12, (m) –Z-S(O)-R12, (n) –ZS(O)2-R12, (o) –CF3 (p) –NR12O-(C1-C6)
alkyl or (q) –CH2ORy;
provided that one of R2 and R3 is absent
when there is a double bond between
CR2R3, (the 7 position) and the F moiety
(the 8 position) of the C-ring; Ry for each
occurrence is independently (a) –OH, (b) –
halo, (c) –Z-CF3, (d) –Z- CF(C1-C3 alkyl)2,
(e) –CN, (f) –NR12R13, (g) –(C3-C6)
cycloalkyl, (h) –(C3-C6) cycloalkenyl, (i) –
(C0-C3) alkyl-aryl, (j)-het or (k) –N3;
or R2 and R3 are taken together to form (a)
=CHR11, (b) =NOR11, (c) =O,(d) =N-NR12,
(e) =N-NR12-C(O)-R12, (f) oxiranyl or (g)
1, 3-dioxolan-4-yl;
R4 and R5 for each occurrence are
independently (a) –H(b) –CN,(c) –(C1-C6)
alkyl substituted with 0 to 3 halo, (d) –(C2C6) alkenyl substituted with 0 to 3 halo, (e)
(C2-C6) alkynyl substituted with 0 to 3
halo, (f) –O-(C1-C6) alkyl substituted with
0 to 3 halo, (g) –O-(C2-C6) alkenyl
substituted with 0 to 3 halo, (h) –O-(C2-C6)
alkynyl substituted with 0 to 3 halo, (i)
halo, (j) –OH(k) (C3-C6) cycloalkyl or (1)
(C3-C6) cycloalkenyl; or R4 are taken
together to form =O;
April 13, 2008– ‫ח' בניסן התשס"ח‬
R6 is (a) –H, (b) –CN, (c) –(C1-C6) alkyl
substituted with 0 to 3 halo, (d) –(C2-C6)
alkenyl substituted with 0 to 3 halo, (e) –
(C2-C6) alkynyl substituted with 0 to 3 halo
or (f) –OH;
R7 and R16 for each occurrence are
independently (a) –H, (b) –halo, (c) –CN,
(d) –(C1-C6) alkyl substituted with 0 to 3
halo, (e) –(C2-C6) alkenyl substituted with
0 to 3 halo or (f) –(C2-C6) alkynyl
substituted with 0 to 3 halo; or R7 and R16
are taken together to form =O;
R8, R9, R14 and R15 for each occurrence are
independently (a) –H, (b)-halo, (c) (C1-C6)
alkyl substituted with 0 to 3 halo, (d) –(C2C6) alkenyl substituted with 0 to 3 halo,
(e) –(C2-C6) alkynyl substituted with 0 to 3
halo, (f) –CN, (g)-(C3-C6) cycloalkyl, (h) –
(C3-C6) cycloalkenyl, (i) –OH, (j) –O-(C1C6) alkyl, (k) –O-(C1-C6) alkenyl, (l) –O(C1-C6) alkynyl, (m) –NR12R13, (n) –
C(O)OR12 or (o) –C(O)NR12R13;
or R8 and R9 are taken together on the Cring to form =O; provided that when m is
2, only one set of R8 and R9 are taken
together to form =O;
or R14 and R15 are taken together to form
=O; provided that when R14 and R15 are
taken together to form =O, D is other than
CR7 and E is other than C;
R10 is (a) –(C1-C10) alkyl substituted with 0
to 3 substituents independently selected
from –halo, -OH and –N3, (b) –(C2-C10)
alkenyl substituted with 0 to 3 substituents
independently selected from –halo, -OH
and –N3, (c) –(C2-C10) alkynyl substituted
with 0 to 3 substituents independently
selected from –halo, -OH and –N3, (d) –
halo, (e) –Z-CN, (f) –OH, (g) –Z-het, (h) –
Z-NR12R13, (i) –Z-C(O)-het, (j)-Z-C(O)(C1-C6) alkyl, (k) –Z-C(O)-NR12R13, (l)-ZC(O)-NR12-Z-CN, (m) –Z-C(O)-NR12-Zhet, (n) –Z-C(O)-NR12-Z-aryl, (o)-Z-C(O)NR12-Z-NR12R13, (p) –Z-C(O)-NR12-ZO(C1-C6) alkyl, (q) –(C0-C6) alkylC(O)OH, (r) –Z-C(O)O(C1-C6) alkyl, (s), Z-O-(C0-C6) alkyl-het, (t)-Z-O-(C0-C6)
alkyl-aryl, (u)-Z-O-(C1-C6) alkyl
April 13, 2008– ‫ח' בניסן התשס"ח‬
substituted with 0 to 2 Rx, (v) –Z-O-((C1C6) alkyl-CH(O), (w)-Z-O-(C1-C6) alkylNR12-het, (x) –Z-O-Z-het-Z-het, (y) –Z-OZ-het-Z-NR12R13, (z) –Z-O-Z-het-C(O)het, (a1)-Z-O-Z-C(O)-het, (b1) –Z-O-ZC(O)-het-het, (c1)-Z-O-Z-C(O)- (C1-C6)
alkyl, (d1) –Z-O-Z-C(S)-NR12R13, (e1) –ZO-Z-C(O)-NR12R13, (f1) –Z-O-Z-(C1-C3)
alkyl-C(O)-NR12R13, (g1) –Z-O-Z-C(O)O(C1-C6) alkyl, (h1) –Z-O-Z-C(O)-OH,
(i1) –Z-O-Z-C(O)-NR12-O(C1-C6) alkyl,
(j1), -Z-O-Z-C(O)-NR12-OH, (k1) –Z-O-ZC(O)-NR12-Z-NR12R13, (ll) –Z-O-Z-C(O)NR12-Z-het, (ml) –Z-O-Z-C(O)-NR12-SO2(C1-C6) alkyl, (n1)-Z-O-Z-C (=NR12)
(NR12R13), (o1) –Z-O-Z-C(=NOR12)
(NR12R13, (p1) –Z-NR12-C(O)-Z-NR12R13,
(q1) –Z-S-C(O)-NR12R13 (rl)-Z-O-SO2(C1-C6) alkyl, (s1)-Z-O-SO2-aryl, (t1) –ZO-SO2-NR12R13, (u1) –Z-O-SO2-CF3, (v1)Z-NR12C(O)OR13 or (w1) –ZNR12C(O)R13;
R11 is (a)-H, (b) –(C1-C5) alkyl, (c)-(C3-C6)
cycloalkyl or (d) –(C0-C3) alkyl-aryl; R12
and R13 for each occurrence are each
independently (a) –H, (b) –(C1-C6) alkyl
wherein 1 or 2 carbon atoms, other than
the connecting carbon atom, may
optionally be replaced with 1 or 2
heteroatoms independently selected from
S,O and N and wherein each carbon atom
is substituted with 0 to 6 halo, (c)-(C2-C6)
alkenyl substituted with 0 to 6 halo or (d) –
(C1-C6) alkenyl wherein 1 carbon atom,
other than the connecting carbon atom,
may optionally be replaced with 1 oxygen
atom and wherein each carbon atom is
substituted with 0 to 6 halo;
or R12 and R13 are taken together with N to
form het;
or R6 and R14 or R15 are taken together to
form 1, 3-dioxolanyl; aryl is (a) phenyl
substituted with 0 to 3 Rx, (b) naphthyl
substituted with 0 to 3 Rx or (c) biphenyl
substituted with 0 to 3 Rx; het is a 5-, 6- or
7-membered saturated or unsaturated ring
containing from one (1) to three (3)
heteroatoms independently selected from
670
the group consisting of nitrogen, oxygen
and sulfur; and including any bicyclic
group in which any of the above
heterocyclic rings is fused to a benzene
ring or another heterocycle; and the
nitrogen may be in the oxidized state
giving the N-oxide form; and substituted
with 0 to 3 Rx; Rx for each occurrence is
independently (a) –halo, (b) –OH, (c) –
(C1-C6) alkyl, (d) –(C2-C6) alkenyl, (e) –
(C2-C6) alkynyl, (f)-O(C1-C6) alkyl, (g)O(C2-C6) alkenyl, (h) –O(C2-C6) alkynyl,
(i) –(C0-C6) alkyl-NR12R13, (j)-C(O)NR12R13, (k) –Z-SO2R12, (l)-Z-SOR12, (m)
–Z-SR12, (n) –NR12-SO2R13, (o)-NR12C(O)-R13, (p)-NR12-OR13, (q) –SO2NR12R13, (r) –CN,(s) –CF3,(t) –C(O) (C1C6) alkyl, (u)=O, (v) –Z-SO2-phenyl or (w)
–Z-SO2-het'; aryl' is phenyl, naphthyl or
biphenyl; het' is a 5-, 6- or 7-membered
The applications for division
from this application have
not yet been published
saturated or unsaturated ring containing
from one (1) to three (3) heteroatoms
independently selected from the group
consisting of nitrogen, oxygen and sulfur;
and including any bicyclic group in which
any of the above heterocyclic rings is fused
to a benzene ring or another heterocycle;
provided that: when R9 and R10 are
substituents on the A-ring, they are other
than mono- or di-methoxy; (2) when R2
and R3 are taken together to form =CHR11
or =O wherein R11 is –O(C1-C6) alkyl, then
–X-R1 is other than (C1-C4) alkyl; (3) when
R2 and R3 taken together are C=O and R9
is hydrogen on the A-ring; or when R2 is
hydroxy, R3 is hydrogen and R9 is
hydrogen on the A-ring, then R10 is other
than –O-(C1-C6) alkyl or –O-CH2-phenyl
at the 2-position of the A-ring.
5868983
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
671
791103
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
2 – HYDROXY – 2 – METHYL – N –
(4 – X – 3 – (TRIFLUOROMETHYL)
PHENYL) – 3 –
(PERFLUOROACYLAMINO)
PROPIONAMIDE DERIVATIVES,
COMPOSITIONS THEREOF AND
THE USE THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS
]00[
]04[
]04[
]04[
]04[
]00[
]01[
25.05.2000
09/502376
]00[ 11.02.2000
Int. Cl.7 A61K 031/165, C07C 237/22
143709
BIOPHYSICA, INC., U.S.A.
WO/2001/058854
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[57] A compound of the formula 2hydroxy-2-methyl-N-(4-X-3(trifluoromethyl) phenyl-3(perfluoroacylamino) propionamide,
– N – ‫ – מתיל‬0 – ‫ – הידרוקסי‬0 ‫נגזרות של‬
– )‫ – (טריפלואורומתיל) פניל‬X – 3 – 4(
,‫ – (פרפלואורואצילאמינו) פרופיונאמיד‬:
‫תרכובות המכילותם ושימושם להכנת‬
‫תכשירים רפואים‬
]00[
US
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
wherein X is nitro, cyano or halo of atomic
number 9-35, and the perfluoroacylamido
group has from 2 to 3 carbon atoms and 0
or 1 hydrogen atom.
__________
]44[]04[
]01[
METHOD OF ENHANCING THE
RATE OF NOVEL GENE
DISCOVERY IN A POPULATION
OF PREVIOUSLY
UNCHARACTERIZED NUCLEIC
ACID MOLECULES
]00[
]04[
]04[
]04[
19.05.2000
09/314698
]00[ 19.05.1999
Int. Cl.8 C12Q 001/68
AVENTIS PHARMACEUTICALS
INC., U.S.A.
]00[ WO/2000/070098
]01[ SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A method for reducing redundancy
in a sample of nucleic acid molecules, the
method comprising:
April 13, 2008– ‫ח' בניסן התשס"ח‬
792191
‫שיטה לשיפור קצב גלוי גנים חדישים‬
‫באוכלוסיית מולקולות של חומצות גרעין‬
‫לא מאופניינות לפני כן‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(a) providing a heterogeneous sample of
nucleic acid molecules;
(b) immobilizing the sample of nucleic
672
acid molecules on a first microarray;
(c) hybridizing to said sample one or more
labeled probes corresponding to sequences
known to be or suspected of being present
in said sample of nucleic acid molecules;
(d) identifying at least one immobilized
molecule that hybridizes weakly or does
not hybridize to the labeled probes,
.
(e) providing a probe which specifically
recognizes the nucleic acid molecule of
(d);
(f) optionally repeating steps (b)-(d) or (b)(e) using a labeled probe which includes
the probe of step (e), thereby reducing
redundancy in said sample of nucleic acid
molecules.
___________
]44[]04[
791274
‫שיטה וציוד להגדרת קצב שידור בקשר‬
‫הפוך במערכת תקשורת אל–חוטית‬/‫נגדי‬
]01[
METHOD AND APPARATUS FOR
DETERMINING A REVERSE LINK
TRANSMISSION RATE IN A
WIRELESS COMMUNICATION
SYSTEM
]00[
]04[
]04[
]04[
30.06.2000
09/346882
]00[ 02.07.1999
]00[ US
Int. Cl.8 H04B 007/005, 007/26, H04J 013/00, H04L 001/00, H04Q 007/38
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/003357
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]01[
[57] A communication system,
comprising: a remote station configured to
transmit reverse link data to a base station
of a plurality of base stations, at a reverse
link transmission rate in accordance with a
combined reverse link busy signal
generated in accordance with the reverse
link busy bits transmitted by each of the
673
base stations of the plurality of base
stations; and a plurality of base stations,
each base station configured to transmit
forward link data to the remote station, the
forward link data including a reverse link
busy bit, the reverse link busy bit
indicating when a base station has reached
its reverse link capacity limit.
April 13, 2008– ‫ח' בניסן התשס"ח‬
5866886
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
791030
‫ הכנתן‬,‫נגזרות חדישות של אמינותיאזול‬
‫והרכבים ריקחיים המכילים אותן‬
]01[
AMINOTHIAZOLE
DERIVATIVES, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]00[
]04[
]04[
]04[
]00[
]01[
11.07.2000
99/09144
]00[ 15.07.1999
]00[ FR
Int. Cl.8 A61K 031/426, A61P 025/00, C07D 277/48, 417/12, 417/14
SANOFI AVENTIS, FRANCE
WO/2001/005776
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A compound of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
674
in which
R1 and R2, which may be identical or
different, each independently represent a
halogen atom, a hydroxy (C1-C5) alkyl; a
(C1-C5) alkyl; an aralkyl in which the aryl
portion is (C6-C8) and the alkyl portion is
(C1-C4); a (C1-C5) alkoxy; a
trifluoromethyl group; a nitro group; a
nitrile group; a group –SR in which R
represents hydrogen, a (C1-C5) alkyl or an
aralkyl in which the aryl portion is (C6-C8)
and the alkyl portion is (C1-C4); a group –
S-CO-R in which R represents a (C1-C5)
alkyl or an aralkyl radical in which the aryl
portion is (C6-C8) and the alkyl portion is
(C1-C4); a group –COORa in which Ra
represents hydrogen or a (C1-C5) alkyl; a
group –CONRaRb with Ra and Rb as
defined above for Ra; a group –NRaRb
with Ra and Rb as defined above for Ra; a
group –CONRcRd or –NRcRd in which
Rc and Rd constitute, with the nitrogen
atom to which they are attached, a 5- to 7membered heterocycle; or a group –
NHCO-NRaRb with Ra and Rb as defined
above for Ra;
R3 represents hydrogen or is as defined
above for R1 and R2;
or alternatively R2 constitutes with R3,
when the latter substitutes the phenyl in
position 5, a group –X-CH2-X- in which X
independently represents a CH2 or an
oxygen or sulphur atom; R4 represents
hydrogen, a (C1-C5) alkyl; a
hydroxymethyl group; a formyl group; a
halogen atom; or a (C3-C5) cycloalkyl
group; R5 represents an alkynyl of 3 to 6
carbon atoms; R6 represents a (C1-C6)
alkyl; a (C1-C6) alkoxy (C1-C3) alkyl; a
(C3-C5) cycloalkyl; a (C3-C6) cycloalkyl
(C1-C6) alkyl; a (C1-C6) alkylthio (C1-C3)
alkyl; a (C1-C6) alkylsulphoxy (C1-C3)
alkyl; or a (C1-C6) alkylsulphodioxy (C1C3) alkyl; R7 represents a phenyl which is
unsubstituted, mono- di-or trisubstituted in
position 3, 4 or 5 with a halogen, with a
(C1-C5) alkyl, with an –O-CH2 –O- group
on two neighbouring carbon atoms of the
phenyl, with a –CF3, -NO2 or –CN, with a
group –COOR8 or –CONR8 R9 or with a
group CH2 OR8 in which R8 and R9
represent a (C1-C3) alkyl, OR10 in which
R10 represents a (C1-C5) alkyl; or
alternatively R7 represents a pyridyl,
thiophene, pyrazolyl, imidazolyl, (C3-C5)
cycloalkyl or (C3-C6) cycloalkyl (C1-C6)
alkyl group; or the acid or base addition
salts thereof, the hydrates thereof and/or
the solvates thereof.
___________
]44[]04[
675
791214
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
PROCESS FOR PREPARING
DIBENZOTHIAZEPINE
DERIVATIVES
]00[
]04[
]04[
09.07.1999
Int. Cl.8 C07D 281/16
ASTRAZENECA UK LIMITED,
UNITED KINGDOM
UBE INDUSTRIES, LTD., JAPAN
WO/2001/004106
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]00[
]01[
‫תהליך להכנת נגזרות דיבנזותיאזפין‬
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל אביב‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
[57] A process for preparing a
dibenzothiazepine compound of the
formula
(5)
in which each of R1, R2, R3, R4, R5, R6, R7
and R8 independently represents a
hydrogen atom, an alkyl group, an alkoxy
group, an alkylcarbonyl group, an aryl
group, an aryloxy group, or an
arylcarbonyl group, each group being
optionally substituted, which comprises the
steps of: reacting a nitrobenzene
compound of the formula
(1)
in which X represents a halogen atom,
with a thiosalicylic acid compound of the
formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
676
(2)
wherein the step of reacting the compound
of formula (1) with a compound of formula
(2) is conducted in a solvent selected from
the group consisting of water, amide
solvents, aliphatic alcohols, ketones, and
nitriles, in the presence of a base, to obtain
a 2-nitro-2'-carboxy-diphenylsulfide
compound of the formula
(3)
reducing the obtained 2-nitro-2'-carboxydiphenylsulfide compound, in the presence
of a compound selected from the group
consisting of Raney-nickel, a ferrous salt,
palladium/carbon, palladium/barium
sulfate, a palladium compound and a
platinum compound, to obtain a compound
of the formula
and subjecting the obtained 2-amino-2'carboxy-diphenylsulfide compound to
dehydration-condensation reaction.
The applications for
division from this
application have not yet
been published
5866898
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
677
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
VERTEBRAL OSTEOSYNTHESIS
PLATE AND OSTEOSYNTHESIS
SYSTEM
]00[
]04[
]04[
]04[
]00[
]01[
03.07.2000
99/08495
]00[ 01.07.1999
Int. Cl.8 A61B 017/70
SPINEVISION, FRANCE
WO/2001/001874
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] Vertebral osteosynthesis plate for
maintaining the correction of the relative
orientation of the vertebrae by means of a
correction instrument, said osteosynthesis
plate being generally rectangular in shape
and having at least four openings (1, 2, 4,
5) for fixing means to pass through each of
the openings, characterized in that at least
two of the openings (4, 5) open onto a
lateral edge (6) of said osteosynthesis plate
791927
‫לוחות אוסטאוסינתזה חולייתית ומערכת‬
‫אוסטאוסינתזה‬
]00[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
so as to allow the plate to the installed and
fixed without the prior removal of the
instrument for correcting the relative
orientation of the vertebrae, the edge of the
plate being defined by an edge running in
the same direction as the longitudinal
direction of the plate, the longitudinal
direction of the plate being approximately
the same as the direction of the vertebral
column.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
678
]44[]04[
]01[
FIXING ELEMENT AND
ANCILLARY FOR STABILISING
VERTEBRAE
]00[
]04[
]04[
]04[
]00[
]01[
30.06.2000
99/08498
]00[ 01.07.1999
Int. Cl.8 A61B 017/70
SPINEVISION, FRANCE
WO/2001/001873
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] Implant of the type comprising a
fastener that can be anchored to a vertebra
and having a head in the shape of a fork in
which the two branches define a
substantially U-shaped reception space,
intended for receiving a link element (1),
and a closure part (3) that can be fixed to
the head, said implant being characterized
in that the closure part is generally Ushaped, whose branches cooperate with the
branches of the fork-shaped part of the
791922
‫רכיב קיבוע וסיוע לייצוב חוליות‬
]00[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
head, and in that the head has, at the
bottom of the "U", the general shape of a
horse saddle allowing the link element to
pivot about a transverse axis (24) of said
implant, when said link element is housed
in the reception space, and means for
guiding the closure part on the outer side
surfaces of the fork-shaped part, said
guiding means being formed by an arched
shoulder such as to allow the closure part
to pivot about the transverse axis.
__________
679
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
DATABASE TABLE RECOVERY
SYSTEM
]00[
]04[
]04[
]04[
23.06.2000
09/349198
]00[ 07.07.1999
Int. Cl.8 G06F 012/00, 017/30
COMPUTER ASSOCIATES THINK,
INC., U.S.A.
WO/2001/004797
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] A system for recovering a database
table comprising: a database table recovery
system, the database table recovery system
operable to retrieve a backup copy of a
tablespace and to apply updates to the
backup copy from a log associated with a
first database table generated from the
tablespace in response to corruption of the
first database table, and to restore the first
database table associated with the
791947
‫מערכת התאוששות לטבלת בסיס נתונים‬
]00[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
tablespace from the updated backup copy
without affecting the tablespace; and a
tablespace access system coupled to the
database table recovery system, wherein
the tablespace access system is operable to
restrict access to the tablespace for other
database tables associated therewith to
read-only access until the first database
table has been recovered.
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
680
]44[]04[
]01[
THERMISTOR AND METHOD OF
MANUFACTURE
]00[
]04[
]04[
]04[
20.01.2002
770556
]00[ 26.01.2001
Int. Cl.8 G01K 007/22, H01C 017/28
CORNERSTONE SENSORS, INC.,
U.S.A.
GREGG LAVENUTA
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]00[
]01[
[57] A thermistor comprising:
(a) a semiconductor body comprising two
opposed surfaces;
(b) a first electrode layer (13a) deposited
on at least a portion of said opposed
surfaces of the semiconductor body said
first layer being formed of a first electrode
material comprising a conductive metal
taken from the group consisting of Au, Ag,
Pt, Pd and combinations and alloys thereof
and having a thickness of greater than
about 5 micrometers;
(c) a second electrode layer (13b)
deposited outward of said first layer, said
second layer being formed of a second
791129
‫תרמיסטור ושיטה לייצורו‬
]00[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
electrode material comprising Ti, said
second layer having a thickness of not
more than about 5 micrometers;
(d) a third electrode layer (13c) deposited
outward of said second layer, said third
layer being formed of a third electrode
material comprising Pt, said third layer
having a thickness of not more than about
5 micrometers; and;
(e) optionally, a fourth electrode layer
(13d) deposited outward of said third
electrode layer, said fourth electrode layer
comprising a conductive metal having a
thickness of not more than about 5
micrometers.
___________
681
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
791412
–N ‫נגזרות ותכשירים רוקחיים של‬
‫הידרוקסימתיל‬
–‫טטראמתילציקלופרופיל‬
‫ בעלות פעילות אנטי‬,‫קרבוקסאמיד‬
‫אפילפטית ונוירולוגית ופעילות‬
‫ ושיטה להכנתם‬CNS– ‫למערכת ה‬
]01[
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
OF N-HYDROXYMETHYL
TETRAMETHYLCYCLOPROPYLCARBOXAMIDE HAVING ANTI EPILEPTIC, NEUROLOGICAL AND
CNS ACTIVITY AND METHOD FOR
THEIR PREPARATION
]00[
]04[
]04[
01.02.2002
Int. Cl.8 A61K 031/16, 031/325, A61P 025/00, C07C 233/60, 271/10
YISSUM RESEARCH DEVELOPMENT
‫יישום חברה לפיתוח המחקר של‬
COMPANY OF THE HEBREW
,‫האוניברסיטה העברית בירושלים‬
UNIVERSITY OF JERUSALEM
‫ירושלים‬
MEIR BIALER, BORIS YAGEN, NINA
‫ נינה איסוהרנן‬,‫ בוריס יגן‬,‫מאיר ביאלר‬
ISOHERRANEAN
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
‫אביב‬
TEL AVIV 61040
]00[
]01[
[57] N-Hydroxyalkyltetramethylcyclopropane carboxamide
derivatives of the formula
wherein n=1-6; and R is hydrogen, an
alkyl group of 1-3 carbons, an arylalkyl
group, an aryl group, a carboxamide or Nmethyl or N-dimethyl carboxamide.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
793211
682
‫ להכנת‬CGRP ‫שימוש באנטגוניסטים של‬
‫תכשיר רוקחות לטיפול בהבזקים חמים‬
‫בתקופת המעבר‬
]01[
USE OF CGRP ANTAGONISTS
FOR PREPARING A
PHARMACEUTICAL
COMPOSITION FOR TREATING
MENOPAUSAL HOT FLASHES
]00[
]04[
]04[
]04[
05.08.2000
199373043
]00[ 10.08.1999
]00[ DE
Int. Cl.8 A61K 031/445, 031/495, 031/505, 031/54, 031/55, 045/06, A61P 015/12
BOEHRINGER INGELHEIM
PHARMA GMBH & CO. KG,
GERMANY
WO/2001/010425
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] Use of a CGRP antagonist for
preparing a pharmaceutical composition
for treating menopausal hot flushes,
characterized in that the CGRP antagonist
is selected from among:
(A) 1-[N2[3, 5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinoazolin-3-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-L-lysyl]4-(4-pyridinyl)-piperazine,
(B) 1-[4-amino-3, 5-dibromo-N-[[4-(2, 3,
4, 5-tetrahydro-2(1H)-oxo-1,3benzodiazepin-3-yl)-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1piperidinyl)-piperidine,
(C) 1-[N2-[4-amino-3,5-dibromo-N-[[4(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-Llysyl]-4-(4-pyridinyl)-piperazine,
(D) 1-[N2-[4-amino-3, 5-dibromo-N-[[4(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-Llysyl]-4-(4-pyridinyl)-piperidine,
(E) 1-[N2-[3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-D-tyrosyl]-Llysyl]-4-(4-pyridinyl)-piperazine,
(F) 1-[N2-[4-amino-3, 5-dibromo-N-[[4-(1,
3-dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-Dphenylalnyl]-L-lysyl]-4-(4-pyridinyl)-
683
piperazine,
(G) 1-[3,5-dibromo-N-[[3,4-dihydro2(1H)-oxothieno [3,4-d] pyrimidin-3-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-4-(1piperidinyl) piperidine,
(H) 1-[4-amino-3, 5-dibromo-N-[[4-(2,4dihydro-5-phenyl-3(3H0-oxo-1,2,4-triazol2-yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-methyl-4-piperidinyl)piperidine,
(I) 1-[4-amino-3,5-dibromo-N-[[4-(2,4dihydro-5-phenyl-3(3H)-oxo-1,2,4-triazol2-yl)-1-piperidinyl] carbonyl-Dphenylalanyl]-4-(1-piperidinyl)-piperidine,
(J) 1-[4-amino-3, 5-dibromo-N-[[4-(2, 4dihydro-5-phenyl-3(3H)-oxo-,1,2,4-triazol2-yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-methyl-4-piperidinyl)piperazine,
(K) 1-[4-amino-3, 5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxothieno [3,2-d]
pyrimidin-3-yl)-1-piperidinyl] carbonyl] –
D-phenylalanyl]-4-(1-piperidinyl)piperidine,
(L) 1-[4-amino-3, 5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]-2(2H)- oxoimidazol-l-yl]-1-piperidin-yl]
carbonyl]-D-phenylalanyl] -4-(1-ethyl-4piperidinyl)-piperidine,
April 13, 2008– ‫ח' בניסן התשס"ח‬
(M) 1-[4-amino-3,5-dibromo-N-[[4-[3, 4dihydro-2(1H)-oxoquinoazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-hexyl-4-piperidinyl)-piperidine,
(N) 1-[4-amino-3,5-dibromo-N-[[4-[3, 4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-cyclopropylmethyl-4-piperidinyl)piperidine,
(O) 1-[4-amino-3,5-dibromo-N-[[4-[N(aminocarbonyl)-N-phenylamino]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-piperidinyl)-piperidine,
(P) (R, S)-1-[4-[4-(3, 4-dihydro-2(1H)oxoquinazolin-3-yl)-1-piperidinyl]-2-[(4hydroxy-3, 5-dimethylphenyl) methyl]1,4-dioxobutyl]-4-(1-piperidinyl)piperidine,
(Q) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-4(5-methoxy-4-pyrimidinyl)-piperazine,
(S) 1-[4-amino-3,5-dibromo-N-[[4-(1,1dioxido-3(4H)-oxo-1,2,4-benzothiadiazin2-yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-piperidinyl)-piperidine,
(T) 1-[4-amino-3, 5-dibromo-N-[[4[2(1H)-oxoquinolin-3-yl]-1piperidinyl]carbonyl]-D-phenylalanyl]-4(1-piperidinyl)-piperidine,
(U) 1-[4-amino-3, 5-dibromo-N-[[4-[3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4[3-(dimethylamino) propyl]-piperazine,
(V) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(4-methyl-1-piperazinyl)-piperidine,
(W) 1-[4-amino-3,5-dibromo-N-[[4-[3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4[(1-methyl-4-piperidinyl) carbonyl]piperazine,
(X) 1-[4-amino-3,5-dibromo-N-[[4-[3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4[(1-methyl-4-piperazinyl) carbonyl]piperazine,
April 13, 2008– ‫ח' בניסן התשס"ח‬
(Y) 1-[4-amino-3, 5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-4[4-[4-(dimethylamino) butyl]phenyl]piperazine,
(Z) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl-D-phenylalanyl]-4[4-(dimethylamino)-1-piperidinyl]piperidine,
(AA) 1-[N2-[[4-(1, 3-dihydro-4-phenyl2(2H)-oxoimidazol-1-yl)-1-piperidinyl]
carbonyl]-N'-methyl-D-tryptyl]-4-(4methyl-1-piperazinyl)-piperidine,
(AB) 1-[N2-[[4-(1,3-dihydro-4-phenyl2(2H)-oxoimidazol-l-yl)-l-piperidinyl]
carbonyl]-N'-(1,1dimethylethoxycarbonyl)-D-tryptyl]-4-(1methyl-4-piperidinyl)-piperidine,
(AC) (R, S)-1-[4-[4-(3, 4-dihydro-2(1H)oxoquinazolin-3-yl)-1-piperidinyl]-2-[(3,5dibromo-4-methylphenyl) methyl]-1,4dioxobutyl]-4-(4-methyl-1-piperazinyl)piperidine,
(AD) (R, S)-1-[4-[4-(3,4-dihydro-2(1H)oxoquinazolin-3-yl)-1-piperidinyl]-2-[(3,5dibromo-4-methoxyphenyl) methyl]-1,4dioxobutyl]-4-(1-methyl-4-piperidinyl)piperidine,
(AE) (R, S) -1-[4-[4-(3,4-dihydro-2(1H)oxoquinazolin-3-yl)-1-piperidinyl]-2-[3,4dibromophenyl) methyl]-1,4-dioxobutyl]4-(4-methyl-1-piperazinyl)-piperidine,
(AF) 1-[N2-[N-[[-(1,3-dihydro-2(2H)oxobenzimidazol-l-yl)-piperidinyl]
carbonyl] 3, 5-dibromo-D-tyrosyl]-Llysyl]-4-(4-pyridinyl)-piperazine,
(AG) 1-[4-amino-3,5-dibromo-N-[[4-(1, 3dihydro-6-hydroxy-2(2H)oxobenzimidazol-1-yl)-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1piperidinyl)-piperidine,
(AH) 1-[N2-[4-amino-3,5-dibromo-N-[[4(1,3-dihydro-2(2H)-oxobenzimidazol-l-yl)1-piperidinyl]carbonyl]-D-phenylalanyl]N6, N6 –dimethyl-L-lysyl]-4-(4-pyridinyl)piperazine,
(AI) 1-[N2-4-amino-3,5-dibromo-N-[[4-(3,
684
4-dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-N6,
N6-dimethyl-L-lysyl]-4-(4-pyridinyl)piperazine,
(AJ) (R, S)-1-(2-(4-amino-3, 5dibromobenzoyl)-4[4-(3, 4-dihydro-2(1H)oxoquinazolin-3-yl)-1-piperidinyl]-4oxobutyl]-4-(1-piperidinyl)-piperidine,
(AK) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2,2-dioxido-2,1, 3benzothiadiazin-3-yl)-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1piperidinyl)-piperidine,
(AL) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-2(2H)-oxoimidazo [4,5-c]
quinolin-3-yl]-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-piperidinyl) carbonyl]piperidine,
(AM) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-piperidinyl)-piperidine,
(AN) 1-[N2-[3,5-dibromo-N[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-N6, N6dimethyl-L-lysyl]-4-(4-pyridinyl)piperazine,
(AO) 1-[4-amino-N-[[4-[4-(3bromophenyl)-1,3-dihydro-oxoimidazol-lyl]-1-piperidinyl] carbonyl-3,5-dibromoD-phenylalanyl]-4-(1-methyl-4piperidinyl) piperidine,
(AP) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl]-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(4-methyl-1-piperazinyl)piperidine,
(AQ) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1piperidinyl)-piperidine,
(AR) 1-[4-amino-3, 5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(exo-8methyl-8-azabicyclo [3,2,1] oct-3-yl)piperazine,
685
(AS) 1-[3,5-dibromo-N-[[4-(1,3-dihydro4-phenyl-2(2H)-oxoimidazol-l-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-4-(1piperidinyl)-piperidine,
(AT) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-[3-trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1-ethyl-4piperidinyl)-piperazine,
(AU) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-phenyl-2(2H)-oximidazol-l-yl]1-piperidinyl] carbonyl]-D-phenylalanyl]4-(hexahydro-4-methyl-1H-1,4-diazepin-1yl) piperidine,
(AV) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3yl)-1-piperidinyl]
carbonyl]-D-tyrosyl]-4-[1(methylsulphonyl)-4-piperidinyl]piperidine,
(AW) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-methyl-4-piperidinyl)piperidine,
(AX) 1-[3,5-dibromo-N-[[4-[1,3-dihydro4-[3-(trifluoromethyl) phenyl]-2(2H)oxoimidazol-1-yl]-1-piperidinyl] carbonylD-tyrosyl]-4-(hexahydro-1H-1-azepinyl)piperidine,
(AY) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]
carbonyl]-D-tyrosyl]-4-(1-methyl-4piperidinyl)-piperidine,
(AZ) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl]carbonyl]-D-phenylalanyl]-4(exo-8-methyl-8-azabicyclo[3,2,1] oct-3yl)-piperazine,
(BA) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-D-phenylalanyl]-4-(1-methyl-4-piperidinyl)piperazine,
(BB) 1-[3,5-dibromo-N-[[4-[1,3-dihydro4-[3-trifluoromethyl) phenyl]-2(2H)oxoimidazol-l-yl]-1-piperidinyl]carbonyl]D-tyrosyl]-4-(1-piperidinyl)-piperidine,
April 13, 2008– ‫ח' בניסן התשס"ח‬
(BC) 1-[N6-acetyl-N2-[3,5-dibromo-N-[[4(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-L-lysyl]4-(4-pyridinyl)-piperazine,
(BD) 1-[3,5-dibromo-N-[[4-(1,3-dihydro4-phenyl-2(2H)-oxoimidazol-l-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-4(hexahydro-1H-1-azepinyl)-piperidine,
(BE) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-(3-thienyl)-2(2H)-oxoimidazol1-yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-methyl-4-piperidinyl)piperidine,
(BF) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-1-piperidinyl]
carbonyl]-D-phenylalanyl]-4-(1-methyl-4piperidinyl)-piperidine,
(BG) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]
carbonyl]-D-tyrosyl]-4-[1(hydroxycarbonylmethyl)-4-piperidinyl]piperidine,
(BH) 1-[4-amino-3,5-dibromo-N-[[4-[3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-methylsulphonyl-4-piperidinyl)piperidine,
(BI) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]
carbonyl]-D-tyrosyl]-4-(4-piperidinyl)piperidine,
(BJ) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-1yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-ethyl-4-piperidinyl)piperidine,
(BK) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-(3-hydroxyphenyl)-2(2H)oxoimidazol-l-yl)-1-piperidinyl] carbonylD-phenylalanyl]-4-(1-methyl-4piperidinyl)-piperidine,
(BL) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3-yl)-1piperidinyl]carbonyl]-D-tyrosyl]-4(hexahydro-1H-1-azepinyl)-piperidine,
(BM) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lApril 13, 2008– ‫ח' בניסן התשס"ח‬
yl)-1-piperidinyl] carbonyl-Dphenylalanyl]-4-(1-piperidinyl)-piperidine,
(BN) 1-[4-amino-3,5-dibromo-N-[[4-[4-(3bromophenyl)-1,3-dihydro-2(2H)oxoimidazol-l-yl]-1-piperidinyl] carbonylD-phenylalanyl]-4-(exo-8-methyl-8methyl-8-azabicyclo[3,2,1]oct-3-yl)piperazine,
(BO) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalnyl]-4(1-ethyl-4-piperidinyl)-piperidine,
(BP) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalnyl]-4(1-ethyl-4-piperidinyl)-piperazine,
(BQ) 1-[4-amino-3, 5-dibromo-N-[[4-[1,3dihydro-4-(3-methoxyphenyl)-2(2H)oxoimidazol-l-yl]-1-piperidinyl] carbonyl]D-phenylalanyl]-4-(exo-8-methyl-8azabicyclo [3,2,1] oct-3-yl)-piperazine,
(BR) 1-[3,5-dibromo-N-[[4-(3,4-dihydro2(1H)-oxoquinazolin-3-yl)-piperidinyl]
carbonyl]-D-tyrosyl]-4-[1(cyclopropylmethyl)-4-piperidinyl]piperidine,
(BS) 1-[4-amino-3,5-dibromo-N-[[4-(3dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-4(hexahydro-1H-1-azepinyl)-piperidine,
(BT) 1-[4-amino-3,5-dibromo-N-[[4-(3,4dihydro-2(1H)-oxoquinazolin-3-yl)-1piperidinyl] carbonyl]-D-phenylalanyl]-4(piperidinyl)-piperidine,
(BU) 1-[3,5-dibromo-N-[[4-(1,3-dihydro4-phenyl-2(2H)-oxoimidazol-2-yl)-1piperidinyl]carbonyl]-D-tyrosyl]-4-(4pyridinyl)-piperidine,
(BV) 1-[3,5-dibromo-N-[[4-[1,3-dihydro4-[3-(trifluoromethyl) phenyl]-2(2H)oxoimidazol-l-yl]-1-piperidinyl] carbonyl]D-tyrosyl]-4-(1-methyl-4-piperdinyl)piperazine,
(BW) 1-[N2-[3,5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-l-piperidinyl]
carbonyl]-D-tyrosyl]-L-lysyl]-4-(4pyridinyl)-piperazine,
686
(BX) 1-[3,5-dibromo-N-[[4-(1, 3-dihydro4-(3-thienyl)-2(2H)-oxoimidazol-l-yl)-1piperidinyl] carbonyl]-D-tyrosyl]-4-(1piperidinyl)-piperidine,
(BY) 1-[4-amino-N-[[4-[4-(3chlorophenyl)-1,3-dihydro-2(2H)oxoimidazol-l-yl]-l-piperidinyl] carbonyl]3,5-dibromo-D-phenylalanyl]-4-(1-methyl4-piperidinyl)-piperidine,
(BZ) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-1piperidinyl]carbonyl]-D-phenylalanyl]-4(hexahydro-1H-1-azepinyl)-piperidine,
(CA) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-[3-(trifluoromethyl) phenyl]2(2H)-oxoimidazol-l-yl]-lpiperidinyl]carbonyl]-D-phenylalanyl]-4(1-methyl-4-piperidinyl)-piperazine,
(CB) 1-[4-amino-N-[[4-[4-(3chlorophenyl)-1,3-dihydro-2(2H)oxoimidazol-l-yl]-1-piperidinyl]carbonyl]3,5-dibromo-D-phenylalanyl]-4(hexahydro-1H-1-azepinyl)-piperidine,
(CC) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(4-pyridinyl)-piperazine,
(CD) 1-[3,5-dibromo-N-[[4-(1,3-dihydro4-phenyl-2(2H)-oxoimidazol-l-yl)-lpiperidinyl] carbonyl]D-tyrosyl]-4-(1-methyl-4-piperidinyl)piperidine,
(CE) 1-[4-amino-3,5-dibromo-N—[[4[1,3-dihydro-4-phenyl-2(2H)-oxoimidazoll-yl]-l-piperidinyl] carbonyl]-Dphenylalanyl]-4-[4-(1-oxoethyl) phenylpiperazine,
(CF) 1-[3,5-dibromo-N-[[4-[3,4-dihydro2(1H)-oxoquinazolin-3-yl]-1-piperidinyl]
carbonyl]-D-tyrosyl]-4-(1-methyl-4piperidinyl)-piperazine,
(CG) 1-[4-amino-3,5-dibromo-N-[[4-[1,3dihydro-4-(3-nitrophenyl)-2(2H)oxoimidazol-l-yl]-l-piperidinyl] carbonyl]D-phenylalanyl-4-(1-methyl-4piperidinyl)-piperidine,
(CH) 1-[4-amino-3,5-dibromo-N-[[4-[3,4dihydro-2(1H)-oxoquinazolin-3-yl]-1piperidinyl] carbonyl]-D-phenylalanyl]-4(1-pyrrolidinyl)-piperidine,
(CI) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-phenyl-2(2H)-oxoimidazol-lyl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(hexahydro-1H-1azepinyl)-piperidine and
(CJ) 1-[4-amino-3,5-dibromo-N-[[4-(1,3dihydro-4-(3-thienyl)-2(2H)-oximidazol-1yl)-1-piperidinyl] carbonyl]-Dphenylalanyl]-4-(1-methyl-4-piperidinyl)piperazine, the tautomers, the
diastereomers, the enantiomers, the
mixtures thereof and the physiologically
acceptable salts thereof.
___________
687
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
793214
‫ ותכשירים‬CTLA–4 ‫נוגדנים אנושיים‬
‫המכילים אותם‬
]01[
HUMAN CTLA-4 ANTIBODIES
AND COMPOSITIONS
CONTAINING THE SAME
]00[
]04[
]04[
]04[
]00[
]01[
24.08.2000
60/150452
]00[ 24.08.1999
]00[ US
Int. Cl.8 A61K 039/395, A61P 037/00, C07K 016/18, 016/28, C12N 015/13, 015/85
MEDAREX, INC., U.S.A.
WO/2001/014424
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
[57] A therapeutically effective human
antibody or antigen-binding portion
thereof that binds human CTLA4 with a
binding affinity of about 108 M-1 or
greater, wherein the antibody or antigen
binding portion thereof does not crossreact with non-lymphoid tissue.
5866986
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
___________
]44[]04[
793732
‫פירולוקרבזולים ואיזואינדולונים מאוחים‬
‫איזומריים ותכשירי רוקחות המכילים אותם‬
]01[
ISOMERIC FUSED
PYRROLOCARBAZOLES AND
ISOINDOLONES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]00[
]04[
18.08.2000
60/150367
]00[ 20.08.1999
]00[ US
6/9016000
4016010666
US
Int. Cl.8 A61K 031/407, 031/437, A61P 013/08, 025/00, 027/02, 035/00, C07D
471/14, 487/00, 487/04, 491/147, 495/14, C12P 017/18
CEPHALON, INC., U.S.A.
WO/2001/014380
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]04[
]04[
]00[
]01[
[57] A compound of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
688
or a stereoisomer or pharmaceutically
acceptable salt form thereof, wherein:
ring D is selected from phenyl and
cyclohexene with double bond a-b; ring B
and ring F, independently, and each
together with the carbon atoms to which
they are attached, are selected from:
(a) a 6-membered carbocyclic ring in
which from 1 to 3 carbon atoms may be
replaced by hetero atoms; and
(b) a 5-membered carbocyclic ring in
which either
(1) one carbon atom may be replaced with
an oxygen, nitrogen, or sulfur atom;
(2) two carbon atoms may be replaced with
a sulfur and a nitrogen atom, an oxygen
and a nitrogen atom, or two nitrogen
atoms; or
(3) three carbon atoms may be replaced
with three nitrogen atoms, one oxygen and
two nitrogen atoms, or one sulfur and two
nitrogen atoms;
G-X-W is selected from:
(a)-(A1A2)C-N(R1)-C(B1B2)-;
(b) –CH(R1A)-C(=O)-N(R1)-; and
(c) –N(R1)-C(=O)-CH(R1A)-;
R1 is selected from:
(a) H, substituted or unsubstituted alkyl of
1 to 6 carbons, substituted or unsubstituted
C6-C12 aryl, substituted or unsubstituted
C7-C15 arylalkyl, substituted or
unsubstituted C6-C12 heteroaryl in which
one or more ring carbon atoms is replaced
by an O, N or S atom, or substituted or
unsubstituted C7-C15 heteroarylalkyl in
which one or more ring carbon atoms is
replaced by an O, N or S atom;
(b) –C(=O)R7 where R7 is selected from
689
substituted or unsubstituted C1-C8 alkyl,
substituted or unsubstituted C6-C12 aryl,
substituted or unsubstituted C7-C8
carbocyclic group, and substituted or
unsubstituted heterocyclyl groups;
(c) –OR8, where R8 is selected from H and
alkyl having from 1 to 6 carbons;
(d) –C(=O)NHR8, -NR9R10, -(CH2)pOR8, O(CH2)pOR8 and –O(CH2)pNR9R10, where
p is from 1 to 4; and where either
(1) R9 and R10 are each independently
selected from H, unsubstituted alkyl of 1 to
5 carbons, and substituted alkyl; or
(2) R9 and R10 together form a linking
group of the formula –(CH2)2-X1-(CH2)2-,
wherein X1 is selected from –O-, -S-, and –
CH2-;
R1A is the same as R1;
R2, R3, R4 and R5 are each independently
selected from:
a) H, C6-C12 aryl, C3-C8 carbocyclyl,
heterocyclyl, -CN, CF3, -NO2, -OH, -OR7,
Br, I, -O(CH2)pNR9R10, -OC(=O)R7, OC(=O)NR9R10, -O(CH2)pOR8, F, Cl, CH2OR8, -NR9R10, -NR8S(=O)R7, or
NR8C(=S)R7;
b) –CH2OR11, where R11 is the residue of
an amino acid after the hydroxyl group of
the carboxyl group is removed;
c) –NR8C(=O)NR9R10, -NR8C(=S)NR9R10,
-CO2R12, -C(=O)R12, -C(=O)NR9R10, C(=S)NR9R10, -CH=NOR12, -CH=NR7, (CH2)pNR9R10, -(CH12)pNHR11, or –
CH=NNR12R12A; where R12 is selected
from H, alkyl of 1 to 6 carbons, -OH,
alkoxy of 1 to 6 carbons, -OC(=O)R7, OC(=O)NR9R10, -OC(=S)NR9R10, O(CH2)pNR9R10, -O(CH2)pOR8, substituted
April 13, 2008– ‫ח' בניסן התשס"ח‬
or unsubstituted C7-C15 arylalkyl having
from 6 to 10 carbons, substituted or
unsubstituted heterocyclylalkyl in which
one or more ring carbon atoms is replaced
by an O, N or S atom, and a substituted or
unsubstituted C3-C8 carbocyclic group;
R12A is the same as R12;
d) –S(O)yR12, -(CH2)pS(O)yR7, CH2S(O)yR11 where y is 0, 1 or 2;
e) alkyl of 1 to 8 carbons, alkenyl of 2 to 8
carbons, and alkynyl of 2 to 8 carbons,
wherein:
(1) each alkyl, alkenyl, or alkynyl group is
unsubstituted; or
(2) each alkyl, alkenyl or alkynyl group is
substituted
with 1 to 3 groups selected from aryl of 6
to 10 carbons, heterocyclyl, arylalkoxy,
heterocycloalkoxy, hydroxylalkoxy,
alkyloxy-alkoxy, hydroxyalkylthio,
alkoxy-alkylthio, F, Cl, Br, I, -CN, -NO2, OH, -OR7, -X2-(CH2)pC(=O)NR9R10, X2(CH2)pC(=S)NR9R10, X2(CH2)pOC(=O)NR9R10, X2(CH2)pCO2R7, -X2(CH2)pS(O)yR7, X2(CH2)pNR8C(=O)NR9R10, -OC(=O)R7, OC(=O)NHR12, O-tetrahydropyranyl,
-NR9R10, -NR8CO2R7, -NR8C(=O)NR9R10,
-NR8C(=S)NR9R10, -NHC(=NH)NH2, NR8C(=O)R7, -NR8C(=S)R7, NR8S(=O)2R7, -S(O)yR7, -CO2R12, C(=O)NR9R10, C(=S)NR9R10, -C(=O)R12, CH2OR,
-CH=NNR12R12A, -CH=NOR12, -CH=NR7,
-CH=NNHCH(N=NH)NH2, S(=O)2NR12R12A, -P(=O)(OR8)2, -OR11,
and a monosaccharide of 5 to 7 carbons
where each hydroxyl group of the
monosaccharide is independently either
unsubstituted or is replaced by H, alkyl of
1 to 4 carbons, alkylcarbonyloxy of 2 to 5
carbons, or alkoxy of 1 to 4 carbons;
X2 is O, S, or NR8;
R6 is selected from H, -SO2R7, -C(=O)R7, C(=O)NR9R10, alkyl of 1-8 carbons,
alkenyl of 2-8 carbons, and alkynyl of 2-8
carbons; and either
(1) each alkyl, alkenyl, or alkynyl group is
unsubstituted; or
(2) each alkyl, alkenyl, or alkynyl group
independently is substituted, as defined for
R2, R3, R4, and R5 in
(e) above;
Y is selected from:
(a) an unsubstituted alkylene of 1-3
carbons;
(b) an alkylene of 1-3 carbons substituted
with R13, where R13 is selected from R12,
thioalkyl of 1-4 carbons, halogen, alkyl of
1-8 carbons, alkenyl of 2-8 carbons, and
alkynyl of 2-8 carbons, where
(i) each alkyl of 1-8 carbons, alkenyl of 28 carbons, and alkynyl of 2-8 carbons is
unsubstituted; or
(ii) each alkyl of 1-8 carbons, alkenyl of 28 carbons, and alkynyl of 2-8 carbons,
independently, is substituted, as defined
for R2, R3, R4, and R5 in e) above; and
(c) a functional group selected from –
CH=CH-, -CH(OH)-CH(OH)-, -O-, -S-, S(=O)-, -S(=O)2-, -C(R6)2-, -C=(R13)2-, C(=O)-, -C(=NOR12)-, -C(OR12)R12, C(=O)CH(R6), -CH(R6)C(=O)-, C(=NOR12)CH(R6)-, -CHR8C(=NOR12)-, C(=O)N(R8)-, -N(R8)C(=O)-, -CH2Z-, ZCH2-, and –CH2ZCH2-, where Z is
selected from –C(R12)-, -O-, -S-, -CO2R12,
-C(=NOR12)-, and –N(R12)-;
A1 and A2 are selected from H, H; H,
OR12; H, -SR12;H, -N(R12)2; and a group
where A1 and A2 together form a moiety
selected from =O, =S, and =NR12; and,
B1 and B2 are selected from H, H; H, OR12; H, -SR12; H, -N(R12)2; and a group
where B1 and B2 together form a moiety
selected from =O, =S, and =NR12;
with the proviso that at least one of the
pairs A1 and A2, or B1 and B2, form =O.
___________
April 13, 2008– ‫ח' בניסן התשס"ח‬
690
]44[]04[
793023
‫תמיסות עמילן שעברו שינוי והשימוש‬
‫האישי בהן‬
]01[
MODIFIED STARCH SOLUTIONS
AND THEIR USE IN PERSONAL
CARE
]00[
]04[
]04[
]04[
]00[
]01[
01.11.2000
60/168939
]00[ 03.12.1999
]00[ US
Int. Cl.8 A61K 000/806000 000/873000 000/89800
CALGON CORPORATION, U.S.A.
WO/2001/039721
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] An aqueous solution of a modified
starch comprising:
(a) about 20% to about 98.599%, by
weight water;
(b) about 1% to about 49.5%, by weight of
a modified starch;
(c) about 0.2% to about 15%, by weight of
urea;
(d) about 0.2% to about 10% by weight of
an alpha hydroxy acid or the
corresponding alpha hydroxy acid salt with
sodium, potassium, and/or substituted
amine;
(e) zero up to about 5% by weight of an
aliphatic carboxylic acid from C2 to C36 in
chain length acid or the corresponding
carboxylic acid salt with sodium,
ammonium and/or potassium;
(f) about 0.001% to about 0.5% by weight
of a preservative; and
(g) having a pH of from about 1 to 9
wherein the modified starch of (b) is of the
formula:
wherein R1 is selected from the group
consisting of ethers (1,2,3 and 4), ester (5)
and amphoteric substituents (6, 7, 8 and 9)
generally described as:
(1) –CH2-(CHR2-)m-CH2-N+(CH3)3X
wherein m is an integer from 0 to 34, each
R2 can independently be H or OH, and X is
Cl or Br-;
(2) –CH2-(-CHR3-)m-CR3H2
wherein m is as defined above and each R3
can independently be H or OH;
(3) –(-CH2-CHR4-O-)n-CH2-(-CHR5-)mCH2-N+ (CH3)3 Xwherein n is an integer from 1 to 100, m is
as defined above, each R4 can
independently be H, OH, CH3 or CH2OH,
691
April 13, 2008– ‫ח' בניסן התשס"ח‬
each R5 can independently be H or OH,
and X- is Cl- or Br-;
(4) -(-CH2-CHR6-O-)n –CH2-(CHR7-)mCR7H2
wherein n and m are as defined above,
each R6 can independently be H, OH, CH3
or CH2OH, each R7 can independently be
H or OH, and X- is Cl- or Br-;
(5) –CO-(CHR8)m-C R8H2
wherein m is as defined above and each R8
can independently be H, OH, CH3 or
CH2OH;
(6) –CH2- (-CHR9-)m-CH2-N+(R10)3
wherein m is as defined above, each R9 can
independently be H, OH, CH3 or CH2OH,
and each R10 can independently be:
(A) ---(CR11H-)p –CH3
(B) ---CH2OH
(C) ---(CR11H-)p-COOH
(D) ---(CR11H-)p-COO-
(E) ---(CR11H-)p-SO3wherein p is an integer from zero to 10 and
each R11 can independently be H, OH, CH3
or CH2OH;
(7) –CH2-(-CHR9-)m-CH2-CO-NH- CH2CH2- CH2-N+(R10)3
wherein m, R9, and R10 are as defined
above;
(8) –CO-CH2-(-CHR9-)m-CH2-N+(R10)3
wherein m, R9, and R10 are as defined
above;
(9) –CO –CH2- (-CHR9-)m-CH2-CO-NHCH2- CH2- CH2-N+(R10)3 wherein m, R9,
and R10 are as defined above;
wherein the mol % of substituted sugar
units (w) out of the total sugar units along
the starch molecule is between about 2 mol
% to about 80 mol % and the mol % of
unsubstituted sugar units (x) is between
about 20 mol % to about 98 mol %.
____________
]44[]04[
]01[
N - HETEROCYCLIC
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES OF SAID
DERIVATIVES
]00[
]04[
]04[
]04[
21.02.2002
09/383813
]00[ 26.08.1999
Int. Cl.8 C07D 403/00
BERLEX LABORATORIES, INC.,
U.S.A.
PHARMACOPEIA, INC., U.S.A.
WO/2001/014371
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
793272
‫ תכשירים‬,‫ – הטרוציקליות‬N ‫נגזרות של‬
‫רוקחיים המכילים אותן והישמושים‬
‫בנגזרות האמורות‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
[57] A compound of the formulae
April 13, 2008– ‫ח' בניסן התשס"ח‬
692
wherein:
n and m are independently an integer from
1 to 4;
A is –C(O)OR1 or –C(O)N(R1)R2;
each W is N or CH;
each R1 is independently hydrogen, alkyl,
aryl or aralkyl;
each R2 is independently hydrogen, C1-C20
alkyl, -(CH2)n-N(R1)2, heterocyclylalkyl
(optionally substituted by alkyl, halo,
haloalkyl or alkoxy), aralkyl (optionally
substituted by halo, alkyl, alkoxy, or –
N(R1)2);
R4 can be cyano or heterocyclyl and, when
m is an integer from 2 to 4, R4 can also be
hydroxy, -N(R1)R2, -N(R1)-C(O)-R1, N(R1)-C(O)OR1, -N(R1)-S(O)t-R1, orN(R1)-C(O)-N(R1)2;
R5 is hydrogen, halo, alkyl, aryl, aralkyl, or
haloalkyl;
t is zero, one or two;
as a single stereoisomer or mixture thereto,
or a pharmaceutically acceptable salt
thereof.
___________
]44[]04[
693
793202
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ שיטות‬,‫אסטרים המותמרים בברום‬
‫להכנתם ושימושם כמונעי בעירה‬
]01[
BROMINATED ESTERS,
METHODS FOR THEIR
PREPARATION AND USE
THEREOF AS FLAME
RETARDANTS
]00[
]04[
]04[
]01[
21.02.2002
Int. Cl.8 C07C 067/02, 069/00, 069/63, C09K 021/00
BROMINE COMPOUNDS LTD.
‫ באר שבע‬,‫תרכובות ברום בע"מ‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] Polyhalogenated benzyl esters of the
formula:
wherein X is halogen; n is an integer from
2 to 5; Y is a saturated aliphatic chain,
substituted or unsubstituted, having at least
4 carbon atoms or a radical
and wherein the substituents are selected
from the group consisting of bromine,
oxygen, and sulfur; wherein X is halogen;
p is an integer from 0 to 5; and Z is
(CH2)m wherein m is zero or an integer
greater than zero, with the proviso that Xp
is not pentafluoro when m equals 2.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
793143
694
‫קומפלקס מולטיפונקציונלי לניתוב‬
‫פאגוציטוזה ספציפית של גורם מטרה‬
‫ותכשיר המכיל אותו‬
]01[
MULTIFUNCTIONAL COMPLEX
FOR TARGETING SPECIFIC
PHAGOCYTOSIS OF A TARGET
AGENT AND A COMPOSITION
COMPRISING IT
]00[
]04[
]04[
]00[
10.03.2002
Int. Cl.8 A61K 039/395, 039/40, 039/44, 047/00, C07K 016/12
YAMIT BIOTECHNOLOGIES LTD.
‫ קרית שמונה‬,‫ימית ביוטכנולוגיות בע"מ‬
ELY MORAG, JACOB PITKOVSKI,
‫ יוסי פנחסוב‬,‫ פיטקובסקי יעקב‬,‫אלי מורג‬
YOSEF PINCHASOV
BEN-AMI & ASSOCIATES,
,'‫עמי ושות‬-‫בן‬
P.O.B. 94, REHOVOT 76100
‫ רחובות‬,64 .‫ד‬.‫ת‬
]01[
[57] A multi-functional targeting
complex that induces a specific immunostimulatory reaction to at least one target
agent, said complex comprising:
(a) at least one target recognition
component comprising a molecule which
specifically binds to said agent or any
functional fragment of said agent;
(b) an immunoactive component
comprising an immuno-stimulatory agent;
and
(c) optionally, a connecting component
that associates said at least one targeting
component and said at least one active
component, wherein the independent
biological functions of said targeting
component and said active component are
retained.
____________
]44[]04[
]01[
ORTHODONTIC FACEBOW
]00[
]04[
]04[
]00[
12.03.2002
Int. Cl.8 A61C 007/00, 007/06
ALINA LOZINSKI
YULI LOZINSKI, VLADIMIR
DINKELIS, BOAZ TSUR
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]01[
[57] An orthodontic facebow of the type
having an inner bow consisting of two
inner arms (4, 4) each having an end
portion (16, 16) and an interconnected
outer bow consisting of outer arms,
characterized in that the free ends of each
inner arm are split into a plurality of arm
695
793201
‫קשת פנים ליישור שניים‬
‫ ירושלים‬,‫אלינה לוזינסקי‬
‫ בועז צור‬,‫ ולדימיר דינקליס‬,‫יולי לוזינסקי‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
portions and at least one arm portion is
fitted with a ratchet type enlargement so as
to allow it to be easily inserted into a tube
connected to a band affixed to a tooth,
while preventing disengagement therefrom
without at least one of said arm portions
being squeezed towards the other or others.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_____________
]44[]04[
]01[
INSERTION AND RETRIEVAL
SYSTEM FOR INFLATABLE
DEVICES
]00[
]04[
]04[
]01[
14.03.2002
Int. Cl.8 A61F 002/00, A61M 029/00
INNOVENTIONS INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A magazine unit comprising:
a body (52) including a chamber
configured for receiving an implantable
device, said body including a passageway
extending therethrough; a rod slidably
received by said passageway in said body
and of a length for sliding beyond said
793120
‫מערכת להכנסת והוצאת התקנים‬
‫מתנפחים‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
body, said rod including a channel for fluid
passage extending at least substantially
therethrough, and a channel member in
fluid communication with said channel,
said channel member configured for
receipt by said implantable device.
____________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
793132
696
‫שיטה לאנליזה גנומית‬
]01[
METHODS FOR GENOMIC
ANALYSIS
]00[
]04[
20.03.2002
60/280530
]00[ 30.03.2001
069040001
4016010664
069000660
6014610664
069000006
0014410664
Int. Cl.8 C12Q 001/68
PERLEGEN SCIENCES, INC., U.S.A.
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]01[
[57] A method for selecting SNP
haplotype patterns, comprising: (a)
isolating a set of substantially identical
nucleic acid strands from a plurality of
different origins for analysis; (b)
determining more than one SNP location
in each nucleic acid strand in said set; (c)
identifying SNP locations that are linked in
said nucleic acid, wherein said SNP
locations that are linked form a SNP
haplotype block, thereby identifying said
The applications for division
from this application have
not yet been published
]00[
US
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
SNP haplotype block; (d) identifying
isolate SNP haplotype blocks; (e)
identifying SNP haplotype patterns that
occur in the SNP haplotype block
identified in step (c) and the isolate SNP
haplotype blocks identified in step (d); and
(f) selecting each identified SNP haplotype
pattern that occurs in at least two of said
substantially identical nucleic acid strands
in said set.
5869866
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
____________
]44[]04[
697
794232
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מנתב ממותג מרחבית עבור יחידות נתונים‬
‫אלחוטיות‬
]01[
SPATIALLY SWITCHED ROUTER
FOR WIRELESS DATA PACKETS
]00[
]04[
10.10.2000
09/417416
]00[ 13.10.1999
]00[ US
6/9100010
6014414///
US
Int. Cl.8 H01Q 015/08, H04L 005/14, 012/28, 012/413, 012/46, 012/56
INTEL CORPORATION, U.S.A.
WO/2001/028162
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]04[
]04[
]00[
]01[
[57] In a microwave network of the type
having a plurality of spatially separated,
mutually communicating network nodes
with a number of the nodes having routing
information regarding transmission and
reception timing and a corresponding
direction of transmission and reception for
data packets, each node having a local
transmitter port and a local receiver port, a
spatially switched router apparatus
comprising, an RF switch assembly
associated with said mutually
communicating network nodes, an RF
optics focusing and collimating antenna
capable of radiating RF energy from a
curved, peripheral surface thereof,
outwardly spanning an angular range
covering the communicating nodes in lineof-sight relation without motion of the
antenna, the antenna in RF communication
with the RF switch assembly, and a
plurality of RF optics feeding-ports
disposed side-by-side about the curved
peripheral surface of the antenna, the
microwave feeding ports communicating
RF energy from the RF switch assembly
and the RF optics and collimating antenna
April 13, 2008– ‫ח' בניסן התשס"ח‬
and using control signals that
synchronously activate the RF switch
assembly to route data packets modulating
an RF signal from the local transmitter port
towards the RF optics feeding-ports,
through the antenna and outwardly toward
one of the network nodes and from another
of the network nodes into the antenna and
toward the RF optics feeding-ports and
then towards the local receiver port, the RF
switch receiving routing information
regarding transmission and reception of
timing schedules and a corresponding
direction of transmission and reception of
data packets, the switch synchronously
switching directions of transmission and
reception of data packets between nodes
upon the reception and transmission of
data packets, wherein the control signals
for switching are based on the routing
information in the data packets, including
updated schedule information for
transmission and reception of timing and
direction of transmission and reception of
data packets between communicating
nodes.
698
___________
]44[]04[
794721
‫פורמולציות נוזל יציבות של בנזימידזולים‬
‫ תהליך להכנתן ושימושן בהכנת‬,‫מותמרים‬
‫תרופה לטיפול במחלות קיבה ומעיים‬
]01[
STABLE LIQUID
FORMULATIONS OF
SUBSTITUTED
BENZIMIDAZOLES, PROCESS
FOR THEIR PREPARATION AND
USE THEREOF IN THE
PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF
GASTROINTESTINAL DISEASES
]00[
]04[
]04[
]04[
]00[
]00[
]01[
13.10.2000
9903831-7
]00[ 22.10.1999
]00[ SE
Int. Cl.8 A61K 045/06, C07D 235/28, 401/12, 471/02, 495/02
ASTRAZENECA AB, SWEDEN
MIKAEL BRULLS
WO/2001/028558
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A water free or less that 6% by
weight of water stable liquid formulation
comprising polyethylene glycol and a
sodium or potassium salt of a H+, K+-
ATPase inhibitor, and optionally
pharmaceutically acceptable excipients
that are soluble in the formulation.
__________
699
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
794719
‫ שיטת הכנה ותכשירי‬, ‫אוליגוסכרידים‬
‫רוקחות המכילים אותם‬
]01[
OLIGOSACCHARIDES,
PREPARATION METHOD AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
]00[
]04[
]04[
18.10.2000
99/13182
]00[ 22.10.1999
]00[ FR
Int. Cl.8 A61K 031/7024, A61P 009/10, 019/00, 019/02, 025/00, 025/14, 025/16,
025/18, C07H 003/00, 019/01, C08B 037/00, 037/10
AVENTIS PHARMA S.A., FRANCE
WO/2001/029055
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]00[
]01[
[57] A purified oligosaccharide of the formula:
in which n is 0 or is an integer from 1 to
25, R1, R3, R4 and R5, which may be
identical or different, represent a hydrogen
atom or an SO3M radical; R2 and R6,
which may be identical or different,
represent a hydrogen atom or a radical
selected from SO3M and COCH3 and M is
sodium, calcium, magnesium or potassium.
____________
April 13, 2008– ‫ח' בניסן התשס"ח‬
700
]44[]04[
]01[
NUCLEIC ACID-CONTAINING
COMPLEX FOR GENE THERAPY
]00[
]04[
09.11.2000
11/318187
]00[ 09.11.1999
0666-000000
4016/10666
Int. Cl.8 A61K 047/48
HIDEZO MORI, JAPAN
YASUHIKO TABATA, JAPAN
]04[
]04[
]00[
]01[
794947
‫קומפלקס המכיל חומצת גרעין לריפוי גני‬
]00[
WO/2001/034206
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A nucleic acid-containing complex
comprising a nucleic acid and a positivelycharged water-insoluble biodegradable
polymer having an introduced positivelycharged group, wherein said nucleic acid
can be released by degradation of the
JP
JP
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
biodegradable polymer, wherein said
positively-charged water-insoluble
biodegradable polymer is crosslinked
before being complexed with the nucleic
acid.
___________
]44[]04[
794113
‫פורמולציות רוקחיות המכילות‬
‫זולמיטריפטאן ותהליך להכנתן‬
]01[
PHARMACEUTICAL
FORMULATIONS CONTAINING
ZOLMITRIPTAN AND PROCESS
FOR THEIR PREPARATION
]00[
]04[
]04[
]04[
]00[
28.11.2000
9928578.5
]00[ 03.12.1999
]00[ GB
Int. Cl.8 A61K 009/00, C07D 413/00, 413/06
ASTRAZENECA AB, SWEDEN
ALAN ROY DEARN, SARAH
LOUISE WILLIAMSON, SIMON
JOHN SUMMERS, TREVOR JOHN
COOMBER
WO/2001/039772
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
701
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] A pharmaceutical formulation for
intranasal administration, which comprises
zolmitriptan and a pharmaceutically
acceptable carrier wherein the pH of the
formulation is below 6.0.
_________
]44[]04[
794347
‫שיטה לייצור ציאנוהידרינים פעילים‬
‫–אוקסיניטרילאז‬R ‫אופטית באמצעות‬
]01[
METHOD FOR THE
PRODUCTION OF OPTICALLY
ACTIVE CYANOHYDRINS USING
R-OXYNITRILASE
]00[
]04[
]04[
]04[
25.11.2000
A2108/99
]00[ 15.12.1999
]00[ AT
Int. Cl.8 C12N 009/88, C12P 013/00, 041/00
DSM FINE CHEMICALS AUSTRIA
NFG GMBH & CO. KG, AUSTRIA
WO/2001/044487
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method for the production of (R)enantiomers of optically active
cyanohydrins by reacting an aldehyde or a
ketone with a cyanide group donor in the
presence of an (R)-oxynitrilase,
characterized in that a reaction mixture of
(a) an aldehyde or ketone dissolved in an
organic, water-immiscible or only slightly
water-miscible diluent,
(b) an aqueous (R)-oxynitrilase solution
and
(c) a cyanide group donor is stirred in such
a manner that an emulsion forms which is
maintained up to the end of the enzymatic
reaction, whereupon, after the enzymatic
reaction is terminated, the corresponding
(R)-cyanohydrin is isolated from the
reaction mixture.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
712713
702
‫הודעות‬/‫שיטה ומכשיר לאספקת קול‬
CATV ‫אחידות בשימוש בציוד קצה מסוג‬
]01[
METHOD AND APPARATUS FOR
PROVIDING VOICE/UNIFIED
MESSAGING SERVICES USING
CATV TERMINALS
]00[
]04[
]04[
]04[
]00[
21.12.2000
473294
]00[ 28.12.1999
]00[ US
Int. Cl.8 H04M 003/53, 011/00, H04N 007/025, 007/173
COMVERSE LTD.
‫קומברס בע"מ‬
EREZ MICHAEL, SHLOMI
‫ שלומי קרינגל‬,‫ארז מיכאל‬
KRINGEL
WO/2001/049032
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] System for providing CATV
subscribers an access to a UMS (Unified
Messaging System) and/or VMS (Voice
Mail System), wherein each subscriber is
provided with a TV set connected to the
CATV network directly or through a settop box, comprising: a connection between
subscribers of the CATV network and the
UMS and/or VMS and an interface for
permitting an exchange of information
between said subscribers and said UMS
and/or VMS; and a client software for the
UMS and/or VMS, which when the
connection is through the set-top box,
resides on, or is coupled to, said set-top
box, wherein subscribers of the CATV
network are able to exchange information
with other subscribers of the CATV
network via the UMS and/or VMS by
transmitting information over only the
CATV network.
__________
]44[]04[
703
712209
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מחבר צינורות‬
]01[
PIPE COUPLING
]00[
]04[
]04[
19.06.2002
Int. Cl.8 F16L 023/08
KRAUSZ METAL INDUSTRIES
LTD.
ELIEZER KRAUSZ, AVI
CHIPROOT
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]00[
]01[
[57] A pipe coupling (10) comprising a
tube-like member (12) with externally
projecting flanges (14) at each extremity,
said flanges being provided with an inner
face (16) and an outer face (18), a pair of
peripheral clamp members (20) being
arranged to contact said projecting flanges
on said inner face thereof and provided
with a recess (22) delimited by an inward
facing flange (24), said recess containing
at least one resilient seal member (28), the
‫ תל אביב‬,‫קראוס תעשיות מתכת בע"מ‬
‫ אבי צ'יפרוט‬,‫אליעזר קראוס‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
improvement being that at least one
resilient ring member (30) in axial
proximity to said seal member carries at
least one metal gripping element (32)
mounted on the inner diameter of said at
least one resilient ring member, and
tightening of said peripheral clamp
member causes said metal gripping
elements to bite into the outer surface of a
pipe to be held in said coupling.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
712227
704
‫או מניעה של‬/‫שיטה ותכשיר לטיפול ו‬
‫זיהומים מחיידקים עמידים לאנטיביוטיקה‬
]01[
METHOD AND COMPOSITION
FOR TREATMENT AND/OR
PREVENTION OF ANTIBIOTICRESISTANT MICROORGANISM
INFECTIONS
]00[
]04[
]04[
]04[
19.12.2000
60/172577
]00[ 20.12.1999
]00[ US
Int. Cl.8 A61K 038/40, A61P 031/00, 031/04
SA MAJESTE LA REINE DU CHEF
DU CANADA AGRICULTURE ET
AGROALIMENTAIRE CANADA,
CANADA
WO/2001/045732
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A composition comprising
ampicillin, wherein said ampicillin is in a
concentration of about 4 µg/ml, and a
protein selected from the group consisting
of a lactoferrin, a lactoferricin or fragment
thereof, in association with an acceptable
carrier, for inhibiting β-lactamase in a
microorganism.
__________
]44[]04[
]01[
SYSTEM AND METHOD FOR
GENERAL PURPOSE DATA
PARSING AND ANALYSIS
]00[
]04[
]04[
]04[
]01[
25.06.2002
898852
]00[ 03.07.2001
Int. Cl.8 G06F 007/00, 017/27, 017/30
N B NETWORKS, U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A method for parsing data according
to configurable criteria, the method
comprising steps of: storing in a first data
storage device a plurality of programmably
configurable protocol descriptions that
define a plurality of control character
characteristics of the data; storing in a
705
712977
‫מערכת ושיטה לבדיקה וניתוח כללי של‬
‫מידע‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
second data storage device a program for
controlling a data parsing function to be
executed by a processing unit, the program
including instructions for causing the
processing unit to selectively retrieve at
least one of the programmably
configurable protocol descriptions from
April 13, 2008– ‫ח' בניסן התשס"ח‬
the first data storage device and to vary the
execution of the data parsing function
based upon the at least one retrieved
protocol description file; delivering the
program for controlling the data parsing
function to the processing unit; delivering
the data to the processing unit; and
enabling the processing unit to execute the
data parsing function.
__________
]44[]04[
]01[
FASTENING DEVICE FOR RAILS
]00[
]04[
]04[
]04[
11.01.2001
00100206.2
]00[ 14.01.2000
Int. Cl.8 E01B 009/48, 029/24
VOSSLOH WERKE GMBH,
GERMANY
WO/2001/051711
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] Elastic tension clamp (10) composed
of spring steel comprising: a central part
(14) having two inner legs (12); and loops
(16) adjoining the inner legs and running
to the free ends (26) of the tension clamp;
characterized in that in the unloaded state
712144
‫אמצעי הידוק עבור פס‬
]00[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
of the tension clamp the open spacing
between the central part and the loop in the
region of the free end is less than the
diameter of the spring steel in the region of
the free end.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
706
]44[]04[
]01[
MEASURING ARRANGEMENT
FOR MEASURING A CRITICAL
DIMENSION OF AT LEAST ONE
FEATURE ON A
SEMICONDUCTOR WAFER
]00[
]04[
]04[
]04[
11.07.2002
10134755.3
]00[ 17.07.2001
Int. Cl.8 H01L 021/66
INFINEON TECHNOLOGIES AG,
GERMANY
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]01[
[57] A measuring configuration for
measuring a semiconductor wafer (1)
having at least one feature (22) with a
critical dimension (21), comprising: a
scanning electron microscope (2) for
measuring the critical dimension of the at
least one feature of the semiconductor
wafer; at least one measuring device (3)
for an angle-dependent measuring of one
of a scattering and a diffraction of light at
the least one feature of the semiconductor
wafer; at least one loading and unloading
station (5) for loading and unloading wafer
transport containers (6) receiving the
semiconductor wafer; a transport system
(4) for transporting the semiconductor
wafer, said transport system having
transport paths including at least a
707
712247
‫התקן למדידת מימד קריטי של לפחות‬
‫מאפיין אחד בפרוסה מוליכה למחצה‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
respective transport path between said at
least one loading and unloading station and
said scanning electron microscope, and
between said at least one loading and
unloading station and said at least one
measuring device for an angle-dependent
measuring of one of a scattering and a
diffraction of light; and a control unit (7)
operatively connected to said transport
system, said control unit selecting and
controlling one of said transport paths of
said transport system in order to
selectively make the semiconductor wafer
available to said at least one measuring
device for an angle-dependent measuring
of one of a scattering and a diffraction of
light and to said scanning electron
microscope.
April 13, 2008– ‫ח' בניסן התשס"ח‬
__________
]44[]04[
]01[
METHOD AND APPARATUS FOR
PROVIDING IMAGES FOR
CALLER IDENTIFICATION OVER
A MOBILE NETWORK
]00[
]04[
]04[
]04[
]00[
16.07.2002
09/907535
]00[ 17.07.2001
Int. Cl.8 H04M 003/42
COMVERSE, INC., U.S.A.
ARDA AKSU, MAKONNEN
MELAKU, SESHADRI MOHAN
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]01[
[57] A method comprising: providing
interactive access to caller identification
information associated with a caller,
wherein the caller interactively enters and
edits the caller identification information
via the Internet; receiving a request for a
call from the caller using a subscriber
handset to a called party over a first
wireless communication system;
identifying the caller identification
information associated with the caller;
retrieving the caller identification
information associated with the caller,
wherein the caller identification
information includes a PCLI header and an
April 13, 2008– ‫ח' בניסן התשס"ח‬
712132
‫שיטה ומכשיר לאספקת תמונות לזיהוי‬
‫המתקשר ברשת טלפונית ניידת‬
]00[
US
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
image; compressing the image in the caller
identification information; forwarding the
PCLI header and the compressed image in
the caller identification information to the
called party over a second wireless
communication system; comparing the
PCLI header received over the second
wireless communication system with a
caller ID received over the first wireless
communication system; displaying the
image to the called party if the PCLI
header matches the caller ID; and
suspending the call over the first wireless
communication system until a verification
of receipt is received over the second
708
wireless communication system.
__________
]44[]04[
712302
‫שיטה ומעגל לאספקת אותות ממשך בין‬
‫מעגלים משולבים‬
]01[
METHOD AND CIRCUIT FOR
PROVIDING INTERFACE
SIGNALS BETWEEN
INTEGRATED CIRCUITS
]00[
]04[
]04[
]04[
17.10.2000
09/489231
]00[ 21.01.2000
]00[ US
Int. Cl.8 G06J 001/00, H03K 019/0175, H04L 027/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/054047
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]01[
[57] Circuitry to generate an interface
signal between a first integrated circuit and
a second integrated circuit comprising: a
reference circuit configured to provide a
reference signal; an interface circuit
implemented on the first integrated circuit
and operatively coupled to the reference
circuit, the interface circuit configured to
receive the reference signal and a data
709
input and to generate the interface signal in
response thereto; and a circuit element
implemented on the second integrated
circuit and operatively coupled to the
interface circuit, the circuit element
configured to receive the interface signal
and provide an output signal in response,
wherein the interface signal is a
differential current signal.
April 13, 2008– ‫ח' בניסן התשס"ח‬
5868665
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
____________
]44[]04[
]01[
HOMOGENEOUS ASSAY OF
DUPLEX OR TRIPLEX
HYBRIDIZATION BY MEANS OF
MULTIPLE MEASUREMENTS
UNDER VARIED CONDITIONS
]00[
]04[
]04[
]04[
]00[
]01[
23.01.2001
490273
]00[ 24.01.2000
Int. Cl.8 C12Q 001/68
INGENEUS INC., BARBADOS
WO/2001/053526
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A method for assaying sequencespecific hybridization, said method
comprising: providing a target comprising
at least one nucleic acid sequence;
providing a probe comprising a nucleic
acid or nucleic acid analog sequence;
adding said probe and said target to a
hybridization medium to provide a test
sample; applying a first stimulus to said
test sample to provide a first stimulated
April 13, 2008– ‫ח' בניסן התשס"ח‬
712399
‫בדיקה הומוגנית של היבריציזציה כפולה או‬
‫משולשת באמצעות מדידות מרובות תחת‬
‫תנאים משתנים‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
test sample; detecting a first signal from
said first stimulated test sample, wherein
said first signal is correlated with a binding
affinity between said probe and said target;
calibrating said first signal against a first
reference signal; determining from said
first signal calibrating a first determination
of an extent of matching between said
probe and said target; applying a second
stimulus to said first stimulated test sample
710
to provide a second stimulated test sample;
detecting a second signal from said second
stimulated test sample, wherein said
second signal is correlated with said
binding affinity between said probe and
said target; calibrating said second signal
against a second reference signal;
determining from said second signal
calibrating a second determination of said
extent of matching between said probe and
said target; comparing said first
determination and said second
determination to accomplish said assaying;
and quantifying said binding affinity,
wherein a fluorophore is provided in said
test sample, and wherein: (a) said first
stimulus is electrical voltage, said first
signal is electrical conductance, said
second stimulus is exciting radiation ad
said second signal is fluorescent intensity;
or (b) said first stimulus is exciting
radiation, said first signal is fluorescent
intensity, said second stimulus is electrical
voltage and said second signal is electrical
conductance.
___________
]44[]04[
]01[
VACUUM EXTRACTION
MONITOR WITH ATTACHMENT
FOR HAND PUMP
]00[
]04[
]04[
]04[
]00[
]01[
27.11.2001
727124
]00[ 30.11.2000
Int. Cl.8 A61B 017/44
VICTOR L. VINES, U.S.A.
WO/2002/045604
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A method of using a recording
device to record a pressure in a vacuum
extraction device, comprising: coupling a
recording device to a vacuum extraction
device; placing the vacuum extraction
device on a fetus, the space between the
fetus and the vacuum extraction device
defining a pressure area in the vacuum
711
712432
‫משגוח למיצוי בריק עם קישור למשאבת‬
‫יד‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
extraction device, the vacuum extraction
device adapted to couple to a fetus via a
suction device; inducing a vacuum
pressure in the pressure area by handactuating the vacuum extraction device;
detecting the vacuum pressure in the
pressure area; and recording the vacuum
pressure to produce a record.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
717224
‫תכשיר תרופתי או מניעתי לאי‬
‫ספיקה ריאתית המכיל תולדות‬
‫דיאמינוטריפלואורומתילפירידין‬
]01[
THERAPEUTIC OR PREVENTIVE AGENT
FOR PULMONARY INSUFFICIENCY
CONTAINING A
DIAMINOTRIFLUOROMETHYLPYRIDINE
DERIVATIVE
]00[
]04[
]04[
]04[
]00[
30.01.2001
2000-24349
]00[
01.02.2000
]00[ JP
Int. Cl.8 A61K 031/44, A61P 011/00, C07D 213/72, 405/12, 409/12
ISHIHARA SANGYO KAISHA LTD., JAPAN
SHUICHI YOTSUYA, KYUYA MORINO,
MASASHI INAMURA
WO/2001/056570
EITAN MEHULAL LAW GROUP,
- ‫ מהולל עורכי דין‬- ‫קבוצת איתן‬
10 ABBA EBEN BLVD.,
,‫עורכי פטנטים‬
P.O. B. 2081,
,0/20 .‫ד‬.‫ ת‬, 0/ ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬
]00[
]01[
[57] Use of a
diaminotrifluoromethylpyridine derivative
represented by the formula (I) or its salt for
the manufacture of a medicament for the
April 13, 2008– ‫ח' בניסן התשס"ח‬
treatment of Acute Respiratory Distress
Syndrome (ARDS) or Chronic Obstructive
Pulmonary Disease (COPD)
712
wherein X is a –CW1R1 group, a –
COCOR2 group, a –CW1NHCOR2 group,
a –C(=W1) W2R3 group or –
SW1N(R4)R5 group; Y is an alkyl group,
a –CW3R6 group, a –COCOR7 group, a –
NHCOR7 group, a –C(=W3) W4R8 group,
a –(NH)mSO2R9 group, a –
(NH)mSO2OR10 group or a –
(NH)MSO2N(R11)R12 group; each of R1,
R6 and R9 which are independent of one
another, is a chain hydrocarbon group
which may be substituted, a monocyclic
hydrocarbon group which may be
substituted, a polycyclic hydrocarbon
group which may be substituted, a
monocyclic heterocycle group which may
be substituted or a polycyclic heterocycle
group which may be substituted; each of
R2 and R7 which are independent of each
other, is an alkyl group which may be
substituted, an alkoxy group which may be
substituted, a phenyl group which may be
substituted or a phenoxy group which may
be substituted; each of R3, R8 and R10
which are independent of one another, is
an alkyl group which may be substituted,
an alkenyl group which may be
substituted, an alkynyl group which may
be substituted, a cycloalkyl group which
may be substituted, a phenyl group which
may be substituted or a benzyl group
which may be substituted; each of R4, R5,
R11 and R12 which are independent of one
another, is an alkyl group which may be
substituted; each of W1, W2, W3 and W4
which are independent of one another, is
an oxygen atom or a sulfur atom; and m is
0 or 1, excluding a case where one of X
and Y is a –COCF2X1 group (wherein X1
is a hydrogen atom, a halogen atom, an
alkyl group or a haloalkyl group), and the
other is –COCF2X2 group (wherein X2 is
a hydrogen atom, a halogen atom, an alkyl
group, a haloalkyl group or an
alkylcarbonyl group), a –COOX3 group
(wherein X3 is an alkyl group which may
be substituted or a phenyl group which
may be substituted) or a –COX4 group
(wherein X4 is an alkyl group, a haloalkyl
group, an alkenyl group, an alkynyl group,
a phenyl group which may be substituted,
a furanyl group or naphthyl group).
__________
713
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
DEVICE AND METHOD FOR
CONTINUOUS HIGH-PRESSURE
TREATMENT
]00[
]04[
16.02.2001
2000-39327
]00[ 17.02.2000
0664-06060
0/16410664
0664-06000
0/16410664
Int. Cl.8 F15B 015/22
KANEKA CORPORATION, JAPAN
THE JAPAN STEEL WORKS, LTD.,
JAPAN
WO/2001/060508
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] A continuous high-pressure
processing method comprising the steps of:
supplying a feedstock continuously from a
supply tank to processing container
through a pressurizing pump; discharging
the processed feedstock from said
processing container through a
717243
‫התקן ושיטה לטיפול רציף בלחץ גבוה‬
]00[
JP
JP
JP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
depressurizing pump disposed in piping;
and setting a first delivery rate of said
pressurizing pump to be larger than a
second delivery rate of said depressurizing
pump, whereby the interiors of said
processing container and said piping are
maintained in a high-pressure state.
___________
April 13, 2008– ‫ח' בניסן התשס"ח‬
714
]44[]04[
]01[
FOOD INTAKE RESTRICTION
APPARATUS WITH
CONTROLLED WIRELESS
ENERGY SUPPLY
]00[
]04[
08.02.2001
09/503149
]00[ 11.02.2000
6/9060000
4416010666
Int. Cl.8 A61F 002/02
OBTECH MEDICAL AG,
SWITZERLAND
WO/2001/047575
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]04[
]04[
]00[
]01[
[57] A food intake restriction apparatus
for an obese patient, comprising: an
operable restriction device (56) adapted to
be implanted in the patient to engage the
stomach (59) or esophagus to form an
upper pouch (60) of the stomach and a
restricted stoma opening in the stomach or
esophagus, an accumulator adapted to be
implanted in the patient for supplying
energy for the operation of said restriction
device to vary the restriction of the stoma
opening, said accumulator being
chargeable from outside the patient's body,
717721
‫מתקן להגבלת צריכת מזון עם מקור‬
‫אנרגיה אלחוטי מבוקר‬
]00[
US
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
a control device (62) operable from outside
the patient's body for controlling said
accumulator to supply energy, a source of
energy (64) external to the patient's body
and capable of releasing wireless energy,
and an implantable energy transfer device
adapted to transfer said wireless energy
into an energy form suited for charging
said accumulator, wherein said control
device is adapted to control said external
source of energy to release said wireless
energy.
_________
715
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
]00[
]04[
]04[
]04[
]00[
]00[
[57]
AMINE DERIVATIVES, THEIR
PREPARATION AND USE AS BAX
MODULATORS
717710
‫ הכנתן והשימוש בהן‬,‫תולדות אמינו‬
BAX ‫כמווסתי‬
13.02.2001
00810128.9
]00[ 15.02.2000
]00[ EP
Int. Cl.8 A61K 031/16, 031/40, 031/425, 031/445, 031/47, A61P 009/00, 025/18,
031/12, 043/00, C07C 237/22, C07D 207/16, 207/48, 211/60, 211/96, C07F 007/08
LABORATOIRES SERONO SA,
SWITZERLAND
SERGE HALAZY, DENIS CHURCH,
MATTHIAS SCHWARZ, BRUNO
ANTONSSON, AGNES BOMBRUN,
JEAN-CLAUDE MARTINOU
WO/2001/060798
Amine derivatives of the formula
and its geometrical isomers, in a optically
active form as enantiomers, diastereomers,
as well as in the form of racemate, as well
as pharmaceutically acceptable salts
thereof, wherein
A1 and A2 are selected independently from
each other from the group consisting ofC(O)-and –SO2-;
Ra is C1-C10 alkyl, Rb is CH3, or
Ra and Rb taken together with the atoms to
which they are attached form a fivemembered saturated ring optically
containing a sulfur atom or a sixmembered saturated ring optionally fused
with an aryl or heteroaryl group; R1 is
either H or C1-C6 alkyl; R2 is –(Rd-X1)m-Re
wherein m is an integer from 0 to 8;
whereby Rd is selected from aryl,
heteroaryl, C1-C18 alkyl, 3-8-membered
cycloalkyl, C2-C18 alkenyl or 3-8membered cycloalkenyl, C2-C18 alkynyl;
April 13, 2008– ‫ח' בניסן התשס"ח‬
X1 is a bond, O, NH, NRg, NRgNg, S,
Si(Rg'Rg), SO, SO2, wherein Rg and Rg' are
independently selected from the group
consisting of substituted or unsubstituted
C1-C6 alkyl, C2-C8 alkynyl, aryl or
heteroaryl;
Re is selected from aryl-C1-C18 alkyl, arylC2-C18 alkenyl, aryl-C2-C18 alkynyl,
heteroaryl- C1-C18 alkyl, heteroaryl-C2-C18
alkenyl, heteroaryl-C2-C18 alkynyl, C1-C18
alkyl, C2-C18 alkenyl, C2-C18 alkynyl,
whereby said C1-C18 alkyl, C2-C18 alkenyl
and C2-C18 alkynyl have a terminal
substituent of the formula –NRR' or –
N+RR'R'' wherein R, R', R'' are H, C1-C6alkyl; or
R1 and R2 together with the N atom to
which they are attached form an
unsubsituted or substituted 4-12 membered
unsaturated or saturated ring containing
one further heteroatom selected from O, N
being optionally substituted by Re, or R1
716
and R2 together with the N atom to which
they are attached form an unsubstituted or
substituted 4-12 membered unsaturated or
saturated ring being substituted by Re, or
by a substituent of the formula –NRR' or –
N+RR'R" wherein R, R', R" are H, C1-C6alkyl;
R0 is a{[({[(methyloxy)
ethyl]oxy}ethyl)oxy]methyl} or Rf-Xx-Rf'
wherein Rf and Rf' are independently from
each other selected from the group
consisting of aryl, heteroaryl, 3-8
membered cycloalkenyl, 3-8-membered
cycloalkyl, C2-C18 alkyl, C2-C18 alkenyl,
C2-C18 alkynyl, aryl- C2-C18 alkyl, aryl- C2C18 alkenyl, aryl- C2-C18 alkynyl,
heteroaryl, C1-C18 alkyl, heteroaryl- C2-C18
alkenyl, heteroaryl- C2-C18 alkynyl;
X2 is a bond or O, S, Si(RgRg), SO, SO2,
wherein Rg and Rg are selected as above
defined.
_________
]44[]04[
]01[
MEDICAL DIAGNOSTIC SYSTEM
]00[
]04[
05.03.2001
60/188115
]00[ 09.03.2000
06904/000
4/16010666
Int. Cl.8 G01N 027/26
CLINICAL ANALYSIS CORP., U.S.A.
WO/2001/067079
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]04[
]04[
]00[
]01[
[57] A system for conducting a plurality
of different medical diagnostic tests, the
system comprising: a hand-held portable,
self-contained electronic instrument (10)
for engaging any one of a plurality of
disposable test cells, each test cell (300)
containing a fluid to be tested, the
instrument for performing a diagnostic test
selected from said plurality of tests upon
the fluid within a selected test cell, the
instrument including a reader (32) which
reads indicia on the selected test cell prior
to engagement of the test cell, the
diagnostic test to be performed being
selected by the instrument based upon
identification information obtained from
the indicia on the selected test cell; and a
plurality of disposable, single use test
cells, each test cell for receiving fluid to be
diagnostically tested, each test cell
717
717911
‫מערכת אבחון רפואית‬
]00[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
including identification information
including indicia indicative of a particular
diagnostic test to be performed upon the
fluid contained therein, the indicia on each
test cell being unique to each medical
diagnostic test which may be performed
and unique with respect to each test cell
which may be used to perform the same
medical diagnostic test so that no two test
cells contain the same indicia, each test
cell being sized and shaped for
engagement by the instrument, the
instrument, upon reading the unique
indicia of a selected test cell comparing the
identification information from the read
indicia to identification information from
indicia read from all previously selected
test cells and proceeding with the selected
diagnostic test only if the selected test cell
has not been previously used.
April 13, 2008– ‫ח' בניסן התשס"ח‬
The applications for division
from this application have
not yet been published
5886568
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
718
]44[]04[
]01[
NEEDLE HOLDER POSITIONING
STRUCTURE FOR SAFETY
HYPODERMIC SYRINGE
]00[
]04[
]04[
]01[
19.09.2002
Int. Cl.8 A61M 005/32
CHANG-PI LO, TAIWAN R.O.C.
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] A needle holder positioning structure
for a safety hypodermic syringe
comprising: a barrel (1), said barrel
comprising a fluid chamber, said fluid
chamber having a front small inner
diameter section, a rear big inner diameter
section, a shoulder connected between said
front small inner diameter section and said
rear big inner diameter section, and an
inside flange means disposed in said rear
big inner diameter section adjacent to said
shoulder; a needle holder (2) mounted in
said barrel, said needle holder comprising
a tubular center base and a sleeve coaxially
formed integral with the periphery of said
tubular center base, said tubular center
base having a retaining portion near a rear
side thereof, said sleeve having a front
engagement section press-fitted into the
inside of the front small inner diameter
section of the fluid chamber of said barrel
and a springy rear expansion section, said
rear expansion section having a front side
edge corresponding to a back side of said
shoulder of said barrel and a rear side edge
stopped at a front side of the inside flange
means of said barrel, said rear expansion
section defining with the periphery of said
tubular center base a backwardly extended
annular coupling chamber; and a locating
ring (3) mounted inside said barrel and
719
717307
‫מבנה מוצב להחזקת מחט עבור בטיחות‬
‫מזרק לזריקה תת–עורית‬
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
coupled to said needle holder, said locating
ring having an outside wall disposed in
contact with an inside wall of the rear big
inner diameter section of said fluid
chamber of said barrel for enabling said
locating ring to be moved axially in said
barrel, an inside wall disposed in contact
with the periphery of said tubular center
base of said needle holder for enabling said
locating ring to be moved axially relative
to said needle holder, the outside wall of
said locating ring having a front section
forming a neck adapted for engaging into
said rear expansion section of said sleeve
of said needle holder, said neck having an
outer diameter not less than the inner
diameter of said expansion section of said
sleeve of said needle holder so as to
expand said rear expansion section of said
sleeve for enabling the rear side edge of
the rear expansion section stopped at the
front side of the inside flange means of
said barrel, a first retaining portion integral
with a front part of the inside wall of said
locating ring and adapted for engaging the
retaining portion of said tubular center
base of said needle holder, and a second
retaining portion formed integral with a
rear part of the inside wall of said locating
ring.
April 13, 2008– ‫ח' בניסן התשס"ח‬
___________
]44[]04[
]01[
CDMA SYSTEM WHICH USES
PRE-ROTATION BEFORE
TRANSMISSION
]00[
]04[
]04[
]04[
28.03.2001
60/192670
]00[ 28.03.2000
Int. Cl.8 H04B 001/707, 007/216
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/073968
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A CDMA communication system for
reducing transmission errors during
communications between at least two
communication units, each communication
unit includes: a receiver for receiving a
CDMA communication signal sent from
another communication unit comprising;
an analyzer for analyzing said received
April 13, 2008– ‫ח' בניסן התשס"ח‬
717421
‫ המשתמשת בקדם–סיבוב‬CDMA ‫מערכת‬
‫לפני העברה‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
signal for errors and for generating a
correction signal; and a correction unit for
correcting said received signal using the
correction signal; a transmitter for
correcting a signal prior to transmission to
another communication unit using said
correction signal.
720
5866858
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
710729
‫תחנת בסיס לתיאום ביצוע בו זמני עבור‬
‫מערכות תקשורת אל–חוטיות‬
]01[
BASE STATION
SYNCHRONIZATION FOR
WIRELESS COMMUNICATION
SYSTEMS
]00[
]04[
05.04.2001
60/195543
]00[ 07.04.2000
]00[ US
069000160
6116010666
US
Int. Cl.8 H04B 001/707, 007/26, H04Q 007/36
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/080461
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] A method for time synchronizing a
plurality of base stations in a wireless
communication system, the method
comprising: determining an estimation of
timing accuracy associated with each base
station; for each base station having its
estimation over a threshold; determining a
neighboring one of the base stations
having its determined estimation indicating
a better timing accuracy than that over
threshold base station; determining an
721
estimated time difference between that
over threshold base station and the
neighboring one base station; adjusting a
timing of that over threshold base station
in response to the estimated time
difference; and updating the estimation of
that over threshold base station wherein
the updated estimation indicates a worse
timing accuracy than the neighboring one
base station.
April 13, 2008– ‫ח' בניסן התשס"ח‬
5866888
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
]01[
PROCESS FOR THE MANUFACTURE
OF ECTEINASCIDIN DERIVATIVES
]00[
]04[
]04[
]04[
]00[
]01[
15.05.2001
PCT/GB00/01852 ]00[ 15.05.2000
Int. Cl.8 C07D 515/22
PHARMA MAR, S.A., SPAIN
WO/2001/087895
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] Process step in the manufacture of an
ecteinascidin compound, wherein the step
comprises deprotecting a compound of
April 13, 2008– ‫ח' בניסן התשס"ח‬
710701
‫תהליך להכנת תולדות אקטינאסידין‬
]00[
WO
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
formula (A) by removing both protecting
groups is a single step, to give an αaminelactone of formula (35), in
722
accordance with the following scheme:
where ProtNH is an amino protecting group,
and ProtOH is a hydroxy protecting group.
__________
]44[]04[
710012
IP ‫פרוטוקול לניתוב לווין עם הפניית‬
‫דינמית‬
]01[
SATELLITE ROUTING
PROTOCOL WITH DYNAMIC IP
ADDRESSING
]00[
]04[
]04[
]04[
]00[
]01[
04.04.2001
60/196054
]00[ 10.04.2000
]00[ US
Int. Cl.8 H04B 007/185, 007/204, H04L 012/56
VIASAT, INC., U.S.A.
WO/2001/078258
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] A method for establishing routing of
communications via a satellite for an IPbased Demand Assigned Multiple Access
(DAMA) Wide Area Netwok (WAN), said
DAMA WAN being characterized by a
bandwidth constricted control channel
under control of a centralized Network
Control Station for communication of
channel allocation and routing information
to each node in said DAMA WAN, said
method comprising: constructing a
723
network map of all directly and indirectly
connected IP network prefixes reachable
via said DAMA WAN; and allocating at
said Network Control Station (NCS),
DAMA WAN type communication
channels via said satellite by a control
channel message over said bandwidth
constricted control channel directed to
each involved subscriber terminal (ST)
node connected to said WAN.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
]01[
USE OF SUBSTITUTED
ACRYLOYL DISTAMYCIN
DERIVATIVES IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF TUMORS
ASSOCIATED WITH HIGH
LEVELS OF GLUTATHIONE
]00[
]04[
]04[
]04[
]00[
]01[
19.04.2001
0011059.3
]00[ 08.05.2000
Int. Cl.8 A61K 031/40, C07D 403/00
PFIZER ITALIA S.R.L., ITALY
WO/2001/085144
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
710233
‫שימוש בנגזרות מותמרות של אקרילאוליל‬
‫דיסטאמיצין בייצור תכשיר רפואי לטיפול‬
‫בגידולים הקשורים עם ריכוז גבוה של‬
‫גלוטאתיון‬
]00[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
[57] Use of an α-halogenoacryloyl
distamycin derivative of the formula
wherein:
R1 is a bromine or chlorine atom; and
R2 is a group of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
724
wherein
m is 0 or 1;
n is 4;
r is 0;
X and Y are both a CH group;
B is selected from the group consisting of
wherein R5, R6 and R7, the same or
different, are hydrogen or C1-C4 alkyl; G is
phenylene, a 5 or 6 membered saturated or
unsaturated heterocyclic ring with from 1
to 3 heteroatoms selected among N, O or
S, or it is a group of the formula
wherein Q is a nitrogen atom or a CH
group and W is an oxygen or sulfur atom
or is a group NR3 wherein R3 is hydrogen
or C1-C4 alkyl; or pharmaceutically
acceptable salt thereof; in the manufacture
of a medicament for the treatment of
tumors in a human being diagnosed with a
tumor over-expressing GSH/GSTs system.
________
]44[]04[
]01[
METHOD AND SYSTEM FOR
INTEGRATED SERVICE FOR
INTELLIGENT TELEPHONE
NETWORKS
]00[
]04[
]04[
]00[
]01[
28.10.2002
Int. Cl.8 H04M 003/42, 007/00
INRA
AVIRAM DAHRI
YORAM ZER,
29 LILIENBLUM ST.,
TEL-AVIV 65133
725
710124
‫שיטה ומערכת לשרותים משולבים ברשת‬
‫טלפונים חכמה‬
‫אי בע"מ‬.‫אר‬.‫אן‬.‫אי‬
‫אבירם דהרי‬
,‫יורם זר עו"ד‬
,06‫לילינבלום‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] A method for mediating between
different (SSP) telephone switching
message protocols and different control
point system (SCP) message protocols,
comprising the steps of: providing an SSP
with a message having a first type of
message protocols; providing an SCP with
a second type of message protocols not
directly communicable with the first type
of message protocols; covering a message
from the SSP to a unified service request
data format using an SSP conversion
module; routing the converted message to
an SCP conversion module; converting the
converted message to the second type of
message protocols using the SCP
conversion module; and routing the
converted message in the second type of
message protocols format to the SCP.
__________
]44[]04[
‫תהליך להכנת פמירולאסט בעל דרגת‬
‫ניקיון גבוהה‬
]01[
PROCESS FOR THE
PREPARATION OF HIGH
PURITY PEMIROLAST
]00[
]04[
]04[
31.10.2002
Int. Cl.8 C07D 471/04
DINAMITE DIPHARMA S.P.A.,
ITALY
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]01[
710117
[57] A process for the purification of
Permirolast comprising:
(a) salifying crude Pemirolast with a
primary or secondary amine in the
presence of solvents selected from water,
C1-C3 alcohols or mixtures thereof;
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
(b) acidifying the solution obtained in (a)
by addition of mineral or organic acids to
pH ranging from 2 to 4;
(c) isolating precipitated Pemirolast and
optionally transforming it into the
corresponding potassium salt.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
726
]44[]04[
]01[
RETROFIT KIT FOR
INTERCONNECT CABLING
SYSTEM
]00[
]04[
]04[
]01[
11.11.2002
Int. Cl.8 H01R 011/00
RIT TECHNOLOGIES LTD.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A system for automatically obtaining
the connectivity status, or map, of a
cabling system in data and/or voice
networks, which includes patch panels
each of which contains sockets, which
sockets are data and/or voice ports to
which one or more patch cords are
connected, and for managing said cabling
system by means of the obtained
connectivity status, or map, said system
comprising patch panels of the existing
cabling system and retrofit kit, said
retrofit kit comprising:
(a) a plurality of upgraded patch cords for
replacement of respective used patch
cords, each of said upgraded patch cords
including one or more internal scanning
wires and one or more electrical scanning
contacts in electrical contact with the
corresponding internal scanning wires, one
or more scanning paths being formed in
each of the upgraded patch cords by means
of said internal scanning wires and one or
more scanning contacts for allowing
scanning signals to be forwarded by a
scanning system (20);
(b) a plurality of adapter panels (51) for
facilitating cabling system management,
each of said adapter panels being attached
to a respective patch panel and including,
for any given socket (38, 39) in the
respective patch panel, a connectivity
.
727
710123
‫ערכת שידרוג למערכת כבלים לקישור הדדי‬
‫ תל אביב‬,‫ריט טכנולוגיות בע"מ‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
status indicator and one or more electrical
contacts, each of said electrical contacts
being intended to mate with a
corresponding electrical scanning contact
of an upgraded patch cord, said scanning
signals being forwarded to said electrical
contacts from said scanning system or
being forwarded to said scanning system
from a respective scanning path, whereby a
scanning signal received by one or more
electrical contacts is processed to generate
data that represents the current
connectivity status, or map, of the cabling
system; and
(c) a plurality of adapted plugs for
initializing the scanning system with a first
connectivity status, or map, one of said
adapter plugs being connected to each end
of a used patch cord and to an adapter
panel, each of said adapter plugs
comprising an adaptation socket, an
adaptation plug, and one or more external
electrical contacts connected to
corresponding conductors associated with
a used patch cord to which the adapter
plug is attached; wherein determination of
which patch cords are to be replaced by
respective upgraded patch cords and,
following completion of the replacement,
management of said cabling system, are
effected in conjunction with said first
connectivity status, or map.
April 13, 2008– ‫ח' בניסן התשס"ח‬
__________
]44[]04[
710414
‫שימוש באוליגודאוקסינוליאוטידים‬
‫הממריצים את המערכת החיסונית להכנת‬
‫תכשיר רוקחי הממריץ את המערכת‬
‫החיסונית‬
]01[
USE OF IMMUNOSTIMULATORY
OLIGODEOXYNUCLEOTIDES
FOR THE PREPARATION OF
IMMUNOSTIMULATORY
PHARMACEUTICAL
COMPOSITIONS
]00[
]04[
07.06.2001
A1000/2000
]00[ 08.06.2000
]00[ AT
A1973/2000
0014410666
AT
Int. Cl.8 A61K 031/12, 039/39, A61P 037/04, C07H 021/00, 021/04, C12N 015/11
INTERCELL AG, AUSTRIA
WO/2001/093905
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Use of an oligodeoxynucleic acid
molecule (ODN) of the formula
any X is O or S,
wherein
any NMP is a 2' deoxynucleoside
monophosphate or monothiophosphate,
selected from the group consisting of
April 13, 2008– ‫ח' בניסן התשס"ח‬
deoxyadenosine-, deoxygunanosine-,
deoxyinosine-, deoxycytosine-,
deoxyuridine-, deoxythymidine-, 2methyl-deoxyinosine-, 5-methyldeoxycytosine-,
728
deoxypseudouridine-, deoxyribosepurine-,
2-amino-deoxyribosepurine-, 6-Sdeoxygunanine-, 2-dimethyldeoxyguanosine- or N-isopentenyldeoxyadenosine-monophosphate or
monothiophosphate, NUC is a 2'
deoxynucleoside, selected from the group
consisting of deoxyadenosine-,
deoxyguanosine-, deoxyinosine-,
deoxycytosine-, deoxyuridine-,
deoxythymidine-, 2-methyl-deoxyinosine-,
5-methyl-deoxycytosine-,
deoxypseudouridine-, deoxyribosepurine-,
2-amino-deoxyribosepurine-, 6-Sdeoxyguanine-, 2-dimethyldeoxyguanosine- or N-isopentenyldeoxyadenosine, a and b are integers from
0 to 100 with the proviso that a + b is
between 4 and 150, B and E are common
groups for 5' or 3' ends of nucleic acid
molecules, for preparing an
immunostimulatory pharmaceutical
composition.
_________
]44[]04[
712040
‫ מערכת ושיטה להיצג אלקטרוני‬,‫התקן‬
‫בצבעים אמיתיים‬
]01[
DEVICE, SYSTEM AND METHOD
FOR ELECTRONIC TRUE COLOR
DISPLAY
]00[
]04[
07.06.2001
60/209771
]00[ 07.06.2000
]00[ US
6/90460/0
4114410666
US
Int. Cl.8 G02B 027/18, G02F 001/13, 001/1335, G03B 021/00, G09F 009/00, H04N
009/31
GENOA COLOR TECHNOLOGIES
‫ הרצליה‬,‫גנואה טכנולוגיות צבע בע"מ‬
LTD.
ILAN BEN-DAVID, MOSHE BEN‫חורין‬-‫ משה בן‬,‫דוד‬-‫אילן בן‬
CHORIN
WO/2001/095544
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]04[
]04[
]00[
]00[
]01[
[57] A method of producing a color
image comprising: projecting
polychromatic light from a light source
onto a first side of a color wheel having at
least four non-white and non-black color
filters; rotating said color wheel such that
the polychromatic light from said light
source is sequentially filtered by
transmission through said at least four
color filters to sequentially produce at a
729
second said of said color wheel, opposite
said first side, light of at least four colors,
each of said at least four colors having a
different chromaticity from the others of
the at least four colors in accordance with
a data signal; and spatially modulating said
light of at least in accordance with a data
signal four colors in accordance with a
data signal to produce said color image.
April 13, 2008– ‫ח' בניסן התשס"ח‬
__________
]44[]04[
]01[
AUTOMATED HORSE TRAINING
SYSTEM
]00[
]04[
01.09.2000
2000/01863
]00[ 22.06.2000
066690000
6016010666
Int. Cl.8 A01K 015/02
MEHMET KURT, TURKEY
WO/2001/097606
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] An automated horse training system,
including: at least one stable (3) with an
associated corridor; a locking arrangement
(15); at least one horse training device (1),
lateral sides and a rear side of the at least
one horse training device being covered by
a flexible material and a front side of the at
least one horse training device being
closed by the locking arrangement; a
tractor actuating the at least one horse
training device, the tractor being arranged
at one of the front side and the rear side of
April 13, 2008– ‫ח' בניסן התשס"ח‬
712212
‫מערכת אוטומטית לאימון סוסים‬
]00[
TR
TR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
the at least one horse training device; one
of a plurality of rails and a line arranged on
a side of the at least one horse training
device for guiding the tractor; and one of
an electrode and veterinarian measurement
arrangement arranged on a body of a horse
for monitoring a physical performance of
the horse by one of remote electronic
signal transmission and remote sensing;
wherein mechanical movements of
components of the horse training system
are performed automatically.
730
___________
]44[]04[
712221
‫מערכת לשידור נתונים בהתאם לשיטת‬
‫דילוג התדרים‬
]01[
SYSTEM FOR DATA
TRANSMISSION ACCORDING TO
THE FREQUENCY HOPPING
METHOD
]00[
]04[
01.06.2001
10029308.5
]00[ 14.06.2000
]00[ DE
4644100110
0016010664
DE
Int. Cl.8 H03M 013/00, 013/23, 013/29, H04B 001/713, H04L 001/00
ROHDE & SCHWARZ GMBH & CO.
KG, GERMANY
WO/2001/097401
EITAN MEHULAL LAW GROUP,
‫ עורכי‬- ‫ מהולל עורכי דין‬- ‫קבוצת איתן‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
‫ הרצליה‬,0/20 .‫ד‬.‫ ת‬, 0/ ‫שדרות אבא אבן‬
HERZLIYA 46120
]04[
]04[
]00[
]01[
[57] System for transmitting data by the
frequency hopping method, in which the
digital data are transmitted in abruptly
changing transmission frequency segments
(hops), wherein the data in the consecutive
frequency segments are encoded according
to a woven code that comprises the
concatenation of an outer and an inner
convolutional code, characterized in that
encoding is performed according to the
731
woven code with outer warp, wherein the
user information items are transmitted in
one of the frequency segments, the test
information items of the other code are
transmitted in another of the frequency
segments and the test information items of
the inner code, together with the user
information items and the test information
items of the outer code, are transmitted in
all the frequency segments.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
712232
‫מערכת חיוב משתמשי אינטרנט‬
]01[
INTERNET USAGE CHARGE
BILLING SYSTEM
]00[
]04[
]04[
]04[
]00[
]01[
28.05.2001
2000-179028 ]00[ 14.06.2000
]00[ JP
Int. Cl.8 G06Q 003/000000 H04L 012/14, 012/46
HIROYUKI WAKAMATSU, JAPAN
WO/2001/097450
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] An Internet usage charge billing
apparatus for passing data passing through
a second provider area when data sent
from a first provider area which is a sender
is sent to a destination of a third provider
area which is different from said second
provider area through said second provider
area which is different from said first
provider area, said system comprising
passing data storing means for storing
sender identifying information or
destination identifying information given
to said passing data, summarizing means
April 13, 2008– ‫ח' בניסן התשס"ח‬
for summarizing information concerning
said passing data for each said sender
identifying information or said destination
identifying information, and billed amount
calculating means for determining a billed
amount for each said sender identifying
information or said destination identifying
information in accordance with a passing
information amount concerning said
passing data summarized for each said
sender identifying information or said
destination identifying information.
732
__________
]44[]04[
712970
‫–ברומו אנילין‬4 ‫שיטה להכנת תולדות‬
]01[
METHOD FOR PRODUCING 4BROMO ANILINE DERIVATIVES
]00[
]04[
]04[
]04[
29.06.2001
10030975.5
]00[ 30.06.2000
]00[ DE
Int. Cl.8 C07C 211/52, 217/58, 255/58, C07D 261/02
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2002/002537
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] Process for preparing 4bromoanilines of the formula
where:
R1 is C1-C6-alkyl, C1-C6-haloalkyl, C1-C6alkoxy, C1-C6-haloalkoxy, C3-C8cycloalkyl, halogen; R2 is C1-C6-alkyl, C1C6-alkoxy, C3-C8-cycloalkyl, C2-C6alkenyl, cyano or a heterocyclic radical
733
selected from saturated, unsaturated or
partially unsaturated heterocycle having 38 ring atoms and one, two or three oxygen,
sulfur or nitrogen atoms;
which comprises reacting a compound of
the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
with a brominating agent in the solvent
pyridine or solvent mixture comprising at
least 55% by weight of pyridine.
_________
]44[]04[
712911
‫פיזורים של פרופופול הניתנים להזרקה‬
]01[
INJECTABLE DISPERSIONS OF
PROPOFOL
]00[
]04[
]04[
]04[
14.06.2001
60/211977
]00[ 16.06.2000
]00[ US
Int. Cl.8 A61K 009/00, 009/10, C07C 039/00
SKYEPHARMA CANADA INC.,
CANADA
AWADHESH K. MISHRA, GARY
PACE, MICHAEL G. VACHON,
ROBERT A. SNOW
WO/2001/097779
JEREMY M. BEN-DAVID & CO.
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
LTD.,
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
HAR HOTZVIM HI-TECH PARK,
‫ירושלים‬
P.O.B. 45087,
JERUSALEM 91450
]00[
]00[
]01[
[57] A sterile, injectable dispersion of
micromatrices or microdroplets having a
mean diameter from about 50 nm to about
1000 nm comprising: propofol in an
amount of from about 1% to about 7.5%
by weight/volume of the dispersion, a
propofol-soluble diluent in an amount of
from about 1% to about 8% by
weight/volume of the dispersion, and a
surface stabilizing amphiphilic agent in an
amount of from about 0.67% to about 5%
by weight/volume of the dispersion,
suspended in an aqueous medium
containing a synergetic quantity of
antimicrobial agent and a tonicity
modifying amount of a pharmaceutically
acceptable water-soluble hydroxyl-groupcontaining excipient, wherein the ratio of
propofol to diluent is in the range of about
0.25 to about 7.5 and the ratio of propofol
to amphiphilic agent is in the range from
about 0.4 to about 1.5.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
734
]44[]04[
]01[
SYSTEM FOR CONTROL OF
IMAGE INTENSIFIER
]00[
]04[
]04[
]00[
16.12.2002
Int. Cl.8 H01J 040/14, H04N 005/238
ELBIT SYSTEMS LTD.
OFER DAVID, YEHUDA
BORENSTEIN
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]01[
[57] A system for handling light that is
amenable for intensification by an image
intensifier (20), and wherein the system
includes – a light regulator (30) adapted to
regulate light intensity, wherein said light
regulator is either positioned externally to
said image intensifier at a focal plane of
the light to be intensified, or placed
internally at a focal plane of said image
intensifier before the photo sensitive area
of said image intensifier; and a circuit
comprising an image sensor (80), wherein
712930
‫מערכת לבקרת מגבר דמות‬
‫ חיפה‬,‫אלביט מערכות בע"מ‬
‫ יהודה בורנשטיין‬,‫עופר דוד‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
said image sensor is capable of detecting
zones of intensely bright light areas in an
acquired image and said circuit is coupled
to an image processor (90) that relates the
locations of said zones with the respective
areas on said light regulator, in a manner
enabling operation of said respective areas
on said light regulator, so that image
received from said image intensifier is
influenced; and wherein said system is
characterized by said light regulator being
a transmissive MEMS component.
_________
]44[]04[
735
712122
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מכשיר קידוח‬
]01[
DRILLING TOOL
]00[
]04[
]04[
]04[
16.06.2001
10030297.1
]00[ 27.06.2000
Int. Cl.8 B23B 051/02
KOMET GROUP HOLDING GMBH,
GERMANY
WO/2002/000381
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]01[
[57] A drilling tool comprising a base
body (14), which can be rotated about a
drilling axis (36), comprising at least two
plate seats (16) arranged on the front face
in the base body, and comprising cutting
plates (20), which can be interchangeably
inserted into the plate seats, and are
preferably identical, and which cutting
plates each have a machining face (30) and
clearance face (24) adjoining a principal
cutting edge (28); a seat face (26) facing
away from the clearance face, and a
guiding land (34) adjoining radially on the
outside through each edge the machining
]00[
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
face, the clearance face and optionally the
seat face, and a hole (48) which extends
through the clearance face and the seat
face for a retaining screw which can be
screwed into a threaded bore (50) open to
the front face of the base body in the area
of the plate seats, characterised in that the
holes with their axis are aligned
perpendicularly to the clearance face of the
associated cutting plates, and that the axes
of the threaded bores are aligned inclined
with respect to the drilling axis and
inclined to each other in the base body.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
712140
736
‫תכשיר רוקחות המכיל קטוקונאזול‬
]01[
PHARMACEUTICAL
COMPOSITION CONTAINING
KETOCONAZOLE
]00[
]04[
]04[
]04[
14.08.2001
0020486.7
]00[ 18.08.2000
]00[ GB
Int. Cl.8 A61K 047/10, A61P 017/08, C07D 405/00, 405/12
DIOMED DEVELOPMENTS LTD.,
UNITED KINGDOM
WO/2002/015936
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]01[
[57] A pharmaceutical composition
suitable for topical application comprising
ketoconazole in a true solution which
comprises:
(i) 13 to 50 wt% water;
(ii) 45 to 85 wt% of an alcohol having a
boiling point of less than 100oC;
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
and
(iii) 2 to 30 wt% of a non-volatile, water
miscible, non-ionic surface active agent;
the ketoconazole being present in an
amount of 1.5 to 2.5 wt%, based on the
total amount of components (i), (ii) and
(iii).
_________
]44[]04[
712149
‫תולדות אמינו כוהל ותכשירי רוקחות‬
‫המכילים אותן‬
]01[
AMINO ALCOHOL DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]00[
]04[
10.07.2001
2000-212246 ]00[ 13.07.2000
]00[ JP
0666-014011
6/16010666
JP
0666-000040
4/16/10666
JP
Int. Cl.7 A61K 031/381, A61P 037/06, C07C 271/16, C07D 333/20, 333/22, 333/32,
409/06, 413/06, C12P 013/00
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WO/2002/006268
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]04[
]04[
]00[
]01[
[57] A compound or a pharmacologically
acceptable salt, ester or other derivative
thereof, of the formula
737
April 13, 2008– ‫ח' בניסן התשס"ח‬
wherein:
R1 and R2 are the same or different and
each represents a hydrogen atom or an
amino protecting group;
R3 represents a hydrogen atom or a
hydroxy protecting group;
R4 represents a lower alkyl group;
n represents an integer from 1 to 6;
X represents an ethylene group, a vinylene
group, an ethynylene group, a group of
formula-D-CH2-(wherein D represents a
carbonyl group, a group of formula
–CH(OH)-, an oxygen atom, a sulfur atom,
or a nitrogen atom), an aryl group, or an
aryl group substituted with 1 to 3
substituents selected from substituent
group a;
Y represent a single bond, a C1-C10
alkylene group, a C1-C10 alkylene group
substituted with 1 to 3 substituents selected
from substituent groups a and b, a C1-C10
alkylene group which has an oxygen atom
or a sulfur atom in said carbon chain or at
the end of said carbon chain, or a C1-C10
alkylene group which is substituted with 1
to 3 substituents selected from substituent
group a and b and has an oxygen atom or
sulfur atom in said carbon chain or at the
end of said carbon chain;
R5 represents a hydrogen atom, a
cycloalkyl group, an aryl group, a
heterocyclic group, a cycloalkyl group
The applications for division
from this application have
not yet been published
substituted with 1 to 3 substituents selected
from substituent groups a and b, an aryl
group substituted with 1 to 3 substituents
selected from substituent groups a and b,
or a heterocyclic group substituted with 1
to 3 substituents selected from substituent
groups a and b;
R6 and R7 are the same or different and
each represents a hydrogen atom or a
group selected from substituent group a;
with the proviso that when R5 is a
hydrogen atom, Y is not a single bond or a
straight chain C1-C10 alkylene group;
substituent group a consists of a halogen
atom, a lower alkyl group, a halogenated
lower alkyl group, a lower alkoxy group, a
lower alkylthio group, a carboxyl group, a
lower alkoxycarbonyl group, a hydroxyl
group, a lower aliphatic acyl group, an
amino group, a mono lower alkylamino
group, a di lower alkylamino group, a
lower aliphatic acylamino group, a cyano
group, and a nitro group; substituent group
b consists of a cycloalkyl group, an aryl
group, a heterocyclic group, a cycloalkyl
group substituted with 1 to 3 substituents
selected from substituent group a, an aryl
group substituted with 1 to 30 substituents
selected from substituent group a, and a
heterocyclic group substituted with 1 to 3
substituents selected from substituent
group a.
5884994
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
738
]44[]04[
]01[
METHOD AND DEVICE FOR
DISPERSING SUBMUNITIONS
]00[
]04[
]04[
]04[
20.06.2001
0002495-0
]00[ 03.07.2000
Int. Cl.8 F42B 012/58
BAE SYSTEMS BOFORS AB,
SWEDEN
TORSTEN RONN, JAN AXINGER
WO/2002/003013
PEARL COHEN ZEDEK LATZER,
5 SHENKAR STREET,
P.O.B. 12704
HERZLIYA 46733
]00[
]00[
]01[
[57] A method of firing submunitions,
comprising: providing an airborne carrier
(1) having a magazine (4) rotatably
mounted with respect to a front section of
a missile, the magazine housing a plurality
of submunitions; activating a gas generator
712207
‫שיטה והתקן לפיזור תת תחמושות‬
]00[
SE
,‫פרל כהן צדק לצר‬
,007/4 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
(6), wherein gases from the gas generator
cause the magazine to rotate; rotating the
magazine relative to the front section of
the airborne carrier to exert centrifugal
forces on the submunitions; and allowing
the submunitions to leave the magazine.
___________
739
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
712119
‫נגזרות פירימידין‬
]01[
PYRIMIDINE DERIVATIVES
]00[
]04[
]04[
]04[
]00[
]01[
06.07.2001
0016877.3
]00[ 11.07.2000
]00[ GB
Int. Cl.8 A61K 031/505, A61P 035/00, C07D 239/48, 401/12, 403/04, 403/12
ASTRAZENECA AB, SWEDEN
WO/2002/004429
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
[57] A compound of the formula
wherein:
R1 is halo, nitro, cyano, hydroxy, amino,
carboxy, carbamoyl, mercapto, C1-6 alkyl,
C2-6 alkenyl or C2-6 alkenyl or C2-6 alkynyl;
p is 0-4; wherein the values of R1 may be
the same or different;
R2 is sulphamoyl or a group B-E-;
q is 0-2; wherein the values of R2 may be
the same or different; and wherein p+q= 15; R3 is hydrogen, C1-6 alkyl, C1-6 alkyl, C26 alkenyl, C2-6 alkynyl or C3-8 cycloalkyl;
wherein R3 may be optionally substituted
on carbon by one or more M;
R4 is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl,
C3-8 cycloalkyl or heterocyclyl; wherein R4
may be optionally substituted by one or
more M; wherein if said heterocyclyl
contains an –NH- moiety that nitrogen
may be optionally substituted by a group
selected from Z; or R3 and R4 together
with the nitrogen to which they are
attached form a heterocyclic ring
optionally substituted on carbon by one or
more M; wherein if said heterocyclic ring
April 13, 2008– ‫ח' בניסן התשס"ח‬
contains an –NH-moiety that nitrogen may
be optionally substituted by a group
selected from Q; B is selected from C1-6
alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8
cycloalkyl, C3-8 cycloalkyl C1-6 alkyl,
phenyl, a heterocyclic group, phenyl C1-6
alkyl or (heterocyclic group) C1-6 alkyl;
wherein B may be optionally substituted
on carbon by one or more D; and wherein
if said heterocyclic group contains an
–NH-moiety that nitrogen may be
optionally substituted by a group selected
from G;
E is –C(O)-, -N(Ra)C(O)-, -C(O)N(Ra)-, S(O)r-, -SO2N(Ra)- or –N(Ra)SO2-;
wherein Ra is hydrogen or C1-6 alkyl
optionally substituted by one or more D
and r is 1-2;
D is independently selected from halo,
nitro, cyano, hydroxy, trifluoromethyl,
trifluoromethoxy, amino, carboxy,
carbamoyl, mercapto, sulphamoyl, C1-6
alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6
alkoxy, C1-6 alkanoyl, C1-6 alkanoyloxy, N-
740
(C1-6 alkyl) amino, N,N-(C1-6 alkyl)2
amino, C1-6 alkanoylamino, N-(C1-6 alkyl)
carbamoyl, N-N(C1-6 alkyl)2 carbamoyl,
C1-6 alkylS(O)a wherein a is 0 to 2, C1-6
alkoxycarbonyl, N-(C1-6 alkyl) sulphamoyl
and N, N-(C1-6 alkyl)2 sulphamoyl;
wherein D may be optionally substituted
on carbon by one or more V;
M is independently selected from halo,
nitro, cyano, hydroxy, trifluoromethoxy,
amino, carboxy, carbamoyl, mercapto,
sulphamoyl, C1-6 alkyl, C2-6 alkenyl, C2-6
alkynyl, C1-6 alkoxy, C1-6 alkanoyl, C1-6
alkanoyloxy, N-(C1-6 alkyl) amino, N,N(C1-6 alkyl)2 amino, C1-6 alkanoylamino, N(C1-6 alkyl) carbamoyl, N,N-(C1-6 alkyl)2
carbamoyl, C1-6 alkylS(O)a wherein a is 0
to 2, C1-6 alkoxycarbonyl, N-(C1-6 alkyl)
sulphamoyl, N,N-(C1-6 alkyl)2 sulphamoyl,
C3-8 cycloalkyl, phenyl or a heterocyclic
group; wherein M may be optionally
substituted on carbon by one or more P;
and wherein if said heterocyclic group
contains an –NH- moiety that nitrogen
may be optionally substituted by a group
selected from T; P, X and V are
independently selected from halo, cyano,
hydroxy, trifluoromethoxy,
trifluoromethyl, amino, carboxy,
carbamoyl, mercapto, sulphamoyl, methyl,
ethyl, methoxy, ethoxy, acetyl, acetoxy,
methylamino, ethylamino, dimethylamino,
diethylamino, N-methyl-N-ethylamino,
acetylamino, N-methylcarbamoyl, Nethylcarbamoyl, N,N-dimethylcarbamoyl,
N,N-diethylcarbamoyl, N-methyl-Nethylcarbamoyl, methylthio, ethylthio,
methylsulphinyl, ethylsulphinyl, mesyl,
ethylsulphonyl, methoxycarbonyl,
ethoxycarbonyl, N-methylsulphamoyl, Nethylsulphamoyl, N,Ndimethylsulphamoyl, N,Ndiethylsulphamoyl or N-methyl-Nethylsulphamoyl; and
G, Q, T and Z are independently selected
from C1-4 alkyl, C1-4 alkanoyl, C1-4
alkylsulphonyl, C1-4 alkoycarbonyl, carbamoyl, N-(C1-4 alkyl) carbamoyl, N,N-(C1-4
alkyl) carbamoyl, benzyl,
benzyloxycarbonyl, benzoyl and
phenylsulphonyl wherein G, Q and T may
be independently optionally substituted on
carbon by one or more X; or a
pharmaceutically acceptable salt or an in
vivo hydrolysable ester thereof.
_________
]44[]04[
712111
‫מכשיר ושיטה למתן שירותי מחשב‬
]01[
METHOD AND APPARATUS FOR
PROVIDING COMPUTER
SERVICES
]00[
]04[
]04[
]04[
03.07.2001
60/216347
]00[ 05.07.2000
]00[ US
Int. Cl.8 G06F 002/120000 009/46, 009/50, 015/00
ERNST & YOUNG LLP, UNITED
KINGDOM
WO/2002/003220
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]00[
]01[
741
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] Apparatus comprising a real
computer (30) on which is set up plural
virtual machines (VS), each virtual
machine having an operating system
running thereon; characterised by: the
apparatus providing one or more computer
services for a plurality of customers (A, B,
C); and by: there being at least one virtual
machine for each of said customers that is
set up at the request of each of said
customers and that has a specification
specified by and configurable by the
respective customer.
_________
]44[]04[
]01[
CYCLIC SUBSTITUTED
AMINOMETHYL COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS AND METHODS
FOR THEIR PREPARATION
]00[
]04[
]04[
]04[
]00[
]01[
06.07.2001
10033459.8
]00[ 10.07.2000
Int. Cl.8 C07C 211/00
GRUNENTHAL GMBH, GERMANY
WO/2002/008218
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
712301
‫תרכובות אמינומתיל מותמרות ותכשירי‬
‫רוקחות המכילים אותן‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
[57] Analgesic cyclic substituted
aminomethyl compounds of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
742
wherein
R1 denotes H, F, Cl, OH, O-CH3, O-(C2-6alkyl), O-(C3-7-cycloalkyl), CH3, C2-6alkyl, CH2F, CHF2 or CF3, in each case in
the 2-, 3-, 4-, 5- or 6-position of the phenyl
ring,
R2 denotes H, F, Cl, CH3, C2-6-alkyl,
CH2F, CHF2 or CF3, in each case in the 2-,
3-, 4-, 5- or 6-position of the phenyl ring,
R3 and R4 independently of one another
denote H, F, Cl, OH, O-CH3, O-(C2-6alkyl), O-(C3-7-cycloalkyl), CH3, C2-6alkyl, CH2F, CF3, O-aryl, aryl or
heterocyclyl, in each case in the α-, β-, γ-
and/or δ-position of the aromatic ring, R5
and R6 independently of one another
denote CH3, C2-6-alkyl, C3-7-cycloalkyl,
CH2-(C3-7-cycloalkyl), aryl, (C1-6-alkyl) –
aryl, heterocyclyl or (C1-6-alkyl)heterocyclyl,
X denotes CH2, O, S, SO or SO2,
n is 0, 1, 2 or 3 if X denotes CH2 and is 1,
2 or 3 if X denotes O, S, SO or SO2, and
the configuration of the exocyclic double
bond in compounds of the general formula
IB is E or Z, and their pharmaceutically
acceptable salts.
_________
]44[]04[
712323
‫חומר תרופתי של אריפיפראזול בעל יכולת‬
‫נמוכה לספיגת לחות ותהליכים להכנתו‬
]01[
LOW HYGROSCOPICITY
ARIPIPRAZOLE DRUG
SUBSTANCE AND PROCESSES
FOR THE PREPARATION
THEREOF
]00[
]04[
25.09.2002
2001-290645 ]00[ 25.09.2001
]00[ JP
0664-010000
4114410664
JP
000/660
0016010660
CA
Int. Cl.8 A61K 031/496, A61P 025/18, C07D 213/00
OTSUKA PHARMACEUTICAL CO,
LTD, JAPAN
WO/2003/026659
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Hydrate A of aripiprazole wherein
said hydrate has a powder x-ray diffraction
spectrum which is substantially the same
743
as the following powder x-ray diffraction
spectrum shown in Figure 3 as given in the
specification; particular infrared absorption
April 13, 2008– ‫ח' בניסן התשס"ח‬
maintained at a temperature of 60oC and a
humidity level of 100%, a powder X-ray
diffraction spectrum which is substantially
the same as the following powder X-ray
diffraction spectrum shown in Figure 5, as
shown in the specification and particular
infrared absorption bands at 2945, 2812,
1678, 1627, 1448, 1377, 1173, 960 and
779 cm-1 on the IR (KBr) spectrum; and
exhibiting an endothermic peak near about
141.5oC in thermogravimetric/differential
thermal analysis (heating rate 5oC/min)
and an endothermic peak near about
140.7oC in differential scanning
calorimetry (heating rate 5 oC/min).
bands at 2951, 2822, 1692, 1577, 1447,
1378, 1187, 963 and 784 cm-1 on the
IR(KBr) spectrum;
an endothermic curve which is
substantially the same as the
thermogravimetric/differential thermal
analysis (heating rate 5oC/min)
endothermic curve shown in Figure 1 as
given in the speficiation; and a mean
particle size of 50 µm or less.
Anhydrous aripiprazole crystals B having
low hygroscopicity wherein said low
hygroscopicity is a moisture content of
0.40% or less after placing said drug
substance for 24 hours in a desiccator
5866455
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
__________
]44[]04[
]01[
METHOD FOR PURIFYING 2CHLORO-5-CHLOROMETHYL
THIAZOLE
]00[
]04[
]04[
]04[
30.07.2001
10038977.5
]00[ 10.08.2000
Int. Cl.8 C07D 277/32
BAYER CROPSCIENCE AG,
GERMANY
WO/2002/012209
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] Process for purifying 2-chloro-5chloromethyl-thiazole, characterized in
that crude material of the compound is
719292
‫–כלורומתיל‬.–‫–כלורו‬0 ‫תהליך לטיהור‬
‫תיאזול‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
distilled under reduced pressure in the
presence of a polyether.
___________
April 13, 2008– ‫ח' בניסן התשס"ח‬
744
]44[]04[
‫שיטה לכיפוף מדוייק של יריעת חומר‬
‫וחומר מחורץ לשם כך‬
]01[
METHOD FOR PRECISION
BENDING OF A SHEET OF
MATERIAL AND SLIT SHEET
THEREFOR
]00[
]04[
]04[
]04[
16.08.2001
09/640267
]00[ 17.08.2000
Int. Cl.8 B21D 028/26
INDUSTRIAL ORIGAMI, INC.,
U.S.A.
WO/2002/013991
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method for precision bending of a
sheet of material along a bend line
comprising the steps of: selecting a solid
sheet of elastically and plastically
deformable material; forming a plurality of
longitudinally extending closed-ended slits
through said sheet of material in axially
spaced relation in a direction extending
along and proximate said bend line to
define at least one bending web between
adjacent ends of at least one pair of said
slits; forming a stress reducing structure at
The applications for division
from this application have
not yet been published
719922
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
each end of said pair of slits, said structure
being formed on said bend line and
connected to said slits; bending of said
sheet of material substantially along said
bend line and across said bending web
between said openings; and during said
bending step, elastically and then
plastically deforming said sheet at said
web by interengagement of solid edges of
said sheet of material on opposite sides of
said slits.
5864868
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
745
719197
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫נוגדנים או מקטעים מהם הקושרים‬
‫פוליפפטידים הממריצים את גידולם של‬
‫תאי עצב‬
]01[
ANTIBODY OR FRAGMENTS
THEREOF THAT BIND
POLYPEPTIDES STIMULATING
NEURONAL GROWTH
]00[
]04[
02.02.1998
09/792019
]00[ 03.02.1997
]00[ US
6/9640001
0616414//0
US
Int. Cl.8 C07K 014/475, 016/22, C12N 015/18
DIVISION FROM 131103
AMGEN, INC., U.S.A.
WO/1998/033922
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]04[
]00[
]04[
]00[
]01[
[57] An isolated and purified antibody or
fragment thereof which specifically binds
to a polypeptide that has a biological
activity of stimulating growth of motor or
sympathetic neurons, said polypeptide
selected from the group consisting of:
(a) the polypeptide of SEQ ID NO:2;
(b) the polypeptide that is amino acid 1198 of SEQ ID NO:2;
(c) the polypeptide that is at least 70%
identical to the polypeptide of (a) or (b);
and
(d) a fragment of any of (a)-(c) which has
said biological activity.
__________
]44[]04[
]01[
NUCLEIC ACIDS ENCODING
POLYPEPTIDES THAT
STIMULATE NEURONAL
GROWTH
]00[
]04[
02.02.1998
09/792019
]00[ 03.02.1997
6/9640001
0616414//0
Int. Cl.8 C12N 015/12, 015/18
DIVISION FROM 131103
AMGEN, INC., U.S.A.
WO/1998/033922
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]04[
]00[
]04[
]00[
]01[
[57] An isolated nucleic acid molecule
encoding a polypeptide which polypeptide
has a biological activity of stimulating
growth of motor or sympathetic neurons,
selected from the group consisting of:
April 13, 2008– ‫ח' בניסן התשס"ח‬
719190
‫חומצות גרעין המקודדים לפוליפפטידים‬
‫הממריצים את גידולם של תאי עצב‬
]00[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(a) the nucleic acid molecule of SEQ ID
NO:1;
(b) the nucleic acid molecule of SEQ ID
NO:3;
(c) a nucleic acid molecule encoding a
746
polypeptide consisting of amino acids 27
through 198 or 1 through 198 or 1 through
198 of SEQ ID NO:2;
(d) a nucleic acid molecule that encodes a
polypeptide that is at least 70 percent
identical to a polypeptide of (c) above; and
(e) a nucleic acid molecule that encodes a
fragment of a polypeptide of (c) or (d)
above, which polypeptide fragment has
said biological activity.
_________
]44[]04[
]01[
ARRANGEMENT FOR THE
CONTINUOUS PRODUCTION OF
A FILAMENT NONWOVEN
FIBROUS WEB
]00[
]04[
]04[
]04[
26.02.2003
02004615.7
]00[ 28.02.2002
Int. Cl.8 D04H 003/14
REIFENHAUSER GMBH & CO.
MASCHINENFABRIK, GERMANY
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]01[
[57] An apparatus for producing a
nonwoven fibrous web comprising a
spinneret (1) for producing a descending
curtain of thermoplastic synthetic resin
filaments; a cooling chamber (2) below
said spinneret and forming a passage (3)
receiving said descending curtain of
thermoplastic synthetic resin filaments; a
stretching unit (4) below said passage and
connected thereto to exclude entry of
external air for aerodynamically stretching
said filaments as said filaments pass
downwardly from said passage through
said stretching unit, said stretching unit
having a draft channel (5) at a bottom
thereof; an air supply chamber adjacent
747
719227
‫סידור לייצור רציף של רשת לא–ארוגה‬
‫של סיבים‬
]00[
EP
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
said cooling chamber and communicating
with said passage through openings in
walls of cooling chamber for introducing
process air into said passage, cooling said
filaments and passing with said filaments
into said stretching unit, said air supply
chamber being subdivided into a first
chamber section (8a) and a second
chamber section (8b) in a direction of
travel of said filaments provided with
means for introducing air of different
temperatures into said passage; and a
collecting device (7) below said stretching
unit for collecting aerodynamically
stretched filaments in the form of a
continuous web.
April 13, 2008– ‫ח' בניסן התשס"ח‬
__________
]44[]04[
]01[
TRAFFIC MANAGEMENT IN
OPTICAL COMMUNICATION
NETWORKS
]00[
]04[
]04[
]00[
27.02.2003
Int. Cl.8 H04B 010/18
ECI TELECOM LTD.
URI MAHLAB, MICHAEL GUTIN,
BORIS MALMED
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
]01[
[57] A method of traffic management in
an optical network, comprising detecting a
condition of non-linearity in a network
section corresponding to an optical path
extending in said network by measuring
chirp of an optical signal passing in the
network section, comprising a value of the
measured chirp with at least one chirp
April 13, 2008– ‫ח' בניסן התשס"ח‬
719291
‫ניהול תעבורה במערכות תקשורת אופטיות‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫איי‬.‫סי‬.‫אי‬
‫ בוריס מלמד‬,‫ מיכאל גוטין‬,‫אורי מחלב‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
‫ פתח תקוה‬,:/‫רחוב הסיבים‬
threshold value preliminarily known for
said network section when being in its
linear condition, and in case the condition
of non-linearity is detected in said network
section, making a traffic management
decision in said optical network for
restricting or avoiding use of said network
section in the network.
748
_________
]44[]04[
719342
,‫תרכובות אליפטיות צקליות המכילים חנקן‬
‫תהליכים להכנתן ותכשירי רוקחות‬
‫המכילים אותן‬
]01[
ALIPHATIC NITROGENCONTAINING CYCLIC
COMPOUNDS, METHODS FOR
THE PREPARATION THEREOF
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]00[
]04[
05.10.2001
2000-308528 ]00[ 06.10.2000
]00[ JP
0666-040000
4014610666
JP
0664-6//004
0616010664
JP
Int. Cl.8 A61K 031/395, A61P 003/10, 043/00, C07D 207/16, 277/06, 401/12,
401/14, 403/12, 403/14, 405/12, 405/14, 409/12, 409/14, 413/12, 413/14, 417/12,
417/14, 471/04, 491/048, 495/04
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
WO/2002/030891
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]04[
]04[
]00[
]01[
[57] An aliphatic nitrogen-containing 5membered ring compound of the formula
749
April 13, 2008– ‫ח' בניסן התשס"ח‬
wherein
A represents –CH2–or –S--,
R1 represents hydrogen atom, a lower alkyl
group, a hydroxy lower alkyl group or a
lower alkoxy lower alkyl group, and R2
represents (1) a cyclic group which may be
substituted, where the cyclic group portion
is (i) a monocyclic, bicyclic or tricyclic
hydrocarbon group, or (ii) a monocyclic,
bicyclic or tricyclic heterocyclic group, or
(2) an amino group which may be
substituted, or a pharmaceutically
acceptable salt thereof.
_________
]44[]04[
711227
‫מנגנון אירועים לניהול ממשק משתמש‬
‫לקוח שרת‬
]01[
CLIENT SERVER USER
INTERFACE EVENTS
MECHANISM
]00[
]04[
19.03.2003
60/415338
]00[ 30.09.2002
]00[ US
469000/14
4116010660
US
Int. Cl.8 G06F 003/14, 009/44, 009/46, 009/54
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]01[
[57] An event mechanism within a clientserver environment for keeping a client
notified of changes in the user interface,
the event mechanism comprising: a logical
tree generation component for generating a
logical tree representing a graphical user
interface provided by an application, said
logical tree generation component residing
on the client and being configured to
utilize an application programming
interface (API) on the client to gather
information from said application defining
said graphical user interface and being
further configured to filter said information
to select one or more visual interface
April 13, 2008– ‫ח' בניסן התשס"ח‬
elements as interesting user interface
information, wherein said logical tree
representing said graphical user interface is
constructed from said interesting user
interface information; a registration
mechanism for allowing the client to
register to receive said interesting user
interface information; a user interface
automation client for receiving registration
information from the client and for
conveying the interface information to the
client upon receipt, wherein the user
interface automation client uses the
registration information to advise a user
interface server;
750
a user interface automation server for
receiving registration information from the
user interface information from a user
interface engine, the user interface
automation server including a filtering
device for filtering out information that is
uninteresting to the client and a
notification device for notifying the user
interface automation client of said
interesting user interface information; and
an assistive technology (AT) product
configured to use said logical tree to
generate a non-graphical representation of
said graphical user interface and being
further configured to convey said nongraphical representation to a user.
_________
]44[]04[
]01[
METHOD FOR THERMAL PEST
CONTROL
]00[
]04[
]04[
]04[
]01[
27.03.2003
132693
]00[ 26.04.2002
Int. Cl.8 A01G 013/00
FLORENCIO LAZO BARRA, CHILE
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
751
711702
‫שיטה לבקרה חומנית על מזיקים‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
[57] A method for thermal pest control in
agriculture and fruit production which
comprising projecting at least one stream
of hot air which exits at a temperature
between approximately 65oC and 250oC
directly at a crop and at a minimum
distance of about 0.20 m from the crop
from a vehicle which moves in a direction
substantially parallel to rows of the crop so
as to provide sufficient transference of heat
to produce the thermal pest control without
damaging the crop, wherein said at least
one stream of hot air is projected at a speed
between approximately 80 and 250 km per
hour.
_________
]44[]04[
711222
‫שימוש בחומצה זולדרונית או מלחי רוקחות‬
‫או הידרטים שלה בהכנת תרופות לטיפול‬
‫בכאב‬
]01[
USE OF ZOLEDRONIC ACID OR
PHARMACEUTICALLY
ACCEPTABLE SALTS OR
HYDRATES THEREOF IN THE
PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF PAIN
]00[
]04[
]04[
]04[
]00[
]01[
27.11.2001
0029111.2
]00[ 29.11.2000
]00[ GB
Int. Cl.8 A61K 031/66, A61P 019/00, 019/08, 019/10, 029/00, C07F 009/00, 009/38
NOVARTIS AG, SWITZERLAND
WO/2002/043738
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] Use of zoledronic acid or a
pharmaceutically acceptable salt thereof,
or any hydrate thereof, in the preparation
of a medicament for the treatment of pain
wherein the medicament is to be
administered once every six months.
__________
April 13, 2008– ‫ח' בניסן התשס"ח‬
752
]44[]04[
]01[
METHOD OF MANUFACTURING
AN INTEGRATED CIRCUIT
CARRIER
]00[
]04[
]04[
]04[
19.10.2001
09/693484
]00[ 20.10.2000
Int. Cl.8 H05K 003/02
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/034019
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] A method of manufacturing an
integrated circuit carrier, the method
including the steps of: providing a
substrate; demarcating at least one
receiving zone for receiving an integrated
circuit or chip on the substrate, the
integrated circuit electrically associating
with a plurality of electrical contacts
within the at least one receiving zone, and
a plurality of island-defining portions
arranged about said at least one receiving
711922
‫שיטה לייצור מצע למעגל משולב‬
]00[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
zone; forming an electrical terminal on
island-defining portions, each electrical
terminal being electrically connected to
one or more of the plurality of electrical
contacts within the at least one receiving
zone; and creating one or more serpentine
members between neighboring islanddefining portions by removing material
from the substrate, thereby reducing
thermal strains involving the said islanddefining portions.
__________
]44[]04[
]01[
CELL UNION ASSEMBLY FOR
ELECTRIC SWITCHGEAR
]00[
]04[
]04[
]04[
]00[
]01[
24.10.2000
155564
]00[ 24.10.2000
Int. Cl.8 H01R 013/64
ORMAZABAL Y CIA., S.A., SPAIN
WO/2002/035668
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] An interconnection assembly for
electrical switchgear cells, applicable to
modular cells that incorporate parts of
operation and protection equipment of
753
711129
‫הרכבה חיבור תא למתג הילוכים‬
]00[
WO
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
electrical distribution and transformation
stations, comprising an independent
connector element housed in each pan,
previously coupled to the cells, in
April 13, 2008– ‫ח' בניסן התשס"ח‬
correspondence with conductor terminals
to be joined and permitting offsetting of
misalignments between conductor
terminals, the pans permitting an
attachable cap when an electrical
connection is not required, an electrical
isolation of the terminal situated in a
bottom of the cap itself being formed,
providing a leakproof coupling both
mechanically and electrically, of the
independent connector element to the
conductive terminal of the pan, the
independent connector element
comprising: an external mount (1) of
elastic material provided internally and
partially on the outside with a
semiconductor to assure good control of
the electric field; a pair of metallic tubes
(2) of a total length less than of the
external elastic mount, arranged internally
in the mount and approximately in
correspondence with its outermost sectors,
in order to leave a central zone of the
external and elastic mount free; a metallic
ring (3) and conductor housed directly in
an interior of the elastic mount; and a
bundle of conductive parts (5) mounted
axially in respective passages provided
radially in the metallic ring, the conductive
ring being in correspondence with the
central zone, intercalated between facing
ends of the metallic tubes, and fitting
tightly between the ring and the mount, the
conductive parts being spaced sufficiently
from the metallic tubes to permit a degree
of swiveling of the bundle formed by those
conductive parts in order to offset possible
misalignments between the conductive
terminals to be connected.
__________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
711130
754
‫מקודד טורבו יעיל מבחינת שטח‬
]01[
SPACE-EFFICIENT TURBO
DECODER
]00[
]04[
]04[
]04[
25.10.2001
09/699252
]00[ 27.10.2000
Int. Cl.8 H03M 013/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/069503
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] A turbo decoding circuit having a
first and a second operational mode of
operation, comprising:
(a) a first functional loop for use in the first
operational mode, the first loop including:
(1) a write interleaver (78) having an input
and an output;
(2) a dual port extrinsic memory (110)
having an input and an output, the input
being coupled to the write interleaver
output;
(3) a read interleaver (106) having an input
and an output, the input being coupled to
the output of the dual port extrinsic
memory;
(4) a buffer circuit (74) having an input
and an output, the input of the buffer being
coupled to the output of the read
interleaver; and
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(5) a log-MAP decoder (76) having an
input and an output, the input being
coupled to the output of the buffer and the
output of the log-MAP decoder being
coupled to the write interleaver; and
(b) a second functional loop for use in the
second operational mode, the second loop
including:
(1) the dual port extrinsic memory;
(2) the buffer circuit, the input of the
buffer circuit being coupled to the output
of the dual port extrinsic memory; and
(3) the log-MAP decoder, the input of the
log-MAP decoder being coupled to the
output of the buffer circuit, and the output
of the log-MAP decoder being coupled to
the input to the dual port extrinsic
memory.
__________
]44[]04[
755
711291
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ תכשירי רוקחות‬,‫נגזרות פתאלאזינון‬
‫המכילים אותם ושימושם לטיפול בסרטן‬
]01[
PHTHALAZINONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND THEIR USE IN ANTICANCER THERAPY
]00[
]04[
25.10.2001
0026505.8
]00[ 30.10.2000
]00[ GB
069000600
4016010664
US
Int. Cl.8 A61K 031/502, A61P 035/00, C07D 237/32, 401/06, 401/10, 401/12,
403/12, 405/06, 405/12, 409/12, 409/14, 413/10, 413/12, 413/14, 417/10, 417/14
KUDOS PHARMACEUTICALS
LIMITED, UNITED KINGDOM
MAYBRIDGE PLC, UNITED
KINGDOM
WO/2002/036576
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Use of a compound of the formula:
and isomers, salts, solvates, chemically
protected forms, and prodrugs thereof, in
the preparation of a medicament for
inhibiting the activity of PARP, wherein:
A and B together represent an optionally
.
substituted, fused aromatic ring; Rc is –
CH2-RL, where RL is an optionally
substituted C5-20 aryl group; and RN is
hydrogen.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
711214
756
]01[
METHOD AND APPARATUS FOR
PROVIDING EMBOSSED
HIDDEN IMAGES
]00[
]04[
]04[
29.04.2003
Int. Cl.8 B31F 001/07, B42D 015/00
STARBOARD TECHNOLOGIES
LTD.
RON GOLAN
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]00[
]01[
[57] A method for providing a hidden
image (88) within a substrate (84) the
method comprising embossing recesses on
the substrate, the recesses forming an at
‫שיטה והתקן להטבעת דמויות חבויות‬
‫ אור עיקבא‬,‫סטארבורד טכנולוגיות בע"מ‬
‫רון גולן‬
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,04 ‫ רחוב שנקר‬,‫בית נולטון‬
least one hidden image, whereby the at
least one hidden image can be viewed with
the use of at least one decoder.
________
]44[]04[
]01[
METHOD AND APPARATUS FOR
CONTROLLING STAGES OF A
MULTI-STAGE CIRCUIT
]00[
]04[
]04[
]04[
31.10.2001
09/703647
]00[ 01.11.2000
Int. Cl.8 H03M 003/02
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/037686
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] A data conversion circuit
comprising: a sigma-delta analog-to-digital
converter (ΣΔ ADC) configured to receive
757
711249
‫שיטה והתקן לשלוט בשלבים של מעגל‬
‫רב שלבי‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
an input signal and provide data samples,
the ΣΔ ADC including a plurality of ΣΔ
stages (1122) coupled in cascade; and a
April 13, 2008– ‫ח' בניסן התשס"ח‬
control circuit (1110) coupled to the ΣΔ
ADC and configured to provide a control
signal that selectively disables zero or
more of the plurality of ΣΔ stages, the
control circuit including one or more
detector stages (1112) configured to
receive the input signal and provide a
detected signal, a conditioning circuit
(1114) coupled to the one or more detector
stages, the conditioning circuit configured
to receive the detected signal and provide
conditioned samples, and a signal
processor (1116) coupled to the
conditioning circuit, the signal processor
configured to receive the conditioned
samples and provide the control signal.
________
]44[]04[
711243
‫מערכת ושיטה לניצול האבטחה של ערוץ‬
‫תקשורת מאובטח לאבטחת ערוץ‬
‫תקשורת לאמאובטח‬
]01[
SYSTEM AND METHOD OF
EXPLOITING THE SECURITY OF
A SECURE COMMUNICATION
CHANNEL TO SECURE A NONSECURE COMMUNICATION
CHANNEL
]00[
]04[
]04[
]04[
]00[
]01[
02.11.2001
09/706117
]00[ 03.11.2000
]00[ US
Int. Cl.8 H04L 009/00, 009/08, 009/32, 029/06
CITRIX SYSTEMS INC., U.S.A.
WO/2002/044858
BOROCHOV, KORAKH, ELIEZRI &
,'‫בורוכוב קורח אליעזרי ושות‬
CO.,
‫אביב‬-‫ תל‬,.20// .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] A method for establishing a secure
communication channel between a client
April 13, 2008– ‫ח' בניסן התשס"ח‬
and an application server comprising the
steps of:
(a) receiving, at a web server, a request
from a client to have an application
758
program executed on an application server
and to have output from said application
program executing on said application
server transmitted to said client;
(b) generating, by a ticket service, a ticket
having a identifier and a session key;
(c) obtaining, by said web server, said
ticket from said ticket service;
(d) transmitting, by said web server, said
ticket to said client over a secure
communication channel;
(e) transmitting, by said client, said
identifier from said ticket to said
application server;
(f) obtaining, by said application server, a
copy of said session key from said ticket
service using said identifier;
(g) establishing an application
communication channel between said
client and said application server;
(h) executing, by said application server,
said application program identified in said
request;
(i) transmitting, by said application server,
output of said application program over
said application communication channel
via a remote display protocol; and
(j) encrypting said output communicated to
said client over said application
communication channel using said session
key.
_________
]44[]04[
]01[
759
MAGNETIC LOGIC ELEMENTS
711492
‫אלמנטים לוגים מגנטיים‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
]00[
]04[
]04[
]04[
]00[
]00[
]01[
19.11.2001
0028092.5
]00[ 17.11.2000
Int. Cl.8 H03K 019/18
EASTGATE INVESTMENTS
LIMITED, BERMUDA
RUSSEL PAUL COWBURN
WO/2002/041492
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A magnetic logic element for a logic
device comprising at least one conduit
capable of substaining and propagating a
magnetic soliton, wherein the conduit is
further adapted by the provision of nodes
]00[
GB
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
and/or directional changes giving rise to
discontinuities in soliton propagation
energy as a result of which logical
functions may be processed.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
711440
760
‫תכשירי רוקחות של חומרים פעילים‬
‫בצורה פרמקולוגית למתן דרך פה‬
]01[
PHARMACEUTICAL
COMPOSITIONS FOR THE ORAL
DELIVERY OF
PHARMACOLOGICALLY ACTIVE
AGENTS
]00[
]04[
]04[
]04[
]00[
]01[
05.12.2001
60/251729
]00[ 06.12.2000
]00[ US
Int. Cl.8 A61K 047/00, 047/16, A61P 019/08
NOVARTIS AG, SWITZERLAND
WO/2002/045754
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A solid pharmaceutical composition
suitable for the oral delivery of calcitonin
comprising
(a) a therapeutically-effective amount of
calcitonin;
(b) a crospovidone or povidone; and
(c) 5-CNAC.
__________
]44[]04[
712212
‫שידור של אותות דיגיטליים ע"י ריבוב‬
‫חלוקת תדרים אורטוגונלי‬
]01[
TRANSMISSION OF DIGITAL
SIGNALS BY ORTHOGONAL
FREQUENCY DIVISION
MULTIPLEXING
]00[
]04[
]04[
16.06.1998
09/879297
]00[ 19.06.1997
]00[ US
Int. Cl.8 H03M 013/15, 013/25, 013/27, 013/29, 013/45, H04J 011/00, H04L 027/26,
H04N 007/24
DIVISION FROM 128579
QUALCOMM INCORPORATED,
U.S.A.
WO/1998/058496
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]04[
]00[
]01[
[57] For a receiver receiving "n"
substreams of an orthogonal frequency
division multiplexed (OFDM) signal
containing complex phase-adjusted
symbols, each symbol representing "m"
data bits, a device, comprising: for each
substream, a soft decision quantizer for
761
determining a binary value of each bit
represented by each symbol in the
substream, the soft decision quantizer
further comprising: means for determining
a first set of possible values for each
symbol, each value in the first set having a
binary value of "0" in a predetermined bit;
April 13, 2008– ‫ח' בניסן התשס"ח‬
means for determining, for each symbol, a
magnitude difference between the symbol
and each possible value in the first set of
possible values; and means for determining
the smallest magnitude difference and
generating a first signal representative
thereof.
__________
]44[]04[
712023
–‫מעקבים הטרוציקליים של יצירת ביטא‬
‫אמילואיד המבוססים על סולפונאמיד‬
]01[
HETEROCYCLIC SULFONAMIDE
INHIBITORS OF BETA AMYLOID
PRODUCTION
]00[
]04[
]04[
11.12.2001
60/255105
]00[ 13.12.2000
]00[ US
Int. Cl.7 A61K 031/341, 031/381, 031/4535, A61P 025/28, C07D 207/48, 307/64,
333, 333/34, 409/12
WYETH, U.S.A.
ARQULE, INC., U.S.A.
]04[
]00[
]01[
WO/2002/057252
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A compound or pharmaceutically
acceptable salt thereof of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
762
wherein:
R1 and R2 are independently selected from
the group consisting of hydrogen, alkyl,
substituted alkyl, CF3, alkenyl, substituted
alkenyl, alkynyl, substituted alkenyl,
alkynyl, substituted alkynyl, cycloalkyl,
substituted cycloalkyl, phenyl, substituted
phenyl, and (CH2)n(1, 3) dioxane, where n
is 2 to 5; R3 is selected from the group
consisting of hydrogen, alkyl, and
substituted alkyl; R4 is selected from the
group consisting of hydrogen, alkyl,
substituted alkyl, alkylcycloalkyl,
substituted alkylcycloalkyl, phenyl
(substituted) alkyl, alkyl OH, substituted
alkyl OH, alkyl OBn, substituted
alkylOBn, alkylpyridyl, substituted
alkylpyridyl, alkylfuranyl, substituted
alkylfuranyl, CH(OH) phenyl, CH(OH)
substituted phenyl, alkenyl, substituted
alkenyl, cycloalkyl, substituted cycloalkyl,
N-substituted-piperidinyl, piperidinyl,
substituted piperidinyl,
tetrahydrothiopyran, substituted
tetrahydrothiopyran, 2-indane, substituted
2-indane, phenyl, substituted phenyl, alkyl
NHR7, and substituted alkyl NHR7; with
the proviso that R3 and R4 are not both
hydrogen; R7 is alkyl, substituted alkyl,
cycloalkyl, substituted cycloalkyl, benzyl,
substituted benzyl, alkylOH, substituted
alkylOH, alkylSR8, or substituted
alkylSR8; R8 is alkyl, substituted alkyl,
benzyl, or substituted benzyl; or R3 and R4
may be joined to form a ring; R5 is selected
from the group consisting of hydrogen,
lower alkyl, substituted lower alkyl,
alkenyl, substituted alkenyl, alkynyl,
substituted alkynyl, CH2cycloalkyl,
substituted CH2cycloalkyl, benzyl,
substituted benzyl, and CH2CH2QR9; Q is
O, NH or S;
R9 is lower alkyl, substituted lower alkyl,
phenyl, or substituted phenyl;
R6 is selected from the group consisting of
hydrogen, halogen and CF3;
T is selected from the group consisting of
W, Y and Z are independently selected
from the group consisting of C, CR10 and
N; R10 is selected from the group
consisting of hydrogen and halogen, with
the proviso that at least one of W, Y and Z
must be C; X is selected from the group
consisting of O, S, SO2, and NR11; R11 is
selected from the group consisting of
hydrogen, lower alkyl, substituted lower
alkyl, benzyl, substituted benzyl, phenyl,
and substituted phenyl; provided that when
the compound contains one or more chiral
centers, at least one of the chiral centers
must be of S-stereochemistry.
763
April 13, 2008– ‫ח' בניסן התשס"ח‬
5866653
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
]01[
VARIABLE CAPACITY
COMPRESSOR HAVING
ADJUSTABLE CRANKPIN
THROW STRUCTURE
]00[
]04[
]04[
]04[
29.03.2002
09/820983
]00[ 30.03.2001
Int. Cl.8 F04B 049/12, F25B 001/00
BRISTOL COMPRESSORS, INC.,
U.S.A.
WO/2002/079652
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]01[
[57] A two stage reciprocating
compressor comprising: a block with a
single cylinder and associated single
compression chamber and single piston; a
crankshaft having an eccentric crankpin
(14) the eccentric crankpin operatively
connected to the piston; a reversible motor
operable to rotate the crankshaft in a
forward direction (270) and in a reverse
direction; an eccentric cam rotatably
mounted on the eccentric crankpin, the
cam held stationary at a first position with
respect to the crankpin when the
crankshaft is rotating in the forward
direction to drive the piston at a full stroke
between a bottom position and a top dead
centre position, the cam rotating with
respect to the crankpin when the
crankshaft is rotating in the reverse
direction to drive the piston at a reduced
stroke between an intermediate position
and the top dead centre position; a
connecting rod (27) operatively linking the
April 13, 2008– ‫ח' בניסן התשס"ח‬
712043
‫מדחס הספק משתנה בעל מבנה חיבור‬
‫יד–ארכובה מתכוונן‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
cam with the piston, and a first stop
mechanism (250) for restricting relative
rotation of the cam about the crankpin
when the motor is running in the forward
direction and a second stop mechanism
(258) for restricting relative rotation of the
cam with respect to the connecting rod
when the motor is running in the reverse
direction, wherein the first stop mechanism
includes a mechanical member configured
to selectively link the cam with the
crankpin along an axis substantially
parallel with an axis of the crankpin, the
mechanical member comprising a pin
(256) biased toward the crankshaft from
the cam, configured to engage a catch in
the crankshaft when the motor is running
in the forward direction or a pin (264)
biased toward the cam from the crankshaft,
configured to engage a catch in the cam
when the motor is running in the forward
direction.
764
________
]44[]04[
]01[
DEVICE FOR MEASURING
BLOOD COAGULATION AND
METHOD THEREOF
]00[
]04[
]04[
]04[
19.12.2001
0030929.4
]00[ 19.12.2000
Int. Cl.8 G01N 011/06
LIFESCAN SCOTLAND LIMITED,
UNITED KINGDOM
WO/2002/050534
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A device for the measurement of
clotting times of a fluid comprising an inlet
port (106) for the collection of the fluid
sample and at least one microchannel
(102) with a lateral dimension of less than
approximately 500 µm, the inlet port in
fluid connection with the at least one
microchannel, and at least two electrodes
765
712220
‫התקן ושיטה למדידת קרישת דם‬
]00[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
(104) situated along the length of the
microchannel, wherein the at least one
microchannel is configured for the fluid
sample to be transported therealong by
capillary action and wherein the inlet port
is an integrated penetration device for
penetration into the skin of a user for
collection of a capillary fluid sample.
April 13, 2008– ‫ח' בניסן התשס"ח‬
________
]44[]04[
]01[
LOCATION-BASED WEATHER
NOWCAST SYSTEM AND
METHOD
]00[
]04[
]04[
]04[
]00[
16.12.2001
60/256149
]00[ 15.12.2000
Int. Cl.8 G01W 001/02
NOOLY TECHNOLOGIES LTD.
DANIEL ROSENFELD, YARON
REICH
WO/2002/049310
DR. D. GRAESER LTD.,
P.O.B. 2496,
RAANANA
43650
]00[
]01[
[57] A method for providing a
meteorological nowcast according to a
location for a user, comprising: receiving
a weather forecast request from an
individual user, said request being
associated with a location, determining an
April 13, 2008– ‫ח' בניסן התשס"ח‬
712909
‫מערכת ושיטה מבוססת–מיקום לקביעת‬
‫מזגאויר נוכחי‬
]00[
US
‫ הרצליה‬,‫נולי טכנולוגיות בע"מ‬
‫ ירון רייך‬,‫דניאל רוזנפלד‬
,‫ גרייזר בע"מ‬.‫ד"ר ד‬
‫ רעננה‬,0469 .‫ד‬.‫ ת‬,
area of up to about 5 kilometers in radius;
and providing an updated meteorological
nowcast requested by said user at intervals
over a perid of less than about 60 minutes
in said area.
766
__________
]44[]04[
]01[
METHOD AND APPARATUS FOR
MANUFACTURING POLYMER
FIBER SHELLS VIA
ELECTROSPINNING
]00[
]04[
17.12.2001
60/256323
]00[ 19.12.2000
069000/00
0616010664
6/9/00640
4/14610664
Int. Cl.8 B29C 041/02
NICAST LTD.
ELI BAR, ALEXANDER DUBSON
WO/2002/049678
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]04[
]04[
]00[
]00[
]01[
[57] An apparatus for manufacturing
polymer fiber shell from liquefied
polymer, the apparatus comprising:
(a) a precipitation electrode (22) being for
generating the polymer fiber shell
thereupon;
(b) a dispenser (24), being at a first
767
712172
‫שיטה ומכשיר ליצור קליפות סיב פולימרי‬
‫על ידי אלקטרוספינינג‬
]00[
US
US
US
‫ קיסריה‬,‫נייקסט בע"מ‬
‫ אלכסנדר דובסון‬,‫אלי בר‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
potential relative to said precipitation
electrode so as to generate an electric field
between said precipitation electrode and
said dispenser, said dispenser being for:
(i) charging the liquefied polymer thereby
providing a charged liquefied polymer; and
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫‪precipitation electrode, said subsidiary‬‬
‫‪electrode being for reducing non‬‬‫‪uniformities in said electric field between‬‬
‫‪said precipitation electrode and said‬‬
‫‪dispenser.‬‬
‫‪(ii) dispensing said charged liquefied‬‬
‫‪polymer in a direction of said precipitation‬‬
‫‪electrode; and‬‬
‫‪(c) a subsidiary electrode (26) being at a‬‬
‫‪second potential relative to said‬‬
‫_________‬
‫‪712123‬‬
‫שיטה לחיתוך גיליון באמצעות מדפסת‬
‫מחשב ומדפסת עבורה‬
‫עידן מורדוב‪ ,‬תל אביב‬
‫עידן מורדוב‪,‬‬
‫בני אפרים ‪ ,:/0‬תל אביב‬
‫[‪ ]58‬שיטה לחיתוך גיליון ע"י מדפסת ביתית‬
‫הפועלת באמצעות דיו נוזלי ו‪9‬או צמיגי‪ 5‬ע"י‬
‫ריקון ומילוי‪ 5‬החלפת נוזל הדיו במיכל המדפסת‬
‫בנוזל חיתוך למשל חומצה גופריתית ושימוש‬
‫בתוכנת מחשב כדוגמת מעבד תמלילים וורד‬
‫לצורך הגדרת איזור החיתוך שהוא כביכול‬
‫צביעה בצבע מסוים‪ 5‬לעיתים יש צורך גם‬
‫בהגדרה כברירת מחדל את ראש הדיו הנדרש‬
‫[‪]44[]04‬‬
‫‪METHOD FOR CUTTING SHEET‬‬
‫‪BY MEANS OF COMPUTER‬‬
‫‪PRINTER AND COMPUTER‬‬
‫‪PRINTER THEREFOR‬‬
‫[‪]01‬‬
‫‪19.06.2003‬‬
‫‪Int. Cl.8 B41J 011/68‬‬
‫‪IDAN MORADOV‬‬
‫‪IDAN MORADOV,‬‬
‫‪301 BNEI EFRAIM ST.,TEL AVIV‬‬
‫[‪]00‬‬
‫[‪]04‬‬
‫[‪]04‬‬
‫[‪]01‬‬
‫לשם החיתוך כלומר באיזה מיכל‪ 5‬צבע המדפסת‬
‫תדפיס וכתוצאה מכך בעת פעולת ההדפסה נגרם‬
‫חיתוך הגיליון באזור בו מוגדר ע"י תוכנת מחשב‬
‫כדוגמת מעבד תמלילים וורד להדפיס על הגיליון‪5‬‬
‫אותו הגיליון יבוא במגע עם החומר החותך‬
‫במקום עם החומר הצובע ע"י פעולת המדפסת‬
‫ובכך יגרום לחיתוך בכל האזור שהיה אמור‬
‫להיות צבוע‪4‬‬
‫__________‬
‫‪712219‬‬
‫‪768‬‬
‫[‪]44[]04‬‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
]01[
PIPE COUPLING
]00[
]04[
]04[
]04[
]00[
]01[
19.04.2002
PR4470
]00[ 19.04.2001
Int. Cl.8 F16L 019/06, 035/00
PHILMAC PTY LTD., AUSTRALIA
WO/2002/086371
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A coupling (10) for connection of a
polymeric pipe (2), said coupling
including; a hollow body (20) having an
external thread (28) extending at least in
part therealong and having an inner surface
(42); a nut (14) threadably engaging said
body external threads (26), said nut having
at one end an internal thread co-operable
with said body external thread and
including a hooked projection (36) adapted
to extend over at least part of said body
inner surface, said projection including a
first inner surface (40) generally parallel to
said body inner surface, a second
outwardly converging surface (46)
extending from the inner edge of said inner
769
‫מקשר צינורות‬
]00[
AU
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
surface; a deformable gripping member
(16) having a first surface generally
parallel to said body inner surface and
having a second outwardly converging
outer surface (48) extending from said first
surface, said member including radially
inward barbs; wherein upon tightening of
said nut, said nut second surface abuts
against and exerts a force on said gripping
members second surface both in the
longitudinal and radial directions to
thereby cause the gripping member to be
urged both radially and longitudinally into
the body, said nut first surface sliding
alongside said body first surface.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
]01[
LAMINATE MATERIAL FOR THE
PROTECTION OF BODY PARTS
AND DEVICE COMPRISING
SUCH LAMINATE
]00[
]04[
]04[
]04[
22.02.2002
1017432
]00[ 22.02.2001
Int. Cl.8 A41D 031/02, B23B 005/22
VERENIGDE BEDRIJVEN NIMCO
B.V., THE NETHERLANDS
J.A.W. KROL, L.J.M. VAN DER MIJN
WO/2002/066187
PEARL COHEN ZEDEK LATZER,
5 SHENKAR STREET,
P.O.B. 12704
HERZLIYA 46733
]00[
]00[
]01[
[57] Laminate material, comprising an
upper layer (I) and a lower layer (II) which
is joined to the upper layer over
substantially the entire surface thereof, the
upper layer comprising a thin layer with a
thickness of between 0.2 and 1.0 mm of
leather material (1), and the lower layer
comprising a layer of material which can
April 13, 2008– ‫ח' בניסן התשס"ח‬
712142
‫חומר למינציה להגנה על חלקי גוף ומתקן‬
‫המכיל את הלמינציה‬
]00[
NL
,‫פרל כהן צדק לצר‬
,007/4 .‫ד‬.‫ ת‬, . ‫ רח' שנקר‬,0 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
be stretched in two directions,
characterized in that the lower layer
comprises at least one support layer (3)
which can be stretched in two directions
and comprises at least two sorts of
interwoven fibres, at least one type of
fibres being produced from an elastic
substance, as well as a layer (5) of a
770
compressible substance that has been
joined to the support layer over
substantially the entire surface thereof and
can be compressed in three mutually
perpendicular directions, wherein the
compressible substance comprises
substantially open-cell, cured plastic foam.
________
]44[]04[
]01[
MINIMALLY INVASIVE
GLAUCOMA SURGICAL
INSTRUMENT
]00[
]04[
]04[
]04[
17.01.2002
60/263617
]00[ 18.01.2001
Int. Cl.8 A61B 018/18, A61F 009/007
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2002/056805
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] A device for treating glaucoma, said
device comprising: an elongate probe
(700); a bipolar electrode (730) that is
useable to form an opening in the
trabecular meshwork such that fluid may
drain through said opening into Schlemm's
canal; and a protector configured to be
advanced into Schlemm's canal, said
771
712327
‫מכשיר לניתוח גלאוקומה חודרני מזעריות‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
protector being configured and positioned
in relation to the bipolar electrode such
that the protector will substantially protect
cells lining the scleral wall of Schlemm's
cana from being substantially damaged by
energy that emanates from the bipolar
electrode.
April 13, 2008– ‫ח' בניסן התשס"ח‬
5866989
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
]01[
DESIGN FOR FRAMELESS
CARTRIDGE MOTORS
]00[
]04[
]04[
]04[
04.02.2002
60/266557
]00[ 05.02.2001
Int. Cl.8 H02K 005/12
KOLLMORGEN CORPORATION,
U.S.A.
WO/2002/063745
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] A cartridge motor comprising: a
housing (10); a stator (18) affixed to the
housing; a rotor (40) sharing a common
central axis with stator; a shaft running
through the rotor along the common
central axis (20); a fastener for locking the
rotor to the housing during shipment, and
thereby maintaining an appropriate gap
between the rotor and the stator; a flexible
member connected to the shaft; a feedback
device stator mounted on the cartridge
April 13, 2008– ‫ח' בניסן התשס"ח‬
712441
‫תכנון למנועים עם מחסנית ללא מסגרת‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
motor such that it is stationary relative to
the rotor; a feedback device rotor
connected to the flexible member, whereby
the flexible member allows axial and radial
adjustments between the shaft and the
feedback device rotor while maintaining
rotational alignment; and a feedback
bearing providing rotational support
between the feedback device rotor and the
feedback device stator.
772
_________
]44[]04[
711030
‫נגזרות פירימידין לעיכוב התרבות התאים‬
]01[
PYRIMIDINE DERIVATIVES FOR
INHIBITION OF CELLPROLIFERATION
]00[
]04[
]04[
]04[
]00[
]00[
]01[
12.02.2002
0103926.2
]00[ 17.02.2001
]00[ GB
Int. Cl.8 A61K 031/5025, A61P 035/00, C07D 487/04
ASTRAZENECA AB, SWEDEN
ANDREW PETER THOMAS
WO/2002/066481
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,40-4. ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
[57] A compound of the formula
wherein:
ring A is a group of the formula
773
April 13, 2008– ‫ח' בניסן התשס"ח‬
wherein one or more of X1, X2, X3 and X4
are nitrogen and the others are CR5
wherein the values of R5 may be the same
or different; R1 is halo, nitro, cyano,
hydroxy, trifluoromethyl,
trifluoromethoxy, amino, carboxy,
carbamoyl, mercapto, sulphamoyl, C1-6
alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6
alkoxy, C1-6 alkanoyl, N-(C1-6 alkyl)
amino, N,N-(C1-6 alkyl)2 amino, C1-6
alkanoylamino, N-(C1-6 alkyl) carbamoyl,
N,N-(C1-6 alkyl)2 carbamoyl, C1-6
alkylS(O)a wherein a is 0 to 2, N-(C1-6
alkyl) sukphamoyl or N, N-(C1-6 alkyl)2
sukphamoyl; wherein R1 may be optionally
substituted on carbon by one or more R6;
R2 and R5 are independently of one other
selected from hydrogen, halo, nitro, cyano,
hydroxy, trifluoromethyl,
trifluoromethoxy, amino, carboxy,
carbamoyl, mercapto, sulphamoyl C1-6
alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6
alkoxy, C1-6 alkanoyl, C1-6 alkanoyloxy, N( C1-6 alkyl) amino, N,N-(C1-6 alkyl) amino,
N,N-(C1-6 alkyl)2 amino, C1-6
alkanoylamino, N-(C1-6 alkyl) carbamoyl,
N,N-(C1-6 alkyl)2 carbamoyl, C1-6
alkylS(O)a wherein a is 0 to 2, C1-6
alkoxycarbonyl, N-(C1-6 alkyl)
sukphamoyl, N,N-(C1-6 alkyl)2
sulphamoyl, phenyl, heterocyclic group,
phenylthio or (heterocyclic group) thio;
wherein any R2 or R5 may be optionally
substituted on carbon by one or more R7;
and wherein if said heterocyclic group
contains an –NH-moiety that nitrogen may
be optionally substituted by a group
selected from R8;
n is 0 to 2, wherein the values of R1 may
be the same or different;
R3 is halo, nitro, cyano, hydroxy, amino,
carboxy, carbamoyl, mercapto,
sulphamoyl, C2-6 alkenyl or C2-6 alkynyl; p
is 0-4; wherein the values of R3 may be the
same or different;
R4 is a group A-E-; wherein
A is selected from C1-6 alkyl, phenyl, a
heterocyclic group, C3-8 cycloalkyl, phenyl
April 13, 2008– ‫ח' בניסן התשס"ח‬
C1-6 alkyl, (heterocylic group) C1-6 alkyl or
C3-8 cycloalkyl C1-6 alkyl; wherein A may
be optionally substituted on carbon by one
or more R9; and wherein if said
heterocyclic group contains an –NHmoiety that nitrogen may be optionally
substituted by a group selected from R10;
E is a direct bond or –O-, -C(O)-, -OC(O)-,
-C(O)O-, -N(Ra)C(O)-,-C(O)N(Ra)-,
-N(Ra)-, -S(O)a-, -SO2N(Ra)-or –
N(Ra)SO2-; wherein Ra is hydrogen or C1-6
alkyl optionally substituted by one or more
R11 and a is 0-2;
R9 is independently selected from oxo,
halo, nitro, cyano, hydroxy,
trifluoromethyl, trifluoromethoxy, amino,
carboxy, carbamoyl, mercapto,
sulphamoyl, C1-6 alkyl, C2-6 alkenyl, C2-6
alkynyl, C1-6 alkoxy, C1-6 alkanoyl, C1-6
alkanoyloxy, N-(C1-6 alkyl) amino,
N-N-(C1-6 alkyl)2 amino, C1-6
alkanoylamino, N-(C1-6 alkyl) carbamoyl,
N, N-(C1-6 alkyl)2 carbamoyl, C1-6
alkylS(O)a wherein a is 0 to 2, C1-6
alkoxycarbonyl, C1-6
alkoxycarbonylamino,
benzyloxycarbonylamino, N-(C1-6 alkyl)
sulphamoyl and N,N-(C1-6 alkyl)2
sulphamoyl; wherein R9 may be optionally
substituted on carbon by one or more R12;
q is 0-2; wherein the values of R4 may be
the same or different; and wherein p+q≤5;
R6, R7, R11 and R12 are independently
selected from halo, nitro, cyano, hydroxy,
trifluoromethoxy, trifluoromethyl, amino,
carboxy, carbamoyl, mercapto,
sulphamoyl, methyl, ethyl, methoxy,
ethoxy, acetyl, acetoxy, methylamino,
ethylamino, dimethylamino, diethylamino,
N-methyl-N-ethylamino, acetylamino, Nmethylcarbamoyl, N-ethylcarbamoyl, N,Ndimethylcarbamoyl, N,Ndiethylcarbamoyl, N-methyl-Nethylcarbamoyl, methylthio, ethylthio,
methylsulphinyl, ethylsulphinyl, mesyl,
ethylsulphonyl, methoxycarbonyl,
ethoxycarbonyl, N-methylsulphamoyl, Nethylsulphamoyl, N,N-
774
dimethylsulphamoyl, N,Ndiethylsulphamoyl or N-methyl-Nethylsulphamoyl; and R8 and R10 are
independently selected from C1-4 alkyl, C14 alkanoyl, C1-4 alkylsulphonyl, C1-4
alkoxycarbonyl, carbamoyl, N-(C1-4 alkyl)
carbamoyl, N-(C1-4 alkyl) carbamoyl, N,N(C1-4 alkyl) carbamoyl, benzyl,
benzyloxycarbonyl, benzoyl and
phenylsulphonyl; or a pharmaceutically
acceptable salt or an in vivo hydrolysable
ester thereof.
_________
]44[]04[
]01[
CATHETER AND METHOD FOR
MAPPING PURKINJE FIBERS
]00[
]04[
]04[
]04[
]01[
10.08.2003
10/231857
]00[ 30.08.2002
Int. Cl.8 A61B 005/042, A61M 025/00
BIOSENSE WEBSTER, INC., U.S.A.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] A catheter comprising: an elongated
catheter body (12) having a proximal end,
a distal end and at least one lumen
extending longitudinally therethrough; a
mapping assembly (18) mounted at the
distal end of the catheter body and
comprising at least two spines (14), each
spine having a proximal end attached at the
711274
‫קטטר ושיטה למיפוי סיבי פורקיניה‬
]00[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
distal end of the catheter body and a free
distal end, wherein each spine comprises at
least one electrode (20); and an irrigation
tube extending through the catheter body
and having an open distal end that is in
communication with the outside of the
distal end of the catheter body.
________
775
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
711944
‫גלגל סרק עבור מסוע תובלה‬
]01[
IDLER ROLLER FOR
TRANSPORT CONVEYOR
]00[
]04[
]04[
]04[
]00[
]01[
05.03.2002
812599
]00[ 20.03.2001
Int. Cl.8 B65G 039/09, F16C 013/02
FMC TECHNOLOGIES INC., U.S.A.
WO/2002/074665
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] An idler roller (10) for a transport
conveyor, comprising: a cylindrical roller
shell (12) having opposite open ends; a
pair of roller heads (14), each of which is
fitted to a respective end of said roller
shell; a pair of bearing assemblies, each of
which is fitted in a respective roller head
and each of which comprises a pair of
roller bearings (26, 28); and a pair of stub
shafts (24), each of which is fitted in a
respective bearing assembly; wherein each
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
of said roller heads comprises an outer
support surface (18) which is
telescopically received within a respective
open end of said roller shell, an inner
bearing cavity (20) within which the
respective one of said bearing assemblies
is fitted, and a plurality of radially oriented
reinforcing webs (22) which extend
between said outer support surface and
said inner bearing cavity.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
776
]44[]04[
‫חופר חלקי לחורים בשיניים‬
]01[
PARTIAL DENTIN CARIES
EXCAVATOR
]00[
]04[
]04[
]04[
20.02.2002
792711
]00[ 23.02.2001
Int. Cl.8 A61C 001/00
TEMPLE UNIVERSITY OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION, U.S.A.
WO/2002/067801
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
711100
[57] A dental bur (210) for use in
removing all or a portion of carious dentin
and, optionally, a portion but not all of precarious dentin from teeth, said bur having
a working surface including cutting
elements (220) said cutting elements being
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
adapted to deflect, deform, or abrade upon
encountering material having a preselected
hardness in the range of about 1 KHN to
abut 40 KHN, wherein said preselected
hardness is less than the lower limit of
hardness of normal dentin.
_________
777
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
METHOD OF PRODUCING SPRAY
DRIED PARTICLES SUITABLE
FOR INHALATION
]00[
]04[
]04[
]04[
17.04.2002
09/837620
]00[ 18.04.2001
Int. Cl.8 A61K 009/00, 009/16
THE PENN STATE RESEARCH
FOUNDATION, U.S.A.
ADVANCED INHALATION
RESEARCH INC., U.S.A.
WO/2002/085326
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] A method of producing spray dried
particles suitable for inhalation
comprising:
(a) selecting a dew point between about 0o
C and – 40oC of a nitrogen drying gas
corresponding to a targeted median
geometric diameter, targeted median
aerodynamic diameter of less than about 5
microns and a targeted tap density of
particles formed by contacting a sprayed
liquid feed with the drying gas;
711124
‫שיטה להכנת תרסיס חלקיקים יבשים‬
‫המתאימים לשאיפה‬
]00[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(b) generating a nitrogen drying gas having
said selected dew point; and
(c) contacting the sprayed liquid feed with
the nitrogen drying gas having said
selected dew point thereby producing
particles having the targeted median
aerodynamic diameter, targeted tap density
and targeted median geometric diameter,
wherein said particles are suitable for
inhalation.
_________
]44[]04[
]01[
DRIVE MECHANISM FOR AN
INJECTION DEVICE
]00[
]04[
]04[
]04[
26.03.2002
0107604.1
]00[ 27.03.2001
Int. Cl.8 A61M 005/00
DCA DESIGN INTERNATIONAL
LIMITED, UNITED KINGDOM
WO/2002/076531
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
April 13, 2008– ‫ח' בניסן התשס"ח‬
711229
‫מנגנון הנעה למכשיר הזרקה‬
]00[
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
778
[57] A drive mechanism for an injection
device in which a piston is successively
moved in relation to a first end of a
medicament cartridge containing a
medicament selectively to drive a bung
closing a first end of the medicament
cartridge into the medicament cartridge to
expel medicament through a delivery
member located at a second end of the
medicament cartridge, in which the drive
mechanism further comprises a
displaceable dosing spindle, a dial dose
means, a transmission means (10), and
cable means (12), the piston comprising a
plurality of nested piston members,
displacement of the transmission means
causing the cable means to move at least
one of the plurality of the nested piston
members to drive the bung.
__________
]44[]04[
]01[
LIGHTWEIGHT ARMOR WITH
REPEAT HIT AND HIGH
ENERGY ABSORPTION
CAPABILITIES
]00[
]04[
]04[
]04[
]00[
]01[
15.03.2002
09/809548
]00[ 15.03.2001
Int. Cl.8 F41H 005/04
ATI PROPERTIES, INC., U.S.A.
WO/2002/075236
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A ballistic armor capable of
withstanding penetration by a projectile
impacting the armor, the ballistic armor
comprising: a first energy absorbing plate
(20) consisting essentially of a metallic
material said metallic material being at
least one of a metallic material that
undergoes a reversible phase change upon
absorbing energy and a metallic material
that exhibits an elastic strain deformation
of at least 5%; and a second plate (30) of a
metallic material that is contiguous with
779
711100
‫שריון קל–משקל העמיד בפני מכות חוזרות‬
‫ונשנות ובעל יכולת בליעה משופרת של‬
‫אנרגיה‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
and metallurgically bonded to the first
energy absorbing plate, wherein said
second plate comprises a material selected
from the group consisting of an alpha
titanium alloy is at least one of grades 1- 4
CPTi, an alpha beta titanium alloy that is
Ti(6-4), and a beta titanium alloy that is at
least one of Ti(10-2-3) or Ti(15-3-3-3):
and the metallic material of said second
plate is different from said metallic
material of said first energy absorbing
plate.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
711311
‫מכשיר ושיטה לייצוג יעיל של סיגנל‬
‫מחזורי וכמעט מחזורי לאנאליזה‬
]01[
APPARATUS AND METHOD FOR
EFFICIENT REPRESENTATION
OF PERIODIC AND NEARLY
PERIODIC SIGNALS FOR
ANALYSIS
]00[
]04[
]04[
]04[
19.03.2002
60/276481
]00[ 19.03.2001
]00[ US
Int. Cl.8 A61B 005/0402, 005/0452, G06F 017/00, 017/14
B.S.P. BIOLOGICAL SIGNAL
‫ תל‬,‫ עיבוד אותות ביולוגיים בע"מ‬.‫פי‬.‫אס‬.‫בי‬
PROCESSING LTD.
‫אביב‬
]00[
ASSAF HASSON, AMIR BEKER,
TAMIR BEN DAVID
WO/2002/075584
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]00[
]01[
[57] Apparatus for graphically
representing a substantially periodic signal
having substantially periodic segments, the
apparatus comprising: a graphic encoder
for converting said periodic segments into
encodings respectively of properties
thereof for arrangement in a single first
dimension, and an indexer, associated with
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ תמיר בן דוד‬,‫ אמיר בקר‬,‫אסף חסון‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
said graphic encoder, for successively
indexing said encodings to show a
succession of said segments over a second
dimension, thereby to represent, within
said two dimensions, dynamic changes of
said properties of said periodic segments
over said signal.
780
_________
]44[]04[
]01[
]00[
]04[
]04[
]04[
ACTIVE DOPED UNITARY
OPTICAL AMPLIFIER
711321
‫מגבר אופטי המשתמש במגבר יחידתי‬
‫באופן פעיל‬
13.03.2002
09/804813
]00[ 13.03.2001
]00[ US
Int. Cl.8 G01S 007/40, H01S 003/063, 003/10
TEXTRON SYSTEMS
CORPORATION, U.S.A.
]00[ WO/2002/073816
]01[ SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] An optical amplifier for amplifying
spatial orientation and phase, the optical
a plurality of input photons, each of the
amplifier comprising: imaging optics
plurality of input photons having a
optically coupled to the plurality of input
April 13, 2008– ‫ח' בניסן התשס"ח‬
781
photons, the imaging optics operative to
provide an image of the input photons; a
pump source for providing a pump signal;
and a unitary optically transparent solid
geometric glass chip, having at least a
portion being homogeneously doped with
rare earth ions to be optically active, the
homogeneously doped portion of the
unitary optically transparent solid
geometric glass chip being coupled to the
pump signal provided by the pump source,
the homogeneously doped portion of the
unitary optically transparent solid
geometric glass chip being further
optically coupled to the imaging optics and
receiving therefrom the image of the
plurality of input photons, wherein at least
one of the plurality of input photons
.
generates a corresponding one or more
generated photons within the
homogeneously doped portion, wherein the
one or more generated photons has
substantially the same spatial orientation
and phase as the corresponding at least one
input photon, the homogeneously doped
portion of the unitary optically transparent
solid geometric glass chip being
configured and arranged to provide output
photons comprising input photons and
generated photons, the output photons
being greater in number than the plurality
of input photons, the output photons
having substantially the same spatial
orientation and phase as a corresponding
input photon.
________
]44[]04[
711421
‫ חומצת גרעין המקודד‬,‫–הידאנטואינז‬D
‫ וקטורי הבעה המכילים חומצת גרעין‬,‫אותו‬
‫זו ותאים פונדקאים המבטאים אותו‬
]01[
D-HYDANTOINASE, NUCLEIC
ACID ENCODING THE SAME,
EXPRESSION VECTORS
INCLUDING SAID NUCLEIC ACID
AND HOST CELLS EXPRESSING
THE SAME
]00[
]04[
]04[
]04[
16.09.2003
60/281150
]00[ 03.04.2001
]00[ US
Int. Cl.8 C12N 005/10, 009/14, 009/86, 015/55, C12P 013/04
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2002/081626
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]01[
[57] An isolated nucleic acid molecule
comprising a sequence that encodes a D-
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
hydantoinase polypeptide comprising the
amino acid sequence of SEQ ID NO:2.
________
April 13, 2008– ‫ח' בניסן התשס"ח‬
782
]44[]04[
711431
‫שיטה והתקן לניתוח אות משודר דרך קו‬
‫תקשורת‬
]01[
METHOD AND DEVICE OF
ANALYZING A SIGNAL
TRANSMITTED VIA A
COMMUNICATION LINK
]00[
]04[
]04[
]01[
18.09.2003
Int. Cl.8 H04B 010/08, H04J 014/02, H04L 001/20
ECI TELECOM LTD.
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫איי‬.‫סי‬.‫אי‬
ECI TELECOM LTD.,
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 HASIVIM ST.,
‫ פתח תקוה‬,:/‫רחוב הסיבים‬
PETACH TIKVA 49517
[57] A method for estimating one or more
characteristics of a main signal transmitted
via a communication link, wherein said
main signal is composed from one or more
component signals possibly comprising
respective data signals and transmitted via
one or more respective communication
channels, the method comprising:
providing an analyzing circuit independent
from said communication link,
transmitting a probe data signal in the
analyzing circuit, monitoring a bit error
rate BER parameter associated with the
probe data signal; introducing into said
analyzing circuit at least a portion of
energy of the main signal, derived from a
particular point of said communication
link, as an interfering signal; judging about
said one or more characteristics of the
main signal at said particular point of the
communication link, based at least on
changes in the monitored BER parameter
of the probe data signal.
________
783
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
713020
‫תמיסת אריפיראזול למתן פומי‬
]01[
ARIPIPRAZOLE ORAL
SOLUTION
]00[
]04[
]04[
]04[
24.04.2002
60/286718
]00[ 25.04.2001
]00[ US
Int. Cl.8 A61K 031/00, 031/496, C07D 401/12
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2002/085366
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A pharmaceutical solution suitable
for oral administration comprising
aripiprazole, a pharmaceutically suitable
solvent system comprised of one or more
agents selected from the group consisting
of water, ethanol, glycerin, propylene
glycol and sorbitol, one or more tasteenhancing/masking agents and one or more
other agents selected from the group
consisting of lactic acid, tartaric acid and
cirtric acid, wherein said solution has a pH
from 2.5 to 4.0.
________
]44[]04[
713099
‫צמחים המאופיינים בגידול מואץ ושיטות‬
‫ומבני חומצות גרעין שימושיים ליצירתם‬
]01[
PLANTS CHARACTERIZED BY
ENHANCED GROWTH AND
METHODS AND NUCLEIC ACID
CONSTRUCTS USEFUL FOR
GENERATING SAME
]00[
]04[
]04[
]04[
26.03.2002
09/828173
]00[ 09.04.2001
]00[ US
Int. Cl.8 A01H 005/00, C07K 014/195, 014/705, C12N 015/31, 015/82
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
THE HEBREW UNIVERSITY OF
JERUSALEM
A. KAPLAN, J. LEIMAN-HURWITZ,
.‫ ר‬,‫ שץ‬.‫ ד‬,‫הורוביץ‬-‫ ליימן‬.'‫ ג‬,‫ קפלן‬.‫א‬
D. SCHATZ, R. MITTLER, S.
‫ רחמילביץ‬.‫ ש‬,‫מיטלר‬
RACHMILEVITCH
WO/2002/081622
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]00[
]00[
]01[
April 13, 2008– ‫ח' בניסן התשס"ח‬
784
[57] A method of enhancing growth
and/or commercial yield of a plant grown
under conditions selected from the group
consisting of low humidity, low CO2
concentration and water stress, the method
comprising expressing within the plant a
polypeptide including an amino acid
sequence at least 65% identical to that set
forth in SEQ ID NOs: 3, 5, 6 or 7, wherein
said polypeptide is capable of enhancing
photosynthesis in said plant under said
growth conditions.
________
]44[]04[
]01[
EXPANSION RING ASSEMBLY
]00[
]04[
]04[
]04[
14.10.2003
10/280917
]00[ 25.10.2002
Int. Cl.8 F16L 017/00, 033/213
PRESS-SEAL GASKET
CORPORATION, U.S.A.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]01[
[57] A expansion ring assembly (20) for
sealing a gasket (26) to an annular wall
(22), said assembly comprising: a ring (36)
defining a pair of end portions (28, 30);
and a drive mechanism (38) disposed
substantially within said ring, comprising:
a pair of block members (58) each having
a threaded bore (62) therethrough, said
block members removably engaged with
713979
‫הרכבה טבעתית מרחיבה‬
]00[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
respective end portions of said ring; and a
bolt (60) including oppositely-threaded
ends (70a, 70b) respectively threaded
within said bores of said block members,
wherein rotation of said bolt in a first
direction causes said block members to be
simultaneously driven apart from one
another to thereby expand said ring.
_________
785
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
METHOD FOR OBTAINING
NOVEL ENDOPHYTIC FUNGI
AND METHODS OF USE
]00[
]04[
11.04.2002
60/283902
]00[ 16.04.2001
069000600
4416010660
Int. Cl.8 A01N 003/02, 025/00, 063/04
GARY A. STROBEL, U.S.A.
DENISE CAROL MANKER, JULIEN
MERCIER
WO/2002/082898
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]04[
]04[
]00[
]00[
]01[
[57] A method for obtaining novel
Muscodor fungi comprising contacting an
effective amount of the fungi to be
screened with volatiles of Muscodor albus
or Muscodor roseus under culturing
713920
‫שיטה לקבלת פטריות אנדופיתיות חדשות‬
‫ושיטות לשימושן‬
]00[
US
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
conditions, selecting fungi resistant to the
volatiles of the Muscodor albus or
Muscodor roseus, and identifying a novel
Muscodor fungus.
________
]44[]04[
]01[
ADJUSTABLE DEBURRING
TOOL
]00[
]04[
]04[
]00[
]01[
20.10.2003
Int. Cl.8 B23B 029/034
ISCAR LTD.
GIL HECHT
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
[57] An adjustable deburring tool having
a longitudinal axis of rotation and
comprising a cutting head (12) adjustably
coupled to a shank (14), the cutting head
having an insert pocket in which a cutting
insert is retained; the cutting head having a
front face (24) and a rear face (26) with a
April 13, 2008– ‫ח' בניסן התשס"ח‬
713943
‫כלי מתכוונן להסרת גרדים‬
‫ תפן‬,‫ישקר בע"מ‬
‫גיל הכט‬
,‫ישקר בע"מ‬
‫ תפן‬,00 .‫ד‬.‫ ת‬,
ridge (28) projecting from the rear face,
the ridge having a recessed portion (30);
the shank having a groove (34)
communicating with an open ended and
open sided threaded adjusting bore (36),
the ridge being slidably located in the
groove with an adjusting screw
786
screw-threaded in the threaded adjusting
bore and partially located in the recessed
portion of the ridge.
__________
]44[]04[
]01[
METHOD AND ASSEMBLY FOR
INCREASING HAIR VOLUME
]00[
]04[
]04[
]04[
21.02.2002
RM2001A000317 ]00[ 07.06.2001
Int. Cl.8 A41G 003/00
INDORATA SERVICOS E GESTAO
LDA., PORTUGAL
WO/2002/098250
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] A method for increasing hair volume
or length, comprising the following steps:
providing a plurality of extensions (C)
comprising several hairs (3), which are
connected by a fixing element (13), said
extensions being aligned and basically in
parallel with their fixing elements located
787
713393
‫שיטה ומרכב להגדלת נפח השיער‬
]00[
IT
,'‫ קולב ושות‬.‫סנפורד ט‬
,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬
on a support tape (11) having an adhesive
face; adhering the adhesive face of the
support tape to head hair and positioning
the extensions; connecting the extensions
with the head hair attaching the fixing
elements to it.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
713427
‫תכשיר חיסון‬
]01[
VACCINE COMPOSITION
]00[
]04[
29.05.2002
0113083.0
]00[ 30.05.2001
]00[ GB
606144010
0416010660
GB
Int. Cl.8 A61K 039/00, 039/145, A61P 031/16, C07K 014/11, C12N 007/04
SAECHISCHES SERUNWERK
DRESDEN BRANCH OF
SMITHKLINE BEECHAM PHARMA
GMBH & CO. KG, GERMANY
WO/2002/097072
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] An inactivated influenza virus
preparation comprising a haemagglutinin
antigen stabilized in the absence of
thiomersal, or at low levels of thiomersal,
wherein the haemagglutinin is detectable
The applications for division
from this application have
not yet been published
by a SRD assay, and wherein the
preparation comprising α-tocopherol
succinate in a sufficient amount to stabilize
the haemagglutinin antigen.
5866634
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
788
]44[]04[
713424
‫ ניידים ברשתות‬IP ‫שיטה ומערכת לצמתי‬
‫הטרוגניות‬
]01[
METHOD AND SYSTEM FOR
MOBILE IP NODES IN
HETEROGENEOUS NETWORKS
]00[
]04[
]04[
]04[
12.06.2002
01810594.0
]00[ 18.06.2001
]00[ EP
Int. Cl.8 H04L 012/28, 012/46, 012/58, 029/06, H04Q 007/22, 007/38
SWISSCOM MOBILE AG,
SWITZERLAND
WO/2002/103978
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]01[
[57] A method for mobile IP nodes (10)
in heterogeneous networks (21-24), in
which a home agent dynamically assigns a
temporary IP care-of address to a static IP
home address when the mobile node is
moved in the heterogeneous networks, the
dynamic care-of address indicating the
topologically current network location of
the mobile node and IP data packets
having the IP home address of the mobile
node as destination address being
redirected to the care-of address of the
mobile node, wherein an interface
administration module (134) of the mobile
node checks the mobile node for available
physical network interfaces (14-17), draws
up a lookup table with the available and
configurable physical network interfaces,
789
and links itself to one of the available
physical network interfaces, one or more
IP applications (11) of the mobile node
access the heterogeneous networks via a
virtual IP network interface (133)
generated in the mobile node, the
generated permanent virtual IP network
interface comprising a generated virtual L3
layer and a generated virtual L2 layer and
being linked to the current network via the
interface administration module (134), and
during a change of the physical network
interface (14-17) of the mobile node, the
link of the permanent virtual IP network
interface to the network is updated based
on the lookup table by means of the
interface administration module.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
713412
‫שימוש באימונוגלובולינים רבי שיכפול‬
‫להכנת חיסון‬
]01[
USE OF POLYCLONAL
IMMUNOGLOBULINS FOR
PRODUCING A VACCINE
]00[
]04[
]04[
]04[
19.03.2002
A860/2001
]00[ 01.06.2001
]00[ AT
Int. Cl.8 A61K 039/395, A61P 031/04, 031/10, 031/12, 035/00, 037/04, 037/08
IGENEON KREBSIMMUNTHERAPIE FORSCHUNGSUND ENTWICKLUNGS AG,
AUSTRIA
WO/2002/096455
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] The use of a polyclonal
immunoglobulin preparation for producing
a vaccine formulation, containing
antibodies of different specificities, for
immunising individuals of the same
species from which the immunoglobulins
have been derived.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
790
]44[]04[
]01[
DEVICE AND METHOD FOR
LOCATING AN ANATOMICAL
CAVITY IN A BODY
]00[
]04[
]04[
]04[
20.06.2002
1018334
]00[ 20.06.2001
Int. Cl.8 A61B 017/34
TIMOTHEUS JOAN MARIE
LECHNER, THE NETHERLANDS
JAN VAN NIEKERK, THE
NETHERLANDS
LEONARDUS JOHANNES MARIA
TEUNISSEN, THE NETHERLANDS
MAARTEN GERARDUS
FRANCISCUS VAN WIJK, THE
NETHERLANDS
MARINUS ADRIAAN DROST, THE
NETHERLANDS
FRANKLIN ROBERT CHRISTIAAN
VAN DORSTEN, THE
NETHERLANDS
CHRISTIANUS JACOBUS MARIA
LANGENBERG, THE
NETHERLANDS
ADRIANUS JACOBUS JOHANNES
MAAS, THE NETHERLANDS
WO/2003/000146
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]00[
]01[
[57] Device for locating a region (15)
which is situated in a body (10),
comprising: a hollow needle (20); a fluidfilled reservoir (30) which is in
communication with the needle; pump
means for pressurizing the fluid;
measuring means (40) for creating a
pressure-measurement signal which is
related to the pressure prevailing in the
fluid; signal-conversion means (50) for
converting the pressure-measurement
791
714222
‫התקן ושיטה לאיתור חלל אנטומי בגוף‬
]00[
NL
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
signal created by the measuring means into
a form which is suitable for further
processing, and reproduction means (60,
70) for emitting an acoustic signal which is
related to the pressure-measurement signal
which has been converted by the signalconversion means, characterized in that the
reproduction means is designed to emit the
acoustic signal which is continuously
representative of the pressure prevailing in
the fluid.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
]01[
CLOSURE DEVICE WITH A
PIERCING ELEMENT
]00[
]04[
]04[
]04[
]00[
]00[
]01[
10.06.2002
1182/01
]00[ 27.06.2001
Int. Cl.8 B65D 005/74
BERICAP HOLDING GMBH
WERNER FRITZ DUBACH
WO/2003/002419
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[57] A closure device of plastic which
may be attached via a piercable location of
a closed receptacle (B) and which consists
of a bung-like lower part (2) with a
cylindrical pour-out spout which is
connected or connectable to the receptacle,
and of a screw cap (4) which may be
screwed onto the lower part as well as of a
cylindrical piercing element (3) which in
the axial direction is open on both sides
and which is displaceably mounted in the
lower part, wherein in the screw cap there
are present means (44) which during the
screwing-off movement of the screw cap
April 13, 2008– ‫ח' בניסן התשס"ח‬
714140
‫התקן סגירה עם אלמנט ניקוב‬
]00[
CH
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
for the first time move the piercing
element helically downwards,
characterised in that the piercing element
is equipped with at least two cutting
elements (33) which are arranged running
after one another by an offset angle (α) of
less than 180o and more than 100o so that
after a rotation of the piercing element by
the offset angle a continuous cutting line of
2α has arisen, and that now a displacing
element (34, 35, 38) acts in the nonseparated region, which pushes the partly
cut-out lobe [tab] of the receptable out of
the region of the pour-out spout.
792
_________
]44[]04[
714291
‫תרכובות אשר הינן מדכאות פעילות של‬
‫ ושימושיות‬NA+/CA² + ‫החלפת מיכנזים‬
‫בטיפול בהפרעות‬
]01[
COMPOUNDS WHICH ARE
POTENT INHIBITORS OF
NA+/CA2+ EXCHANGE
MECHANISM AND ARE USEFUL
IN THE TREATMENT OF
ARRHYTHMIAS
]00[
]04[
]04[
10.07.2002
20011507
]00[ 10.07.2001
]00[ FI
Int. Cl.8 A61K 031/085, 031/353, 031/44, 031/4433, 031/4439, A61P 009/06, 009/10,
C07C 217/14, 217/54, 217/90, C07D 213/64, 311/00, 311/28, 311/58, 311/60, 405/12,
405/14, 411/12
ORION CORPORATION, FINLAND
WO/2003/006452
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
]04[
]00[
]01[
[57] Use of a compound of the formula
793
April 13, 2008– ‫ח' בניסן התשס"ח‬
wherein
X is –O-, -CH2- or –C(O)-;
Z is –CHR9- or valence bond;
Y is –CH2-, C(O)-, CH(OR10)-,
CH(NR11R12)-, -O-, -S- -S(O)- or –S(O2)provided that in case Z is a valence bond,
Y is not C(O); the dashed line represents
an optional double bond in which case Z is
–CR9-and Y is –CH-, C(OR10)- or –
C(NR11R12)-; R1 is –(CH2)nNR4R7 or one
of the following groups:
n is 1-4,
R2 and R3 are independently H, C1-7 alkyl,
C1-7 alkoxy, -NO2, halogen, -CF3, -OH, NHR8 or –COOH, R4 and R7 are
independently H, C1-7 alkyl or C1-7
hydroxyalkyl,
R5 is H, C1-7 alkoxy, -CF3, NH2 or –CN, R6
is –NO2, -NR14R19, -CF3 or
R8 and R16 are independently H,
alkylcarbonyl or alkenylcarbonyl;
R9 is H or C1-7 alkyl;
R10 is H, alkylsulfonyl, alkylcarbonyl or
alkenylcarbonyl;
R11 and R12 are independently H, C1-7
alkyl, alkylcarbonyl or alkenycarbonyl;
R13 and R18 are independently H or –OR20,
R14 and R19 are independently H,
alkylcarbonyl, alkenylcarbonyl,
alkylsulfonyl, C(S)NHR17 or C(O)NHR17,
R15 is H or NH2, R17 is H or C1-7 alkyl,
R20 is H, alkylcarbonyl or alkenylcarbonyl,
and pharmaceutically acceptable salts and
esters thereof; in the manufacture of a
medicament for inhibiting Na+/Ca2+
exchange mechanism in a cell or for the
treatment of arrhythmias.
_________
April 13, 2008– ‫ח' בניסן התשס"ח‬
794
]44[]04[
714247
‫שיטה ומתקן להמרת אנרגית גלי ים ורוח‬
‫לאנרגיה חשמלית‬
]01[
METHOD AND APPARATUS FOR
CONVERTING SEA WAVES AND
WIND ENERGY INTO
ELECTRICAL ENERGY
]00[
]04[
]04[
]01[
01.01.2004
Int. Cl.8 B63H 001/34, F03B 013/00, 013/12
HAIM MORGENSTEIN
‫ בית אריה‬,‫חיים מורגנשטיין‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] Energy converter, which comprises:
(a) a buoy (105), substantially floating on
the surface of the water and substantially
maintained in a fixed horizontal position;
(b) a water impervious outer sleeve (101)
pivotally connected to said buoy such that
most of said outer sleeve is submerged in
the water, said outer sleeve comprising:
(i) a cylindrical inner surface;
(ii) a first wing (102) rigidly affixed to said
outer sleeve, wherein in a rest position,
said first wing floats essentially
horizontally on the surface of the water,
and is disposed at a wave side of said outer
sleeve; and,
(iii) a sleeve weight attached to the bottom
of said inner surface, for assuring said first
wing is returned to said rest position
following rotation of said outer sleeve;
and,
(c) a generator, housed within said sleeve
in a longitudinal manner, said generator
795
comprising magnetic field generation
(MFG) means and a rotor, wherein:
(i) said MFG means, or, alternatively, said
rotor, is a stationary component that is
maintained essentially in a fixed position
with respect to said buoy;
(ii) said rotor, or, alternatively, said MFG
means, is a rotatable component that has
an axis of rotation coinciding with the
longitudinal axis of said stationary
component, and wherein said rotatable
component is angularly displaced by said
sleeve, relative to said stationary
component, in coordination with said first
wing being angularly displaced by waves
impacting upon said first wing, wherein
said relative angular displacement
generates electrical power; and
(iii) on the shore side, a lower surface of
said buoy is shaped to repel water flowing
back from the shore.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
722724
‫תכשיר תרופתי לטיפול מקומי‬
]01[
TOPICAL PHARMACEUTICAL
FORMULATION
]00[
]04[
]04[
]04[
23.07.2002
60/307548
]00[ 24.07.2001
]00[ US
Int. Cl.8 A61K 047/00, 047/02, 047/44, A61P 017/02
ADVANCED BIOTECHNOLOGIES,
U.S.A.
WO/2003/009877
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]00[
]01[
[57] A wound dressing comprising a
composition including a non-volatile
silicone fluid in admixture with fumed
silica and an antibacterial active agent.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
722014
796
]01[
PRINTING CARTRIDGE WITH
CAPACITIVE SENSOR
IDENTIFICATION
]00[
]04[
]04[
]04[
06.08.2002
09/922112
]00[ 06.08.2001
Int. Cl.8 B41J 002/175
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2003/013862
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] A printing cartridge (1230)
comprising: a housing (1231); and an
actuating formation (1238) that is
positioned on the housing and is capable of
actuating a number of capacitive sensors in
an array (1232) of such sensors, the
‫מחסנית הדפסה עם זיהוי חיישן קיבולי‬
]00[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
actuating formation being configured to
represent data relating to at least one of: a
serial number of the cartridge, a media and
a media colorant, so that the capacitive
sensors, when actuated, together generate a
signal carrying such data.
__________
]44[]04[
797
722921
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
LARYNGEAL MASK AIRWAY
DEVICE
]00[
]04[
21.08.2002
60/314438
]00[ 23.08.2001
400060
6016010660
Int. Cl.8 A61M 016/04
THE LARYNGEAL MASK
COMPANY LIMITED, SEYCHELLES
ARCHIBALD IAN JEREMY BRAIN
WO/2003/018094
NAOMI ASSIA & CO. LAW
OFFICES,
32 HABARZEL ST.
RAMAT HACHAYAL
TEL AVIV 69710
]04[
]04[
]00[
]00[
]01[
[57] A laryngeal mask airway device,
comprising an inflatable cuff (3460)
having a generally toroidal shape and
defining a central opening when inflated;
and
an airway tube (3410) extending from a
proximal end (3417) via a curved
intermediate portion (3418) to a distal end
(3419) and defining an internal
passageway (3421), the airway tube being
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫התקן גרוני לפתיחת נתיבי אויר‬
]00[
US
US
,‫נעמי אסיא ושות' משרד עורכי דין‬
‫אביב‬-‫ תל‬,‫ רמת החייל‬:0 ‫רח' הברזל‬
connected at its distal end to the inflatable
cuff with the internal passageway of the
airway tube in communication with the
central opening of the inflatable cuff, the
curved intermediate portion of the airway
tube being characterized by an elongated
notch (3424) extending along the internal
surface of the convex side (3410-0)
thereof.
798
________
]44[]04[
]01[
BENDING BEAM LOAD CELL
WITH TORQUE SENSITIVITY
COMPENSATION
]00[
]04[
]04[
]04[
19.02.2004
368347
]00[ 20.02.2003
Int. Cl.8 G01L 001/04
THE FLINTEC GROUP, LTD., HONG
KONG
HARRY E. LOCKERY, ROBERT L.
GRAY
JEREMY M. BEN-DAVID & CO.
LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]00[
]01[
[57] A bending beam load cell (20)
comprising: axially oriented strain gages
(18, 18', 19, 19') sensing tension and
compression strains connected in a main
bridge circuit having two power input
terminals and two signal output terminals
providing an output signal proportional to
799
722914
‫מתמר כפיפה עם פיצוי לרגישות מומנט‬
‫פיתול‬
]00[
US
,‫דוד ושות' בע"מ‬-‫ בן‬.‫ירמיהו מ‬
,4./27 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
a load on the load cell; a shear sensing
strain gage (22) sensing torque on said
load cell; and means for connecting said
torque sensing strain gage in series with
one of said axially oriented strain gages to
compensate for torque sensitivity in said
output signal.
April 13, 2008– ‫ח' בניסן התשס"ח‬
__________
]44[]04[
]01[
PROCESS FOR MAKING
POLYAMIDE TEXTILE
ARTICLES BEARING DESIGNS IN
DIFFERENT COLORS
]00[
]04[
]04[
]04[
]00[
19.02.2004
154571
]00[ 20.02.2003
Int. Cl.8 D01D 005/08, D02G 003/02
NILIT LTD.
RAN ROTEM, SAMUEL GAZIT,
MICHAEL EROSHOV, ALON
WEISER, MAMODALY THIERRY,
BORIS STRELTSES, YEDVAB
ARIEL, JULIA KATZ, ALEXANDER
YERMOLAEV
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]01[
[57] Process for manufacturing a fabric
having distinctive and sharp differentially
colored patterns or designs, which process
comprises the steps of:
(i) producing a first and a second
polyamide, said polyamides having
different concentrations of amine groups;
(ii) producing a first and a second
polyamide having different concentrations
April 13, 2008– ‫ח' בניסן התשס"ח‬
722934
‫תהליך לייצור פריטי אריג פוליאמיד‬
‫המניבים מדגמים בצבעים שונים‬
]00[
IL
‫ מגדל העמק‬,‫נילית בע"מ‬
‫ אלון‬,‫ מיכאל ארושוב‬,‫ שמואל גזית‬,‫רן רותם‬
‫ ידוב‬,‫ בוריס סטרלצס‬,‫ ממודלי טיירי‬,‫וייזר‬
‫ אלכסנדר יירמולייב‬,‫ יוליה כץ‬,‫אריאל‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
of carboxyl end-groups and sulfonate
groups;
(iii) producing a first yarn from said first
polyamide and a second yarn from said
second polyamide;
(iv) making a fabric having first surface
areas defined by said first yarn and second
surface areas defined by said second yarn;
and
800
(v) chemically dyeing said fabric in a
dyeing bath comprising at least one
anionic (acid) dyestuff and at least one
cationic (basic) dyestuff, whereby said first
yarn and therefore said first surface areas
are dyed predominantly by said anionic
dyestuff and said second yarn and
therefore said second surface areas are
dyed predominantly by said cationic
dyestuff.
_________
]44[]04[
722224
‫תכשירי חלבון מטריצת אמייל לוויסות‬
‫התגובה החיסונית‬
]01[
ENAMEL MATRIX PROTEIN
COMPOSITIONS FOR
MODULATING IMMUNE
RESPONSE
]00[
]04[
06.09.2002
PA200101340 ]00[ 14.09.2001
]00[ DK
069000000
4/16/10664
US
Int. Cl.8 A61K 035/32, 038/39, A61P 001/04, 003/10, 005/40, 007/08, 009/10,
011/06, 017/02, 017/06, 021/04, 029/00, 037/08
BIORA BIOEX AB, SWEDEN
WO/2003/024479
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Use of an active enamel substance
and/or a preparation of an active enamel
substance and/or a preparation of an active
enamel substance for the manufacture of
pharmaceutical composition for the
prevention and/or treatment of a systemic
inflammation and/or systemic infection in
a mammal.
__________
801
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
SEMICONDUCTOR LASER
BASED ON THE EFFECT OF
PHOTONIC BAND GAP CRYSTALMEDIATED FILTRATION OF
HIGHER MODES OF LASER
RADIATION
]00[
]04[
]04[
]04[
]00[
29.08.2002
09/946016
]00[ 04.09.2001
Int. Cl.8 H01S 005/183
PBC LASERS LTD.
VITALY SHCHUKIN, NIKOLAI
LEDENTSOV
WO/2003/021726
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]00[
]01[
[57] A semiconductor edge-emitting laser
(100) comprising:
(a) an n-doped region, at least a part of
which comprises a photonic band gap
crystal (120) including a layered structure
comprising at least one layer, wherein each
layer is doped by an n-typed impurity,
wherein the layered structure has a
periodically modulated refractive index,
wherein the periodically modulated
refractive index is modulated in a direction
perpendicular to a direction of light
propagation;
(b) a defect (121) contiguous with said
photonic band gap crystal (120),
comprising a light generating layer that
emits light when exposed to an injection
current when a forward bias is applied;
April 13, 2008– ‫ח' בניסן התשס"ח‬
722233
‫לייזר מוליך למחצה המבוסס על האפקט‬
‫של סינון אופני קרינת לייזר גבוהים על ידי‬
‫גביש מרווח–פס–פוטוני‬
]00[
US
‫ משגב‬.‫נ‬.‫ ד‬,‫ לייזרים בע"מ‬.‫ סי‬.‫ בי‬.‫פי‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
(c) a p-doped layered structure, comprising
at least one layer, wherein each layer is
doped by a p-type impurity, and wherein
said p-doped layered structure is located
on a side of said defect opposite said ndoped region, wherein the p-doped layered
structure has a variable refractive index
that hinders an extension of a fundamental
mode to at least one doped layer within the
p-doped layered structure and to a pcontact (115) wherein the fundamental
mode of laser radiation is localized by the
defect, while all other modes are extended
over the photonic band gap crystal;
wherein a total thickness of said photonic
band gap crystal and said defect provides a
low beam divergence.
802
__________
]44[]04[
]01[
FLAT-PANEL PROJECTION
DISPLAY
]00[
]04[
]04[
25.09.2001
Int. Cl.8 G03B 021/14
CAMBRIDGE FLAT PROJECTION
DISPLAYS LIMITED, UNITED
KINGDOM
ADRIAN ROBERT LEIGH TRAVIS
WO/2003/027754
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]00[
]00[
]01[
[57] A flat-panel projection display
comprising a waveguide system including
a display slab waveguide (1) having a
grating (2) acting to cause light
propagating in the waveguide to emerge
from one face of the waveguide, a lens
element (3) for directing light into an edge
of the waveguide system, and means (4)
located in the focal plane of the lens
.
803
722420
‫צג הקרנה שטוח‬
,‫) בע"מ‬066.( ‫ארליך‬.‫אי‬.‫ג'י‬
,00 ‫רחוב מנחם בגין‬, 0. ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
element for modulating the intensity of the
light as a function of lateral position and of
elevational direction of travel, relative to
the waveguide, the grating being such as to
eject light directed into the waveguide
system from the slab towards a viewer at
an angle depending on the said lateral
position and elevational direction.
April 13, 2008– ‫ח' בניסן התשס"ח‬
________
]44[]04[
]01[
SHOE HAVING A
MULTILAYERED INSOLE
]00[
]04[
]04[
]04[
18.03.2004
390829
]00[ 18.03.2003
Int. Cl.8 A43B 013/38
H.H. BROWN SHOE COMPANY,
INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]01[
[57] A shoe, comprising: a footbed (44);
an insole (14) having a first layer (16) and
a second layer (20); said first layer having
a top surface (16), a bottom surface, and a
hole extending from said top surface to
said bottom surface; said second layer
having a top surface, a bottom location,
and a hole extending from said top surface
April 13, 2008– ‫ח' בניסן התשס"ח‬
722429
‫נעל בעלת סוליה רב–שכבתית‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
to said bottom location; a protrusion (46)
extending from said footbed through said
first layer to said bottom location of said
second layer; and said protrusion is
integrally connected to said footbed so that
said protrusion and said footbed define a
single unit.
804
________
]44[]04[
]01[
FIBER OPTIC CIRCUIT BOARD
LINK
]00[
]04[
]04[
18.03.2004
Int. Cl.8 G02B 006/12, H04B 010/00
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]00[
SHIMON WASSERMAN, RONEN
BETMAN
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]01[
[57] A device for fiber optic free-space
optical communication between electronic
components, the device comprising:
(a) at least a first electronic component
including:
(i) at least a first fiber optic transceiver;
(ii) at least a first optical fiber having a
connection end that is connected to said
first fiber optic transceiver and a first
terminal free-end; and
(iii) at least a first alignment mechanism
configured to support said first optic fiber
and align said first terminal free-end;
and
(b) at least a second electronic component
805
722410
‫חיבור לוח אם באמצעות סיב אופטי‬
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫ רונן בטמן‬,‫שמעון וסרמן‬
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, .4.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
including:
(i) at least a second fiber optic transceiver;
(ii) at least a second optical fiber having a
connection end that is connected to said
second fiber optic transceiver and a second
terminal free-end; and
(iii) at least a second alignment mechanism
configured to support said second optic
fiber and align second said terminal freeend;
wherein, when said first and said second
electronic components are deployed, said
first and said second terminal free-ends are
aligned such that light emitting from one
of said first and said second terminal freeApril 13, 2008– ‫ח' בניסן התשס"ח‬
ends is received by the other of said first
and said second terminal free-ends, and
thereby transmitted to a corresponding one
of said first and said second transceivers,
thereby establishing optical
communication between said first and said
second transceivers across the free-space
separating said first and said second
terminal free-ends.
_________
]44[]04[
]01[
PASSIVE OPTO-ELECTRONIC
MONITORING DEVICE
]00[
]04[
]04[
]04[
]00[
]01[
01.10.2002
01/12667
]00[ 02.10.2001
Int. Cl.8 G02B 017/08
THALES, FRANCE
WO/2003/029876
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] An optronic passive surveillance
device, comprising a front optic (1) of
given useful instantaneous field, means (2)
for scanning a scene with a given total
field of observation, means (3) for forming
the image of the scene and means (4) for
April 13, 2008– ‫ח' בניסן התשס"ח‬
727712
‫אלקטרוני פסיבי‬-‫התקן ניטור אופטו‬
]00[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
detecting said image, characterized in that
the detection means comprise a twodimensional matrix detector (41), the field
of the detector along each of the
dimensions being greater than or equal to
said useful instantaneous field of the front
806
optic along said dimension, and allowing
the acquisition, for each elementary area of
the scene corresponding to the useful
instantaneous field of the front optic, of N
subimages formed on said detector (N≥1),
with a given integration time for each
subimage, and in that the device includes
counterscanning means (6) to make it
possible to compensate for the movements
of the image that are due to the scanning of
the scene during the acquisition of the N
subimages.
_________
]44[]04[
]01[
METHOD FOR DETERMINING A
SEISMIC WAVE VELOCITY
MODEL IN A HETEROGENEOUS
UNDERGROUND FORMATION
]00[
]04[
]04[
]04[
26.04.2004
03/05292
]00[ 29.04.2003
Int. Cl.8 G01V 001/28
INSTITUT FRANCAIS DU
PETROLE, FRANCE
KARINE BROTO
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] A method for determining a velocity
model of seismic waves picked up by
seismic receivers coupled with an
underground formation, in response to the
807
727223
‫שיטה לקביעת מודל מהירות של גל‬
‫סיסמיב מבנה תת–קרקעי הטרוגני‬
]00[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
emission of subsoil seismic waves by a
seismic source, after reflection by geologic
interfaces of the formation, from multioffset records of the waves, for each
April 13, 2008– ‫ח' בניסן התשס"ח‬
seismic event located for the multi-offset
records and for each layer delimited by the
interfaces comprising:
(a) from the prestack seismic records,
constructing an iso-offset collection from
which kinematic information or travel
times associated with the event are
extracted;
(b) selecting a velocity distribution around
a reference velocity in the layer, that is
sampled with a predetermined interval;
(c) for each velocity sample, applying an
inversion technique at a fixed velocity so
as to determine, from the travel times
extracted from the iso-offset collection, a
geometry of the interface for the velocity
sample in order to obtain a series of
interface/velocity pairs for the event;
(d) calaculating the kinematic information
associated with each obtained
interface/velocity pair, for source-receiver
pairs corresponding to multi-offset
collections existing in the multi-offset
seimic records;
(e) for each interface/velocity pair and for
each multi-offset collection selected,
evaluating coherence between calculated
multi-offset travel times and the seismic
records, and selecting for each multi-offset
collection a travel time curve showing
maximum coherence with the seismic
records;
(f) applying a prestack kinematic inversion
method using the multi-offset travel times
obtained for all the multi-offset collections
selected, in order to determine a geometry
and a velocity of the layer being
considered; and
(g) iterating n times steps (a) to (f) by
considering for each iteration a velocity
model obtained during a previous iteration
as a reference velocity model to define the
reference velocity, and wherein n is an
integer.
________
]44[]04[
]01[
METHOD FOR
MANUFACTURING
MULTIFOCAL LENSES
]00[
]04[
]04[
]04[
17.10.2002
003991
]00[ 02.11.2001
Int. Cl.8 G02C 007/06
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE), FRANCE
WO/2003/040807
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method for manufacturing a
progressive addition spectacle lens,
comprising depositing on at least a portion
April 13, 2008– ‫ח' בניסן התשס"ח‬
727172
‫שיטה לייצור עדשות רב–מוקדיות‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
of a surface of a lens substrate at least one
layer of surface forming amount of an
inorganic high refractive index material,
808
wherein the material is deposited under
conditions suitable so that the material
forms on the lens substrate surface a
progressive surface.
__________
]44[]04[
]01[
HOLLOW WEDGE SHAPE LIGHT
GUIDE FOR BACK
ILLUMINATION
]00[
]04[
30.10.2002
60/336350
]00[ 02.11.2001
001000
0614610660
Int. Cl.8 G02B 006/10
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2003/040816
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] A hollow wedge shaped light guide
comprising:
(a) a rectangular input aperture having
parallel opposing top and bottom edges
and parallel opposing side edges (30);
(b) a transparent top planar sheet (10)
orthogonally affixed to the top edge of said
rectangular aperture;
(c) a bottom planar sheet (20) affixed to
the bottom edge of said rectangular
aperture, wherein said bottom planar sheet
slopes toward said top planar sheet,
forming a gap between the top planar sheet
and the bottom planar sheet that decreases
along the length of said light guide;
809
727120
‫מוליך אור חלול דמוי טריז לתאורה‬
‫אחורית‬
]00[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
(d) wherein said top planar sheet further
comprises a top surface having total
internal reflecting features thereon, said
total reflecting features comprising
a plurality of right triangle cross-sections
(11) that run for substantially the length of
said top planar sheet perpendicular to said
top edge of said rectangular aperture; and
(e) wherein said bottom planar sheet
includes reflective light extraction features
(21) on one surface,
said light extraction features including
surfaces that are angularly displaced from
being parallel to rectangular aperture by a
predefined clocking angle.
April 13, 2008– ‫ח' בניסן התשס"ח‬
________
]44[]04[
]01[
OPTICAL MEASUREMENTS OF
ARTICLES WITH PERIODIC
PATTERNS
]00[
]04[
]04[
27.05.2004
Int. Cl.8 G01N 021/88
NOVA MEASURING
INSTRUMENTS LTD.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]01[
[57] A method for use in
measuring/inspecting an article having a
substantially periodic pattern, the method
comprising applying optical measurements
to a measurement site on the article by
illuminating the measurement site with a
plurality of wavelengths at substantially
normal incidence of the illuminating light,
April 13, 2008– ‫ח' בניסן התשס"ח‬
720744
‫מדידות אופטיות של פרטים בעלות תבניות‬
‫מחזוריות‬
‫ רחובות‬,‫נובה מכשירי מדידה בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
detecting light returned from the
illuminated site, and generating measured
data indicative thereof, wherein the
measurements are applied to the
measurement site through a polarizer
rotatable between its different orientations
selected from a number of pre-calibrated
orientations.
810
________
]44[]04[
]01[
CLAMP WITH CLAMP FORCE
SENSOR
]00[
]04[
]04[
]00[
]01[
01.06.2004
Int. Cl.8 B25B 001/20
TEFENTOOLS LTD.
DAVID KLEIN, ZION BEN-GIGI
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.
REHOVOT 76209
[57] A clamp comprising: at least one
clamping element and a hand-operated
actuator operative to move the at least one
clamping element in a clamping direction;
and a clamping force sensor in operative
connection with said at least one clamping
element, wherein said clamping element
811
720047
‫מלחצת בעלת חיישן לכח לחיצה‬
‫ איזור התעשיה תפן‬,‫תפנטולס בע"מ‬
‫גיגי‬-‫ ציון בן‬,‫דוד קליין‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,07 ‫חדר‬, 02 ‫מנוחה ונחלה‬
comprises a clamping jaw, and wherein
said clamping force sensor is disposed on a
clamping face of said clamping jaw, and
wherein said clamping force sensor is in
operative connection with a clamping force
indicator.
April 13, 2008– ‫ח' בניסן התשס"ח‬
________
]44[]04[
]01[
COLLISION AVOIDANCE
SYSTEM AND A METHOD
THEREOF
]00[
]04[
]04[
29.06.2004
Int. Cl.8 G08G 001/0969, 001/16
ISRAEL AEROSPACE
INDUSTRIES LTD.
]01[ REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A collision avoidance system
mounted onboard a rotary-winged host
vehicle participating in a data link
communication network, comprising: an
Inertial Navigation System (INS)
providing inertial motion information; a
Global Positioning System (GPS) receiver
providing position information and time
synchronization; a data link radio for
receiving data indicative of state
information of at least one participant
vehicle; a central processing unit
configured for receiving said inertial
motion information from said INS, said
April 13, 2008– ‫ח' בניסן התשס"ח‬
720121
‫שיטה ומערכת למניעת התנגשות‬
‫ לוד‬,‫התעשייה האוירית לישראל בע"מ‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
position information and time
synchronization from said GPS and said
data indicative of state information of said
at least one participant from the data link
radio, and for producing a collision
avoidance data regarding said host and
said at least one participant; at least one
display unit for presenting said collision
avoidance data, wherein said central
processing unit is further configured, in the
case that state information in respect of
said participant is not received, for
providing approximated data indicative of
state information of said participant based
812
on previously received data indicative of
state information of said participant; and
for a duration that does not exceed a
predetermined value, using said
approximated data for generating collision
avoidance data regarding said host and
said participant, thereby enabling
overcoming discrepancies in said state
information of said participant due to rotor
interruption.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
8696 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
5866836
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
]01[
DIRECT CONVERSION WITH
VARIABLE AMPLITUDE LO
SIGNALS
]00[
]04[
]04[
]04[
14.11.2003
10/295639
]00[ 15.11.2002
Int. Cl.8 H04B 001/30
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/047324
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]00[
]01[
[57] An integrated circuit (120)
comprising: a local oscillator (LO)
generator (144) operative to receive a
voltage controlled oscillator (VCO) signal
813
720131
‫המרה ישירה עם סיגנלים בעלי‬
‫אמפליטודה משתנה של מתנד מקומי‬
]00[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(142) and generate an LO signal having a
variable amplitude and a frequency that is
related to the frequency of the VCO signal;
and a variable gain amplifier (132)
April 13, 2008– ‫ח' בניסן התשס"ח‬
operative to receive a first control signal
and adjust the amplitude of the LO signal
based on the first control signal, wherein
the variable amplitude LO signal is used
for frequency upconversion of an input
signal to obtain an output signal.
5868889
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
722273
]01[
MUNICIPAL WIRELESS
PARKING MONITORING
SYSTEM AND METHOD
]00[
]04[
]04[
02.08.2004
Int. Cl.7 G06Q 003/000000 G07B 015/02
BERMAN REUBEN
AVRAHAM DAHAN
ITZHAQ DANINO
]01[
BERMAN REUBEN,
16 ZALMAN ARAN ST.
BEER-SHEVA 84789
[57] A parking monitoring system (100)
comprising: a control center (400) having a
computer (400), transceiver (410), and
database (420) which associates each
authorized user name with a specified car
license plate number and a specified
cellular phone number (240), one or more
wireless mobile terminals (310), each of
which in data communication with said
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שיטה ומערכת אלחוטית לניטור חניונים‬
‫עירוניים‬
‫ באר שבע‬,‫ברמן ראובן‬
‫ באר שבע‬,‫אברהם דהאן‬
‫ אופקים‬,‫יצחק דנינו‬
,‫ברמן ראובן‬
‫ באר שבע‬,09‫רח' ארן זלמן‬
control center and being associated with
different municipal inspector (300); and
one or more requesting cellular phones by
which a request signal for initiating a
parking operation for corresponding
parked car is transmittable to said control
center, wherein said control center is
provided with means for preventing each
mobile terminal from issuing a ticket
814
when parked car is engaged in a parking
operation and for enabling each mobile
terminal to issue a ticket when a parked car
is not engaged in a parking operation.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
8696 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
5866496
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
815
722273
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫תהליך ריאקטיבי של אלקילציה בזיקוק‬
‫הכולל בתוכו רגנרציה של הזרז‬
]01[
REACTIVE DISTILLATION
ALKYLATION PROCESS
INCLUDING IN SITU CATALYST
REGENERATION
]00[
]04[
]04[
]04[
16.01.2003
090859
]00[ 05.03.2002
]00[ US
Int. Cl.8 B01D 003/00, B01J 029/90, 038/56, C07B 061/00
SASOL NORTH AMERICA INC.,
U.S.A.
WO/2003/076074
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A process for the regeneration of a
solid acid alkylation catalyst in a reactive
distillation alkylation process taking place
in a pressurized distillation column
including an intermediate reactive catalyst
zone having supported therein a solid acid
alkylation catalyst, a first rectification zone
at the top of the distillation column and a
second rectification zone including a
reboiler below said reactive catalyst zone
wherein at least a portion of an olefincontaining feedstock is brought into
contact with at least a portion of an
aromatic hydrocarbon feedstock in
counter-current flow within the reactive
catalyst zone, wherein the internal pressure
in the reactive catalyst zone is maintained
above one atmosphere and the temperature
maintained at reflux of said aromatic
hydrocarbon feedstock comprising:
(A) periodically ceasing the introduction
into the distillation column of the olefin-
April 13, 2008– ‫ח' בניסן התשס"ח‬
containing feedstock while continuing the
flow of aromatic hydrocarbon feedstock
and introducing into the column an
effective amount of a paraffin feedstock at
a point such that the paraffin feedstock
intermixes in counter-current flow with the
refluxing unreacted aromatic hydrocarbon
feedstock as it flows through the catalyst to
remove by-products from the catalyst;
(B) adjusting the reflux rate of said
aromatic hydrocarbon to achieve a desired
temperature in the catalyst reaction zone
above about 175oC at a column operating
pressure within the range of from about
125 to about 370 psig;
(C) separating said by-products from said
paraffin and aromatic hydrocarbon in said
second rectification zone; and
(D) removing said by-products from said
rectification zone.
816
________
]44[]04[
]01[
BATCHWISE QUILTING OF
PRINTED MATERIALS
]00[
]04[
]04[
]04[
26.02.2003
60/361127
]00[ 01.03.2002
Int. Cl.8 D05B 011/00, 021/00
L&P PROPERTY MANAGEMENT
COMPANY, U.S.A.
WO/2003/074772
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A method of quilting a material
having printing thereon comprising:
feeding, into a quilting station of a quilting
machine, a layer of a material having
coded information thereon that relates to a
product to be quilted on the material, the
layer of material having one or more of the
following properties: the material has
printed thereon a series of panels printed
on the material and wound onto a roll in an
order that is opposite the order in which
the panels are to be quilted, the coded
information contains information of the
amount of shrinkage expected to occur
817
722103
‫רפוד של חומרים מודפסים‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
during quilting and the layer of material
has printed thereon one or more panels
having a longitudinal dimension increased
by said amount, and the coded information
contains information of the amount of crop
to be made between adjacent ones of a
plurality of panels to be quilted from the
layer of material; reading the coded
information from the material with a
sensor at the quilting machine; quilting the
material at the quilting station in
accordance with the information read from
the material with the sensor.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
729200
‫תולדות פוספטיות של פלואורואקסאינדול‬
‫ותכשירי רוקחות המכילים אותן‬
]01[
PHOSPHATE DERIVATIVES OF
FLUOROOXINDOLE AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]00[
]04[
]04[
20.03.2003
60/366010
]00[ 20.03.2002
]00[ US
Int. Cl.8 A61K 031/675, A61P 009/00, 013/00, 015/00, 025/00, 025/08, 039/02, C07F
009/00, 009/572
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2003/080047
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]04[
]00[
]01[
[57] A compound of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
818
wherein the wavy bond
represents
the racemate, the (R)-enantiomer or the
(S)-enantiomer;
A is a direct bond or (C=O);
B is a direct bond, oxygen, or nitrogen;
m is 0 or 1;
n is 1, 2 or 3;
R1 and R2 each are independently
hydrogen, C1-6 alkyl, benzyl, 4methoxybenzyl, (lower) alkanoyloxy
(lower) alkyl, (lower) alkoxycarbonyloxy
(lower) alkyl, (lower) alkoxycarbonyl
(lower) alkyl, (5-methyl-2-oxo-1,3-dioxol4-yl) methyl or dihydroxypropyl; and
when R1 is hydrogen, R2 may also be
–P(O)OR5OR6 or heteroaryl; R3 and R4
each are independently hydrogen or C1-4
alkyl; and R5 and R6 each are
independently hydrogen, C1-6 alkyl,
benzyl, 4-methoxybenzyl, (lower)
alkanoyloxy (lower) alkyl, (lower)
alkoxycarbonyloxy (lower) alkyl, (lower)
alkoxycarbonyl (lower) alkyl, (5-methyl-2oxo-1,3-dioxol-4-yl) methyl or
dihydroxypropyl; or a nontoxic
pharmaceutically acceptable salt or solvate
thereof.
__________
]44[]04[
]01[
METHOD FOR COATING FIBERREINFORCED PLASTIC
STRUCTURAL PARTS AND
STRUCTURAL PART SO
PRODUCED
]00[
]04[
20.03.2003
10212415.9
]00[ 21.03.2002
4606/0441/
6016010660
Int. Cl.8 B29C 037/00
MENZOLIT-FIBRON GMBH,
GERMANY
WO/2003/080310
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]04[
]04[
]00[
]01[
[57] Method for refining surfaces of
structural parts made from fiber-reinforced
plastics materials that may be deformed by
means of extrusion or thermal molding,
characterized in that, firstly, a two-layer or
819
729212
‫שיטה לציפוי חלקי פלסטיק מתוגברי‬
‫סיבים וחלקים שיוצרו בשיטה זו‬
]00[
DE
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
three-layer co-extruded film with a dyed
layer for the refining of the construction
element is placed on a mold, which
displays the topography of the surface of
the structural part, in that the film already
April 13, 2008– ‫ח' בניסן התשס"ח‬
displays the final desired properties with
regard to the structure and color of the
surface, in that the film is deformed in
accordance with the topography of the
surface of the structural part, in that the
preformed film is inserted into a
corresponding mold, in that an already
impregnated fiber mat or a polymer melt is
placed in the mold facing the side of the
film that is not the surface, in that the
forming is done and/or the mat is
impregnated with resin and hardener under
vacuum and filled into the mold, and in
that, after cooling and/or hardening of the
fiber-reinforced plastics material, the
finished structural part consisting of the
film and the fiber-reinforced plastics
material bonded to it, is removed from the
mold.
________
]44[]04[
]01[
DEVICE FOR THE INJECTION
MOULDING OF MOULDED
BODIES MADE FROM PLASTIC
]00[
]04[
]04[
]00[
]01[
17.04.2002
Int. Cl.8 B29C 045/12
MONIKA WERNER, GERMANY
WO/2003/086729
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A device for the injection molding of
parts made of plastic, comprising an
injection molding machine (1) and a tool
(2) dedicated thereto, where said tool
contains at least two cavities (11, 12) that
correspond to the dimensions of the
molded parts to be produced, where the
tool comprises at least three parts which
are moveable in relation to each other, a
front part (4), a central part (5) and a rear
part (6), and which in the operating
position are firmly pressed against each
other by the pressure force of a pressure
generator (8) along separation planes (9,
10) that pass through the cavities and are
parallel to each other and at right angles to
the moving direction of the parts, and
where the tool contains at least one
channel for supplying molten plastic,
which on the one hand ends in the cavities
April 13, 2008– ‫ח' בניסן התשס"ח‬
729722
‫מתקן ליציקות הזרקה של גופים יצוקים‬
‫עשויים מפלסטיק‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
and on the other hand on the surface of the
tool which in the operating position is
connected to the injection molding
machine, characterized in that for the use
of a conventional, customary injection
molding machine a centrally located
channel (13) is provided in that front part
of the tool which extends from the inlet
area to a first separation plane, and
continues to the second separation plane
within the central part of the tool, the
channel having a conical shape within the
front part of the tool as well as in the
central part and partial channels (15, 16)
extending from the channel to the cavities,
and that a lock, which can be adjusted in
two positions, is located on the parts of the
tool, where after lifting of the pressure
force, from the pressure generator in a first
position only the central part and the front
820
part of the tool that contains the inlet area
of the channel are locked together, and in a
second position only the central part and
the rear part of the tool are locked together.
________
]44[]04[
729022
‫תערובת פיזור מוצקה‬
]01[
SOLID DISPERSION
COMPOSITION
]00[
]04[
]04[
]04[
]00[
]01[
15.04.2003
60/372416
]00[ 16.04.2002
Int. Cl.8 A61K 009/00, 009/14, 031/50
KOWA COMPANY, LTD., JAPAN
WO/2003/086405
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] A solid dispersion composition
containing 2-benzyl-5-(4-chlorophenyl)-6[4-(methylthio) phenyl]-2H-pyridazin-3.
]00[
US
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,94.0 .‫ד‬.‫ ת‬, 076 ‫רחוב הירקון‬
one, hydroxypropylmethyl cellulose, and
polyoxyethylene polyoxypropylene glycol.
__________
]44[]04[
821
729029
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
PROCESS FOR THE REMOVAL
OF NITROGEN OXIDES
]00[
]04[
]04[
]04[
]00[
]01[
21.03.2003
10215605.0
]00[ 09.04.2002
Int. Cl.8 B01D 053/86
UHDE GMBH, GERMANY
WO/2003/084646
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A process for reducing the content of
NOx and N2O in gases, in particular in
process gases and offgases, which
comprises the measures:
(a) addition of at least one nitrogencontaining reducing agent to the NOx- and
N2O-containing gas in at least the amount
required for complete reduction of the
NOx,
‫תהליך להסרה של תחמוצות חנקן‬
]00[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
(b) addition of a hydrocarbon, of carbon
monoxide, of hydrogen or of a mixture of
one or more of these gases to the NOx- and
N2O-containing gas for the reduction of
the N2O and
(c) introduction of the gas mixture into at
least one reaction zone at temperatures of
up to 450oC which contains one or more
iron-laden zeolites.
__________
]44[]04[
]01[
PROCESS FOR FORMING A
PLATINUM COATING
CATALYST LAYER
]00[
]04[
]04[
]04[
14.10.2003
2002-301423 ]00[ 16.10.2002
Int. Cl.8 B01J 021/04, 023/42
TADAHIRO OHMI, JAPAN
FUJIKIN INCORPORATED, JAPAN
]00[
]01[
WO/2004/035209
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A process of forming a platinum
coating catalyst layer in a moisturegenerating reactor where a moisturegenerating reactor having a platinum
coating catalyst layer on the inner wall
surface in the reaction space is formed and
hydrogen and oxygen supplied into the
reaction space are both brought into
April 13, 2008– ‫ח' בניסן התשס"ח‬
729019
‫תהליך ליצירת ציפוי פלטינה בשכבת מזרז‬
]00[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
contact with the platinum coating catalyst
layer and radicalized thereby so that the
radicalized hydrogen and oxygen are
reacted to generate moisture without high
temperature combustion wherein the
moisture-generating reactor is made of an
alloy containing aluminum, a principally
aluminum oxide (Al2O3)-composed barrier
822
film is formed by applying an aluminum
selective oxidation treatment on the inner
wall surface of the moisture generating
reactor, and thereafter a platinum layer is
stacked on and affixed to the barrier film
such that a platinum coating catalyst layer
is formed.
_________
]44[]04[
]01[
CHEWING GUM IN POWDER
FORM AND METHOD OF
PREPARATION
]00[
]04[
]04[
]04[
]00[
]01[
04.04.2003
02425209.0
]00[ 05.04.2002
Int. Cl.8 A23G 000/40600
GUM BASE CO. S.P.A., ITALY
WO/2003/084338
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] Method of producing chewing gum
in powder form, constituted by the
following steps:
(a) mixing of a soft basic gum with at least
one sweetener and, optionally, at least one
other typical chewing gum ingredient, at a
temperature of between about 35 and 75oC,
(b) cooling of the mixture thus obtained to
a temperature of between about 0 and 40oC,
(c) grinding and subsequent screening of
the mixture thus obtained to give a powder
729970
‫גומי לעיסה בצורת אבקה ושיטה להכנתו‬
]00[
EP
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
having a particle size less than about 10
mesh,
(d) mixing of the powder thus obtained
with at least one anti-agglutination agent,
(e) optional mixing of the powder thus
obtained with one or more of sweeteners,
flavourings, colourings, food acids, or
other additives,
(f) optional compression of the mixture
thus obtained.
__________
]44[]04[
823
729222
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מתקן העתקה‬
]01[
TRACING DEVICE
]00[
]04[
]04[
15.10.2004
Int. Cl.8 B41F 031/10, G09B 011/06
SHORASHIM GAMES WITH
DEPTH LTD.
]01[
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.
REHOVOT 76209
[57] A tracing device (10) comprising:
a mounting surface (12) for placing
thereon a design (14); a translucent
substrate (16) generally parallel to said
mounting surface for tracing the design
thereon; and a resting element (18)
extending from said mounted surface
‫ פתח‬,‫שורשים משחקים עם עומק בע"מ‬
‫תקוה‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,07 ‫חדר‬, 02 ‫מנוחה ונחלה‬
against which an edge of said design is
abuttable, wherein said resting element
connects said mounting surface to said
translucent substrate, said translucent
substrate being spaced from said mounting
surface to define a pocket in which the
design is placeable.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
729323
824
‫מכלול משקוף דלת‬
]01[
DOOR JAMB ASSEMBLY
]00[
]04[
]04[
27.10.2004
Int. Cl.8 E06B 001/04, 001/08, 001/18, 001/52, 001/56, 001/60
RAV BARIACH SECURITY
‫ יבנה‬,‫רב בריח מוצרי בטחון בע"מ‬
PRODUCTS LTD.
EYAL ARTSIELY
‫אייל ארציאלי‬
DEKEL PATENT LTD.,
,‫דקל פטנט בע"מ‬
18 MENUHA VENAHALA ST.
‫ רחובות‬,07 ‫חדר‬, 02 ‫מנוחה ונחלה‬
REHOVOT 76209
]00[
]01[
[57] A door jamb assembly comprising: a
door jamb (10), installable either as a
strike jamb (12) or hinge jamb, comprising
an outer face (14) configured to face an
outside (15) of a doorway (16), an inner
face (18) configured to face an inside (17)
of the doorway, and a door-edge face (20)
extending between the outer and inner
faces of the door jamb and configured to
face either a strike edge (22) or hinge edge
of a door (24), and a recess (30) formed in
the door-edge face, said recess being
distanced from both the outer and inner
faces, and configured to receive therein a
door retainer assembly (32) for a door to
move thereagainst, and wherein a groove
(26) is formed in the outer face generally
parallel to and spaced from the door-edge
face, and another groove (28) is formed in
the inner face generally parallel to and
spaced from the door-edge face
__________
]44[]04[
825
721077
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מוצרים לגרימת התחלת פעילות ותהליכים‬
‫לייצורם ולשימוש בהם‬
]01[
TRIGGERED START PRODUCTS
AND PROCESSES FOR THE
PRODUCTION AND USE
THEREOF
]00[
]04[
]04[
]04[
]01[
08.05.2003
146314
]00[ 15.05.2002
]00[ US
Int. Cl.8 A01N 025/26, B01J 002/00, C05F 011/08
OMS INVESTMENTS, INC., U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
P.O.B. 1426,
TEL AVIV 61013
[57] A coated triggered start product
comprising: a particulate core material
comprising at least one water soluble
active constituent, and at least one coating
layer applied on the particulate core
material; the coating layer causing the
product to exhibit "lock-off" type release
characteristics whereby release of the
active constituent of the core material from
the coated product is essentially
completely suppressed until release is
initiated by application of a trigger
material to the coating layer after the
product is exposed to moisture.
__________
]44[]04[
722992
‫תצמידי פלטינה בעלי פעילות נוגדת‬
‫גידולים המכילים חומצות מרה שעברו‬
‫שינוי כימי‬
]01[
PLATINUM COMPLEXES
CONTAINING CHEMICALY
MODIFIED BILE ACIDS HAVING
ANTITUMOR ACTIVITY
]00[
]04[
]04[
]04[
]00[
]01[
08.05.2003
MI2002A000992 ]00[ 10.05.2002
]00[ IT
Int. Cl.8 A61K 031/58, A61P 035/00, C07F 015/00, C07J 051/00
ICE S.R.L., ITALY
WO/2003/095462
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
‫אביב‬
TEL AVIV 61040
[57] Platinum (II) complex of the formula
April 13, 2008– ‫ח' בניסן התשס"ח‬
826
in which n is 0 or 1 and A is C or the CHCH group.
_________
]44[]04[
]01[
CRYO-SURGICAL APPARATUS
AND METHOD OF USE
]00[
]04[
]04[
]04[
07.07.2003
10/213568
]00[ 06.08.2002
Int. Cl.8 A61B 018/02, 018/14, 018/18
ERBE ELEKTROMEDIZIN GMBH,
GERMANY
WO/2004/012616
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]00[
]01[
[57] Cryosurgical apparatus comprising
an elongate cryoprobe (10) having a
proximal end (12b) a distal end (12a), a
cooling portion (16) adapted to be
positioned in tissue (70) to be treated and
operative to cool tissue to form an ice ball
(72) in such tissue upon activation, and an
electrically conductive first portion (12),
an energy conducting element (14) coupled
to said cryoprobe and having an
827
722227
‫מתקן קריו–ניתוחי ושיטה לשימוש בו‬
]00[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,00922 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
electrically conductive second portion (46)
in a region spaced from said first portion,
electrical insulation (38) interposed
between said first portion and said second
portion, and a source (66) of
electromagnetic energy operatively
connected to one of said first portion and
second portion operable to produce heating
of tissue in the region of said iceball to
control the configuration of the iceball.
April 13, 2008– ‫ח' בניסן התשס"ח‬
_________
]44[]04[
]01[
PROCESS FOR THE
MANUFACTURE OF FROZEN
AERATED PRODUCTS
]00[
]04[
]04[
]04[
01.08.2003
02255801.9
]00[ 20.08.2002
Int. Cl.8 A23G 009/20, 009/28
UNILEVER PLC, UNITED
KINGDOM
WO/2004/017748
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
April 13, 2008– ‫ח' בניסן התשס"ח‬
722119
‫תהליך ליצור תוצרים קפואים מאווררים‬
]00[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
828
[57] Process for the manufacture of
frozen aerated products comprising;
providing two separate forming elements,
providing at least one open cavity on a
surface of each forming element, providing
filling devices for filling said cavities with
a frozen aerated material, filling two
cavities, one on each forming element,
with a frozen aerated material, wherein
(a) at least one of the cavities is filled with
a frozen aerated product having an overrun
of between 30% and 130%,
(b) this product is then allowed to expand
outside its cavity,
(c) the two cavities are then moved
opposite one another and the frozen
aerated product in each cavity is pressed
against the frozen aerated product in the
other cavity.
________
]44[]04[
]01[
RADIATION-SELECTIVE
ABSORBER COATING WITH AN
ADHERENT OXIDE LAYER AND
METHOD OF MAKING SAME
]00[
]04[
]04[
]04[
]01[
24.02.2005
102004010689.4 ]00[ 27.02.2004
Int. Cl.8 B32B 003/00, F24J 002/48
SCHOTT AG, GERMANY
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] Absorber having a radiationselective absorber coating (3), having a
metal substrate, a diffusion barrier layer
(11), a metallic reflection layer (12), a
cermet layer (13) and an antireflection
721232
‫ציפוי קולט קרינה בררני עם שכבת‬
‫אוקסיד נדבקת ושיטה ליצורו‬
]00[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
‫אביב‬
coating (14), characterized in that the
diffusion barrier layer is an oxide layer
which consists of oxidized components of
the metal substrate.
_________
]44[]04[
829
721292
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מערכת קירור למנוע בעירה פנימית ערבה‬
‫פעימות‬
]01[
COOLING SYSTEM FOR A
FOUR-STROKE INTERNAL
COMBUSTION ENGINE
]00[
]04[
]04[
]01[
24.03.2005
Int. Cl.8 F01P 001/00, 001/02, 005/00, 005/02, 005/06
SERGEI LATYSHEV
SERGEI LATYSHEV,
JASMIN ALLEY 2/6, JERUSALEM
93750
[57] A cooling system for a four-stroke
internal combustion engine comprising:
(a) a compressor (1) rigidly connected to
the engine body (12) and designed for the
supply of air under high pressure to the
working cylinder (8) of the engine;
(b) an air inlet manifold (7A) connecting
said compressor with said working
cylinder and designed for an entry of fresh
air into working cylinder of the engine;
‫ ירושלים‬,‫סרגיי לטישב‬
,‫סרגיי לטישב‬
‫ ירושלים‬,0/9 ‫מבוא יסמין‬
(c) inlet (9A) and exhaust (9B) valves are
situated on the walls of the combusting
chamber of said working cylinder and are
set into motion through cams of a gas
distribution system designed both for gas
distribution, compressor supercharging in
engine operation and for cooling of inside
walls of said working cylinder and engine
exhaust manifold by blowing air under
high pressure from said compressor.
________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
721133
830
]01[
WATER DISPENSER AND FILTER
CARTRIDGE FOR USE THEREIN
]00[
]04[
]04[
]04[
31.03.2005
60/559351
]00[ 02.04.2004
Int. Cl.8 B67D 001/16
TANA INDUSTRIES (1991) LTD.
]01[
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A water dispenser (100) comprising:
a water inlet adapted to receive water from
a water supply; a water filter operative to
filter water received from said water
supply via said water inlet; a water outlet
(120) operative to provide filtered water
received from said water filter; a water
spill collector (116) and a pivotably
mounted drainage-equipped water
container support (108) having a first
operative orientation underlying said water
outlet and defining a downwardly inclined
water spill drainage pathway
The applications for division
from this application have
not yet been published
‫מתיז מים ופילטר נייד ושימוש בתוך מתיז‬
‫המים‬
]00[
US
‫ אור‬,‫) בע"מ‬0660( ‫חברת תנה תעשיות‬
‫יהודה‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,007: .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
communicating with said water spill
collector and a second, non-operative,
orientation not underlying said water
outlet, said pivotably mounted drainageequipped water container support
comprising a perforated grid element (150)
which is seated in a recess (152) formed in
a tray element (154), having a drain
aperture (155), said tray element being
attached to a pivotable tray element
support (156) which is pivotably supported
onto a chassis by means of a pair of pivot
axle assemblies.
5868896586889858688995868895
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
_________
]44[]04[
831
721422
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
POWER SUPPLY FOR A FOUR
COLOR MODULAR PRINTHEAD
]00[
]04[
]04[
]00[
]04[
07.12.2000
PQ4559
]00[ 09.12.1999
Int. Cl.8 B41J 002/145
DIVISION FROM 149966
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/042022
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]00[
]01[
[57] An inkjet printhead assembly (10)
comprising:
an elongate support member (14) for
mounting in an inkjet printer, the support
member having an ink reservoir (16) with
an ink outlet; a printhead module (12) with
ink ejection nozzles and an ink inlet in
fluid communication with the nozzles; the
printhead module and the support having
mutually interengeable snap locking
‫ספק כוח עבור ראש מדפסת מודולרי בעל‬
‫ צבעים‬4
]00[
AU
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,.:.0 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
formations for mounting the printhead
module to the support member such that
the ink outlet establishes fluid
communication with the fluid inlet; and a
resilient seal element for creating a fluid
seal between the ink inlet and the ink
outlet when the module is mounted to the
support member and simultaneously
maintaining the snap locking formation in
firm engagement.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
723227
832
‫מפעיל חומני עם אגני חום‬
]01[
THERMAL ACTUATOR WITH
HEAT SINKS
]00[
]04[
]04[
]00[
]04[
20.04.2000
PP9931
]00[ 22.04.1999
]00[ AU
Int. Cl.8 B41J 002/05, 002/35, B81B 003/00
DIVISION FROM 145972
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/064804
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A thermal actuator (7) for a micro
electro-mechanical device (1), the actuator
comprising a first conductive material arm
(11) which is attached at one end to a
substrate and which, at its other end, is
connected to or integrated with a movable
element, the first arm being arranged, in
use, to be heated by passage of electrical
current and the first arm being formed
along its length with a profile that
functions to concentrate heating in the arm
to a region adjacent the attachment to the
substrate, the actuator further comprising
one or more heat sinks in a central portion
of the arm.
________
]44[]04[
833
723931
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מדחס בוכנה‬
]01[
PISTON COMPRESSOR
]00[
]04[
]04[
]04[
09.12.2003
10257951.2
]00[ 12.12.2002
]00[
Int. Cl.8 F04B 027/04, 039/10, F25B 009/14
LEYBOLD VACUUM GMBH,
GERMANY
WO/2004/053331
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]00[
]01[
[57] Piston compressor comprising: a
piston (12) which oscillates in a cylinder
(14) and, in filling position, compresses
gas in a cylinder pressure space (20), gas
bearing nozzles (28) arranged in the piston
area for gas-supporting the piston, a
compressed-gas accumulator (34)
connected with the gas bearing nozzles, a
compressed-gas supply line (18) between
the cylinder pressure space and the
compressed-gas accumulator, and an inlet
DE
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,0409 .‫ד‬.‫ ת‬, :0 ‫רח' יבנה‬
valve (42) in the compressed-gas supply
line, the inlet valve being open in the
filling position of the piston, characterized
in that the inlet valve is defined by a
cylinder wall opening (22) and a piston
wall opening (38) which, in the filling
position of the piston, are located opposite
each other and define an open valve, and,
in a non-filling position, are closed by the
piston wall (40) and the cylinder wall (24),
respectively, and define a closed valve.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
712222
834
CDMA ‫בקר לרשת רדיו‬
]01[
CDMA RADIO NETWORK
CONTROLLER
]00[
]04[
]04[
]00[
]04[
19.05.2000
60/135073
]00[ 20.05.1999
]00[ US
Int. Cl.8 H04J 013/00, H04L 012/56, H04Q 007/00
DIVISION FROM 146571
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2000/072608
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]00[
]01[
[57] A code division multiple access
(CDMA) radio network controller (RNC)
comprising: a medium access controllercontrolling/shared (MAC-c/sh) entity
having a flow control entity, the flow
control entity controls a flow of data by a
plurality of sources through a forward
access common channel (FACH), each
The applications for division
from this application have
not yet been published
source has a specified amount of data that
it is permitted to buffer for transfer over
the FACH, the flow control entity controls
the flow of the data for each source in
response to the specified amount and an
associated priority of the data for the
source.
5865484
‫בקשות חלוקה מבקשה זו‬
4‫שטרם פורסמו‬
________
]44[]04[
835
711211
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
METHOD FOR THE
PREPARATION OF
INTERMEDIATES USEFUL FOR
THE SYNTHESIS OF VITAMIN D
ANALOGUES
]00[
]04[
]04[
]04[
]00[
]01[
23.03.2005
60/558546
]00[ 02.04.2004
Int. Cl.8 C07C 401/00, C07F 009/40
LEO PHARMA A/S, DENMARK
WO/2005/095336
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
‫שיטה להכנת חומרי ביניים יעילים‬
D ‫לסינטזה של אנלוגים של ויטמין‬
]00[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4/9/ .‫ד‬.‫ ת‬, 00 ‫רחוב אחד העם‬
[57] A method of preparing a compound
of the formulae
April 13, 2008– ‫ח' בניסן התשס"ח‬
836
wherein R1 and R2 are the same or
different and represent hydrogen or a
hydroxy protecting group, and wherein R5
837
represents hydrogen or a hydroxy
protecting group; the method comprising
reacting a compound of the formulae
April 13, 2008– ‫ח' בניסן התשס"ח‬
wherein R1, R2 and R5 are as defined
above; with a phosphonate of the formula
wherein R3 and R4 are the same or
different and represent alkyl, haloalkyl,
hydroxyalkyl, alkenyl, alkynyl, aralkyl,
aralkenyl aralkynyl, aryl, each being
optionally substituted with one or more
substituents selected from the group
consisting of alkyl, aralkyl, cycloalkyl,
cycloalkenyl, haloalkyl, hydroxyalkyl,
alkenyl, alkynyl, aralkyl, aralkenyl,
aralkynyl, aryl, oxo, alkoxycarbonyl,
alkylcarbonyloxy, halogen, alkoxy,
carboxy, sulfo or hydroxy, in the presence
of a base.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
8696 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
711100
838
]01[
SYSTEM AND METHOD FOR
POWER GENERATION BY
HYDROTHERMAL MEANS
‫מערכת ושיטה לייצור אנרגיה על ידי‬
‫אמצעים הידרותרמיים‬
]00[
]04[
]04[
]04[
]00[
]01[
16.08.2006
60/732670
]00[ 03.11.2005
]00[ US
Int. Cl.8 F01D 001/00, 001/02, F24J 001/00
YAD KONENA LTD.
‫ ירושלים‬,‫יד כוננה בע"מ‬
SHMUEL TZIVYON
‫שמואל ציביון‬
YAD KONENA LTD.,
,‫יד כוננה בע"מ‬
P.O.BOX 6868
‫ ירושלים‬,9292 .‫ד‬.‫ ת‬, - ‫ לידי ציביון שמואל‬JERUSALEM 91068
[57] A system for generating power, said
communication with a single one of said
system comprising: a working liquid; a
first and second conduits, wherein at least
low-boiling point fluid flowing through the
a portion of said low boiling point fluid in
system with said working liquid; at least
said first tank absorbs energy from said
two flow-through tanks, including a first
energy collector and is thereby brought to
tank (1) and a second tank (2), through
its gas phase forming bubbles causing said
which said working liquid and said low
working liquid and said low boiling point
boiling point fluid flow; a first conduit (19)
fluid to flow from one of said first and
and a second conduit (13) for connecting
second flow-through tanks to the other and
and bringing said first and second flowthen back again, said flow passing through
through tanks into fluid communication
said first and second conduits, and said
with each other; an energy collector (11) in
working liquid while passing through at
thermal communication with said working
least one of said first and second conduits
liquid and said low boiling point fluid; and
transfers energy to said at least one power
at least one power generating means (7)
generating means thereby providing
each of which being in fluid
power.
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
8696 – ‫ תשכ"ח‬5‫הפטנטים‬
_________
839
April 13, 2008– ‫ח' בניסן התשס"ח‬
]44[]04[
]01[
BIPOLAR MAPPING OF
INTRACARDIAC POTENTIALS
]00[
]04[
]04[
]00[
]04[
]01[
04.07.2001
09/612490
]00[ 07.07.2000
Int. Cl.8 A61B 005/04, 005/042
DIVISION FROM 144153
BIOSENSE, INC., U.S.A.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] A method for measuring near-field
electrical activity at a location in a heart
comprising: introducing into the heart a
catheter comprising: an elongated tubular
body having a distal region and a
circumferential recess along the length of
the distal region, a first electrode mounted
on the distal region in close proximity to
the circumferential recess, and a second
electrode mounted within the
circumferential recess, the second
electrode being configured such the second
electrode is not is direct contact with heart
711397
‫מיפוי דו–פולרי לפוטנציאלים קרדיולוגיים‬
]00[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,0046/ .‫ד‬.‫ ת‬, 004 ‫אבן גבירול‬
tissue but is in contact with blood when the
distal region is positioned against heart
tissue at a side of the distal region;
positioning the distal region at the location
in the heart so that the first electrode is in
direct contact with heart tissue; obtaining a
first signal with the first electrode;
obtaining a second signal with the second
electrode; comparing the first signal and
the second signal to obtain the near-field
electrical activity at the location in the
heart.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
713472
840
]01[
AIRBORNE RF DECOY AND
METHOD FOR DECEIVING
RADAR-BASED MISSILES USING
IT
‫) ושיטה‬RF( ‫פתיון מוטס המשדר תדרי רדיו‬
‫להטעיית טילים מונחי מכ"ם על ידי ניצולו‬
]00[
]04[
]04[
26.10.2006
Int. Cl.8 F41H 011/02
RST REUT SYSTEMS &
ADVANCED TECHNOLOGIES
LTD.
]01[ PAULINA BEN-AMI, BEN-AMI &
ASSOCIATES,
P.O.B. 94,
REHOVOT 76100
[57] A stand-alone airbone RF decoy (20)
adapted for protecting an airbone platform
(10) against multiple enemy radar-based
threats (40) said airborne RF decoy
comprising:
(i) means for receiving a plurality of radar
signals from one or more directions;
(ii) means for storing said plurality of radar
signals;
‫ רעות מערכות וטכנולוגיות‬.‫טי‬.‫אס‬.‫אר‬
‫ רעננה‬,‫מתקדמות בע"מ‬
,'‫ בן עמי ושות‬, ‫עמי‬-‫פאולינה בן‬
‫ רחובות‬,64 .‫ד‬.‫ת‬
(iii) means for analyzing said plurality of
radar signals to identify threat parameters;
(iv) means for altering said plurality of
radar signals in order to deceive said
multiple enemy radar-based threats;
(v) means for transmitting the altered radar
signals; and
(vi) an independent power supply source.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
8696 – ‫ תשכ"ח‬5‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
________
]44[]04[
841
732911
April 13, 2008– ‫ח' בניסן התשס"ח‬
]01[
REMOVABLE SIZE INDICATOR
FOR A GARMENT HANGER
]00[
]04[
]04[
]00[
]04[
05.04.2002
09/827072
]00[ 05.04.2001
Int. Cl.8 A47G 025/14
DIVISION FROM 158169
SPOTLESS PLASTICS PTY. LTD.,
AUSTRALIA
WO/2002/080741
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]00[
]01[
[57] A triangular cross-section size
indicator (111a) to be removably secured
to a web (106a) of a garment hanger, the
size indicator comprising two sides (126,
128) depending from an apex (125)
defining a V-shaped channel (113), each of
the sides terminating in a foremost edge
(130, 132), the apex defining a trough
substantially configured to receive an
‫מציין גודל הניתן להסרה עבר קולב לדברי‬
‫לבוש‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
outermost portion of the web therebetween
for preventing a lateral movement of the
size indicator when the size indicator is
secured on the web, each of the sides
having an inwardly facing ridge (131a,
134b) disposed at each of the foremost
edges and projecting inwards towards the
V-shaped channel for engaging a fixed
ridge and a pivoting ridge on the web.
_________
]44[]04[
April 13, 2008– ‫ח' בניסן התשס"ח‬
732242
842
]01[
METHOD AND APPARATUS FOR
CASCADING DATA THROUGH
REDUNDANT DATA STORAGE
UNITS
]00[
]04[
]04[
]00[
]04[
]00[
]01[
12.10.1999
09/251812
]00[ 17.02.1999
Int. Cl.8 G06F 011/14
DIVISION FROM 139069
EMC CORPORATION, U.S.A.
WO/2000/049500
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] In a data processing network having
a production site, first and second remote
sites, a first communications link between
the production and first remote sites and a
communication link between the first and
second remote sites wherein the production
site includes a magnetic disk storage
device and a host adapted to update the
data in the magnetic disk storage device,
wherein the first remote site includes a first
data store that mirrors the data in the
magnetic disk storage device, a second
data store that operates in a first mode to
mirror the data on the first data store, first
and second tables for recording the
occurrence of any change in the data in
first data store and a copy programme and
wherein the second remote site includes
another data store, the data processing
network being characterized by a method
for providing a backup of the data at the
production site in each of the first and
second remote sites by:
(a) establishing in the first remote site a
third table for recording the need for any
transfer of data from the second data store
‫שיטה והתקן להעברה מדורגת של נתונים‬
‫דרך יחידות איחסון מידע יתרות‬
]00[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,0:.0 .‫ד‬.‫ ת‬,
the data in the data store in the second
remote site corresponds to the data in the
first data store at a point in time;
(c) re-establishing the first operating mode
for the second data store by combining
information in the first and third tables to
identify the changes made to the first data
store while the second data store was
operating in the second operating mode,
and
(d) differentially splitting, after
synchronism is achieved between the first
and second data stores, the second data
store from the first data store by:
(i) copying the information in the second
table to the third table,
(ii) clearing the second table, and
(iii) enabling the copy programme to
transfer the changed data in the second
data store to the data store in the second
remote site whereby the data store in the
second remote site is brought into
synchronism with the data that existed in
the first data store at the time of said
differential splitting.
to the data store in the second remote site;
(b) initially establishing a state whereby
843
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫__________‬
‫‪844‬‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
‫פטנטים‬
‫‪PATENTS‬‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪400010‬‬
‫‪400040‬‬
‫‪400000‬‬
‫‪40640/‬‬
‫‪401000‬‬
‫‪410/06‬‬
‫‪410066‬‬
‫‪410000‬‬
‫‪41/40/‬‬
‫‪41//00‬‬
‫‪41000/‬‬
‫‪401004‬‬
‫‪4000/4‬‬
‫‪414410‬‬
‫‪4060/6‬‬
‫‪404060‬‬
‫‪400600‬‬
‫‪400006‬‬
‫‪400000‬‬
‫‪401000‬‬
‫‪400016‬‬
‫‪400400‬‬
‫‪400001‬‬
‫‪40/400‬‬
‫‪400000‬‬
‫‪410/00‬‬
‫‪410/00‬‬
‫‪410000‬‬
‫‪41/400‬‬
‫‪41/001‬‬
‫‪4140//‬‬
‫‪401000‬‬
‫‪440100‬‬
‫‪40/000‬‬
‫‪406006‬‬
‫‪404010‬‬
‫‪400600‬‬
‫‪400000‬‬
‫‪400000‬‬
‫‪401000‬‬
‫‪400100‬‬
‫‪400/00‬‬
‫‪400410‬‬
‫‪400041‬‬
‫‪40/400‬‬
‫‪40060/‬‬
‫‪410000‬‬
‫‪410004‬‬
‫‪410006‬‬
‫‪41/600‬‬
‫‪41/000‬‬
‫‪414100‬‬
‫‪401440‬‬
‫‪400616‬‬
‫‪400010‬‬
‫‪406000‬‬
‫‪404000‬‬
‫‪404040‬‬
‫‪400006‬‬
‫‪40006/‬‬
‫‪401040‬‬
‫‪40000/‬‬
‫‪400000‬‬
‫‪400/00‬‬
‫‪400004‬‬
‫‪40/600‬‬
‫‪44000/‬‬
‫‪410060‬‬
‫‪410000‬‬
‫‪410000‬‬
‫‪41/604‬‬
‫‪41/14/‬‬
‫‪400/04‬‬
‫‪411//1‬‬
‫‪400/44‬‬
‫‪400004‬‬
‫‪406106‬‬
‫‪404160‬‬
‫‪404000‬‬
‫‪4001/1‬‬
‫‪4001/6‬‬
‫‪401100‬‬
‫‪4000/0‬‬
‫‪400000‬‬
‫‪400/00‬‬
‫‪400066‬‬
‫‪400000‬‬
‫‪404006‬‬
‫‪400600‬‬
‫‪4100/0‬‬
‫‪41006/‬‬
‫‪41/604‬‬
‫‪41/04/‬‬
‫‪400400‬‬
‫‪411000‬‬
‫‪400/06‬‬
‫‪400601‬‬
‫‪406110‬‬
‫‪404006‬‬
‫‪404000‬‬
‫‪40016/‬‬
‫‪4000//‬‬
‫‪4010/0‬‬
‫‪400004‬‬
‫‪400000‬‬
‫‪400000‬‬
‫‪400010‬‬
‫‪400010‬‬
‫‪404001‬‬
‫‪400010‬‬
‫‪410004‬‬
‫‪410040‬‬
‫‪410/00‬‬
‫‪41/006‬‬
‫‪400101‬‬
‫‪410001‬‬
‫‪400000‬‬
‫‪400014‬‬
‫‪40600/‬‬
‫‪404400‬‬
‫‪404040‬‬
‫‪40001/‬‬
‫‪400001‬‬
‫‪401000‬‬
‫‪40000/‬‬
‫‪4060/6‬‬
‫‪400001‬‬
‫‪400000‬‬
‫‪400004‬‬
‫‪406/46‬‬
‫‪400600‬‬
‫‪410000‬‬
‫‪410040‬‬
‫‪410000‬‬
‫‪41/000‬‬
‫‪400400‬‬
‫‪410400‬‬
‫‪400406‬‬
‫‪40006/‬‬
‫‪406400‬‬
‫‪406000‬‬
‫‪404060‬‬
‫‪400016‬‬
‫‪400404‬‬
‫‪400010‬‬
‫‪400060‬‬
‫‪40/40/‬‬
‫‪400010‬‬
‫‪40004/‬‬
‫‪400106‬‬
‫‪406000‬‬
‫‪400606‬‬
‫‪410400‬‬
‫‪41006/‬‬
‫‪410006‬‬
‫‪41/400‬‬
‫‪406644‬‬
‫‪41041/‬‬
‫‪401/00‬‬
‫‪400000‬‬
‫‪406401‬‬
‫‪406000‬‬
‫‪404000‬‬
‫‪400010‬‬
‫‪400446‬‬
‫‪40000/‬‬
‫‪401000‬‬
‫פטנטים שחודשו‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
‫‪845‬‬
PATENTS RENEWED
/0000
/0006
/000/
/0010
/00/0
460000
46000/
460/00
460/00
46/600
46/600
46/410
46/400
400060
400000
400000
400000
400010
4000/0
400006
406000
404140
404010
404000
404000
404016
404/60
404/06
400400
400116
400/01
414640
410000
410400
410601
410001
410060
410044
41/1/6
406066
400400
4000//
400/0/
400116
401000
400660
/0100
/00/0
/0001
/0004
/0/60
460046
4600/0
460/10
460//4
46/616
46/600
46/404
46/40/
400600
400000
400000
40000/
400000
400/60
400000
4060/0
404101
404000
404006
404000
404000
404/44
400660
400400
400106
400001
41400/
410000
410101
410100
410000
410004
41004/
41/010
406064
400000
400040
400//0
400044
401010
40041/
/0010
/00/1
/0000
/0001
/0/6/
460000
4600/1
460/00
460//0
46/600
46/600
46/400
46/4/6
40060/
400010
400060
400006
400000
400/60
400006
406/00
404100
4040/0
404000
40400/
404000
404/40
400604
400410
400044
400014
414006
410001
410040
4101/0
41000/
410000
410001
41/040
404606
400011
400000
400400
400000
401046
4004/0
April 13, 2008– ‫ח' בניסן התשס"ח‬
/00/1
/0040
/0001
/0000
/0/00
460060
460/46
460/00
460//0
46/601
46/6/0
46/401
46/000
4000/6
400010
400040
4000/1
40000/
401440
400000
404614
404100
404061
40400/
404000
404000
404/40
400616
400400
400/0/
4006/0
4100/6
410000
410040
410060
410060
410016
410000
41/000
404006
400000
400004
400401
4000/0
401060
400000
/0060
/0006
/0006
/0004
/0/00
460000
460/44
460/00
460//0
46/600
46/460
46/406
46/0/1
40000/
40000/
400040
400066
400000
400040
400/06
404404
404100
404004
404001
404044
404006
404/11
400614
400000
401000
400010
41000/
41000/
410046
410000
410000
410000
41/60/
41/00/
404/00
4000/0
400/44
400400
400010
401040
400000
/0010
/0000
/0004
/0000
/0/00
460000
460/40
460/04
46/660
46/60/
46/441
46/400
440006
400040
400006
400040
400060
400000
400000
40/000
404010
4041/0
404016
4040/0
404040
404004
404/06
400600
400000
400000
400000
410110
411060
410000
410006
410000
4100/1
41/446
41//61
4006/0
400106
400/10
400000
401600
401000
400001
/0006
/0000
/0000
/0000
/0/01
460004
460/04
460/0/
46/66/
46/604
46/440
46/400
4401/4
400004
400004
400001
400040
400000
4000/1
40/000
4040/0
404040
404004
404010
404040
404000
404/00
400441
400000
400001
40/000
410006
411100
410000
410000
410060
410061
41/04/
406040
400460
400100
400/00
400006
401100
40100/
400001
/000/
/0000
/0010
/0000
/0//4
460000
460/01
460/06
46/640
46/600
46/400
46/400
4401/0
40001/
400000
400000
400004
4000/1
400006
40/000
404160
404010
404000
404006
404004
4040/0
404/00
400400
400006
400/60
416/00
410006
410006
410000
41000/
410061
410060
41/100
406000
400400
400000
400/00
400161
40110/
401/00
400101
846
‫‪400/04‬‬
‫‪4001/0‬‬
‫‪400000‬‬
‫‪400400‬‬
‫‪4000/4‬‬
‫‪40/000‬‬
‫‪404046‬‬
‫‪4014/0‬‬
‫‪406000‬‬
‫‪400000‬‬
‫‪400160‬‬
‫‪4000/0‬‬
‫‪400400‬‬
‫‪400006‬‬
‫‪40000/‬‬
‫‪4041/0‬‬
‫‪400004‬‬
‫‪400000‬‬
‫‪400010‬‬
‫‪400000‬‬
‫‪4000/4‬‬
‫‪400604‬‬
‫‪400046‬‬
‫‪400000‬‬
‫‪40400/‬‬
‫‪400000‬‬
‫‪400401‬‬
‫‪400000‬‬
‫‪400010‬‬
‫‪400000‬‬
‫‪400601‬‬
‫‪400060‬‬
‫‪400060‬‬
‫‪404400‬‬
‫‪40004/‬‬
‫‪400006‬‬
‫‪400000‬‬
‫‪400000‬‬
‫‪400040‬‬
‫‪400/60‬‬
‫‪400400‬‬
‫‪40010/‬‬
‫‪406/10‬‬
‫‪400461‬‬
‫‪400604‬‬
‫‪4006/0‬‬
‫‪400001‬‬
‫‪40040/‬‬
‫‪400044‬‬
‫‪4000//‬‬
‫‪400400‬‬
‫‪400000‬‬
‫‪406004‬‬
‫‪400000‬‬
‫‪400166‬‬
‫‪4006/4‬‬
‫‪400010‬‬
‫‪400601‬‬
‫‪400000‬‬
‫‪400000‬‬
‫‪400400‬‬
‫‪400040‬‬
‫‪406001‬‬
‫‪400406‬‬
‫‪400010‬‬
‫‪404044‬‬
‫‪4001/0‬‬
‫‪400604‬‬
‫‪400001‬‬
‫‪400000‬‬
‫‪400401‬‬
‫‪4000/0‬‬
‫‪406600‬‬
‫‪404004‬‬
‫‪401114‬‬
‫‪40410/‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
‫‪847‬‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
/460/
/4000
460100
460006
460000
440040
404146
400000
400006
406004
41106/
410100
400006
/4464
/4000
460100
460016
460011
44/440
404110
4000/0
400006
40/400
411000
410000
400040
/4400
/400/
4601/4
460000
460000
44/0/0
404110
4000//
400100
414060
410461
41/410
400/00
/4400
4600/1
4601/0
460001
460000
44/0//
404100
400/00
400061
410010
410460
404000
/44/1
460100
4601/0
460000
460000
44/006
404104
400606
400060
410011
410016
400/01
/4006
460100
460060
4600/0
460000
44/004
404000
400406
40/60/
410040
410066
401401
/4000
46010/
46006/
4600/0
460006
40400/
404000
400404
40/400
411000
410010
401001
/4006
460100
460044
460060
4600/4
4040/6
404001
4004/4
40/400
411000
410101
401000
‫פטנטים שחודשו לעשרים שנה‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
848
PATENTS RENEWED FOR 20 YEARS
410001
‫פטנטים שפג תוקפם‬
849
April 13, 2008– ‫ח' בניסן התשס"ח‬
PATENTS EXPIRED
06044
04100
NOTICE
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הודעה‬
850
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
4000/0
4690660
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫יעקב גוגנהיים‬
YAKOV GUGENHIM
:‫שם האמצאה‬
Title of invention:
‫הדמיה אקוסטית‬
ACOUSTIC IMAGING
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
NOTICE
851
‫כל אדם רשאי להתנגד‬
‫לבקשה האמורה תוך‬
‫שלושה חודשים מתאריך‬
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
0692
‫הודעה‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
4001/0
4690660
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫מנחם קראוס‬
MENAHEM KRAUS
:‫שם האמצאה‬
‫תומך ממברנה לתא טפטוף‬
MEMBRANE SUPPORT FOR DRIP CHAMBER
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0692
Title of invention:
April 13, 2008– ‫ח' בניסן התשס"ח‬
852
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
400014
4690660
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫אריה סנסולו‬
ARIE SANSOLO
:‫שם האמצאה‬
‫התקן מדמה נפץ‬
EXPLOSION SIMULATION DEVICE
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0692
Title of invention:
853
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
400401
4090660
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
VISSON IP, LLC
Title of invention:
:‫שם האמצאה‬
‫מתקן אלקטרולומינסי ושיטה לייצורו‬
ELECTROLUMINESCENT DEVICE AND METHOD OF MANUFACTURING SAME
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0692
April 13, 2008– ‫ח' בניסן התשס"ח‬
854
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
410040
4490660
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
PLAIN SIGHT SYSTEMS, INC.
Title of invention:
:‫שם האמצאה‬
‫ ספקטרומטר ומכשיר הדמייה המשתמש במערך מיקרו–מראה‬,‫מסנן קרינה‬
RADIATION FILTER, SPECTROMETER AND IMAGER USING A MICRO-MIRROR
ARRAY
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0692
855
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הודעה‬
NOTICE
‫ לחוק‬9/ ‫לפי סעיף‬
0697-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
410600
4090661
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
JOSEPH A. MCGILL
Title of invention:
:‫שם האמצאה‬
‫עמעמת מתכווננת עבור מערכות איוורור‬
ADJUSTABLE DAMPER FOR AIRFLOW SYSTEMS
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
60 ‫ לחוק ובתקנה‬90 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
0692
April 13, 2008– ‫ח' בניסן התשס"ח‬
856
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
857
44/660
090666
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0692
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
April 13, 2008– ‫ח' בניסן התשס"ח‬
410400
/90660
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0692
858
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
859
406044
/90660
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0692
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
April 13, 2008– ‫ח' בניסן התשס"ח‬
40/400
490660
,‫ לחוק הפטנטים‬99 ‫לפי סעיף‬
0697-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬97 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.0692
860
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי שם הבעלים‬
CHANGE OF NAME OF PROPRIETORS
No. of Patent:
Previous name:
4000/1 ,400104 ,4006/0 ,440000 ,460001
:‫מס' פטנט‬
:‫השם הקודם‬
NOVEON, INC
:‫השם החדש‬
New name:
LUBRIZOL ADVANCED MATERIALS, INC.
861
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫שינויים בכתובת‬
CHANGES IN ADDRESS
:‫מס' המדגם‬
:‫הכתובת החדשה‬
No. of design:
34118, 34119
New address:
14 Siriusdreef Hoofddorp, The Netherlands
2132 WT
No. of design:
38984, 38985, 38986,
38987, 40574, 40575,
40576, 40577, 40578,
41218, 41219, 41220,
41221, 41222, 41223,
41224, 41225, 41226,
41227, 41228, 41229,
New address
41230, 41231, 41232
:‫מס' המדגם‬
:‫הכתובת החדשה‬
Arastirma Teknoloji Gelistirme Merkezi
34950 Tuzla, Istanbul, Turkey
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
862
‫תיקוני טעויות‬
CORRIGENDA
Journal
P. 4496 Patent application No. 166282
Correct name of applicant toLUZZATTO & LUZZATTO
P.O.B. 5352
BEER-SHEVA 84152
Correct international publication no. to-
11/2007
‫יומן‬
099020 '‫ בקשת פטנט מס‬4469 '‫ע‬
‫תקן המען למסירת‬
‫לוצאטו את לוצאטו‬
.:.0 .‫ד‬.‫ת‬
240.0 ‫באר שבע‬
-‫תקן את מספר הפרסום הבינלאומי ל‬
WO/2000/71358
Journal
P. 4495 Patent No. 165539
Correct name of applicant toLUZZATTO & LUZZATTO
P.O.B. 5352
BEER-SHEVA 84152
Correct international publication no. to-
11/2007
‫יומן‬
09..:6 '‫ פטנט מס‬446. '‫ע‬
‫תקן המען למסירת‬
‫לוצאטו את לוצאטו‬
.:.0 .‫ד‬.‫ת‬
240.0 ‫באר שבע‬
-‫תקן את מספר הפרסום הבינלאומי ל‬
WO/2000/71356
863
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
MY
Malaysia
April 13, 2008– ‫ח' בניסן התשס"ח‬
864
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
865
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
41000
25(01)
12. 7.2005
‫סוג‬
‫כל חן בע"מ וחיים אזולאי‬
KOL CHEN LTD. AND HAIM
AZOULAY
‫פרופיל‬
Profile
Class
41780, 41781
3(01)
22. 12.2005
‫סוג‬
‫אמנון בן משה‬
AMNON BEN MOSHE
‫תיק לטלית ותפילין‬
Talit and tefillin bag
Class
41945
21(01)
2.2.2006
‫סוג‬
‫ג'סיקה כהן‬
JESSICA COHEN
‫כרית לריהוט מודולרי לילדים‬
Pillow for modular children's furniture
Class
42121
9(03)
9.3.2006
‫סוג‬
‫דר פלסט בע"מ‬
DAR PLAST LTD.
‫מיכל‬
Container
Class
KLIL INDUSTRIES LTD.
Profile
April 13, 2008– ‫ח' בניסן התשס"ח‬
42125
25(01)
9. 3.2006
‫סוג‬
‫קליל תעשיות בע"מ‬
‫פרופיל‬
866
Class
42449
1(01)
11. 5.2006
‫סוג‬
‫יצחק קליימן ואדי קליימן‬
ITZHAK KLEIMAN AND EDI
KLEIMAN
‫תה דקורטיבי‬
Decorative tea
Class
42469
14(02)
17. 5.2006
ON TRACK INNOVATIONS LTD.
‫סוג‬
‫און טרק אינובישנס בע"מ‬
‫קורא כרטיס חכם‬
Smart card reader
Class
42475
3(01)
18. 5.2006
SHAHAL TELEMEDICINE LTD.
‫סוג‬
‫שחל טלרפואה בע"מ‬
‫תיק החייאה‬
Resuscitation bag
Class
42556
9(01)
6. 6.2006
NEVIOT-NATURE OF GALILEE
LTD.
‫סוג‬
‫טבע הגליל בע"מ‬-‫נביעות‬
‫בקבוק‬
Bottle
Class
42614
9(03)
15. 6.2006
‫סוג‬
‫) בע"מ‬0662( ‫מוצרי שלם אריזות‬
SHALEM PRODUCTS
PACKAGING (1998) LTD.
‫אריזה‬
Package
Class
ISRAEL AZRIEL
Roof for sukkah toy
867
42676
5(06)
5. 7.2006
‫סוג‬
‫ישראל עזריאל‬
‫סכך לסוכת צעצוע‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
43030
11(01)
4. 11.2004
Class
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫עגיל‬
Earring
43063
6(06)
13. 9.2006
Class
YUVAL ALDUBI AND SHACHAR
LIFSHITZ LTD.
‫סוג‬
‫יובל אלדובי ושחר ליפשיץ בע"מ‬
‫מעמד לעיתונים‬
Newspaper rack
43190
26(05)
15. 10.2006
Class
‫סוג‬
‫גדון יסקרביץ ויוסף כהן‬
GIDEON YASKIROVITZ AND
YOSEF COHEN
‫גוף תאורה‬
Lighting fixture
Class
DUBY OFIR-INDUSTRIAL
DESIGN LTD.
43259, 43260
6(06)
1. 11.2006
‫סוג‬
‫דובי אופיר – עיצוב תעשייתי‬
‫בע"מ‬
‫עמדת עבודה לבקרה‬
Control stand
Class
PROFILE GLASS LTD.
Profile
April 13, 2008– ‫ח' בניסן התשס"ח‬
43266, 43268, 43269
25(01)
1. 11.2006
‫סוג‬
‫פרופיל גלס בע"מ‬
‫פרופיל‬
868
43420
24(04)
3. 12.2006
Class
‫סוג‬
CIPLA LIMITED
Inhaler container
Convention date (India)
00.0.2009
Class
43549
26(01)
26. 12.2006
‫סוג‬
‫אור עיצוב תעשייתי‬-‫יונתן בר‬
‫בע"מ‬
JONATHAN BAR-OR
INDUSTRIAL DESIGN LTD.
‫מערכת יומית של נרות חנוכה ואריזה‬
Hanukah candles array and package
Class
‫מיכל למשאף‬
)‫(ארצות הברית‬
)‫האמנה (הודו‬
‫תאריך אמנה‬
43668
13(03)
25. 1.2007
‫סוג‬
3M INNOVATIVE PROPERTIES COMPANY
Electrical connector
Convention date (U.S.A.)
Class
01.0.2009
43958
8(08)
20. 3.2007
METZERPLAS INDUSTRIES LTD.
‫מחבר חשמלי‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫מצרפלס תעשיות בע"מ‬
‫פס בסיס‬
Base plate
Class
44015
9(01)
1. 4.2007
ISRAEL BEER BREWERIES LTD.
‫סוג‬
‫מבשלות בירה ישראל בע"מ‬
‫בקבוק‬
Bottle
Class
GILI GOLAN LITMAN
Playmat
869
44016
6(09)
1. 4.2007
‫סוג‬
‫גילי גולן ליטמן‬
‫מזרון פעילות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
44151
8(07)
8. 5.2007
Class
MUL-T-LOCK TECHNOLOGIES
LTD.
‫סוג‬
‫מולטילוק טכנולוגיות בע"מ‬
‫ראש מפתח‬
Key head
44205
25(03)
21. 5.2007
Class
‫סוג‬
‫וולפמן תעשיות בע"מ‬
WOLFMAN INDUSTRIES LTD.
‫מערכת קברים טרומיים‬
System of prefabricated graves
44218
24(04)
24. 5.2007
Class
‫סוג‬
CIPLA LIMITED
Capsule chamber for inhaler device
00.44.2009
Convention date (India)
Class
44223
28(03)
24. 5.2007
‫תא קפסולה למכשיר שאיפה‬
)‫(ארצות הברית‬
)‫האמנה (הודו‬
‫תאריך אמנה‬
‫סוג‬
‫רחמים גיל ושר שלום‬
RAHAMIM GIL AND SAR
SHALOM
‫פינצטה מוארת‬
Illuminated tweezers
Class
44228
24(04)
27. 5.2007
‫סוג‬
NICHOLAS WILLIAM GILES FINN
Absorbent genital shield
Convention date (South Africa)
Class
BINYAMIN YIRMIYAHU AND
MORDECHAI YIRMIYAHU
Piston pump
April 13, 2008– ‫ח' בניסן התשס"ח‬
00.44.2009
44245
8(05)
28. 5.2007
‫מגן גניטאלי סופגני‬
)‫אפריקה‬
)‫(ארצות הברית‬
‫האמנה (צפון‬
‫תאריך אמנה‬
‫סוג‬
‫בנימין ירמיהו ומרדכי ירמיהו‬
‫משאבת בוכנה‬
870
44247
8(05)
28. 5.2007
Class
‫סוג‬
‫בנימין ירמיהו ומרדכי ירמיהו‬
BINYAMIN YIRMIYAHU AND
MORDECHAI YIRMIYAHU
‫בסיס למשאבת בוכנה‬
Base for piston pump
44264
2 (04)
31. 5.2007
Class
‫סוג‬
CROCS, INC.
Footwear
1.40.2009
23.5.2007
Convention date (U.S.A.)
(U.S.A.)
Class
44373
9(07)
18. 6.2007
‫נעל‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫(ארצות הברית‬
‫סוג‬
AMRAZ LTD.
‫אמרז בע"מ‬
Lid for container
‫מכסה לאריזה‬
Class
44385
8(08)
20. 6.2007
SHACHAR LIFSHITZ LTD. AND
YUVAL ALDUBI
‫סוג‬
‫שחר ליפשיץ בע"מ ויובל אלדובי‬
‫תומך מדף‬
Shelf support
Class
44450
9(05)
3. 7.2007
‫סוג‬
‫כרמית מדינה פלטקין‬
CARMIT MEDINA PLATKIN
‫שקית ניילון‬
Plastic bag
Class
44474
9(01)
5. 7.2007
NEVIOT-NATURE OF GALILEE
LTD.
871
‫סוג‬
‫טבע הגליל בע"מ‬-‫נביעות‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫בקבוק‬
Bottle
44481
9(01)
10. 7.2007
Class
‫סוג‬
‫טבע הגליל בע"מ‬-‫נביעות‬
NEVIOT-NATURE OF GALILEE
LTD.
‫בקבוק‬
Bottle
44549
25 (01)
23. 7.2007
Class
‫סוג‬
SAVIO S.P.A.
‫פרופיל‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Profile
29.4.2007
Convention date (OHIM)
44550
19(02)
24. 7.2007
Class
‫סוג‬
‫דניאל זך‬
DANIEL ZACH
‫מחזיק ספר‬
Book holder
44559
14 (03)
25. 7.2007
Class
‫סוג‬
POLYMER VISION LTD.
Communication Device
Convention date (OHIM)
Class
‫התקן תקשורת‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
26.4.2007
44560, 44561, 44562,
44563, 44564, 44565,
44566, 44567
25(02)
26. 7.2007
‫סוג‬
‫רב בריח מוצרי בטחון בע"מ‬
RAV-BARIACH SECURITY
PRODUCTS LTD.
‫דלת‬
Door
Class
April 13, 2008– ‫ח' בניסן התשס"ח‬
44573
9(03)
29. 7.2007
‫סוג‬
872
‫חיים הניג‬
HAIM HOENIG
‫אריזה לבקבוק‬
Bottle packing
Class
44582, 44583, 44584,
44585, 44586, 44587,
44588
11(02)
1. 8.2007
‫סוג‬
‫תור‬-‫יצחק קן‬
ISAAC KEN-TOR
‫חמסה‬
Hamsa
44600
10(01)
5. 8.2007
Class
SHACHAR LIFSHITZ LTD. AND
YUVAL ALDUBI
‫סוג‬
‫שחר ליפשיץ בע"מ ויובל אלדובי‬
‫שעון‬
Clock
44637
23(01)
14. 8.2007
Class
‫סוג‬
‫גרי פייבל‬
GARY FAVEL
‫מיכל לאגירת מי גשם‬
Container for collection of rain water
44641
8(09)
15. 8.2007
Class
‫סוג‬
‫מרדכי קבסו‬
MORDEHAY CABASSO
‫מנוף לתריס‬
Lever for shutter
44642
6(07)
15. 8.2007
Class
ALICIA GUBLER BERDUGO
‫אליסיה גובלר ברדוגו‬
‫מסגרת לתליית עגילים‬
Frame for hanging earrings
Class
‫סוג‬
44644, 44646, 44647,
44648
21 (01)
15. 8.2007
‫סוג‬
SMART BABY TOYS AND SMART TRIKE
873
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫צעצוע רכב לילדים‬
Child vehicle toy
44662
9(01)
20. 8.2007
Class
‫סוג‬
‫עפיף טנוס‬
AFIF TANUS
‫צנצנת‬
Jar
44779
8(03)
10. 9.2007
Class
‫סוג‬
‫ישקר בע"מ‬
ISCAR LTD.
‫מפתח לראש חיתוך למקדח‬
Key for drill cutting head
44790
7(01)
17. 9.2007
Class
‫סוג‬
‫ססיליה כשר וולקוב ויטס‬
CECLILIA KASHER VOLCOFF
VITAS
‫כלי הגשה‬
Serving dish
Class
44791
21(01)
16. 9.2007
‫סוג‬
SMART BABY TOYS AND SMART TRIKE
‫תלת אופן‬
Tricycle
Class
44825
11(02)
19. 9.2007
‫סוג‬
ERAN GREBLER
‫ערן גרבלר‬
Mezuzah dreidel
‫מזוזת סביבון‬
Class
44873
11(01)
10. 10.2007
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
Jewel
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫תכשיט‬
874
Class
44897
14 (03)
16. 10.2007
‫סוג‬
SOMFY SAS
Remote control
Convention date (OHIM)
Class
40.1.2007
44925, 44926
11(02)
24. 10.2007
‫שלט רחוק‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫עדי פיינר‬
ADI FAINER
‫מזוזה‬
Mezuzah
Class
44927, 44928
26(01)
24. 10.2007
‫סוג‬
‫עדי פיינר‬
ADI FAINER
‫פמוט‬
Candlestick
Class
44929
11(02)
24. 10.2007
‫סוג‬
‫עדי פיינר‬
ADI FAINER
‫פסלון‬
Statuette
Class
44930
11(02)
24. 10.2007
‫סוג‬
‫עדי פיינר‬
ADI FAINER
‫קערה‬
Bowl
Class
ADI FAINER
Passover plate
875
44931
11(02)
24. 10.2007
‫סוג‬
‫עדי פיינר‬
‫צלחות פסח‬
April 13, 2008– ‫ח' בניסן התשס"ח‬
Class
44933
9(07)
25. 10.2007
‫סוג‬
‫רן שגיא‬
RAN SAGY
‫פקק מושיט‬
Dispensing plug
Class
44986, 44987
7 (04)
6. 11.2007
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Blender
/.0.2007
Convention date (OHIM)
Class
45028
8 (03)
12. 11.2007
‫סוג‬
‫רוזנפלג פרומושיין בע"מ‬
‫מסורית‬
ROSENFELD PROMOTION LTD.
Fret saw
Class
‫מערבל מזון‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
45031, 45032
7 (04)
13. 11.2007
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Blender
01.0.2007
Convention date (OHIM)
Class
45180
3(01)
18. 5.2006
SHAHAL TELEMEDICINE LTD.
Doctor's bag
April 13, 2008– ‫ח' בניסן התשס"ח‬
‫מערבל מזון‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫שחל טלרפואה בע"מ‬
‫תיק רופא‬
876
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪0/061‬‬
‫‪00041‬‬
‫‪00060‬‬
‫‪0/060‬‬
‫‪00000‬‬
‫‪00060‬‬
‫‪0/000‬‬
‫‪0000/‬‬
‫‪00000‬‬
‫‪0/140‬‬
‫ח' בניסן התשס"ח –‪April 13, 2008‬‬
‫‪0/000‬‬
‫‪001/6‬‬
‫‪00000‬‬
‫‪00464‬‬
‫‪0/0/0‬‬
‫‪00106‬‬
‫‪00000‬‬
‫‪00000‬‬
‫‪0/00/‬‬
‫‪041/0‬‬
‫‪00000‬‬
‫‪00060‬‬
‫‪0/000‬‬
‫‪0/001‬‬
‫‪00006‬‬
‫‪00011‬‬
‫‪29061‬‬
‫‪0/000‬‬
‫‪00006‬‬
‫‪00016‬‬
‫‪877‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
06141
06100
061/0
06000
060/0
00060
00004
000/4
000//
0////
00000
00000
00/40
06140
06100
061/0
0600/
060/0
00060
00000
000/0
00166
06666
00000
0000/
06140
0610/
061//
06006
060/1
0006/
00000
000/0
00164
06664
00001
00006
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
April 13, 2008– ‫ח' בניסן התשס"ח‬
06140
06100
06066
06001
00006
00046
00001
000/1
00160
06660
00011
00004
06140
06100
06040
06000
00000
00041
00000
000/0
00160
06660
00010
000/1
0614/
0610/
0604/
06000
00066
00000
0000/
000/0
00161
06661
00006
000/0
06106
061/6
06000
06000
00060
00006
00004
000/0
00106
0004/
00000
000/0
06100
061/4
06000
060/4
00060
00006
00000
000/0
00100
00006
00000
000/0
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
878
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אברהם דהאן ‪09::02‬‬
‫אזימוט טכנולוגיות בע"מ ‪0:0060‬‬
‫אי‪.‬אן‪.‬אר‪.‬אי בע"מ ‪0.0./6‬‬
‫אי‪.‬סי‪.‬איי‪ .‬טלקום בע"מ ‪0.762. ,0.4947‬‬
‫אלביט מערכות בע"מ ‪0.:420‬‬
‫אלינה לוזינסקי ‪042907‬‬
‫אלקור מיכשור רפואי בע"מ ‪042907‬‬
‫אקסוטק ביו סולושין בע"מ ‪0:2.9.‬‬
‫אר‪.‬אס‪.‬טי‪ .‬רעות מערכות וטכנולוגיות‬
‫מתקדמות בע"מ ‪07260/‬‬
‫בי‪.‬אס‪.‬פי‪ .‬עיבוד אותות ביולוגיים בע"מ‬
‫‪0.72..‬‬
‫ברמן ראובן ‪09::02‬‬
‫גיוון אימג'ינג בע"מ ‪040/09‬‬
‫גנואה טכנולוגיות צבע בע"מ ‪0.:060‬‬
‫‪NAME INDEX‬‬
‫יראל יאירוב ‪0:0966‬‬
‫ישקר בע"מ ‪0.2462‬‬
‫ישקר בע"מ ‪0.2462‬‬
‫מדינת ישראל‪ ,‬משרד החקלאות‪ ,‬מרכז‬
‫וולקני ‪0404/2‬‬
‫מוניקה קולט ‪0:2.9.‬‬
‫מירצ'ה דן בוצ'בסקי ‪0:2.9.‬‬
‫נובה מכשירי מדידה בע"מ ‪090066‬‬
‫נולי טכנולוגיות בע"מ ‪0.9404‬‬
‫נייקסט בע"מ ‪0.9.0:‬‬
‫נילית בע"מ ‪09/426‬‬
‫סטארבורד טכנולוגיות בע"מ ‪0..9.6‬‬
‫סרגיי לטישב ‪097949‬‬
‫עידן מורדוב ‪0.9.:2‬‬
‫הדסית שרותי מחקר רפואי ופיתוח בע"מ‬
‫‪0404/2‬‬
‫התעשייה האוירית לישראל בע"מ ‪090797‬‬
‫חברת תנה תעשיות (‪ )0660‬בע"מ ‪097722‬‬
‫חיים מורגנשטיין ‪0.6960‬‬
‫יד כוננה בע"מ ‪077.00‬‬
‫יולי לוזינסקי ‪042907‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪040/09‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪0476.:‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪0.2044‬‬
‫ימית ביוטכנולוגיות בע"מ ‪042.62‬‬
‫יצחק דנינו ‪09::02‬‬
‫‪i‬‬
‫‪2008‬‬
‫פי‪ .‬בי‪ .‬סי‪ .‬לייזרים בע"מ ‪09/922‬‬
‫קומברס בע"מ ‪0./0.2‬‬
‫קראוס תעשיות מתכת בע"מ ‪0./:04‬‬
‫רב בריח מוצרי בטחון בע"מ ‪094292‬‬
‫ריט טכנולוגיות בע"מ ‪0.0792‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫‪09/6.0‬‬
‫שורשים משחקים עם עומק בע"מ‬
‫‪0949::‬‬
‫תפנטולס בע"מ ‪090060‬‬
‫תרכובות ברום בע"מ ‪042:09‬‬
‫ח' בניסן התשס"ח – ‪April 13,‬‬
ADRIANUS JACOBUS JOHANNES
MAAS 159366
ADVANCED BIOTECHNOLOGIES
160109
ADVANCED INHALATION
RESEARCH INC. 157569
ALBEMARLE CORPORATION 135524
ALCOR MEDICAL INSTRUMENTS
LTD. 148627
ALINA LOZINSKI 148627
AMGEN, INC. 143706
AMGEN, INC. 154541, 154542
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. 151172
ARQULE, INC. 156268
ASTRAZENECA AB 149107, 149578
ASTRAZENECA AB 153754, 157282
ASTRAZENECA UK LIMITED 147379
ATI PROPERTIES, INC. 157722
AVENTIS PHARMA S.A. 149154
AVENTIS PHARMACEUTICALS INC.
143405
AVENTIS PHARMACEUTICALS INC.
146547
AVRAHAM DAHAN 163318
AZIMUTH TECHNOLOGIES, LTD.
132191
B.S.P. BIOLOGICAL SIGNAL
PROCESSING LTD. 157855
BAE SYSTEMS BOFORS AB 153621
BASF AKTIENGESELLSCHAFT
153412
BAYER AKTIENGESELLSCHAFT
130330
BAYER CROPSCIENCE AG 154040
BERICAP HOLDING GMBH 159592
BERLEX LABORATORIES, INC.
148313
BERMAN REUBEN 163318
BIOGEN IDEC INC. 134937
BIOPHYSICA, INC. 145728
BIORA BIOEX AB 160639
BIOSENSE WEBSTER, INC. 157319
ii
BIOSENSE, INC. 177841
BIOTECON GESELLSCHAFT FUR
BIOTECHNOLOGISCHE
ENTWICKLUNG UND CONSULTING
MBH 143528
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG 148057
BRISTOL COMPRESSORS, INC.
156298
BRISTOL-MYERS SQUIBB
COMPANY 157937
BRISTOL-MYERS SQUIBB
COMPANY 158202
BRISTOL-MYERS SQUIBB
COMPANY 164022
BROMINE COMPOUNDS LTD. 148326
CALGON CORPORATION 148268
CAMBRIDGE FLAT PROJECTION
DISPLAYS LIMITED 160902
CAPSULE VIEW INC. 134017
CEPHALON, INC. 148180
CHANG-PI LO 151821
CHRISTIANUS JACOBUS MARIA
LANGENBERG 159366
CHRISTOS ZOUBOULIS 144683
CHROMAGENICS B.V. 141371
CITRIX SYSTEMS INC. 155698
CLINICAL ANALYSIS CORP. 151477
COMPUTER ASSOCIATES THINK,
INC. 147491
COMVERSE LTD. 150158
COMVERSE, INC. 150780
CORNERSTONE SENSORS, INC.
147734
DAIICHI SANKYO COMPANY
LIMITED 153594
DCA DESIGN INTERNATIONAL
LIMITED 157604
DINAMITE DIPHARMA S.P.A. 152571
DIOMED DEVELOPMENTS LTD.
153592
DSM FINE CHEMICALS AUSTRIA
April 13, 2008– ‫ח' בניסן התשס"ח‬
NFG GMBH & CO. KG 149891
EASTGATE INVESTMENTS LIMITED
155943
ECI TELECOM LTD. 154647, 157985
ELBIT SYSTEMS LTD. 153482
EMC CORPORATION 139069, 183096
ERBE ELEKTROMEDIZIN GMBH
166661
ERNST & YOUNG LLP 153755
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE) 161713
EXOTECH BIO SOLUTION LTD.
138565
FLORENCIO LAZO BARRA 155126
FMC TECHNOLOGIES INC. 157499
FRANKLIN ROBERT CHRISTIAAN
VAN DORSTEN 159366
FUJIKIN INCORPORATED 164274
GARY A. STROBEL 158432
GENENTECH, INC. 135704
GENOA COLOR TECHNOLOGIES
LTD. 153292
GENOA COLOR TECHNOLOGIES
LTD. 153292
GIVEN IMAGING LTD. 142026
GRUNENTHAL GMBH 153825
GUM BASE CO. S.P.A. 164412
H.H. BROWN SHOE COMPANY, INC.
160934
HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.
141408
HAIM MORGENSTEIN 159691
HIDEZO MORI 149491
HIROYUKI WAKAMATSU 153386
HONEYWELL INTERNATIONAL INC.
161732
ICE S.R.L. 166446
ICU MEDICAL, INC. 139515
IDAN MORADOV 156538
IGENEON KREBS-IMMUNTHERAPIE
April 13, – ‫ח' בניסן התשס"ח‬
FORSCHUNGS-UND
ENTWICKLUNGS AG 158950
INDIAN OCEAN MEDICAL INC.
160467
INDORATA SERVICOS E GESTAO
LDA. 158848
INDUSTRIAL ORIGAMI, INC. 154406
INDUSTRIAL ORIGAMI, INC. 154406
INDUSTRIAL ORIGAMI, LLC. 154406
INFINEON TECHNOLOGIES AG
150691
INGENEUS CORPORATION 150844
INGENEUS INC. 150844
INNOVENTIONS INC. 148702
INRA 152509
INSTITUT FRANCAIS DU PETROLE
161638
INTEL CORPORATION 149083
INTERCELL AG 152959
INTERDIGITAL TECHNOLOGY
CORPORATION 151905, 152104,
176033
ISCAR LTD. 158498
ISCAR LTD. 158498
ISHIHARA SANGYO KAISHA LTD.
151009
ISRAEL AEROSPACE INDUSTRIES
LTD. 162767
ITZHAQ DANINO 163318
JAN VAN NIEKERK 159366
JANSSEN PHARMACEUTICA N.V.
143859
JOHNSON & JOHNSON VISION
CARE, INC. 161713
KANEKA CORPORATION 151098
KOLLMORGEN CORPORATION
156995
KOMET GROUP HOLDING GMBH
153536
KONINKLIJKE PHILIPS
ELECTRONICS N.V. 141620
KOWA COMPANY, LTD. 164206
KRAUSZ METAL INDUSTRIES LTD.
150324
iii
2008
KUDOS PHARMACEUTICALS
LIMITED 155645
L&P PROPERTY MANAGEMENT
COMPANY 163728
LABORATOIRES SERONO SA 151172
LEHMANN GMBH & CO. KG 164160
LEO PHARMA A/S 177357
LEONARDUS JOHANNES MARIA
TEUNISSEN 159366
LEYBOLD VACUUM GMBH 168485
LIFESCAN SCOTLAND LIMITED
156302
MAARTEN GERARDUS FRANCISCUS
VAN WIJK 159366
MACROMED, INC. 135415
MARINUS ADRIAAN DROST 159366
MAYBRIDGE PLC 155645
MEDAREX, INC. 148079
MEHMET KURT 153350
MENZOLIT-FIBRON GMBH 164076
MICROSOFT CORPORATION 155001
MINDSET BIOPHARMACEUTICALS
(USA), INC. 143768
MIRCEA DAN BUCEVSCHI 138565
MITSUBISHI TANABE PHARMA
CORPORATION 154893
MONICA COLT 138565
Monika Werner 164160
MYCOGEN CORPORATION 142171
N B NETWORKS 150411
NEW YORK UNIVERSITY 132113
NICAST LTD. 156513
NILIT LTD. 160489
NOOLY TECHNOLOGIES LTD.
156424
NOVA MEASURING INSTRUMENTS
LTD. 162199
NOVAMONT S.P.A. 129745
NOVARTIS AG 155363, 155992
NOVO NORDISK A/S 128332
OBTECH MEDICAL AG 151137
OMS INVESTMENTS, INC. 165211
ORION CORPORATION 159647
ORMAZABAL Y CIA., S.A. 155564
iv
OSI PHARMACEUTICALS, INC.
129994
OTSUKA PHARMACEUTICAL CO,
LTD 153838
PBC LASERS LTD. 160688
PENTAPHARM AG 134356
PERLEGEN SCIENCES, INC. 148783
PFIZER INC. 129994
PFIZER ITALIA S.R.L. 152388
PFIZER PRODUCTS, INC. 129994,
145450
PHARMA MAR, S.A. 152125
PHARMACOPEIA, INC. 148313
PHILMAC PTY LTD. 156654
PRESS-SEAL GASKET
CORPORATION 158414
QUALCOMM INCORPORATED
147019
QUALCOMM INCORPORATED
150820, 155582, 155694, 156053, 162787
RADIANT NETWORKS PLC 149083
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. 160952
RAV BARIACH SECURITY
PRODUCTS LTD. 164868
REGENERON PHARMACEUTICALS,
INC. 137858
REIFENHAUSER GMBH & CO.
MASCHINENFABRIK 154631
RIT TECHNOLOGIES LTD. 152768
ROHDE & SCHWARZ GMBH & CO.
KG 153367
RST REUT SYSTEMS & ADVANCED
TECHNOLOGIES LTD. 178910
RTP PHARMA INC. 141095
RYMED TECHNOLOGIES INC. 142461
SA MAJESTE LA REINE DU CHEF DU
CANADA AGRICULTURE ET
AGROALIMENTAIRE CANADA
150361
SAECHISCHES SERUNWERK
DRESDEN BRANCH OF SMITHKLINE
BEECHAM PHARMA GMBH & CO.
KG 158931
April 13, 2008– ‫ח' בניסן התשס"ח‬
SANOFI AVENTIS 147282
SASOL NORTH AMERICA INC.
163618
SCHOTT AG 167080
SERGEI LATYSHEV 167646
shorashim games with depth ltd. 164633
SILVERBROOK RESEARCH PTY.
LTD. 168331
SILVERBROOK RESEARCH PTY.
LTD. 155460, 160259, 167966
SKYEPHARMA CANADA INC. 153457
SMITHKLINE BEECHAM
BIOLOGICALS S.A. 137442
SPINEVISION 147401, 147403
SPOTLESS PLASTICS PTY. LTD.
180455
STARBOARD TECHNOLOGIES LTD.
155659
STATE OF ISRAEL, MINISTRY OF
AGRICULTURE , VOLCANI CENTER
141408
SWISSCOM MOBILE AG 158939
SYNGENTA PARTICIPATIONS AG
124907
TADAHIRO OHMI 164274
TANA INDUSTRIES (1991) LTD.
167788
TEFENTOOLS LTD. 162291
TEMPLE UNIVERSITY OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION 157522
TERXO AG 159592
TEXTRON SYSTEMS CORPORATION
157865
THALES 161150
THE FLINTEC GROUP, LTD. 160479
THE GOVERNMENT OF THE UNITED
STATES OF AMERICA 129919
THE JAPAN STEEL WORKS, LTD.
151098
THE LARYNGEAL MASK COMPANY
LIMITED 160467
THE PENN STATE RESEARCH
FOUNDATION 157569
April 13, – ‫ח' בניסן התשס"ח‬
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA 156831
TIMOTHEUS JOAN MARIE LECHNER
159366
UBE INDUSTRIES, LTD. 147379
UHDE GMBH 164234
UNILEVER PLC 166774
VERENIGDE BEDRIJVEN NIMCO
B.V. 156790
VIASAT, INC. 152250
VICTOR L. VINES 150983
VIRGIN COTTON COMPANY PTY
LTD. 134114
VOSSLOH WERKE GMBH 150599
WYETH 156268
YAD KONENA LTD. 177522
YAMIT BIOTECHNOLOGIES LTD.
148598
YAREL YAIROV 132699
YASUHIKO TABATA 149491
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
147953
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 142026
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM 158244
YULI LOZINSKI 148627
v
2008
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01G – 155126
B23B – 153536, 156790, 158498
A01H – 134114, 158244
B25B– 162291
A01K – 153350
B29C – 156513, 164076, 164160
A01N – 142171, 158432
B31F – 155659
A23G – 164412, 166774
B32B – 167080
A41G – 158848
A43B – 160934
B41J – 156538, 160259, 167966,
168331
A47G – 180455
B63H – 159691
A61B – 134017, 147401, 147403,
150983, 156831, 157319,
157855, 159366, 166661,
177841
B65D – 159592
B65G – 157499
B67D – 167788
A61C – 148627, 157522
A61F– 148702, 151137
A61J– 134356
A61K – 129919, 134937, 141095,
141408, 143706, 143768,
148057, 148268, 148598,
149107, 149491, 149578,
150361, 152959, 153457,
153592, 155363, 155992,
157569, 158202, 158950,
160109, 160639, 164206
C07C– 135524, 145728, 147953,
148326, 153412, 153825
C07D – 129994, 143405, 143859,
145450, 147282, 147379,
148313, 151009, 151172,
152125, 152388, 152571,
153594, 153754, 153838,
154040, 154893, 155645,
156268, 157282, 159647
C07F –164022, 166446, 177357
C07H – 149154
A61M– 139515, 142461, 151821,
157604, 160467
C07K – 128332, 143528, 154541
B01D – 163618, 164234
C08G – 135415
B01J – 164274, 165211
C08L – 129745, 138565
B21D – 154406
vi
April 13, 2008– ‫ח' בניסן התשס"ח‬
G02B – 161150, 161732
C12N – 124907, 132113, 137442,
137858, 141371, 144683,
148079, 154542, 157937,
158931
G02C – 161713
G02F – 153292
C12P –130330, 148180, 149891
G03B – 160902
C12Q – 135704, 146547, 148783,
150844
G06F – 139069, 147491, 150411,
153755, 155001, 183096
D02G – 160489
G06Q – 153386, 163318
D04H – 154631
G08G – 162767
D05B –163728
G09B – 164633
E01B – 150599
G11B – 141620
E06B –164868
H01J – 153482
F01D – 177522
H01L – 150691
F01P – 167646
H01R – 132699, 152768, 155564
F15B – 151098
H01S – 157865
F16L – 156654, 158414
H02K – 156995
F25B – 156298, 168485
H03K – 150820, 155943
F41H – 157722, 178910
H03M – 155582, 155694
F42B –153621
G01C – 132191
H04B – 151905, 152250, 153367,
154647, 157985, 160952,
162787
G01K – 147734
H04J – 156053
G01L – 160479
H04L – 147019, 149083, 155698,
158939, 176033
G01N – 142026, 151477, 156302,
162199
H04M – 150158, 150780, 152509
G01V – 161638
H04Q –152104
G01W – 156424
H05K – 155460
April 13, 2008– ‫ח' בניסן התשס"ח‬
vii
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER